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Abstract 
All eukaryotic mRNAs process a cap structure (m7G(S')ppp(S')N) at the S' end of 
their message and most have an A as the first nucleotide after the cap. However, 30% of 
messages within eukaryotic cells have a C (m7G(S')ppp(5')C) as the first nucleotide 
followed by a short polypyrimidine tract. These mRNAs are termed TOP (Tenninal 
Oligopyrimidine tract) messages and are co-ordinately regulated by mitogenic, growth 
and nutritional stimuli. This work describes the construction of a reporter vector that 
encodes mRNA containing the TOP motif, and its use in a series of systematic 
experiments to further investigate the translational regulation of TOP messages. Given 
that TOP containing mRNAs are known to encode proteins involved in the translational 
machinery, these findings have important implications with regard to translational control 
and translation related disease. 
In this study, reporter vectors have been used to investigate the role of the mTOR 
and PI3K signalling pathways, which have previously been implicated in the translational 
regulation of TOP containing mRNAs. The data obtained suggests that the mTOR 
signalling pathway may be involved in the regulation of TOP containing mRNAs. The 
canonical initiation and frans-acting factor requirements of TOP mRNAs were also 
investigated using a combination of protein over-expression and affinity purification of 
TOP-containing-mRNA:protein complexes. The data obtained raises the possibility that 
eIF4E may not be required in the initiation of TOP containing mRNA translation. The 
candidate frans-acting factors that were identified include La, ILF2 and EBPl, the latter 
of which has previously been shown to associate with mature ribosomes in the cytoplasm. 
Finally, affinity purification of TOP-containing-mRNA:microRNA complexes was 
carried out. Candidate microRNAs which may be involved in the regulation of TOP 
containing mRNAs were identified. The data obtained was consistent with a previous 
study, which suggested that microRNA-IOa may bind to the S'UTR of TOP containing 
mRNAs. 
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Chapter One 
Introduction 
1.1 Gene Expression and Protein Synthesis: An Overview 
The encoded genetic information contained within DNA is used to synthesise 
proteins in a multi-stage and highly regulated process known as gene expression. The 
regulation required to ensure normal cell growth can be achieved at multiple stages 
along the gene expression pathway. In transcription, the first stage of gene 
expression, RNA polymerase produces a complementary RNA copy of the DNA 
template, adding one nucleotide at a time. Post-transcriptional modifications, convert 
the pre-mRNA into mature mRNA. These events also occur in the nucleus, which is 
the site of transcription in most eukaryotic cells. In one such event, a 7-
methyl guanosine (m7G) cap structure is added to the 5' end of the pre-RNA. This 
process involves the formation of a triphosphate bond, in a S' to S' orientation 
between the pre-mRNA and guanine residue. Methylation of the guanine ring at the 
N-7 position then occurs in a reaction catalysed by S-adenosyl methionine. The 
presence of a correctly orientated 5' cap structure ensures that the mRNA is protected 
from ribonucleases, whose action is specific to phosphodiester bonds, which are in a 
3' to S' orientation. At the 3' end of the mRNA, the molecule is cleaved at a site 
which lies downstream of a polyadenylation signal sequence. Following cleavage a 
poly(A) tail is attached in a process catalysed by the enzyme Poly(A) polymerase. In 
the final post transcriptional modification, splicing occurs, removing non-coding 
regions called introns. This process is catalysed by a large protein complex called the 
spliceosome and in some instances can occur co-transcriptionally. The remaining 
exons are reconnected to form a single, continuous mature mRNA. In a process 
1 
known as alternate splicing, many different mature mRNAs that encode different 
protein sequences may be obtained from a single pre-mRNA as a result of multiple 
ways that splicing may occur. Following post transcriptional modification, the mature 
mRNA is exported from the nucleus into the cytoplasm. 
An intricate process is required to decode the triplet codons of the mature 
mRNA following transportation from the nucleus. This process comprises three 
sequential events and is termed translation (Figure 1.1). Initiation is the first of these 
events and encompasses the processes required for the formation of the 80S initiation 
complex, with a ribosome located at the appropriate translation start site. In the 
elongation phase, each codon is recognised by tRNAs charged with amino acids. As 
the ribosome translocates the mRNA in a 5' to 3' direction, anticodon recognition and 
peptide bond formation occur, adding each successive amino acid to the growing 
polypeptide chain. This process is aided by elongation factors. The final termination 
phase of translation occurs when the ribosome reaches the stop codon. At this stage, 
eukaryotic release factor eRFl binds and hydrolyses the peptidyl-tRNA, resulting in 
the release of the polypeptide chain along with the ribosome form the mRNA. The 
entire process of translation is highly regulated, with regulation at the initiation stage 
being of particular important. 
1.2 The Initiation Of Protein Synthesis 
Initiation is the first step in the process of translation and is believed to be the 
rate-limiting step. It is therefore a highly regulated process and as a result has been a 
subject of great interest for many years (Pain 1996). One of the main advantages of 
controlling gene expression at the translational level is that the cell can respond 
A Initiation 
+ ®GDP 
/ 3' 
S OP 
S'Cap 
B Elongation 
---.. - - ~ ~
3' 
S' 
C Termination 
5' 
Figure 1.1 Overview of Protein Synthesis 
The process of Translation involves sequential events. Following recognition 
of the cap-structure, initiation (A) takes place. The 40S subunit is recruited to 
the mRNA and scans to the initiation codon, where formation of the 80S 
ribosome occurs. During elongation (B), the ribosome translocates the 
mRNA in a 5' to 3' direction. Anticodon recognition and peptide bond 
formation occur, adding successive amino acids to the growing polypeptide 
chain. When the ribosome reaches the stop codon, termination occurs CC), 
resulting in the release of the polypeptide chain and dissociation of the 40S 
and 60S subunits. 
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rapidly to external stimuli, without the need for the nuclear pathways of mRNA 
synthesis and transport. For large genes that take a considerable amount of time to 
transcribe, the expression of the encoded protein can be modulated more rapidly in the 
short term at the translational level. Regulation at the translational level can be 
reversed in a more energetically favourable manner than transcriptional regulation and 
also facilitates the targeted regulation of specific genes or subsets of genes (Matthews 
2000). 
In prokaryotes, initiation takes place when the Shine-Dalgrano sequence, 
located upstream of the initiation codon on the mRNA, is bound by the 16S ribosomal 
RNA (Hershey and Merrick 2000). Eukaryotic initiation by contrast, is a much more 
complicated process and two main mechanisms exist: cap-dependent initiation and 
cap-independent initiation. It is believed that approximately 85% of total cellular 
mRNAs are translated via a cap-dependent pathway, which will now be discussed in 
greater detail. 
1.2.1 Cap-Dependent Initiation of Translation 
Following its export from the nucleus into the cytoplasm, mature mRNA is 
packaged into a messenger ribonucleoprotein (mRNP) complex. This highly 
structured complex requires a sophisticated recognition process. The scanning model 
proposed by Kozak describes the recognition of the 5' terminal m'O-cap structure, 
resulting in recruitment of the 40S ribosomal subunit. The 40S ribosomal subunit 
scans the mRNA strand in the 5' to 3' direction, until an AUO codon is reached, 
which is in the correct context (Kozak 1987). In addition for the requirement of 5' 
m'O-cap recognition, methylated guanine and a large number of proteins known as 
4 
eukaryotic initiation factors (eIFs) are required in order for the initiation to proceed. 
Many of these factors are proteins which are regulated by signalling resulting in 
changes in their phosphorylation status (Hershey and Merrick 2000). In simplistic 
tenns, the initiation of protein synthesis can be broken down into four sequential 
phases: 1) formation of the ternary complex; 2) formation of the 43S preinitiation 
complex; 3) the fonnation of the 48S preinitiation complex; 4) fonnation of the 80S 
initiation complex. 
1.2.2 The Ternary Complex 
The Ternary complex consists of eIF2 bound to both GTP and Met-tRNAret, 
is the first step in the process of initiation. The sequence and structural characteristics 
of eukaryotic tRNAtMet allow it to be distinguished from elongator tRNAs by eIF2 
(Hinnebusch 2000). These distinguishing features, which are implicated in eIF2 
binding, include the Al :U72 base-pair at the 5' TOP of the acceptor stem and a region 
of G:C binding pairs in the anti-codon stem (Farruggio et al. 1996). 
Between rounds of initiation, ribosomal sub-units are maintained in a 
dissociated state through their interaction with initiation factors. In particular, the 60S 
ribosomal sub-unit has been shown to interact with eIF6 (Ceci et al. 2003), whilst the 
40S sub-unit is associated with eIFIA and eIF3 (Goumans et al. 1980). The ternary 
complex is responsible for delivering Met-tRNAjMet to the 40S ribosomal subunit and 
its formation is essential for the translation of all mRNAs. As a result, the assembly 
of this complex is an early stage at which translation can be regulated. 
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1.2.2.1 eIF2 
elF2 is a heterotrimer, which is comprised of three non-identical subunits a, p 
and y sub-units (Figure 1.2). During a round of initiation, the three subunits remain 
associated with the elF2 complex and the GTP is hydrolysed to GDP. The eIF2y 
subunit has binding sites for both GTP and Met-tRNAMet and is homologous to 
eEFIA (eukaryotic elongation factor lA), which is also a translational GTPase. It is 
thought that the 3' end of the Met-tRNAret binds to cleft region of elF2y, which is 
formed from a region of the GTPase active site (Roll-Mecak et al. 2004; Yatime et at. 
2005). Structural changes in eIF2y caused by GTP hydrolysis are likely to account 
for a decrease in its affinity for Met-tRNAjMet (Yatime et al. 2006). This model is 
supported by the observation that replacement of GTP with GDP, results in a 
breakage of the interactions between eIF2y and the methionine moiety at the 3' end of 
Met-tRNAret (Kapp and Lorsch 2004). 
Although the role of the eIF2p subunit is not fully understood, it is known that 
eIF2p is comprised of three distinct regions. A zinc finger located within the 
carboxy-terminal region is responsible for elF2p's RNA-binding activity (Cho and 
Hoffman 2002). It has been suggested that this region is important for start codon 
recognition, as mutations around the zinc finger allow initiation at UUG codons 
(Donahue et al. 1988). The amino-terminal region is believed to contribute to RNA-
binding and also interacts with eIF2B and elF5 (which will be introduced in more 
detail later). The central region of eIF2p is known to interact with eIF2y. 
The eIF2a subunit does not appear to play a critical role in the binding of 
either GTP or Met-tRNAret and has been shown to be dispensable in yeast, when 
eIF2p and elF2y are over-expressed (Erickson et at. 2001). Crystal structure data 
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Figure 1.2 The Role of eIF2 Availability in Translational Regulation 
Phosphorylation of the a subunit of eIF2, prevents the dissociation of eIF2 from 
eIF2B and inhibits the recycling of eIF2-GDP to eIF2-GTP. Consequently, 
translation is negatively regulated by this process. Translational is allowed to 
commence following dephosphorylation of eIF2a. 
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shows that elF2a and e 1 F 2 ~ ~ bind at independent sites on elF2y and do not appear to 
interact with each other (Schmitt et a1. 2002). It has been proposed that the carboxy-
terminal domain of elF2a interact directly with elF2y and stabilises the interaction 
between Met-tRNAjMeI and elF2y (Yatime et al. 2004). Arguably the most critical 
function of the elF2a subunit, is as a regulator of elF2 function. Phosphorylation of a 
conserved Ser-51 site of elF2a, results in an inhibition of the recycling of inactive 
eIF2·GDP to eIF2·GTP through a mechanism that will be discussed in the following 
section (Hershey and Merrick 2000; Dever 2002). 
1.2.2.2 eIF2B and Formation of the Ternary Complex 
Following successive rounds of translation, elF2 is released as an inactive 
complex with GDP, having been hydrolysed on release from the initiation complex 
(Raychaudhuri et al. 1985). Prior to its involvement in a further round of translation, 
eIF2.GDP must be recycled to eIF2·GTP (Goss et a1. 1984). Following the 
replacement of GDP with GTP, the affinity of eIF2 for Met-tRNArt is increased 
(Kapp and Lorsch 2004). eIF2B, a guanine nucleotide exchange factor (GEF) 
comprised of five subunits, is responsible for at least a tenfold acceleration of this 
conversion (Nika et al. 2001; Williams et a1. 2001). It is known that eIF2B bio-
availability is directly influenced by the phosphorylation of Ser-51 site on eIF2a 
(Figure 1.2). In its phosphorylated state, the interaction between eIF2 and eIF2B is 
strengthened, resulting in the inhibition of the recycling of inactive eIF2·GDP to 
eIF2·GTP (Hershey and Merrick 2000; Dever 2002). Ser-51 is the target for multiple 
protein kinases, which include PERK (Harding et a1. 2000), PKR and GCN2 (Hershey 
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and Merrick 2000) and as a result, it plays a key role in the control of translation 
initiation. 
1.2.3 Assembly of the 438 Preinitiation Complex 
The fonnation of the 438 preinitiation complex, involves the interaction of the 
ternary complex with a 408 subunit in a process facilitated by eIFI, eIFIA and eIF3 
(Figure 1.3) (Trachsel et al. 1977; Benne and Hershey 1978). The importance of 
these factors in 43S complex fonnation has been confinned genetically, 
biochemically, and through analysis of the involvement of the corresponding yeast 
factors in 438 complex formation. It is through this analysis that eIFS has also been 
implicated in 43S complex fonnation. In a reconstituted yeast system, it has been 
shown that the binding of the ternary complex to 43S-mRNA, is stimulated by both 
eIFI and eIFIA in the absence of eIF3 (Algire et al. 2002; Maag et al. 2005). 
However, the binding oftemary complex to the 438 preinitiation complex, which has 
a 50-fold lower affinity for ternary complex than 438-mRNA, is enhanced by the 
presence of both eIFS and eIF3 (Maag et al. 2005). Perhaps the most compelling 
evidence for the involvement of eIFS comes from the observation that eIFI, eIF3, 
eIFS and the ternary complex can be isolated in a multifactor complex (Asano et al. 
2000). This suggests that these factors are recruited to the 408 subunit as a prefonned 
unit, possibly through the known interaction of eIFS with both eIF2 and eIF3 (Das 
and Maitra 2000). 
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Figure 1.3 Formation of the 438 Pre-initiation Complex 
A) The interaction of eIF6 with the 60S subunit and eIFIA and elF3 with the 
40S subunit, ensure that the subunits remain dissociated. 
B) The guanine nucleotide exchange factor eIF2B, recycles eIF2-GDP to 
eIF2-GTP. 
C) eIF2-GTP binds to the initiator methionine (Met-tRNAjMet), resulting in 
formation of the ternary complex. 
D) The 43S pre-initiation complex forms, following the interaction of the 
ternary complex with the 40S subunit. 
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1.2.3.1 elFl and eIFIA 
Assembly of a 48S complex at the initiation codon, cannot be accomplished 
by a 43S complex comprised of a 40S subunit, the ternary complex, ATP and the 
initiation factors eIF3, eIF4A, eIF4B and eIF4F. Instead, a ribosomal "complex 1" is 
formed, which was confirmed by toe-printing assay to adopt a stationary cap-proximal 
position (Pestova et al. 1998a). Using a rabbit reticulocyte lysate system, it has been 
shown that two additional factors were required for the 43S complex to scan to the 
initiation cod on. Purification of these factors was carried out and subsequent 
sequencing determined them to be elF 1 and elF 1 A. These factors were found to 
synergistically promote the formation of the 48S complex at the correct initiation 
codon. With both eIFl and elFIA present, ribosome "complex 1" was not detected 
(pestova et a1. 1998a). 
eIFl is known to weakly stimulate binding of the mRNA and ternary complex 
to the 40S subunit when acting alone (Trachsel et al. 1977), but promotes ribosomal 
scanning to the initiation complex synergistically with eIFIA (Pestova and Hellen 
2001). It has been demonstrated that eIFl is capable of recognition and 
destabilisation of stalled complexes within the 5' UTR and those that have assembled 
aberrantlyat an incorrect AUO codon in internal ribosomal entry (discussed in further 
detail in section 1.6) (Pestova et a1. 1998a). It has not yet been determined whether 
eIFl and eIFIA are required for scanning per se, to stabilise correctly positioned 
complexes or to destabilise those, which are not located at an AUO codon 
(Hinnebusch 2000). 
eIFIA is a single polypeptide that is one of the most conserved initiation 
factors in eukaryotes (Kyrpides and Woese 1998). It has been implicated in the 
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processes of ribosome dissociation, ternary complex binding and mRNA binding to 
the ribosome. More specifically, it has been shown to increase the binding affinity of 
43S complexes for mRNA and increases the processing capability of scanning 
ribosomal complexes (Pestova et a1. 1998b). In the absence of mRNA, it has been 
shown that eIFIA stabilises the interaction between the 40S subunit and the ternary 
complex (Chaudhuri et a1. 1999). 
1.2.3.2 elF3 
One of the main functions of eIF3 is to stabilise the interaction between the 
40S subunit and Met-tRNA;Mct, therefore promoting the recruitment of the ternary 
complex (Hinnebusch 2000). eIF3 also plays an important role in ensuring that this 
recruitment can occur in the presence of 60S ribosomal subunits and indeed stimulates 
the recruitment of the ternary complex to the 40S subunit under conditions that favour 
40S-60S subunit joining (Trachsel et al. 1979). It has been shown that this 
stimulation does not occur when an AUG triplet is present (Chaudhurl et a1. 1999). In 
contrast, the stimulating affect of eIFIA, which has been shown to be more effective 
than eIF3, was found to be absent in conditions that promoted 40S and 60S subunit 
joining and when mRNA was present (Chaudhuri et a1. 1999). These data suggests 
that eIF3 and eIFIA are both required to form a stable 43S preinitiation complex. It 
has also been proposed that prior to mRNA binding, eIF3 is required to protect the 
43S complex from disruption by the 60S ribosomal subunit. However, following base 
pairing of the Met-tRNA;Met to the AUG start cod on, eIF3 is required for the disruption 
of the 43S complex (Chaudhuri et a1. 1999). eIF3 also appears to be required for 
mRNA binding and strongly stimulates mRNA binding by the 40S initiation complex 
(Trachsel et al. 1977). This is generally believed to be due to eIF3 acting as a bridge 
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between the 40S subunit and the eIF4F complex, via eIF4G (Figure 1.5A) (Lamphear 
et a1. 1995; Hershey and Merrick 2000). The implications of this bridging interaction 
will be discussed in more detail in section 1.2.4.3. 
1.2.3.4 eIF2C I Co-eIF-2A I AG02 
At low eIF2 concentrations it has been shown in vitro that mRNA destabilises 
the ternary complex. The presence of eIF2C (also known as Co-eIF-2A and AG02), 
a 94 kDa polypeptide, is sufficient to relieve this destabilisation (Roy et al. 1988). 
eIF2C has also been shown to stimulate and stabilise Met-tRNA;Met binding to eIF2 
(Roy et al. 1981; Chakravarty et al. 1985). eIF2C/AG02 is known to have other 
important functions in post-transcriptional regulation and these will be discussed in 
more detail in section 1.8.3. 
1.2.4 Formation of the 48S Preinitiation Complex 
It has been shown that 43S complexes are intrinsically capable of binding to 
the 5' terminus of mRNAs which posses an unstructured 5' UTR (Pestova and 
Kolupaeva 2002). However, most mRNAs are known to possess some secondary 
structure in their 5' UTR and additional initiation factors are therefore required. 
These factors are believed to be involved in the recognition and binding of the m7G 
cap structure at the 5' terminus of the mRNA. This structure, which results from a 
post transcriptional modification, is therefore an essential requirement of cap-
dependent initiation. The role of each of these initiation factors in the recruitment of 
the 43S subunit to the mRNA, will be discussed in more detail in the following 
sections. 
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1.2.4.1 eIF4E: Cap Recognition and mRNA Binding 
The 5' m'G cap is recognised by the cap-binding protein eIF4E, which is part 
of the eIF4F complex. The eIF4F (Figure 1.4) complex is a heterotrimer that also 
contains eIF4A and eIF4G, whose functions will be discussed later. Previously, as a 
result of studies in several cell lines, it was thought that the abundance of eIF4E was 
limited in comparison to other members of the translational machinery (Hiremath et 
al. 1985; Duncan et al. 1987). However, additional data have shown that this may not 
be the case for many systems (Rau et al. 1996) and eIF4E may not be the rate limiting 
factor in the initiation of translation (von der Haar et al. 2004). The mRNA cap 
structure has been shown to stack between two tryptophan residues, which are located 
on the concave surface of eIF4E (Tomoo et al. 2002). The affinity of eIF4E for the 
cap structure is increased when eIF4E is bound to eIF4G (Haghighat and Sonenberg 
1997). A structural study of the interaction of yeast eIF4E and an eIF4G fragment 
have revealed that eIF4G forms a ring like structure as a result of a coupled folding 
transition. This ring wraps around a narrow protrusion of eIF4E formed by induced 
folding of its amino terminus (Gross et al. 2003). Dissociation rate of eIF4E from the 
cap is reduced and the complex is stable with a higher affinity for the cap than eIF4E 
alone (Ptushkina et al. 1998; von Der Haar et al. 2000). The corresponding region of 
mammalian eIF4G is homologous to the folded domain of yeast eIF4G, suggesting 
that stabilisation of eIF4F occurs via a similar mechanism. The binding of eIF4E to 
eIF4G appears to be stabilised by additional contacts between eIF4E and the 
nucleotide adjacent to the cap (Slepenkov et al. 2006). 
In resting cells eIF4E remains tightly bound to hypo-phosphorylated members 
of the eIF4E-binding protein (4E-BP) family (Figure I.4B) (Gingras et al. 2001a; 
Gingras et al. 2001b). The 4E-BPs compete with eIF4G for a common binding site on 
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Figure 1.4 The elf4F Complex 
A) eIF4E recognises the 5' cap-structure and recruits the scaffold protein 
eIF4G. eIF4G has binding sites for many initiation factors and is shown 
bound the helicase eIF4A. 
B) 4E-BPs sequester eIF4E, preventing its association with eIF4G and the 
initiation of translatioll. Growth signals result in the phosphorylation of 
4E-BP, thus releasing eIF4E. eIF4E can also be phosphorylated in 
response to growth signals by the MAP kinase interacting kinaselMAP 
kinase signal integrating kinase, Mnkl. This alters the affinity of eIF4E 
for the cap-structure. 
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eIF4E and as a result, impede assembly of the cap-binding complex (Sonenberg 
1993a). Phosphorylation of the 4E-BPs weakens their interaction with elF4E, 
allowing translation to proceed (Gingras et al. 2001b). The mTOR (mammalian target 
of Rapamycin) signalling pathway is responsible for the phosphorylation of at least 
two sites within 4E-BPs, in response to insulin or m i t ~ g e n i c c stimuli (Sonenberg 
1993a). As a result this is an important stage in the initiation pathway, at which 
translation can be regulated. The mTOR signalling pathway is also involved in the 
phosphorylation of other initiation factors and will be discussed in the following 
section and in more detail in section 1.7.4. 
1.2.4.2 eIF4A, eIF4B and eIF4H 
elF4A is an important component of the eIF4F complex. It is a DEAD box 
helicase protein and is comprised of two domains, which are connected by an 
extended linker (Caruthers et al. 2000). It alternates between an open and closed 
conformation during its working cycle and although only the open structure has been 
determined (Caruthers et al. 2000), the closed active conformation can be mapped 
onto the structure of other similar helicases (Oberer et al. 2005; Sengoku et al. 2006). 
eIF4A is involved in the binding and hydrolysis of ATP, binding RNA, and with 
coupled ATP hydrolysis and helicase activity (Cordin et al. 2006). A thermodynamic 
investigation of the binding and hydrolysis of ATP has revealed that the 
conformational changes, which result, may be sufficient to fulfil the energy 
requirements for the disruption of base-pairing in RNA helices (Lorsch and Herschlag 
1998). It is believed that eIF4A unwinds the secondary structure within the 5' UTR, 
facilitating the binding of the 43S ribosomal subunit and subsequent scanning to an 
AUGcodon. 
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Acting alone, eIF4A possesses only a weak helicase function. As a 
component of the elF4F complex, its functionality is enhanced more than 20-fold and 
can be further activated by the cofactor eIF4B (Rozen et al. 1990; Komeeva et al. 
2005). It is believed that eIF4B increases the affinity of eIF4A for RNA (Abramson 
et al. 1988). The factor eIF4H has also been shown to activate and enhance the 
functionality of e1F4A. Despite being related to eIF4B and possessing a homologous 
amino-terminal region, it cannot substitute elF4B in all conditions and has been 
shown to be less effective than elF4B in the activation of eIF4A (Rogers et al. 2001; 
Dmitriev et al. 2003). It has not yet been determined whether the action of elF4H and 
elF4B is mRNA-specific, or whether the differences observed are due to 
physiological conditions. 
The mTOR signalling pathway (which will be discussed in more detail in 
section 1.7.4), is a downstream SerlThe kinase in the PI3K1Akt signalling pathway 
and is activated in response to insulin or mitogenic stimuli (Kim et al. 2002). The S6 
kinases (S6Ks) are involved in the mTOR signalling pathway and are downstream 
targets for phosphorylation by the mTOR Complex 1 (mTORC1) (Kim et al. 2002). 
The S6Ks phosphorylate the tumour suppressor processor Pdcd4, which in its 
unphosphorylated state binds to and consequently inhibits elF4A (Dorrello et al. 
2006). Phosphorylation of Pdcd4 results in its ubiquitination and degradation by the 
protesomome, thus alleviating the inhibition of eIF4A. It has been shown that the 
S6Ks also phosphorylate eIF4B on Ser-422, resulting in an enhanced interaction of 
elF4B with elF3 (Holz et al. 2005). Phosphorylation at Ser-422 has also been shown 
to occur as a result of signalling through the RAS-MAPK pathway (Holz et al. 2005). 
eIF4A and elF4B are therefore involved in regulation at the level of translation 
initiation. 
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1.2.4.3 eIF4G: Role and Regulation 
The initiation factor eIF4G acts a molecular scaffold and plays an integral part 
in bringing together many of the canonical initiation factors. It has been shown that 
the two isoforms of eIF4G, known as elF4GI and eIF4GII, share 46% identity at the 
amino acid level (Gradi et a1. 1998). Both isoforms bind a number of initiation 
factors. It has also been determined that alternative start codons may be used, 
resulting in multiple isoforms of elF4GI. The function of these isoforms are still 
currently unclear (Byrd et a1. 2002). eIF4G has several important functions during 
ribosomal recruitment, including coordinating the cap-binding activity of eIF4E and 
the RNA helicase activity of e1F4A. The cross linking of RNA to eIF4A is also 
enhanced by the central HEAT-repeat domain of elF 4G (pestova et al. 1996; Oberer 
et al. 2005). The crystal structure of the yeast eIF4A-eIF4G complex has revealed 
that when bound to eIF4G, the two lobes of eIF4A are held in an orientation that 
results in the alignment of the DEAD-box helicase motifs. This alignment is 
necessary to facilitate the A TP-dependent helicase activity (Schutz et a1. 2008). 
An important regulatory mechanism that is utilised during cellular stress, 
involves the cleavage of eIF4G. Following cleavage, eIF4G is no longer available to 
function within the eIF4F complex. Consequently, a new round of cap-dependent 
initiation cannot occur and translation is shut down. Caspase-3 is responsible for 
eIF4G cleavage during apoptosis, at a location close to the eIF4E binding site 
(Clemens et al. 1998; Marissen and Lloyd 1998; Morley et al. 1998). Shut down of 
host cell protein synthesis by picornavirus infection, involves a similar mechanism at 
a site amino acids away from the caspase 3 site (Etchison and Fout 1985; Lloyd et a1. 
1987). During heat shock, eIF4G is localised into insoluble granules (stress granules) 
in a process chaperoned by hsp27 (heat shock protein 27). In this instance elF4G is 
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not cleaved and this process is rapidly reversible following the release of hsp27 
(Cuesta et aI. 2000). This mechanism ensures that restoration of translation can be 
effected both quickly and energetically efficiently following recovery from stress. 
The phosphorylation of eIF4G is believed to correlate, in most cases, with an 
increase in the rate of protein synthesis. Although the mechanism has not been fully 
determined, a number of sites on eIF4G have been implicated as phosphorylation 
targets of kinases such as PKA, PKC and GSK2 (Morley and Traugh 1990; Raught et 
aI. 2000). 
The MAP kinase interacting kinaselMAP kinase signal integrating kinase, 
Mnkl, interacts with the C-terminus of eIF4G. When bound to eIF4G, Mnkl can 
phosphorylate eIF4E on Ser-209 in response to signalling pathways (Raught et al. 
2000). Phosphorylation of eIF4E is increased by serum treatment of cells and 
addition of growth factors in a process, which appears to be mediated via the 
MEKlERK pathway (FIynn and Proud 1996). It has been the subject of considerable 
debate as to whether the phosphorylation state of eIF4E plays a role in the regulation 
of translation initiation (Scheper and Proud 2002). Interestingly, it has been shown 
that mice, which have both Mnkl and Mnk2 genes deleted are apparently normal, 
leading to the suggestion that eIF4E phosphorylation is not significantly important 
(Ueda et aI. 2004). It has also been shown, that chemical inhibition of eIF4E 
phosphorylation does not hinder de novo initiation of translation, during the recovery 
from hypertonic stress (Morley and Naegele 2002). However, other data appears to 
support the view that eIF4E phosphorylation is a positive regulator of translation, 
including the observation that mutation of the eIF4E phosphorylation site of 
Drosophila results in a reduction in body size and viability (Lachance et al. 2002). 
Despite the uncertainty as to the exact role of eIF4E phosphorylation, two models 
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have been proposed for the role of eIF4E phosphorylation in translation initiation, 
which differ only at the proposed stage at which phosphorylation occurs (Scheper and 
Proud 2002). In both models, phosphorylation of eIF4E increases its affInity for 
capped RNA, which is consistent with the observation that high levels of eIF4E 
phosphorylation can impair cap dependent translation (Scheper et al. 2002). 
As previously introduced in section 1.2.3.2, the central domain of eIF4G can 
interact with eIF3 and act as a bridge between the 40S subunit and the eIF4F complex 
(Figure 1.5A) (Lamphear et al. 1995; Hershey and Merrick 2000). To date, the 
subunit(s) involved in the binding of eIF3 to eIF4G have not been identified. In yeast 
it has been observed that eIF3 does not bind to eIF4G directly. Instead, interaction 
has been shown to occur via eIFl and eIF5, which are components of a yeast eIF3C-
eIF5-eIFl complex (Yamamoto et al. 2005). 
Poly(A)-binding protein (PABP) can interact with eIF4G (Figure 1.5B), 
resulting in circularisation of the mRNA. The resultant "closed loop" structure links 
the 5' cap and the 3' poly(A) tail of the mRNA. It is thought that P ABP is able to 
stimulate the association of the 43S preinitiation complex with the mRNA, by 
enhancing the interaction of eIF4F and the cap structure (Pestova et al. 2007). This 
enhancement is likely to be due to induced conformational changes exerted on eIF4E 
(Borman et al. 2000; von Der Haar et al. 2000). PABP is involved in coupling the 
different stages of protein synthesis, as it known to associates with eukaryotic release 
factor eRF3 (Cosson et al. 2002) 
PABP-interacting protein 1 (PAIP-l) is a homologue of eIF4G, which shares 
25% sequence identity. It is able to bind both eIF3 and PABP, resulting in a 
stimulation of translation, which may be due to mRNA circularisation 
20 
A 
3' __ -
---_ ... 
mRNA 
B 
ORF 
mRNA 
Figure 1.5 The 48S Preinitiation Complex 
A) The 43S pre-initiation complex is recruited to the mRNA through the 
interaction between eIF3 and eIF4G. 
B) The binding of Poly(A)-binding protein (PABP) to both the poly(A) tail 
and eIF4G, results in circularisation of translation. The resultant "closed 
loop" structure stabilises the complex and enhances translation. 
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(Craig et a1. 1998; Martineau et al. 2008). PAIP-2 is a binding competitor of PABP-l, 
thus repressing the stimulation of translation associated with the binding of P AIP-l to 
PABP. When bound to PABP, PAIP-2 has the direct effect of repressing translation 
by reducing the affinity of PABP for poly(A) RNA (Khaleghpour et a1. 2001a; 
Khaleghpour et at. 2001 b). Death associated protein-5 (DAP-5) is also a close 
relative of eIF4G, and is also believed to act as an inhibitor of translation. This 
inhibition may be due to its ability to sequester eIF3, eIF4A and Mnkl for which it 
has binding sites (Gingras et al. 1999; Pyronnet et al. 1999). 
1.2.4.3 Migration of the 43S Preinitiation Complex to the AUG Start Codon 
Following recruitment of the 43S preinitiation complex to the 5' end of the 
mRNA, the complex scans in a 5' to 3' direction (Figure 1.6A) until it recognises an 
AUG codon with a correct Kozak consensus sequence (Kozak 1987). As previously 
described in section 1.2.4.2, eIF4A, eIF4B and eIF4H are believed to be involved in 
aiding the scanning processes (Rozen et al. 1990; Rogers et a1. 200 l). For 
unstructured mRNA it has been shown that scanning can take place with 43S 
complexes containing eIFl, eIFlA, eIF3 and the ternary complex, with the absence of 
ATP, eIF4A, eIF4B, and eIF4F (Pestova and Hellen 2001). The intrinsic ability of the 
43S complex to move on the mRNA is therefore clearly reflected by the scanning 
process. During scanning, successive triplets on the mRNA enter the P site of the 
preinitiation complex. These triplets are inspected for complementary to the Met-
tRNAjMet, which is anchored to the GTP bound form of eIF2 (Pestova et al. 2007). A 
perfect match with an AUG codon in the correct context triggers the irreversible 
hydrolysis of GTP and the subsequent release of eIF2-0DP, eIF3 and eIFl (Paulin et 
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aI. 2001). The eIF2B mediated recycling of eIF2·GDP to eIF2·GTP was previously 
discussed in section 1.2.2.2. 
The context of the start codon is important in the selection of the AUO codon 
which is utilized for translation. In higher eukaryotes it has been determined the ideal 
context is CCRCCAUGG. The most important nucleotides in terms of AUO 
selection are highlighted in bold. Without the presence of a guanosine at the +4 
position (where the A of the AUG is defined as the + 1 position), and a purine at the -3 
position, initiation efficiency is reduced and "leaky scanning" can occur (Kozak 
1989b; Kozak 1991a; Kozak 1997). When this happens, the 43S subunit continues to 
scan until it reaches an AUO codon in better context (Figure 1.68), where it may 
more successfully initiate translation (Kozak 1995). Leaky scanning can produce 
peptides of different lengths from a single mRNA. In 95-97% of cases, the AUO 
codons, which initiate the main open reading frame of the mRNA, are in a good or 
adequate context (Meijer and Thomas 2002). In some cases, OUG, CUG and AeO 
are also utilized for initiation, although at lower efficiency that AUG (Kozak 1989b). 
Selection of alternative initiation codons is dependent upon the correct surrounding 
consensus sequence (Kozak 1997). Recognition of an AUO codon can also be 
stimulated by a hairpin loop structure in the mRNA, approximately 14-18nt 
downstream of the AUG (Kozak 1990). This structure is believed to increase the 
efficiency of initiation by reducing the scanning rate of the 43S complex, thus aiding 
start site selection. 
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Figure 1.6 The Scanning Mechanism 
A) Following its recruitment to the mRNA. the 43S complex scans in a 
5' to 3' direction until it recognises an AUG codon with a Kozak 
consensus sequence. The scannjng process is aided by the factors 
eIF4A, eIF4B, eIF4H, eIFI and eIFIA. 
B) If the first initiation codon reached is in poor context, the 43S subunit 
may continue to scan until it reaches an AUO codon in better context. 
This process is called leaky scanning (Kozak 1995) and may produce 
peptides of different lengths from a single mRNA. 
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1.2.5 Formation of the 80S Initiation Complex 
The final stage in the process of initiation is the joining of the 48S complex 
with the 60S ribosomal subunit, to form an 80S ribosome (Figure 1.7). Following 
start site recognition, the eIF2y subunit irreversibly hydrolyses GTP in a process, 
which is activated by eIF5 (which was introduced in section 1.2.3) (paulin et al. 
2001). It is thought that the hydrolysis of GIP by eIF2, can only be induced by eIF5 
when eIF2 is incorporated into the 43S complex and perfect base-pairing occurs 
between the start codon and Met-tRNAjMet (Huang et a1. 1997). 
A second factor called eIF58, acts together with eIF5 in mediating the joining 
of the 48S complex and 60S ribosomal subunit (Pestova et al. 2000). Sequence 
motifs, which are characteristic of GIP-binding proteins are present within the central 
domain of eIF58 and the activity of eIF58 is stimulated approximately three-fold in 
the presence of GTP (Pestova and Bellen 2001). Although eIF58 does not have an 
intrinsic GTPase activity, in the presence of the 60S subunit alone, or the 40S and 60S 
subunits together, hydrolysis of GIP is induced. It is believed that the hydrolysis of 
eIF58-bound GTP is required in order for eIF58 to dissociate from the 80S ribosome 
(pestova and Hellen 2001). This hydrolysis reaction, which triggers eIFS8 release for 
the initiation complex, is stimulated by the interaction of eIFS8 with the C terminus 
of eIFIA (Shin et a1. 2002; Acker et a1. 2006). Evidence suggests that when eIFS8 is 
bound to the ribosome, elongation factor 1, which is required for the next stage of 
translation, is unable to bind (Wilson et a1. 2000). It appears that eIF58 is able to 
catalyse multiple rounds of ribosomal subunit joining without the requirement of a 
guanidine nucleotide exchange factor to exchange eIF58 bound GDP for GTP 
(Pestova and Hellen 2001). 
25 
8 
1 Met 
Figure 1.7 The Joining of the 60S Subunit 
The joining of the 60S subunit results in the formation of the 80S ribosome. 
Following recognition of the AUG start codon, the 60S subunit joins and GTP 
hydrolysis occurs on both eIF5B and eIF2. Initiation factors are also released 
and the competent 80S complex is able to commence elongation. 
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PABP, previously introduced in section 1.2.4.3, has also been shown to 
stimulate ribosomal subunit joining (Kahvejian et al. 2005). Following experiments 
carried out in yeast, it has been suggested that the poly(A) tail is required to block the 
effects of two RNA helicases, which inhibit elF5B (Searfoss et al. 2001). It has not 
yet been determined whether P ABP influences subunit joining via this mechanism in 
higher eukaryotes. 
1.3 The Elongation Phase of Protein Synthesis 
Following the initiation of translation, the process of elongation occurs, which 
is also a highly regulated process. Briefly, during the elongation stage of translation, 
the ribosome translocates along the mRNA in a 5' to 3' direction and through a 
process of anticodon recognition by aminoacyl-tRNA and peptide bond formation, 
successive amino acid are added to the nascent polypeptide chain. This process is 
facilitated by the elongation factors eEFIA, eEFIB and eEF2. Recruitment of the 
aminoacyl-tRNA to the aminoacyl (A) site on the ribosome, is facilitated by eEFIA 
bound to GTP. During this process, the GTP is hydrolysed to GDP, followed by 
subsequent release of eEFIA bound to GDP. In a similar process to the recycling of 
eIF2 by the guanine nucleotide exchange factor eIF2B, eIFIA in its GDP-bound form 
is recycled to its GTP-bound form using e1F2B. 
In the next stage of elongation, eEF2 mediates the transfer of aminoacyl-tRNA 
from the ribosomal A-site, to the P-site. In doing so, the next codon is exposed to the 
A-site and the nascent polypeptide (or the initiator methionine) is transferred from the 
tRNA located in the P-site to the new aminoacyl-tRNA located in the A-site. The 
formation of a new peptide bond can then occur, increasing the length of the growing 
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polypeptide chain. The new peptidyl-tRNA is then transferred to the P-site while the 
anticodon remains in the A-site. The deacylated tRNA is then switched to the 
ribosomal E-site. During this cycle, eEF2 which is bound to GTP is hydrolysed. The 
process can be regulated through phpshphorylation events effected by the eEF2-
kinase. Phosphorylation of eEF2 has been shown to inhibit the activity of eEF2 
(Redpath and Proud 1993). De-phosphorylation of eEF2 as a result of insulin 
treatment has been shown to increase the rate of translation at the elongation phase 
(Redpath et al. 1996). 
1.4 The Termination of Protein Synthesis 
The final termination phase of translation occurs when the ribosome reaches 
one of three termination codons (UAA, UAG or UGA). At this stage, eukaryotic 
release factor eRFl binds and hydrolyses the peptidyl-tRNA, resulting in cleavage of 
the last aminoacyl bond and the release of the polypeptide chain along with the 
ribosome form the mRNA. eRF3 (bound to GTP) stimulates the activity of eRFl in a 
GTP-dependent manner. In some circumstances the 40S ribosomal subunit may 
remain associated with the mRNA and can re-initiate translation at a downstream 
initiation codon (Kozak 1992). 
1.5 Regulation of Cap-dependent Initiation of Protein Synthesis 
As previously discussed, cellular signalling pathways involving the 
subsequent phosphorylation or dephosphorylation of various initiation factors, are 
important components in the regulation of translation. In addition to these control 
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mechanisms, there are many structural elements within the mRNA that are involved 
in the regulation of translation. Features installed during post-transcriptional 
modification (refer to section 1.1), including the 5' m7G cap and the poly(A) tail are 
known to enhance translation. The 5' VTR is an important region in the control of 
translation and up to 90% of all eukaryotic mRNAs contain a 5' VTR of between 20-
100 nucleotides (Kozak 1997). There are several different types of elements within 
both the 5' VTR and 3' VTR which contribute to translational regulation and these 
will be described in more detail in the following sections. 
1.5.1 Secondary Structure 
In conjunction with eIF4B and eIF4H, the RNA helicase eIF4A is able to 
unwind secondary structure within the 5' VTR under normal conditions (Rogers et al. 
2001). The presence of stronger secondary structure in the 5' VIR drastically inhibits 
translation efficiency of the mRNA, as they cannot be unwound by the helicase action 
of eIF4A (Figure 1.8A). Increasing eIF4F complex formation through the over-
expression of eIF4E, results in the binding of more eIF4A and has been shown to 
overcome the repressive effect (Rogers et al. 2001). Translational efficiency is also 
affected by the position of the secondary structure in relation to the 5' cap. For 
example, a stem-loop structure of -30 kcallmol free energy 12 nucleotides 
downstream of the cap, inhibited translation, as the position of the structure prevents 
the 43S complex from binding to the mRNA. However, the same structure positioned 
52 nucleotides downstream of the cap, does not inhibition translation (Kozak 1989a). 
Complete blockage of translation can be achieved by the insertion of higher free 
energy stem-loop structures (-61 kcaVmol) approximately 71 nucleotides downstream 
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A Secondary Structure 
3' 5' Cap 
. - - - - - ~ ~ ~ - - - - ORF AAAA 
B Upstream Open Reading Frames 
3' 
ORF AAAA 
C Ribosomal Shunting 
3' 
ORF AAAA 
Figure 1.8 Translational Regulation by Elements Within the 5' UTR 
A) Translation is inhibited by the presence of secondary structure, such as 
hairpins, with the 5' UTR. 
B) The presence of upstream open reading frames (uORFs) can reduce the 
translational efficiency of downstream open reading frames (ORPs). 
C) The ribosome can by-pass areas of secondary structure within the 5' 
UTR by a process called shunting. 
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of the cap structure (Kozak 1989a; Gray and Hentze 1994). It has been shown that 
the length of the 5' UIR can also affect the translational efficiency of mRNA. 
Messages containing longer 5' UIRs are translated with lower efficiency that those 
with shorter 5' UIRs. 
1.5.2 Upstream Open Reading Frames 
Upstream open reading frames (uORFs) are a common feature of proto-
oncogenes (Child et a1. 1999) and genes involved in cell proliferation (Kozak 1991b). 
Upstream open reading frames are generally much shorter than the physiological ORF 
and are translated in preference to it, resulting in the downregulation of translation 
(Child et al. 1999). In order for translation of the main downstream ORF to occur, 
the ribosome must reinitiate following the termination of translation at the uORF 
(Figure 1.8B). It is believed that the 40S ribosomal subunit may remain associated 
with the mRNA in order to re-initiate translation at the downstream initiation codon 
(Kozak 1992). The distance that the attached 40S subunit must scan before reaching 
the downstream initiation codon and the length of the uORF, are thought to be 
important factors in determining whether a re-initiation event is likely to occur. 
Before re-initation can take place, the scanning 40S subunit must acquire ternary 
complex and other initiation factors in order for the 80S ribosome to reform. As the 
distance between the uORF termination codon and the downstream ORF initiation 
codon is increased, the scanning time and consequently the chance of re-initiation is 
also increased (Hinnebusch 1997). The time taken to translate a short uORF appears 
to be more important than uORF length in determining whether re-initiation occurs 
(Morris and Geballe 2000). Although the mechanism of reinitiation is not fully 
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understood, it has been shown that in mammalian systems efficient reinitiation 
following uORF translation only occurs if the complete eIF4F complex, or eIF4A, 4B 
and central domain of eIF4G participated in the original initiation event (Poyry et al. 
2004). Perhaps unsurprising when the ribosome is paused during uORF translation by 
the presence of a pseudo-knot, downstream re-initiation does not occur (Kozak 2001). 
1.5.3 Ribosomal Shunting 
Although little is known about the mechanism of ribosomal shunting, it is 
believed that it allows secondary structure present in an mRNA, to be bypassed by a 
40S ribosomal subunit under conditions, which shut down cap-dependent translation 
(Figure 1.8C). It is thought that the process is mediated by trans-acting factors and 
the l8S ribosomal subunit (Yueh and Schneider 2000). The 35S RNA of the 
cauliflower mosaic virus (CaMV) contains a hairpin and five uORFs within its 5' 
UTR. It is believed that ribosomal shunting is responsible for translation of this 
mRNA, since the ribosome is able to bypass these inhibitory features and continue 
scanning (Futterer et al. 1993; Hemmings-Meiszczak and Hohn 1999) 
1.5.4 The Iron Response Element 
A structural motif known as the iron response element (IRE) and located in the 
5' UTR is responsible for the translational regulation of a number of proteins involved 
in the storage and utilisation of iron (Hentze et al. 1987). The binding of iron 
regulatory proteins (lRP.l and IRP-2) to the IRE co-ordinate the translational control, 
resulting in binding and translational repression when cellular iron levels are low. 
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This translation repression results from the proximity of the IRE stem loop to the cap. 
When the IRE is bound by IRP-I or IRP-2, the 43S pre-initiation complex is 
prevented from binding to the mRNA, interfering with translation initiation (Goossen 
and Hentze 1992; Muckenthaler et al. 1998). When the IRE is positioned further 
away from the cap structure, the regulatory effect of IRP-l and IRP-2 are reduced 
(Goossen and Hentze 1992). When no iron is present, the IRPs dissociate or degrade 
and therefore do not function to repression of translation. 
1.5.5 Elements within the 3' UTR 
The 3' UTR of an mRNA has many important roles in the control of 
expression of specific proteins. As previously mentioned in section 1.2.4.3, Poly(A)-
binding protein (PABP) which binds to the poly(A) tail at the 3' end of the mRNA 
can interact with eIF4G forming a closed loop complex. This results in circularisation 
of the mRNA, stimulating the association of the 43S preinitiation complex with the 
mRNA, and promoting re-initiation on an mRNA (Pestova et al. 2007). 
In oocytes of Xenopus Laevis, translational repression occurs through storage 
of mRNAs, which posses short poly(A) tails. During maturation, polyadenylation by 
the cytoplasmic poly(A)-polymerase GLD2 occurs, resulting in a long poly(A) tail 
and translational stimulation via the closed loop mechanism described above (Kim 
and Richter 2006). An element within the 3' UTR called a cytoplasmic 
polyadenylation element (CPE) is a Uridine-rich sequence, which is involved in both 
the activation and repression of polyadenylation (Figure 1.9A) (Richter 2000). 
Activation of polyadenylation during oocyte maturation is facilitated by the binding 
of Cytoplasmic-polyadenylation-element-binding protein (CPEB) to the CPE within 
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the target mRNA. Through the binding of CPEB, several additional proteins 
including CPSF. GLD2 and the deadenylase PARN become associated with the target 
mRNA, forming a protein complex. Phosphorylation at several sites on CPEB, results 
in rearrangement of the complex and subsequent ejection of PARN, allowing 
elongation of the poly(A) tail by GLD2 (Radford et at. 2008). Two models have 
been proposed to account for the repression of translation through CPE. The first 
involves Maskin binding to the CPE and preventing the binding of eIF4G. It has been 
shown that this binding event can silence a target mRNA by preventing 
polyadenylation from occurring prior to oocyte maturation (Stebbins-Boaz et al. 1999; 
Charlesworth et al. 2000; Mendez and Richter 2001). An alternative model proposes 
that PARN is recruited to the CPE and its proximity to the cap prevents eIF4E from 
binding, thus preventing initiation from occurring. The presence and binding of 
Maskin is not a requirement of this model (Kim and Richter 2006). 
Another structural feature, which has shown to be involved in translational 
regulation, is the bicoid response element (BRE) (Figure 1.98). Bicoid protein has a 
role in organising anterior development in Drosophila and has been shown to bind 
direction to the BRE element and eIF4E, resulting in the repression of translation 
(Niessing et al. 2002). The work detailed in this thesis concentrates mainly on the 5' 
VTR and as a result, the elements described above merely serve as an example of the 
numerous regulation pathways which involve elements within the 3' VTR. 
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Figure 1.9 Translational Regulation by Elements Within the 3' UTR 
A) The binding of cytoplasmic polyadenylation element binding protein 
(CPEB) to the CPE within the 3' U T ~ ~ results in the binding of 
Maskin. This prevents the formation of eIF4F, thus negatively 
regUlating translation. 
B) The binding of Bicoid to the Bicoid response element (BCR) within 
the 3' UTR, also prevents the formation of eIF4F and negatively 
regulates translation. 
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1.6 Internal Ribosome Entry Segments 
1.6.1 The Identification of IRES-mediated Translation 
Following their initial identification in the 5' UTR of encephalomyocarditis 
(Jang et a1. 1988) and polio (Pelletier and Sonenberg 1988) viral RNAs, Internal 
Ribosome Entry Segments (lRESs) have been subsequently identified in the 5' UTR 
ofRNAs from all members of the picornaviral family (Figure 1.10). The 5' UIR of 
these mRNAs contain features that would be expected to inhibit cap-dependent 
translation, including multiple AUOs upstream of the initiation codon (Herman 1989), 
long 5' UIRs with a high degree of secondary structure (Belsham and Sonenberg 
1996) and a 5' terminal pUp in place of the m'G cap structure (Nomoto et al. 1977). 
The latter feature suggested that eIF4E was not required for their initiation and this 
was subsequently confirmed through studies in which eIF4E was depleted or 
sequestered through the over-expression of 4E-BPs (Pause et al. 1994) and 4E-BP 
phosphorylation through Rapamycin treatment respectively (Beretta et al. 1996). It 
was later determined that members of the picornavirus family encode proteases which 
cleave eIF4G, uncoupling the cap-binding and ribosome recruitment functions of 
elF 4 F. The consequence of this cleavage is that the cap-dependent translation of the 
host cell is shut down in order to make way for viral particle synthesis (Lamphear et 
a1. 1995). Using dicistronic reporter constructs it has been definitively determined 
that IRESs are capable of internal initiation, which is independent of the cap structure 
or the eIF4F complex. When the 5' UIR of EM CV or poliovirus mRNA was cloned 
into the intercistronic space of dicistronic reporter constructs, these sequences were 
able to initiate translation of the second cistron (Jang et al. 1988; Pelletier and 
Sonenberg 1988). 
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A Cap-dependent: 
3' 
ORF 
- - --
5' Cap 
B Cap-independent: 
3' ORF 
- - --
5' Cap ITAFs 
Figure 1.10 Cap-dependent and Cap-independent Initiation 
A) Cap-dependent initiation of translation requires the recognition of the 
5' cap-structure and formation of an initiation complex. This 
subsequently results in the recruitment of the 40S ribosomal subunit. 
scanning and the formation of the 80S ribosome. 
B) A 5' cap-structure is not required for cap-independent initiation of 
translation. lnstead, an internal ribosome entry segment (IRES) 
directly recruits subunits to the mRNA, in a process aided by IRES 
trans-acting factors (ITAPs). 
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1.6.2 Cellular IRESs 
The first identification of an lRES element within cellular mRNA, followed 
the discovery that the mRNA of the immunoglobulin heavy chain binding protein 
(BiP) continued to be translated after viral infection and the subsequent shut-down of 
translation within the host cell (Sarnow 1989; Macejak and Sarnow 1991). Numerous 
cellular IRESs have since been reported and it is estimated that the capability to 
initiate translation by internal initiation, is present in 10% of eukaryotic mRNA 
(Johannes et aI. 1999). It has been shown that genes important for cell cycle and 
progression, including the c-myc gene, often contain lRESs. Translation of c-myc 
mRNA can occur by both cap-dependent and lRES mediated initiation, suggesting 
that cellular IRESs promote the selective synthesis of proteins under conditions in 
which cap-dependent translation is compromised (Stoneley et al. 1998; Stoneley et al. 
2000). It has been shown that these conditions may include apoptosis (Stoneley et al. 
2000; Bushell et al. 2006), genotoxic stress (Subkhankulova et al. 2001) and viral 
infection (Johannes et aI. 1999). 
Cellular IRESs are generally shorter than those identified in the picornaviral 
mRNAs and harbour fewer AUGs. They are known to contain a high degree of 
secondary structure, although few similarities with the secondary structure have been 
shown between different cellular IRES elements. In contrast to viral lRESs, it is 
thought that the structural mechanisms for ribosomal recruitment by cellular lRESs 
are more complex. This is supported by the observation that the function of viral 
lRESs can be significantly inhibited by single point mutations, however by 
comparison the effect of single point mutations carried on cellular lRES activity is 
much less (Yang and Sarnow 1997; Huez et aI. 1998; Stoneley et aI. 1998). It has 
also been shown that in several instances, including the c-myc IRES, cellular IRESs 
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are often modular with sections working in concert to recruit the ribosome (Le 
Quesne et al. 2001). Direct recruitment of the ribosome by mRNA-rRNA base 
pairing has also been shown to be an important mechanism in cellular lRESs and it 
has been suggested that many cellular lRESs contain modules that utilise this 
mechanism (Chappell et al. 2000). It has been observed that some lRESs are more 
active in the presence of specific cellular proteins, which include La autoantigen and 
poly(rC)-binding protein (PCBPl) (Yueh and Schneider 2000). These proteins are 
described as IRES-trans acting factors (ITAFs) and it is possible that they acts as 
RNA chaperones and that the activity of certain mRNAs may correlate with their 
cellular distribution (Pilipenko et al. 2000b). The examples described above provide 
an insight into cap-independent translation, however, a more detailed analysis beyond 
the scope of this thesis. La and PCBP 1 will be revisited in greater detail in sections 
1.7.5.1 and 1.7.5.2 respectively. 
1.7 5' TOP Containing mRNAs 
1.7.1 eis-Regulatory Element of5' TOP Containing mRNAs 
Many of the mRNAs that encode the components of the translational 
machinery, including ribosomal proteins and elongation factors, possess a 
characteristic structural hallmark in their 5' untranslated region (VTR). This feature 
is known as a 5' terminal oligopyrimidine tract (5' TOP) and has been identified in all 
currently sequenced mRNAs that encode ribosomal proteins (RPs) (Meyuhas 2000). 
Its presence has also been confirmed in the mRNAs encoding the eukaryotic 
elongating factors (eERFs), eEFla and eEEF2 and in the mRNAs that encode the e, f 
and h subunits ofeIF3 (Iadevaia et al. 2008). PABP, which has been implicated in the 
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initiation of translation (Oalili et a1. 1988) and mRNA stability (CoIl er et al. 1998), is 
also encoded by mRNA that is known to contain the 5'TOP motif. As will be 
discussed in more detail in section 1.7.3, there is evidence to suggest that the common 
presence of the 5'TOP motif within mRNAs encoding the translational apparatus 
maybe associated with the coordinated regulation of these mRNAs at the translational 
level. 
5' TOP messages are characterized by the presence of a C residue followed by 
4-14 uninterrupted pyrimidine residues immediately after the cap structure at their 5' 
end (Schibler et a1. 1977). This uninterrupted pyrimidine sequence normally contains 
a roughly equal distribution of U and C residues (Meyuhas 2000). The presence of a 
C residue immediately after the cap is relatively uncommon and is only found in 
about 17% of mammalian transcripts (Schibler et al. 1977). In the majority of 
mRNAs the 5' cap structure is usually followed by an A residue (Bucher 1990). The 
5' terminus of many mammalian 5'TOP containing mRNAs has been determined by 
primer extension and SI nuclease mapping techniques (Meyuhas 2000). Comparative 
analysis of these mRNA sequences, clearly shows the common occurrence of a C 
residue immediately after the cap structure followed by a region of uninterrupted 
pyrimidine residues with no significant consensus sequence (Figure 1.11). 
The first 30 nucleotides of the 5' TOP motif are believed to contain the 
activity of this major eis-regulatory element (Avni et al. 1994). Additional features 
which are common in S' TOP containing mRNAs are CO rich sequences following 
the 5' TOP motif and short 5' UTRs, which lack upstream AUO codons (Meyuhas 
2000). 
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A 
5' TOP Motif 
5' 3' 
ORF 
- - --/1 
m7G Cap 5/ UTR 
B 
Protein Sequence 5' TOP (nt) 5' UTR (nt) 
rpS6 CCUCUUUUCCGUGGCGCCUC 10 42 
rpS8 CUCUUUCCAGCCAGCGCCGA 8 23 
rpS11 CUUUUUUUCAGGCGGCCGGG 9 24 
rpS14 CUCUUUCCGGUGUGGAGUCU 8 37 
rpS17 CCUCUUUUACCAAGGACCCG 8 25 
rpS24 CUUUUCCUCCUUGGCUGUCU 12 37 
rpL7a CUCUCUCCUCCCGCCGCCCA 12 22 
rpL13a CUUUUCCAAGCGGCUGCCGA 7 27 
rpS4Y CUCUUCCGUCGCAGAGUUUC 7 23 
eEFlA CUUUUUCGCAACGGGUUUGC 7 63 
eEFlB CUUUUUCCUCUCUUCAGCGT 15 84 
PABP CCCCUUCUCCCCGGCGGUUA 12 505 
QM CUCUUUCCCUUCGGUGUGGU 12 143 
B23 CUUUCCCUGGUGUGAUUCCG 8 100 
P23 CUUUUCCGCCCGCUCCCCCC 4 90 
Figure 1.11 5'TOP Containing mRNAs 
A) Diagram showing the structure of a typical TOP containing mRNA. 
The TOP motif if located within the 5'UTR immedioately succeeding 
the m 7 G cap structure. 
B) Typical sequence and alignment of the TOP motif from fifteen known 
TOP containing human mRNAs. The first twenty nucleotides 
immediately succeeding the cap structure are shown (column 2), along 
with the length of the 5' TOP motif (column 3) and the total 5'UTR 
length (column 4). Notable features are the uninterrupted 
polypyrimidine tract and the high C / U ratio within the first twenty 
nucleotides. 
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1.7.2 Growth Dependent Regulation of5' TOP Containing inRNAs 
The ability of a cell to modify its rate of protein synthesis is linked to its 
ability to produce the machinery of protein synthesis and in turn the mechanism of S' 
TOP regulation. In growing cells,S' TOP containing mRNAs are found to be 
polysomally associated and loaded with a full complement of ribosomes. In contrast, 
in cells that are growth-arrested, the S' TOP containing mRNAs are found to be 
shifted into the sub-polysomal region and stored in RNP (Loreni and Amaldi 1992). 
These two contrasting states suggest that 5' TOP mRNA translation can be activated 
or repressed in a binary control mechanism, which alternates between the two 
extremes. Analysis of the polysomal association of mRNAs, which encode the 
translational machinery, such as eIFIA and PABP, supports this data (de Melo Neto 
et al. 1995; Wu and Bag 1998). The levels of mRNAs encoding ribosomal proteins 
were found to be constant during the shift from polysomes to RNPs. This suggests 
that mRNA stability was not affected and that a reversible transfer of mRNA 
encoding ribosomal proteins between polysomes and RNP, was responsible for the 
observed shift (Loreni and Amaldi 1992). In vivo studies have shown that the 5' 
TOP containing mRNAs extracted from mRNPs, have a similar translational 
efficiency to those extracted from translationally active polysomes (Shama and 
Meyuhas 1996). This suggests that mRNAs are not modified structurally during 
sequestration. 
Interestingly, this binary 'all-or-none' control mechanism only occurs when 
the 5' TOP is positioned immediately after the cap structure (Hornstein et al. 1999b). 
It has been suggested that the binomial distribution of 5' TOP containing mRNAs 
between polysomes and mRNP, is indicative of block at their initiation stage of 
protein synthesis (Meyuhas 2000). The characteristic growth-dependent expression of 
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5' TOP containing mRNAs thereby facilitates a mechanism for their co-ordinated 
expression. This is likely to be particularly important in the context of ribosome 
biogenesis, which accounts for a large proportion of cellular energy expenditure 
(Warner et al. 2001). 
1.7.3 5' TOP Containing mRNAs and the Translational Apparatus 
The mRNAs encoding ribosomal proteins (RPs) were the first 5' TOP 
containing mRNAs to be identified in vertebrates. Their translation was found to be 
regulated in a growth dependent manner and their discovery confirmed the existence 
of an abundance of mRNAs with a 5' terminal m7GpppPy (Schibler et al. 1977; 
Geyer et al. 1982). Random selection of almost forty vertebrate RP mRNAs, have yet 
to identity a single RP which is not encoded by an mRNA containing a 5' TOP motif 
(Meyuhas 2000). As will be discussed in more detail in section 1.7.4, the mTOR 
signalling pathway has been implicated in translational regulation of 5'TOP 
containing mRNA (Jefferies et al. 1997). Disruption of the mTOR signalling pathway 
can be achieved using Rapamycin, a macrocyclic metabolite isolated from 
Streptomyces hygroscopicus, which form an inhibitory complex which targets mTOR 
(Vezina et al. 1975; Pullen et al. 1998; Mothe-Satney et al. 2000). Separate 
experiments in which cDNA microarray analysis was carried out following 
Rapamycin treatment, have shown that translation of the mRNAs encoding ribosomal 
proteins and eukaryotic elongating factors (eERFs) are concurrently repressed 
(Grolleau et al. 2002). It is therefore likely that all ribosomal protein mRNAs contain 
the 5' TOP motif and are consequently regulated in a growth-dependent manner. 
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Growth-dependent regulation, similar to that observed for RP mRNAs, has 
also been observed for the mRNA encoding elongation factor 1. An increase in the 
synthesis rate of eEFIA without a concomitant increase in eEFIA mRNA abundance, 
was detected following the growth stimulation of resting Swiss 3T3 cells (Thomas 
and Luther 1981; Thomas 1986). Further analysis indicated that eEFIA mRNAs 
shifted from mRNP particles to polysomes following mitogenic stimulation (Rao and 
Slobin 1987; JetTeries and Thomas 1994). Subsequent growth stimulation 
experiments and detailed sequencing at the transcription start site, have revealed that 
like eEFIA, all the translation elongation factors are encoded by 5' TOP containing 
mRNAs (Iadevaia et al. 2008). Interestingly, mRNAs encoding additional proteins 
that are involved in the translational machinery, including the e, f and h subunits of 
eIF3, also contain the 5' TOP motif (Iadevaia et al. 2008). Similarly, growth-
dependent translational regulation has also been confirmed for mRNA encoding 
PABP (Homstein et al. 1999a). PABP has been implicated in the initiation of 
translation (Galili et al. 1988) and mRNA stability (Coller et al. 1998). 
1.7.4 Signalling Pathways Involved in the Translational Control of 5' TOP 
Containing mRNAs 
An apparent correlation between translational activation of 5' TOP messages 
in response to mitogenic stimuli and the phosphorylation of RPS6 (ribosomal protein 
S6) by the kinases S6Kl and S6K2 was an initial focus of research involving 
signalling pathways and their role in 5' TOP mRNA translational regulation (Thomas 
et al. 1980). Mobilization into polysomes appeared to be higher in ribosomes with a 
higher proportion of phosphorylated RPS6 (Thomas et at. 1980). This led to the 
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proposal that selective 5' TOP message initiation was a result of S6K activation, 
leading to RPS6 phosphorylation (Jefferies et al. 1997). 
Both S6Kl and S6K2 are known to be involved in the mTOR (mammalian 
target of Rapamycin) signalling pathway. They have been shown to be downstream 
targets of mTORCl (mTOR Complex 1) and are phosphorylated in response to 
insulin, growth factors, serum and amino acids (Kim et al. 2002). mTORCl, 
comprised of mTOR, Raptor, mammalian LST8 and PRAS40, is one of two catalytic 
complexes through which mTOR functions (Kim et al. 2002). The function of 
mTORl and hence the phosphorylation of S6Kl and S6K2, has been shown to be 
sensitive to inhibition by Rapamycin. Interestingly, when S6K activity was blocked 
using Rapamycin as an inhibitor of mTOR, the translation of 5' TOP containing 
mRNAs was initially repressed (Jefferies et aI. 1997). However, in several different 
cell lines only a moderate effect on 5' TOP mRNA translation was observed 
following Rapamycin treatment, despite the complete inhibition of S6K activity (Tang 
et aI. 2001; Stolovich et al. 2002), suggesting that the effect of S6K inhibition is 
dependent upon cell type. The direct relationship between RPS6 phosphorylation and 
5' TOP mRNA translation has been further called into question by several interesting 
observations. 5' TOP containing mRNAs were found to undergo translational 
repression during mouse erythroleukaemia (MEK) cell differentiation, despite RPS6 
being constitutively dephosphorylated in these cells (Barth-Baus et al. 2002). It has 
also been shown that the translational regulation of 5' TOP containing mRNAs is 
unaffected by the targeted disruption of the S6K alleles (Tang et al. 2001) or by the 
disruption of S6K alleles, which is present in embryonic stem cells (Pende et aI. 
2004). Similarly, the combined knockout of both S6Kl and S6K2 has been shown to 
have no effect on the translational regulation of 5' TOP containing mRNAs in 
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response to mitogenic stimuli (Pende et al. 2004). It would appear therefore, that the 
translational regulation of 5' TOP containing mRNAs is not dependent upon the 
phosphorylation of RPS6 phosphorylation or on S6K. 
Signalling through the mTOR signalling pathway in response to growth 
factors and nutritional stimuli make it ideally positioned for a regulatory role in 
translation initiation. It is, therefore, possible that an additional downstream target of 
mTOR, 4E-BPl (eIF4E-binding protein I) plays a role in the regulation of 5' TOP 
containing mRNAs. Phosphorylation of 4E-BPl, facilitated by mTORCI results in 
the dissociation of 4E-BPI from the initiation factor eIF4E (Hay and Sonenberg 
2004). It is known that phosphorylation by mTOR can occur on at least two sites 
within 4E-BPs and can be prevented by the use of Rapamycin (Pull en et al. 1998; 
Mothe-Satney et al. 2000). Following the phosphorylation of 4E-BPI, dissociation of 
eIF4E facilitates the formation of the cap-binding complex and translational activation 
can then take place (Sonenberg 1993a). 
Whilst the mTOR signalling pathway is clearly implicated in the translational 
regulation of 5' TOP containing mRNAs, the contradictory data surrounding the 
response to inhibition by Rapamycin and the apparent dependence upon cellular 
context indicate that other signalling pathways may also be involved in 5' TOP 
mRNA regulation. The PI3K (phosphoinositide 3-kinase) signalling pathway has 
recently been implicated in translational regulation of 5' TOP containing mRNAs. It 
has been shown that activation of PI3K signalling occurs upon insulin or mitogenic 
stimuli and results in the downstream activation of PKB (protein kinase B) through 
PDKI (phosphoinositide dependent kinase I) (Burgering and Coffer 1995; Kohn et al. 
1995). When cells are treated with L Y294002, a specific inhibitor of the PI3K 
signalling pathway (Vlahos et al. 1994), the translational activation of 5' TOP 
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containing mRNAs is completely blocked (Tang et al. 2001). This result is also 
obtained when cells are treated with the PI3K inhibitor Wortmannin (Caldarola et al. 
2004). The tumour suppressor PTEN (phosphatase and tensin homologue deleted on 
chromosome 10), is known to dephosphorylate PI-3,4,5-triphosphate and PI-3,4-
diphosphate, which are both upstream of PKB within the PI3K pathway (Cantley and 
Neel 1999). Over-expression of PTEN has been shown to inhibit the recruitment of 
5' TOP containing mRNAs to polysomes upon serum stimulation (Tang et al. 2001). 
Furthermore, the same result was obtained upon over-expression of a dominant-
negative mutant version of the PI3-kinase regulatory subunit, p85, which lacks the 
binding site for the pllO catalytic subunit. Together, these data strongly suggest that 
that both PI3K and PKB are involved in the growth regulated recruitment of 5' TOP 
containing mRNAs into polysomes. 
Precisely how signalling via PI3K mediates the recruitment of 5' TOP 
containing mRNAs into polysomes is still not clearly defined. It has been proposed 
that PKB is a mediator conveying signals from PI3K to S6Kl, and that S6Kl is 
involved in the translational activation of 5' TOP containing mRNAs (Meyuhas 
2000). Supporting this model, the over-expression of PKB has been shown to result 
in the activation of S6Kl in unstimulated cells (Pullen et al. 1998; Romanelli et al. 
1999). However, several lines of evidence (reviewed above) have indicated that the 
. translational regulation of 5' TOP containing mRNAs is not dependent upon the 
phosphorylation of RPS6 phosphorylation or on S6K. Evidence also exists, which 
indicates that the mTOR signalling pathway can be directly activated by PI3K (Hay 
and Sonenberg 2004). However, it has been observed that the translational activation 
of 5' TOP containing mRNAs is only moderately affected by mTOR inhibition but 
fully dependent upon PI3K signalling (Stolovich et a1. 2002). This indicates that the 
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direct activation of mTOR by PI3K signalling does not significantly contribute to the 
regulation of 5' TOP containing mRNAs. Despite a large volume of evidence, which 
implicates both the mTOR and PI3K signalling pathways in the translational 
regulation of 5' TOP containing mRNAs, the precise role of each pathway remains 
undetermined. 
1.7.5 Trans-acting Factors implicated in the Translational Regulation of 5' TOP 
Containing mRNAs 
1.7.5.1 La and CNBP 
It has been suggested that the translational regulation of 5' TOP containing 
mRNAs may be mediated through the recognition of the 5' TOP motif by specific 
Irans-acting factors. Without specifically identified proteins, which recognise the 5' 
TOP motif, several lines of evidence have emerged which support this proposal. It 
has been shown that the translational of 5' TOP containing mRNAs is selectively 
repressed in reticulocyte lysate derived from non growing cells (Shama and Meyuhas 
1996). Interestingly, this repression can be relieved by the pre-incubation of the 
translational extracts with a synthetic 5' TOP RNA oligonucleotide (Biberman and 
Meyuhas 1999). This suggests that the accumulation of a titratable repressor, as 
opposed to the loss of a translational activator, may be involved in the translational 
repression of 5' TOP containing mRNAs. One such protein implicated in the 
translational regulation of 5' TOP containing mRNAs, is La autoantigen. 
It has been shown using sucrose density gradient analysis, that La co-
sediments with polysomes in an RNA-dependent manner and is specifically 
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associated with 5' TOP containing mRNAs in the polysome fraction (Cardinali et al. 
2003). This data is supported by the observed shift of RPL4 mRNA from sub-
polysomes to polysomes, when wild-type La is over-expressed in growth-arrested 
cells (Crosio et al. 2000). These experiments have led to a model, in which the 
specific interaction of La with 5' TOP containing mRNAs results in translational up-
regulation of these mRNAs. Further evidence, which supports the involvement of La, 
has been provided by in vitro binding studies and has shown that La and cellular 
nucleic acid binding protein (CNBP) can interact with the 5' UTR of both Xenopus 
Laevis and Human 5' TOP containing mRNAs (Pellizzoni et al. 1996; Crosio et al. 
2000). It has been shown in Xenopus, that both La and CNBP compete for 
interaction with the autoantigen R060, whose co-operation is required in order to bind 
the 5' UTR of ribosomal protein-L4 mRNA (Pellizzoni et al. 1998; Crosio et al. 
2000). The interaction between the 5' UTR and R060 associated La and CNBP was 
found to be mutually exclusive, leading to the proposal that CNBP acts a translational 
repressor, while La exerts a positive effect on translation through competitive binding 
(pellizzoni et al. 1998). 
Recently, conflicting evidence has emerged which has challenged the 
proposed roles of La and CNBP in the regulation of 5' TOP containing mRNAs. It 
has been shown in vivo that 5' TOP containing mRNAs preferentially associate with 
La which is not phosphorylated on Se266 (Intine et al. 2004). The over-expression of 
a mutant fonn of La protein, unable to undergo phosphorylation on Ser366, resulted in 
an increase in La association with RPL37 mRNA and the proportion of RPL37 
mRNA associated with sub-polysomal particles (Schwartz et al. 2004). Studies 
carried out in vitro, have also shown that La can inhibit S' TOP mRNA translation 
(Zhu et al. 2001). Therefore, these data suggest that La regulates 5' TOP mRNA 
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translation in a manner which is opposite to that proposed by the earlier model. 
Interestingly, in contrast to the proposed role of CNBP in 5' TOP regulation, it has 
been shown that CNBP promotes cap-independent translation as part of an IRES-trans 
acting factor (ITAF) complex (Gerbasi and Link 2007). To date, no direct in vivo or 
in vitro evidence has emerged, which has demonstrated a direct relationship between 
the growth-dependent translational regulation of 5' TOP containing mRNAs and the 
binding of LA or CNBP. Whilst it is clear that both La and CNBP can interact with 
5' TOP containing mRNAs, the precise role of these proteins in the regulation of 5' 
TOP containing mRNAs is still not well defined. 
1.7.5.2 Pyrimidine-Binding Proteins 
It has been suggested that several pyrimidine-binding proteins may associate 
with the polypyrimidine tract, which is present in all 5' TOP containing mRNAs 
(Meyuhas 2000). PTB (polypyrimidine tract binding protein) is a multi-function 
protein, which preferentially binds polypyrimidine-rich regions of mRNA (Garcia-
Blanco et al. 1989). It is known that PTB often functions in combination with other 
proteins to initiate translation (Sawicka et al. 2008). For example, the combined 
action ofPTB and PCBPl (poly(rC)-binding protein 1) is required in the stimulation 
of the BAG-l (Bc1-2-associated anthanogene 1) IRES. PCBPl also known as 
heterogeneous nuclear ribonuclear protein El (hnRNP El) is involved in remodelling 
the RNA structure to allow PTB to bind (Pickering et al. 2004). hnRNP El has been 
shown to operate in conjunction with hnRNP K as a translational silencer (Ostareck et 
al. 1997). The latter selectively binds poly(C) homopolymer and has, therefore, been 
implicated in the translational regUlation of 5' TOP containing mRNAs (Matunis et al. 
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1992). It has been suggested that the over-expression of hnRNP El, hnRNP K or 
PTB does not repress the translational efficiency of reporter 5' TOP mRNA in 
growing cells and does not further repress the efficiency in amino acid starved cells 
(Meyuhas 2000). However, it should be noted that this suggestion originated in a 
review publication and was largely based upon unpublished data. To date, no direct 
evidence has been published, which has definitively proven or disproven the 
involvement of PTB in the regulation of 5' TOP containing mRNAs. Whilst this data 
appears to confirm that hnRNP El, hnRNP K and PTa are not repressors of 5' TOP 
mRNA translation, it remains unclear as to whether they are specifically required to 
initiate translation of 5' TOP containing mRNAs. 
1.8 Regulation of Gene Expression by MicroRNAs 
1.8.1 MicroRNA Function and Biogenesis 
MicroRNAs (or miRNAs) are a class of short non-coding RNAs, which are 
typically 21 to 25 nucleotides in length (Cannell et al. 2008). They are genomically 
encoded as monocistronic and polycistronic gene clusters, which are located within 
intronic regions of genes, or as independent transcriptional units (Lagos-Quintana et 
at. 2001; Lau et al. 2001; Lee et al. 2002). MicroRNAs are involved in post 
transcriptional regulation of gene expression through a mechanism, which requires 
them to bind with imperfect complimentary to their target mRNA (Pillai et al. 2007). 
Nucleotides 2 to 8 of the miRNA are known as the seed region and share Watson-
Crick base-pairing complementarity with a region that is generally located within the 
3' UTR of the target mRNA. Binding of the miRNA to the target mRNA results in 
the repression of protein production by mRNA destabilisation and translational 
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silencing (Lewis et al. 2005). Individual miRNAs may regulate a cohort of mRNAs, 
and miRNA binding sites may be conserved in several different species (Lewis et al. 
2005; Pillai et al. 2007). 
RNA polymerase 11 transcribes miRNA genes, resulting in the production of 
primary miRNA (pri-miRNA) precursors (Cai et al. 2004; Lee et al. 2004). The 
functional miRNAs are contained within pri-miRNA hairpin structures, which are 
rapidly cleaved in the nucleus by the RNase III enzyme Drosha to form pre-miRNAs 
(Kim 2005). Pre-miRNAs are stem loop structures, approximately 70 nucleotides in 
length (Figure 1.12A), which are exported from the nucleus by Exportin 5, prior to 
cleavage by a second RNAse III enzyme called Dicer (Kim 2005). The resultant 
miRNA duplexes, which are approximately 22 nucleotides in length, then undergo 
strand selection. It is currently believed that the RNA strand, which possesses the 
weakest thermodynamic stability at its 5' terminus, is the one selected for 
incorporated into a miRNA-containing-ribonucleoprotein particle (miRNP) 
(Khvorova et al. 2003). The resultant miRNP, also known as a miRNA-containing 
RNA-induced silencing complex (RISC), contains a number of protein components in 
addition to the miRNA guide strand (Figure 1.12B). This complex targets and 
inhibits proteins expression from specific mRNAs (Hutvagner and Zamore 2002) 
(Figure 1.12C). 
The RIse complex is also involved in the targeted repression of mRNAs by 
small interfering RNAs (siRNAs). siRNAs share Watson-Crick base-pairing 
complementarity with a region located within the 3' VTR of their target mRNA 
(Elbashir et al. 2001). Unlike miRNAs, the entire siRNA binds to its target mRNA, 
resulting in the degradation rather than the repression of the target mRNA mediated 
by the RISe complex (Bernstein et al. 2001). Synthetic siRNAs that have complete 
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Figure 1.12 MicroRNA Biogenesis and Function 
A) Transcription of miRNAs as pri-miRNAs occurs in the nucleus. The 
nuclease Drosha, cleaves pri-miRNAs into pre-miRNAs, which are 
exported into the cytoplasm by Exportin 5. 
B) In the cytoplasm, Dicer cleaves pre-miRNAs into mature miRNAs. 
After the process of strand selection has taken place, mature miRNAs 
form part of the RNA-induces silencing complex (RISC). 
C) The miRNA within the RISC, binds to its target mRNA. This results 
in either mRNA cleavage or translational repression, depending upon 
the level of sequence complementarity. 
';1 
3' 
sequence complementarity with a region located in the 3' UTR of a target mRNA can 
be used experimentally to reduce the expression of specific proteins, in order to 
investigate gene function. 
1.8.2 The Mechanisms of MicroRNA Mediated Translational Repression 
At present, the precise mechanism by which miRNAs mediate translational 
repression remains unclear (Cannell et al. 2008). It has been shown that mRNAs in 
which the poly(A) tail has been substituted with a histone loop, still undergo 
translational repression by miRNAs without associated mRNA destabilization (Wu et 
al. 2006). Repression has also been shown to occur prior to deadenylation and 
destabilisation, indicating that these processes take place after miRNA-mediated 
translational repression (Mathonnet et al. 2007). 
It has been shown by sucrose density gradient analysis that mRNAs repressed 
by miRNAs sediment in the subpolysomal fractions, suggesting that they are 
translationally inactive (Pillai et al. 2005; Bhattacharyya et al. 2006). It has been also 
been demonstrated that an m'Oppp cap is required at the 5' terminus of the target 
mRNA, in order for repression to occur (Bhattacharyya et al. 2006; Wang et al. 2006; 
Mathonnet et al. 2007; Wakiyama et al. 2007). Together these data led to the 
proposal that miRNAs mediate translational repression at the initiation phase of 
protein synthesis. However, this model has been challenged by experiments carried 
out using different reporter constructs. These experiments indicated that miRNA 
targeted mRNAs were associated with polysomes, despite synthesis of their 
corresponding proteins being repressed (Nottrott et al. 2006; Petersen et al. 2006). 
This suggests that miRNA mediated repression occurs post-initiation and is supported 
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by the observation that large numbers of miRNAs co-sediment with polysomes (Kim 
et al. 2004b; Nelson et al. 2004; Maroney et al. 2006). Analysis of the reporter 
constructs used in the experiments, which proposed contrasting models, led to the 
discovery that these constructs employed a different promoter element (Kong et al. 
2008). Subsequently, it has been suggested that the mechanism of miRNA mediated 
repression at the translational level, is dependent on the promoter element (Kong et al. 
2008). Specifically, it has been proposed that miRNA target mRNAs derived from 
the SV 40 (Simian vacuolating virus 40) promoter are repressed at initiation and those 
derived from the TK promoter are repressed post initiation (Kong et at. 2008). 
MicroRNA targeted mRNAs derived from the SV 40 promoter were found to shift to 
sub-polysomal fractions. However, when ribosome translocation rate was reduced by 
treatment with low dose of cycloheximide, mRNAs were found to return to 
polysomes (Kong et a1. 2008). This suggests that while an initiation block in 
translation is likely to occur, it is not complete and elongation may still occur at a 
reduced rate. In contrast, miRNA targeted mRNAs derived from the TK promoter 
were shown to be polysomally associated, indicating that miRNA mediated 
translational repression occurs at a post-initiation stage (Kong et al. 2008). 
1.S.3 The Argonaute Family of Proteins 
Investigations carried out to identify proteins associated with miRNPs, found 
that four Argonaute (AGO) proteins co-immunoprecipitate with Dicer (Sasaki et al. 
2003; Gregory et al. 2004; Chendrimada et al. 2005). Although the roles of AGO!, 
AG03 and AG04 have not been specifically detennined, AG02 appears to be a 
component of the mature miRNA (Gregory et al. 2004; Chendrimada et al. 2005). 
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AG02 has also been implicated in miRNA mediated cleavage which occurs when the 
miRNA has perfect complementarity with its target mRNA (Liu et al. 2004; Meister 
et al. 2004). Reporter mRNA derived from the TK promoter was found to shift into 
the subpolysomal region following artificial tethering of A002 to its 3' UTR, without 
a requirement for mRNA (Pillai et al. 2005). This suggests that AG02 may be 
involved in the imposition of an initiation block on mRNA, which is normally 
repressed at a post-initiation stage. It has also been suggested that A002 interacts 
with the m70ppp mRNA cap, following its detection by affinity chromatography with 
m70-Sepharose (Kiriakidou et al. 2007). More recently however, it has been reported 
that human AG02 does not contain an eIF4E-like mRNA cap binding motif and that 
the positions of the AG02 aromatic residues are inconsistent with analogous cap-
binding modes (Eulalio et al. 2008; Kinch and Orishin 2009). 
1.8.4.1 Translational Up-regulation by Micro-RNAs 
A002 is also known as Co-eIF-2A, and has previously been implicated in 
stabilising the ternary complex and performs an essential role in translation. In direct 
contrast to its role in miRNA mediated translational repression, AG02 has been 
shown to stimulate and stabilise Met-tRNAjmet binding to eIF2 (Roy et al. 1981; 
Chakravarty et al. 1985), and antibodies prepared against homogenous Co-eIF2A 
strongly inhibited protein synthesis in rabbit reticulocytes (Chakravarty et al. 1985). 
Interestingly, despite the apparent dual function of AG02, miRNA-mediated up-
regulation of translation appears relatively uncommon. In the first reported instance, 
miR-122 was shown to regulate hepatitis C virus replication (Jopling et al. 2005). It 
has also been shown that miRNAs can stimulate translation when cells enter 
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quiescence. It has been determined that translational stimulation is mediated by the 
binding of AG02, and FXRl, a second RIse associate protein, to the 3' UTR of the 
target mRNA (Vasudevan et aI. 2007). 
1.8.4.2 MicroRNA-lOa Enhances the Translation of 5' TOP containing mRNAs 
More recently, it has been reported that miR-IOa binds to the 5' UTR of 
mRNAs that encode ribosomal proteins and enhances their translation (Orom et aI. 
2008). In this study, biotin-tagged miR-IOa was transfected into cells and affinity 
purification was carried out using Streptavidin beads and purified mRNAs were then 
identified using cDNA micro array analysis. It was found that miR-lOa co-purified 
with a specific subset of mRNAs, which were not found to be enriched by any of the 
control miRNAs used in the experiment. In particular, 55% of the most enriched 
mRNAs were known 5' TOP containing mRNAs, which encoded proteins involved in 
protein biosynthesis including the RPs (Orom et al. 2008). Subsequent analysis of the 
radio-labelled methionine incorporation following miR-IOa transfection revealed that 
miR-IOa significantly increased the synthesis of ribosomal proteins. Using a primer 
extension assay to map the site at which miR-IOa interacted with mRNAs that encode 
RPs, it was determined that this site was located within the 5' UTR of the target 
mRNA. Interestingly, it was found that complete binding of the miR-IOa seed region 
to the 5' UTR of the target mRNA was not required to achieve translational regulation 
(Orom et al. 2008). 
In the context of 5' TOP mRNA translation, it has been shown that miRIO-a 
can alleviate the translational repression imposed upon 5' TOP containing mRNAs 
following amino acid starvation (Orom et al. 2008). The requirement for the 5' TOP 
motif has also been specifically demonstrated, by the observation that miR-IOa 
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mediated translational enhancement does occur when mutagenesis is carried out 
within the 5' TOP region of reporter mRNAs. It has also been shown that the 
translational enhancement imposed by miR-I0a is rapamycin sensitive, which 
suggests that mTOR signalling pathway may also be involved in the miR·I0a 
mediated translational regulation of 5' TOP containing mRNAs (Orom et al. 2008). 
This is in agreement with data which has also implicated the mTOR signalling 
pathway in the translational regulation of 5' TOP containing mRNAs (Jefferies et al. 
1997). 
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1.9 Project Aims 
Since the discovery almost three decades ago of the 5' TOP containing 
mRNAs that are regulated in a growth dependent manner, only limited progress has 
been made towards identifying the mechanism by which their regulation occurs at the 
translational level. Although it has been proposed that the PI3K and mTOR signalling 
pathways are involved in the translational regulation of 5' TOP containing mRNAs, 
the precise mechanism by which these pathways signal to these containing mRNAs 
remains undefined. Furthennore, several trans-acting factors have also been 
implicated in the regulation of 5' TOP containing mRNAs, without a clearly defmed 
mechanism of how they are involved, or indeed the location at which they bind. 
The aims of this project were: 
1) to develop a 5' TOP mRNA reporter vector that would facilitate the direct 
investigation of the proteins that are associated with 5' TOP containing mRNAs; 
2) to use affinity purification to obtain 5' TOP containing mRNAs and associated 
proteins and to directly identify these proteins using both mass spectroscopic analysis 
and western blotting; 
3) to investigate the role of the mTOR and PI3K signalling pathways in this 
experimental system; 
4) to use the 5' TOP reporter constructs developed in this study, to investigate the 
canonical initiation factors requirements of 5' TOP containing mRNAs. To date, 
there have been no direct attempts to characterise the involvement of the canonical 
initiation factors in the translation of 5' TOP containing mRNAs. 
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Chapter Two 
Materials and Methods 
2.1. General Reagents 
2.1.1 Reagents and Equipment Suppliers 
Unless otherwise stated, all chemical reagents were of analytical grade and 
were obtained from BDH laboratory supplies (Lutterworth, Leicestershire), Fisher 
Scientific (Loughborough, Leicestershire), ICN Flow Ltd (Thame, Oxfordshire), 
Oxoid (Unipath, Basingstoke, Hampshire) or Sigma Chemical Company Ltd (Poole, 
Dorset). Products for molecular biological techniques were routinely purchased from 
Ambion (Huntingdon, Cambridgeshire), Calbiochem (clo CN Biosciences UK, 
Beeston, Nottingham), Gibco-BRL (Paisley, Scotland), MBI Fermentas (clo Helena 
Biosciences, Sunderland, Tyne and Wear), New England Biolabs (NEB)(C/o CP 
Labs, Bishops Stortford, Hertfordshire), Perbio (Tattenhall, Cheshire), Pharmacia 
Biotech (Milton Keynes, Buckinghamshire), Promega (Southampton), QIAGEN 
(Crawley, West Sussex), Roche UK Ltd (Lewes, East Sussex), Sigma-Aldrich UK 
(Cambridge), Stratagene Ltd (Cambridge), and USB (Cleveland, Ohio, USA). 
Radiolabelled chemicals were purchased from Amersham International (Little 
ChaIfont, Buckinghamshire) and NEN Dupont (Hounslow). 
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2.1.2 Antibodies 
Actin was detected with a mouse monoclonal antibody at a dilution of 1 :2000 
(Sigma). Polyc1onal rabbit antibody against PTB was raised in the lackson 
laboratory. Rabbit antibodies to eIF4E, eIF4G (dilution 1:5000) and eIF4A were 
kindly provided by Dr. Simon Morley of the University of Sussex. 4E-BP, 4E-BP-
Phospho, hnRNP-K, AG02 and La antibodies were purchased from Cell Signaling 
Technology (New England Biolabs). Monoc1onal anti-Flag-M2 antibody produced in 
mouse clone M2 was purchased from Sigma-Aldrich. All primary antibodies were 
used at a dilution of 1: 1 000 unless otherwise stated. Secondary antibodies raised 
against mouse and rabbit IgG and conjugated to horseradish peroxidase were obtained 
from Sigma and used at a dilution of 1 :5000. 
2.2. Tissue Culture Techniques 
2.2.1 Tissue Culture Solutions 
Phosphate buffered saline (PBS): 4.3mM Na2HP04, 1.5mM KH2P04, 137mM NaCI, 
2.7mM KCl, pH 7.4. 
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2.2.2 Cell Lines 
Cell lines were purchased from the American Type Culture Collection 
(ATCC). Details of the cell lines used can be found in table 2.1. 
Name Cell Type 
HeLa Human cervical epithelioid carcinoma 
HEK-293 Human embryonic kidney cell line 
Immortalised with adenovirus DNA 
HEK-293T Human embryonic kidney cell line 
Immortalised with adenovirus DNA and 
containing the SV 40 Large T -antigen 
Table 1.1. Descriptions of cell lines used. 
2.2.3 Maintenance of Cell Lines 
Cells were typically cultured in gamma sterilised plasticware (TPP clo Helena 
Biosciences) in Dulbecco's modified Eagle's medium, without sodium pyruvate 
(GIBCO-BRL), supplemented with 10% fetal calf serum (FCS) (Helena Biosciences) 
and 2mM L-glutamine (Sigma), under a humidified atmosphere containing 5% C02. 
Cells were grown to confluence in 75cm2 flasks, washed with phosphate buffered 
saline (PBS) and treated with Ix trypsin-0.5mM EDTA solution (GIBCO-BRL). Cells 
were resuspended in fresh medium pre-incubated at 37°C, and approximately 1 x 106 
cells re-seeded into new 75cm2 flasks. 
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2.2.4 Transfection of Cell Lines 
Transfections were routinely carried out in 6 or 24 well plates. The following 
quantities are stated per well for 6 well plates, a six-fold reduction of all reagents and 
DNA was used for each well in 24 well plates. 
2.2.4 Fugene-6 Mediated DNA Transfection 
Cells were transfected using FuGene 6 (Roche) as specified by the 
manufacturer. Approximately 20 hours prior to transfection, 1 X 10s cells were seeded 
into each well of a 6-well plate in 1 mL of complete media. 3 JlL of Fugene-6 was 
added to 97 JlL of serum-free DMEM media per well and incubated at room 
temperature for five minutes, following which the solution was added to 1 J..lg of TOP 
plasmid DNA in combination with other plasmids as described in the results chapters. 
The DNAlFugene-6 reaction mixture was incubated for a further fifteen minutes at 
room temperature and added drop wise to the cells. Cells were harvested 40 hours 
after transfection. Unless otherwise indicated, all transfections were performed in 
duplicate. Error bars represent standard deviations of three independent experiments. 
2.2.5 Serum Starvation 
To induce growth inhibition by serum starvation, cells were transfected as 
before. 24 hours post-transfection, the medium was aspirated and cells washed 
extensively with PBS to remove serum. The medium was replaced with fresh medium 
containing 10%, or 0.1% or serum. Cells were grown for a further 18 hours (unless 
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otherwise stated) and the medium was replaced with fresh medium containing 10% 
serum for 4 hours (unless otherwise stated) prior to harvesting. 
2.3. Bacterial Methods 
The bacterial strain used for most manipulations was Escherichia coli strain 
JMI09: eI4-(mrcA)recAI, endAI, gyr A96, thi-I, hsdRl7, supE44, relAI, A(lac-
proAB), F', traD36, proAB, lacZAMIS 
The BL2I(DE3) strain of E.coli was used for production of recombinant 
proteins: r, ompT, hsdSs, (rs", mB"), dcm, gal 
The INVllO strain of E.coli (Invitrogen) was used for transformation of 
plasmids containing XbaI restriction sites which were used for cloning: F' (traD36 
proAB lacIq lacZDM15) rpsL (StrR) thr leu endA thi-I lacY galK gaiT ara tonA tsx 
dam dcm supE44 D(lac-proAB) D(mcrC-mrr)I02::TnIO (TetR) 
2.3.1. Preparation of Competent Cells 
A single bacterial colony was inoculated into 2.5 mL of LB medium and 
incubated overnight at 37°C in a shaking incubator. The entire overnight culture was 
used to inoculate 250 mL of LB medium supplemented with 20mM mgS04. The 
culture was incubated at 37°C in a shaking incubator until AS9S = 0.4-0.6. Cells were 
pelleted by centrifugation at 4S00x g for 5 min at 4°C. The pellet was resuspended in 
100 mL ice-cold filter sterile TFB 1 (30mM Kac, 10mM CaCh, 50mM MnCh, 
100mM RbCI, 15% (v/v) glycerol, adjusted to pH 5.8 with IM acetic acid). The 
solution was incubated on ice for 5 min. Cells were pelleted as before and 
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resuspended in 10 mL of ice-cold filter-sterile TFB2 solution (ImM MOPS, 75mM 
CaCh, 10mM RbCI, 15% (v/v) glycerol, adjusted to pH 6.5 with IM KOH), incubated 
on ice for 1 hour. 200 J.lL aliquots of cells were snap frozen in liquid nitrogen or dry 
ice/isopropanol and stored at -80°C. 
2.3.2. Transformation of Competent Cells 
lOng of plasmid DNA or ligation products were incubated on ice. Competent 
cells were thawed on ice and 50 J.lL added to the DNA. Incubation was continued for 
15-20 minutes. Cells were heat-shocked at 42°C for I minute and 150 J.lL LB medium 
added. Cells were incubated in a shaking incubator at 37°C for 45-60 minutes and 
spread on a pre-warmed LB agar plate containing ampicillin. Plates were incubated 
overnight at 37°C. 
2.4. Molecular Biology Techniques 
2.4.1. Buffers and solutions 
TE: 10mM Tris-HCI pH 8.0, ImM EDTA 
• X T AE: 40mM Iris, 40mM acetic acid, ImM EDIA, pH 8.0 . 
• X THE: 89mM Iris base, 89mM boric acid, 2.5mM EDTA, pH 8.0. 
S X TBE loading buffer: 50% (v/v) glycerol, 200mM Tris, 200mM acetic acid, 5mM 
EDTA, 0.1 % (w/v) bromophenol blue, 0.1 % (w/v) xylene cyanol. 
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DNA sequencing formamide loading dye: 100% deionised fonnamide, 0.1 %(w/v) 
xylene cyanol FF, 0.1 %(w/v) bromophenol blue, ImM EDTA. 
2.4.2 Plasmids Used 
The vector pcluc-MS2x3 was kindly supplied by Dr. Mark Stoneley, 
University of Leicester. pSilencer31, pSilencer-31M, pcDNA3.1-eIF4Glf-WT, 
pcDNA3.1-eIF4Glf-M, pcDNA3.1-eIF4Glf-eIF4E were the kind gift of Dr. M. J. 
Coldwell (University of Southampton) and Dr. S. J. Morley (University of Sussex). 
The construct pSL-MS2-12X was a kind gift from Prof. Robert H. Singer, Albert 
Einstein College of Medicine, Yeshiva University. Flag-MS2 mammalian expression 
vector was a kind gift from Dr A. Marcello, Laboratory of Molecular Biology, 
ICGEB, Trieste, Italy. pGL3-control vector was purchased from Promega. 
2.4.3 Purification of Nucleic Acids 
2.4.3.1. Determination of Nucleic Acid Concentrations 
The concentration of RNA, DNA and oligonucleotides were detennined 
spectrophotometrically by measuring absorbance at 260nm or alternatively, in the 
case of DNA, by comparison to a known concentration of DNA separated on an 
agarose gel. 
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2.4.3.2. Phenol-Chloroform Extraction 
To separate nucleic acids from contaminating proteins, phenol-chIoroform 
extraction was performed. An equal volume of phenol was added to nucleic acid 
solution, followed by an equal volume of chIoroform:isoamyl alcohol (24:1) and 
centrifuged at 12,000x g for 15 minutes. The aqueous phase was removed to a new 
eppendorf and an equal volume of chloroform:isoamyl alcohol (24:1) added. The 
mixture was centrifuged at 12,000x g for 3 minutes and the aqueous layer removed to 
a new tube prior to precipitation of the nucleic acid. 
2.4.3.3. Ethanol Precipitation of Nucleic Acids 
Nucleic acids were precipitated by addition of 0.1 volumes of 3M NaAc, pH 
5.2 and 2 volumes of absolute ethanol, incubated on ice for 15 minutes. DNA was 
pelleted by centrifugation at 12,OOOx g for 15 minutes. The pellet was washed with 
70% ethanol to remove excess salt, air-dried and re-suspended in sterile deionised 
water. 
2.4.4.1 Agarose Gel Electrophoresis 
Electrophoresis through agarose gels was carried out to separate nucleic acids 
according to molecular weight. For the majority of manipulations, agarose was melted 
in 1 X TBE buffer, unless DNA fragments were to be eluted, in which case 1 X T AE 
gels were prepared. 2 JlL of 10 mgl mL ethidium bromide was added to the melted 
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agarose gel solution and the gel was cast in a gel tray. Samples were mixed with 5 X 
TBE loading buffer and loaded into the gel. Gels were run submerged in 1 X TBE or 
1 X T AE buffer in a horizontal electrophoresis tank, typically at 1 OOV, and visualised 
on a DV trans-illuminator. 
2.4.4.2 Purification of DNA from Agarose Fragments Using Glass Wool 
To obtain purified DNA from Agarose gel fragments, the fragment was placed 
on top of a small amount of glass wool in a 0.5 mL Eppendorf tube. A hole was made 
in the bottom of a 0.5 mL Eppendorf using a needle, and this Eppendorf placed into a 
large 1.5 mL Eppendorf. The lid was closed on the small Eppendorf and the lid was 
removed from the larger Eppendorf. Following centrifugation at 12,000x g 10 mill, 
the supematant was transferred to a 1.5 mL tube and the 0.5 mL Eppendorf was 
discarded. The DNA was extracted by phenol-chloroform extraction and ethanol 
precipitated. This method was used to obtain DNA that was sent for sequencing and 
as the method of first choice for obtaining DNA to be used in ligation reactions. 
2.4.4.3 Purification of DNA from Agarose Gels 
DNA fragments were excised from agarose gels and purified using a Qiaquick 
spin column (Qiagen). 3 volumes of buffer QG were added to the gel slice and the 
solution melted at 55°C. The gel solution was added to a Qiaquick spin column and 
bound by centrifugation at 12,000x g for 1 minute. DNA fragments were washed with 
buffer PE by centrifugation and last traces of buffer removed by an additional 
centrifugation as before. DNA was eluted in 30 J.lL of sterile deionised water by 
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incubation on the column for one minute prior to centrifugation. Due to expense, this 
method was only used to obtain DNA for use in ligation reactions when poor yield 
was obtained following purification using the glass wool method (section 2.4.4.2). 
2.4.5.1 Oligonucleotide Synthesis and Purification 
Oligonucleotides (Table 2.2) were synthesised by Promega at a scale of 
0 . 2 ~ M . . Concentration determined by absorbance at 260nm (section 2.4.3.1). 
Oligonucleotides were then re suspended in 1 00 ~ L L H20. 
Name Sequence 
Primers Used For Cloning 
rpS6 F 
rpS6RV 
3xMS2F 
3xMS2RV 
S'-CGTTCAGGTGCTTCAAGATG -3' 
S'-GGAAAGTCTGCGTCTCTTCG -3 
S'-TAGGTGACACTATAGAATAGGGCCC ·3' 
S'-GGAATTCTAGAGATATCGTACACC ·3' 
Primers Used For Mutagenesis 
Mout F 5' - ATCGATAGGTACCGAGCTCTT - 3' 
Mout RV 5' - AACGGACATTTCGAAGTACTCA - 3' 
MtrctF 
MtrctRV 
MmirF 
MmirRV 
S'-AGCGGAAGTTGGCCGACTTTTCCGTGGCGG -3' 
S'-GCGCCACGGAAAAGTCGGCCAATTCCGCT -3' 
5'-CGCCTCGGTCCCGTTCAGCT -3' 
5'·AGCTGAACGGGACCGAGGCG -3' 
Primers Used For Quantification of5' mRNA End Using qPCR 
qRLM all F 5' - CGTTTGCTGGCTTTGATGAA - 3' 
qRLM top F 5' - TTGCTGGCTTTGATGAAACCT ·3' 
qRLM mut F 5' - TGCTGGCTTTGATGAAACGA ·3' 
qRLM top F· 5'· GTTTGCTGGCTTTGATGAAACTC ·3' 
qRLM mut F· 5' - CGTTTGCTGGCTTTGATGAAAGA - 3' 
Primers Used For PCR Prior To T7 RNA Transcription 
T7F 5'-TAATACGACTCACTATAGGGAAGTTGGCCC -3' 
Control RV 5' - GCGGCCGTTACTAGTGGAT ·3' 
MS2 RV 5' - ATGTATCTTATCATGTCTG - 3' 
Table 2.2 Oligonucleotides used for Cloning and Sequenclng 
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2.4.5.2 Polymerase Chain Reaction (PCR) 
PCR reactions were perfonned using 100 ng of template in a reaction 
containing IX KOD buffer 1 (Novagen), 125 ng of each primer, 0.2mM dNTPs, IM 
Betaine, 2% (v/v) DMSO, 2 mM mgCh and 2 units KOD DNA polymerase 
(Novagen). Reactions were performed in a Techne TC512 Temperature Gradient 
thermal cylinder. DNA was denatured at 94°C for three minutes and then subjected to 
cycling by denaturing at 94°C for 1 minute, annealing at a gradient of the 
oligonucleotide melting temperature +/- 5°C for 2 minutes and extending at 72°C for 
1 minute. The reaction was cycled for 35 cycles and finally extended for 10 minutes at 
72°C. 
2.4.5.3 peR Mutagenesis 
Mutagenic PCRs were carried out by perfonning two half-reactions using the 
standard PCR procedure (section 2.4.5.2). The regions 5' and 3' of the mutation to be 
introduced into the rpS6 5' VTR were amplified using the primer pairs Mout Ft Mtrct 
RV and Mtret Ft Mout RV. PCR products were gel isolated and 1 ~ L L of a 11500 
dilution of each product was used as the template for a PCR reaction using the primer 
pair Mout Ft Mout RV. The mutant rpS6 5' VTR produced was digested with Sac! 
and BstBI and ligated into the vector pRF. 
2.4.6 Restriction Enzyme Digestion 
DNA was digested with restriction enzymes using buffers and quantities 
recommended by the manufacturers. The reaction volume was typically 1 0-50 ~ L L and 
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the reaction mixture was incubated at the recommended temperature for 1-2 hours. 
For digests with restriction sites occurring close to one another or requiring different 
buffers, the DNA was incubated with one enzyme, the enzyme deactivated by heat 
inactivation at 65°C for 10 min and the DNA extracted by phenol-chloroform 
extraction, ethanol precipitated and incubated with the second enzyme. Following the 
digestion period, the restriction enzymes were deactivated as before. 
2.4.7 Alkaline Phosphatase Treatment of DNA for Subdoning 
Prior to Iigation, linearised plasmids were treated with calf intestinal alkaline 
phosphatase (ClAP) to remove the 5' phosphate in order to prevent re-annealing of 
the plasmid vector. Dephosphorylation was performed in a final reaction volume of 
50 J.lL with 1 unit of ClAP and 1 X ClAP buffer (MBI Fermentas). The reaction 
mixture was incubated at 37°C for 15 min followed by 15 min incubation at 56°C. 
The reaction was terminated by heat inactivation at 75°C for 10 min. 
2.4.8 Ligations 
1 J.lL of restriction digested, phosphatased vector was added to differing 
concentrations of insert with corresponding sticky ends. 2J.lL "Ligafast"TM rapid 
ligation buffer (Promega) and 2.5 units ofT4 DNA ligase (Promega) were added to a 
final volume of 10 J.lL with sterile water. Ligations were incubated at 16°C for 3-16 
hours. Reactions were terminated by heat inactivation at 65°C for 10 minutes. 5 J.lL of 
the ligation reaction mixture was used to transform competent E.coli. 
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2.4.9 Fill-in of Recessed 3'-termini of Double-stranded DNA Using Klenow 
Restriction digested DNA (0.1-4Jlg) was dissolved in 10-15 JlL of water. 
Klenow fragment (1JlL), 2mM dNTP mixture (0.5JlL) and lOx Klenow Reaction 
Buffer (2JlL) were added to the dissolved DNA. The volume was made up to 20 JlL 
with water, and the mixture incubated at 37°C for 10 minutes. The reaction was 
stopped by heating at 70°C for 10 minutes. The DNA was purified as necessary. 
2.4.10 Preparation of Plasmid DNA 
2.4.10.1 Mini-preparations 
A single colony of E.coli transformed with plasmid DNA was grown in 5 mL 
ofLB medium containing ampicillin for 12-16 hours in a 37°C shaking incubator. 1.5 
mL was subsequently pelleted by centrifugation and the pellet resuspended in 100 J.1L 
of ice-cold solution I (2SmM Tris-HCI, 10mM EDTA, SOmM glucose, pH 8.0). The 
mixture was incubated for 5 minutes at room temperature after which 200 JlL of fresh 
solution 11 (1 % (w/v) SDS, 0.2M NaOH) was added and the solution mixed gently 
prior to incubation on ice for 5 minutes. 150 JlL of solution III (7.5M NH4Ac, pH 7.6) 
was added and the mixture vortexed before incubation on ice for 5 minutes. 
Precipitated cell debris was pelleted by centrifugation at 12,000x g for 5 minutes and 
the supernatant removed to a fresh tube. Plasmid DNA was ethanol precipitated, 
washed in 70% ethanol, air-dried and re-suspended in 30 J.1L sterile deionised water. 5 
ilL of prepared plasmid DNA was digested with restriction enzymes to identify 
successful clones. 
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2.4.10.2 Maxi-preparations 
To prepare larger quantities of plasmid DNA, a 5 mL culture of E.coli 
transformed with plasmid DNA was inoculated into 250 mL of LB plus ampicillin 
medium and grown for 12-16 hours in a 37°C shaking incubator. Cells were 
subsequently pelleted by centrifugation at 5,000x g for 10 minutes at 4°C. The pellet 
was re-suspended in 6 mL of ice-cold solution I and incubated at room temperature 
for 5 minutes. 12 mL of solution II was added and the mixture incubated on ice for 10 
minutes. Neutralisation was carried out by addition of 9 mL of 7.5M NHtAc, pH 7.6 
with a further 10-minute incubation on ice. Cell debris was pelleted by centrifugation 
at 1O,000x g for 10 minutes at 4°C and the supematant removed to a new tube. The 
solution was incubated with 0.6 volumes of isopropanol for 10 minutes at room 
temperature and the pellet re suspended in 2M NJ4Ac, pH 7.4. The insoluble matter 
was pelleted and the supematant removed to a fresh tube upon which an equal volume 
of isopropanol was added and the solution incubated at room temperature for 10 
minutes. Plasmid DNA was then pelleted by centrifugation as before and resuspended 
in 1 mL of sterile water. RNA was removed by addition of 100 J.lg of RNase A and 
incubation for 15 minutes at 37°C. Contaminating proteins were removed by 
precipitation with 0.5 volumes of 7.5M NJ4Ac, pH 7.6 at room temperature for 5 
minutes and pelleted by centrifugation. The supematant was removed to a fresh tube 
and plasmid DNA was precipitated with an equal volume of isopropanol and 
centrifugation as before. The pellet was washed with 70% ethanol, air-dried and 
re suspended in 0.5 mL sterile deionised water. 
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2.4.10.3 Preparations by QiagenIWizardiP) Columns 
To produce plasmid DNA suitable for transfection, the Wizard® plasmid 
purification kit (Promega) was used to produce up to 50 ~ g g of DNA. Alternatively, 
the Qiagen midilmega kit was used to produce larger quantities of plasmid DNA 
according to the manufacturer's instructions. 
2.5 RNA Methods 
All solutions used for RNA methods were purified by passage through a 
0.2J.LM filter prior to use, unless purchased sterile and used only for RNA purposes. 
2.5.1 In vitro Run-off Transcription 
Template DNA was linearised from the appropriate plasmid by restriction 
digestion using a site downstream of the region of interest. Uncapped transcripts were 
synthesised in a reaction mixture containing 1 X transcription buffer (MBI 
Fermentas), 40 U RNAguard or RNasin, ImM ATP, ImM UTP, ImM CTP, ImM 
GTP, 1 ~ g g DNA template and 20 U T7 or T3 RNA polymerase to a fmal volume of 
50 ~ L . . The reaction mixture was incubated at 37°C for 1 hour, following which a 
further 10 units of RNA polymerase were added and the incubation continued for 30 
minutes. The DNA template was digested with 10 units of RNase-free DNase I for 15 
min at 37°C. The RNA was purified by phenol/chloroform extraction and passed 
through a Sephadex G-50 column (Amersham) to remove unincorporated nucleotide. 
The RNA was ethanol precipitated and re suspended in 50 ~ L L of sterile deionised 
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water. 5 p,L of the RNA was subjected to agarose gel electrophoresis to ensure the 
integrity of the product. 
For radiolabelled RNAs, eTP was replaced with 50 p,Ci [a)2p]CTP. For 
electrophoretic mobility shift assays, with the exception of the inclusion of 
radio labelled nucleotide and a decrease of unlabelled CTP to a final concentration of 
0.5mM, the reaction mixture was identical to that described for unlabelled transcripts. 
2.5.2 Folding RNA 
5 p,g RNA was combined with 5 p,L standard structure probing buffer, SSPB 
(lOOmM Tris-HCt pH 7.0, IM KCl). 5 p,L of 100mM MgOAc was added and the 
mixture brought to 50 p,L with sterile deionised water. The RNA was heated to 80°C 
for 3 minutes then cooled to 4°C over a one-hour period in a PCR machine. The 
mixture was then incubated at ooe for 10 minutes to allow structural equilibrium. 
2.6. Biochemical techniques 
2.6.1. ButTers and solutions 
1 X SOS sample buffer: SOmM Tris pH 6.8, 10% (v/v) glycerol, 4% (w/v) SDS, 0.1 % 
(w/v) bromophenol blue, 10% (w/v) ~ - m e r c a p t o e t h a n o l , , ImM EDTA 
SOS-PAGE resolving butTer: 1.5M Tris, 0.24% (v/v) TEMED, 1 % (v/v) SDS pH 8.8 
SOS-PAGE stacking butTer: 0.2SM Tris, 0.12% (v/v) TEMED, 0.2% (v/v) SDS pH 
6.8 
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1 X SDS running buffer: 25mM Tris, 192mM glycine, 0.1 % (v/v) SDS pH 8.3 
TBST (Tris buffered saline, Tween): 10mM Tris pH 8.0, 0.9% (w/v) NaCI, 0.1% 
(v/v) Tween 
Destaining solution: 5:1:5 methanol: acetic acid: water 
Protease inhibitors: 19 J.1g/ mL Aprotinin, 1 J.1g/ mL Leupeptin, 1 J.1g/ mL TLCK, 20 
J.1g/ mL PMSF, 20 J.1g/ mL pepstatin 
2.6.2 Harvesting Lysates from Transfected Cells 
After transfection, the medium was aspirated and cells washed twice with 
phosphate buffered saline (PBS). Lysates were prepared by incubating each well of a 
6-well plate of cells with 200 J-lL of 1 X passive lysis Buffer (promega) for five 
minutes (50 J-lL of passive lysis buffer was added per well of a 24-well plate). The 
cells were subjected to a freeze-thaw cycle at -20°C to disrupt cell membranes and the 
wells scraped with a cell scraper. Cells were removed to a tube, insoluble matter 
pelleted by centrifugation and the supematant removed to a fresh tube. In cells that 
had been subjected to cell stress! induction of apoptosis, detached cells were 
harvested from the aspirated medium by centrifugation and combined with the cell 
lysate from the same well. 
2.6.3 Luciferase Assays 
5 J.1L of lysate from transfected cells was used to assay enzyme activity. In the 
case of monocistronic constructs, the luciferase reporter assay system (promega) was 
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used. 25 J.lL of luciferase assay reagent was added to the lysate and light emission 
measured over 10s using an Optocomp I luminometer (MGM Instruments). 
For cells co-transfected with vectors expressing both firefly and Renilla 
luciferase, activities of cell lysates were measured using the dual-Iuciferase reporter 
assay system (Promega) according to the manufacturer's instructions with the 
exception that only 25 J.lL of each reagent was used. Light emission was measured as 
before. 
2.6.4 ~ - g a l a c t o s i d a s e e Assays 
p-galactosidase activity produced from the transfection control plasmid 
pJ7/acZ in celllysates was measured using a Galactolight Plus assay system (Tropix). 
5 J.1L of cell lysate was added to 25 J.1L of Galacton Plus reaction buffer (Galacton-
Plus substrate diluted 1:100 with reaction buffer diluent) and the reactions incubated 
at room temperature for 1 hour. 37.5 J.1L of Light Emission Accelerator 11 was added 
and enzyme activity measured immediately by light emission over 10s using a 
luminometer as described previously. 
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2.6.5 SDS-polyacrylamide Gel Electrophoresis (SDS-PAGE) 
SDS-PAGE gels were cast and run in a Bio-Rad Protean 11 system. 
Depending on resolution required, the following gel mixtures were prepared: 
Resolving gel Stacking gel 
% 10% 12.5% 6% 
distilled water 2.1 mL 1.7mL 1.8mL 
resolving/stacking buffer 1.25 mL 1.25 mL 2.5mL 
30%:0.8% 1.67mL 2.1 mL 0.67mL 
acrylamide: bisacylamide 
25% 50 J.1L 50 J.1L 50 J.1L 
ammonium persulphate 
Tetramethylethylenediamine 20 J.1L 20 J.1L 20 J.1L 
(TEMED) 
Table 2.3 Recipes for SDS-polyacrylamide gels 
25% ammonium persulphate and TEMED were added last to polymerise the 
gel. Samples were denatured prior to loading by boiling at 95°C for 5 minutes. Gels 
were run in SDS running buffer at a constant voltage of 150V for approximately 1-2 
hours. 
To analyse endogenous protein levels, celllysates were prepared in 1 x SDS 
buffer supplemented with protease inhibitors and solubilised by passage through a 
25G needle. Protein extracts were heated to 95°C for 2 min prior to loading and 
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analysed by SDS-polyacrylamide gel electrophoresis (PAGE) as described above. 
Gels were typically run at a constant voltage of 150V in SDS running buffer until the 
bromophenol blue dye front reached the bottom of the gel, typically between 1-2 
hours. 
2.6.6 Transfer of Proteins onto Nitrocellulose Membranes. 
Gels were electroblotted and probed as described previously (West et al., 
1998). Briefly, cell extracts were separated by SDS-PAGE and transferred onto 
nitrocellulose membrane (Schleicher and Schuell) by semi-dry blotting in transfer 
buffer (SOmM Tris, 192mM glycine, 20% (v/v) methanol) for between 30 and 90 min 
at 10V. Protein transfer was confirmed by visualising with Ponceau-S solution (0.5% 
w/v in 5% w/v trichloroacetic acid [TCA]). 
2.6.7 Western blotting I Immunodetection 
Proteins immobilized on nitrocellulose membranes (Section 2.6.6) were 
detected immunologically using antibodies to PTB, hnRNP-K, eIF4G, eIF4E, eIF4B, 
AG02, actin or anti-Flag-M2. Binding at non-specific sites was first blocked by 
incubation of the nitrocellulose membranes in a 5% dried milk in TBST solution for 
approximately 1 hour at room temperature, with agitation. The blocking solution was 
aspirated and replaced with 10-20 mL of appropriately diluted primary antibody 
(Section 2.1.2) in 5% milk TBST solution and incubated overnight at 4°C with 
agitation. Excess antibody was removed by washing for 10 minutes with TBST, 
repeated 3 times. Membranes were incubated with peroxidase-conjugated secondary 
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antibodies raised against mouse immunoglobulins (Dako AlS) or rabbit 
immunoglobulins (Sigma) diluted 1:2000 and 1: 10,000 respctively, for 1 hour at 
room temperature with agitation. Excess secondary antibody was removed by 
washing for lO minutes with TBST, repeated 3 times. Protein-antibody complexes 
were detected by enhanced chemiluminescence (ECL) according to a recipe kindly 
provided by Professor Ken Siddle (University of Cambridge). 1 mL of luminol 
solution (50 mg luminol [ 5 - a m i n o ~ 2 , 3 - d i h y d r o - l , 4 - p h y h a l a z i n e d i o n e ] ] in O.1M Tris-
HCI pH 8.6), 10 ilL enhancer (11 mg para-coumaric acid in lO mL DMSO) and 3.1 
ilL 3% hydrogen peroxide were mixed and applied to the membrane for 60s with 
agitation. 
2.6.8 Stripping and Re-probing or Western Blots 
Nitrocellulose membranes were stripped of existing protein-antibody 
interactions by incubation in a solution of lOOmM ~ - m e r c a p t o e t h a n o l , , 2% (v/v) SDS 
and 62.5mM Tris-HCI pH 6.7 for 10 min at 50°C. Membranes were washed in TBST 
for 15 min at room temperature with agitation. The membranes were then re-probed 
with a different antibody. 
2.6.9 Measuring Protein Synthesis Rates by Incorporation of 35S Methionine 
Approximately 1 X 105 cells were seeded into each well of a 6-well plate and 
incubated at 37°C in a humidified atmosphere containing 5% C02. The media was 
aspirated and the cells washed 3 X with PBS before adding 1 mL of methionine-free 
media supplemented with lO% (v/v) dialysed fetal calf serum. 10 IlCi of 35S_ 
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Methionine was added to each well, in addition to the appropriate concentration of 
vincristine or cisplatin, as denoted in the text, as required. For concentration-
dependence experiments, cells were incubated for a further 24 hours. Cells were 
harvested by washing 3 X with PBS, scraped using a cell scraper and re suspended in 1 
mL of 10% TCA. Cell suspensions were stored at -80°C. To assay methionine 
incorporation, cell suspensions were filtered onto Whatman glass fibre filter paper 
circles, washed thoroughly with ice-cold 10% TCA and air-dried. Dried papers were 
placed in scintillation vials with 5 mL scintillation fluid and methionine incorporation 
was measured by counting for 1 minute using a scintillation counter. 
2.6.10 Affinity Purification of mRNA Containing MS2 Binding Sites Using Flag-
MS2 Protein and Anti-Flag M2 Agarose Beads 
Lysis of HEK-293T cells was carried out using a modified lysis buffer (Tris-
HCt pH 8.0, 50 mM; Igepal (Sigma) 0.5%; NaCl 150 mM; EDTA 1 mM; MgCh 5 
mM; protease inhibitor mix (PIM) (Roche); DIT 1 mM) and by passing through a 27 
gauge needle. In order to reduce background non-specific binding, the lysate was 
first incubated with Protein NG PLUS-Agarose (Santa Cruz Biotech), supplemented 
with normal mouse serum (Santa Cruz Biotech). The cleared lysate was then 
incubated for 4 hours at 4°C with anti-Flag-M2 affinity resin. The anti-Flag-M2 
affinity resin was then washed three times with wash buffer (Tris-HCl pH 8.0, 50 
mM; NaCI 150 mM; EDT A 1 mM; MgCh 5 mM; protease inhibitor mix (PIM) 
(Roche); DIT 1 mM). Samples were eluted either using TRI reagent or SDS loading 
buffer (40 J.11). For protein analysis experiments, samples were eluted in SDS loading 
buffer. The fractions obtained from the three successive washes, were combined and 
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subjected to TCA precipitation. Following centrifugation, the protein pellets obtained 
were also re-suspended in SDS loading buffer (40 ~ l ) . .
2.6.11 Microarray Analysis of Micro-RNAs Associated with Affinity Purified 
Reporter mRNAs 
Following RNA extraction using TRI reagent (Sigma), the concentration of 
both total and affinity purified mRNA was obtained by UV-Vis spectroscopy. A 
Genisphere FlashTag microarray labelling kit was used to label RNA, in accordance 
with the manufacturer's instructions. Total RNA (2.5 ~ g ) ) was labelled using Cy5 
fluorescent dye (-650 nm excitation 1670 nm emission) and affinity purified RNA 
was labelled using Cy3 dye (-550/570 nm). Labelled samples were denatured, 
loaded microRNA micro array chips (obtained from Dr T.W. Gant, MRC Toxicology 
Unit, University of Leicester) prior to hybridisation at 45°C for 16 hours. Following 
hybridisation, the chips were scanned using an Axon Genepix 4000b scanner and a 
grid containing probe definitions was assigned by using the gridding algorithm within 
the Genepix Pro software (Molecular Devices). The algorithm assigned grid was 
visually verified and assignments corrected as necessary. The fluorescence intensities 
of the Cy5 and Cy3 dyes and the respective background were then recorded in 
preparation for data analysis. 
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Chapter Three 
Construction of a 5' terminal oligopyrimidine tract (fOP) Containing mRNA 
Luciferase reporter system 
3.1 Introduction 
A 5' terminal oligopyrimidine tract (TOP) containing mRNA is defined in 
terms of its sequence by the presence of a C residue immediately preceding the 5' 
terminal m'O cap structure of the mRNA and an uninterrupted 4-14 nucleotide 
polypyrimidine tract (Meyuhas 2000; Hamilton et al. 2006). Transcription initiation at 
a C residue occurs in 17% of eukaryotic mRNAs, although it has yet to be determined 
what proportion of these mRNAs also possess a 5' terminal oligopyrimidine tract 
(Meyuhas 2000). Despite this, many individual mRNAs have been identified which 
contain the 5'TOP motif, including those which encode proteins involved in ribosome 
biogenesis. The mRNAs encoding Ribosomal Proteins (RPs), which comprise a 
significant proportion of this group, were the first TOP containing mRNAs to be 
identified in vertebrates (Schibler et al. 1977; Geyer et al. 1982). Experimentally, 
sucrose density gradient analysis has been used to determine the translational 
characteristics of this group of mRNAs. Two distinct translational modes have been 
identified, which operate in a growth dependent manner. In growing cells, TOP 
containing mRNAs are loaded with a full complement of ribosomes and are, 
therefore, not only part of the translationally active population of mRNAs, but are 
also translated with full efficiency. In growth arrested cells however, TOP containing 
mRNAs are entirely shifted into the sub-polysomal, non-translating population 
(Loreni and Amaldi 1992). This distinct growth-associated bimodal distribution is a 
characteristic unique to TOP containing mRNAs and has proven dependency on both 
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the integrity of the eis-acting TOP motif and its immediate Cap-proximal position 
(Avni et al. 1994). The mechanism is common to all TOP containing mRNAs and 
thereby facilitates a mechanism for their co-ordinated expression. This is particularly 
important in the aforementioned case of ribosome biogenesis, which accounts for a 
large proportion of cellular energy expenditure (Wamer et al. 2001). 
3.2 TOP and Mutated-TOP Constructs 
The first aim of this project was to construct a model, which accurately 
reproduces the structural and translational characteristics of TOP containing mRNAs. 
This model can then be manipulated by mutagenesis to deduce the location and length 
requirements of the TOP motif. Additionally, such a model would present an 
opportunity for the identification of trans-acting, factors, which are specifically 
required for the growth dependent regulation of TOP containing mRNAs. This 
chapter describes the development of such a model system using reporter plasmids 
containing a firefly luciferase open reading frame. Upon transfection, mRNA is 
encoded in vivo facilitating the quantitative measurement of translational efficiency, 
by the observation of firefly luciferase expression. The use of reporter constructs 
alleviates the problem associated with exogenous transcription reactions using T3. T7 
or Sp6 RNA polymerases, which have low levels of efficiency when transcribing 
mRNA with a C residue immediately preceding the 5' terminal m'G cap structure 
(Milligan and Uhlenbeck 1989). 
The pGL3 Control vector, which contains the firefly luciferase open reading 
frame. was chosen as a starting point for the cloning of a TOP containing construct. 
A cloning strategy was devised in which the completed construct would be under the 
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control of a promoter found within an endogenous 5'TOP containing mRNA. By 
incorporating this promoter and the 5'UTR from the same TOP containing mRNA, 
the completed construct would be expected to encode mRNA with a C residue 
immediately succeeding the 5' terminal m'O cap structure and the characteristic 
uninterrupted polypyrimidine tract TOP motif. The promoter element and 5' UTR 
sequence of Ribosomal Protein S6 (rpS6) was chosen as the basis of the TOP 
construct, since rpS6 mRNA is known to contain the 5'TOP motif and this promoter 
region has been the focus of prior characterisation and analysis (Antoine and Kiefer 
1998). 
The full length rpS6 promoter has previously been shown to be approximately 
900bp in length and has been shown to include a core 40bp promoter region upstream 
of the transcription start site and initiation region (Antoine and Kiefer 1998). An 
initial attempt was made to clone the full length 900bp promoter region and rpS6 
5'UTR into the pOL3 control vector. A polymerase chain reaction (PCR) was carried 
out on cDNA obtained from HeLa cells in order to obtain a DNA fragment. 
However, despite attempts at optimising the reaction conditions, the PCR was 
repeatedly unsuccessful. As a result of this failure, the literature relating to the rpS6 
promoter was reviewed, in order to ascertain whether a modification to the cloning 
strategy was possible. 
It has previously suggested that different transcription factors from different 
cell types, may be functionally interchangeable and bind to common regions within 
the promoter (Antoine and Kiefer 1998). This would ensure high-level expression of 
housekeeping genes independently of the cell type. An experiment has been reported 
in which an attempt was made to determine the length of promoter required in order 
for transcriptional activity to be retained. Reporter constructs were made, with full· 
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length and truncated rpS6 promoter regions of differing size. The relative activity of 
these promoter regions was then determined in a variety of cell types (Antoine and 
Kiefer 1998). This study indicated that a region of 400bp immediately preceding the 
transaction start site, is the minimum promoter length required to achieve activity in 
excess of 95%, when compared to the full-length promoter (Antoine and Kiefer 
1998). For this reason, the PCR reaction was repeated with a set of primers which 
had been redesigned to amplify a 400bp promoter region and the rpS6 5 'UTR. The 
primary considerations in this cloning strategy were to maintain a system which is 
similar to endogenous conditions and to retain an unaltered transcription start site. 
The DNA fragment containing the 400bp rpS6 promoter element and 5' UTR, 
was then cloned into the pGL3 Control vector between the HindUI and the NcoI 
restriction sites, by restriction digest and ligation. The NcoI site contains the ATG 
sequence which corresponds to the AUO start codon of the in vivo transcribed mRNA, 
ensuring in-frame cloning of the 5' UTR with the firefly luciferase open reading 
frame. The simian virus 40 (SV 40) promoter was then removed by restriction digest 
using XhoI and HindIII followed by blunt end ligation. (Figure 3.1.1). Following 
cloning, sequencing was carried out, which confirmed that the construct contained 
both the 400bp rpS6 promoter region and 5' UTR, and that the SV 40 promoter was no 
longer present (Figure 3.1.2). 
The main considerations when designing a suitable control construct were to 
maintain an unaltered transcription start site and make only the minimum required 
modification to disrupt the 5'TOP motif. For this reason the 400bp rpS6 promoter 
element was maintained along with the 1 st nucleotide downstream of the 5' terminal 
m70 cap position. Carrying out mutagenesis at the 1st nucleotide downstream of the 
5' terminal m70 cap could potentially disrupts the transcription start site, thus 
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SV40 
pG13-Control 
Vector 
(5256bp) 
Xbal 1934 
TOP-Vector 
(5604bp) 
Xba I 2124 
Figure 3.1.1: Construction of TOP Vector 
Synthetic poly(A) Signal 
Kpn I 5 
Xhol 32 
SV40 Promoter 
Hind III 245 
Nco I 278 
Hind III 
Nco I 
Synthetic poly(A) Signal 
Kpn I 5 
rpS6 Promoter 
rpS6 S'UTR 
Nco I 468 
Step 1: The peR fragment containing the rpS6 promoter and 5'UTR was digested 
with Ncol and HindIJl. This fragment was ligated into the pGL3 vector, which had 
been digested with NcoI and HindIU and dephospborylated. 
Step 2: The vector was digested with Hind III and XhoI. Blunt end ligatioD was 
carried out to produce the pGL3-rpS6 construct. 
Step 3: A final cloning step was carried out to obtain the TOP construct (refer to 
Section 5.2.1 & Figure 5.1.1 for more details). 
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Figure 3.1.2: DNA equence of TOP Vector Construct 
DNA equence of TOP vector construct from base-pair 1 (refer to Figure 3.1.1) up to 
and including the V40 late poJy(A) signa\. Vector is unchanged from pGL3-
Control eclor out ide of th is region. Mutation in case of TOP-trctM ut is indicated. 
Key: 
Ribosomal Protein 6 promoter - Purple 
Ribosomal Protein 6 5'UTR - '.tn 
Firefly Luciferase coding region - (,reen 
Start (ATG) and Stop (T AA) codons - Red 
SV40 late po\y(A) signal -
Restriction enzyme sites - Underlined 
88 
producing mRNA with an entirely different length and 5'UTR. This would not be 
suitable as a control, construct since any differences observed could not be singularly 
attributed to disruption of the 5'TOP motif. Similarly, introducing a large number of 
mutations within the 5'UTR could also result in unforeseen effects such as differences 
in binding of other non TOP-specific Irans-acting factors. It was therefore decided 
that the polypyrimidine tract element of the TOP motif should be disrupted at only 
two adjacent nucleotides. Mutagenesis was employed at the 2nd and 3rd nucleotide 
downstream of the 5' terminal m'G cap (Figure 3.2). This mutation pair was chosen 
because it interrupts the polypyrimidine tract, thus disrupting the integrity of the 
5'TOP motif, with the minimum possible modification (Figure 3.3A). The expected 
consequence of this mutation is the alleviation of the growth-dependent translational 
control that is unique to TOP containing mRNAs. 
To confirm that that new constructs were translationally active, TOP and TOP 
control (TOP-trctMut) constructs were transfected into HEK-293 cells in conjunction 
with Renilla luciferase expression vector (transfection control). This cell line was 
chosen because it has previously been used for a large range of experiments to 
investigate the characteristics of TOP containing mRNAs (reviewed in Meyuhas 
2000). The cells were harvested 48 hours after transfection and northern blotting was 
carried out to detect aclin andfirefly (reporter) mRNAs (Figure 3.3B). The cells were 
grown under control conditions throughout and were not subject to serum starvation 
or re-feeding. A dual luciferase assay was also carried out and Firefly (reporter) 
activity was normalised using the Renilla luciferase transfection control (Figure 
3.3C). These data confirmed that both constructs expressed the Firefly luciferase 
gene and were translationally active. 
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Figure 3.2: Construction of TOP-trctMut Vector 
Reaction 2 
F Luc 
1 ~ ~MoutRV 
Mutated I 
5'UTR 
~ ~
MoutRV 
BstB I 
I 
PCR Product (7S0bp) 
Nco I 468 
A. Two PCR reactions were carried out to perform the mutation using the TOP vector as a 
template. Reaction 1 used the MoutF primer and the reverse primer Mtrct RV, which 
contained the mutated sequence. Reaction 2 used the primer MoutRV and the forward 
primer Mtrct F, which contained the mutated sequence. 
B. A second PCR reaction was carried out, which used the MoutRF and MoutF primers and 
the amplified fragments as a PCR template, to produce a fragment with a mutated 
5'UTR. 
C. A restriction digest was carried out on both the TOP vector and PCR fragment, using 
Sac I and BstB I. The digested TOP vector was then dephosphorylated. 
D. The digested TOP vector and PCR fragment were ligated to produce the TOP-trctMut 
vector which contains two point mutations in the polypyrimidine tract of the 5'UTR. 
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5' UTR of TOP Vector (Human rpS6 5'UTR) 
1 
-CCTCTTTTCCGTGGCGCCTCGGAGGCGTTCAGCTGCTTCACCATG-
1 5' UTR of TOP-trctMut Vector 
-CGACTTTTCCGTGGCGCCTCGGAGGCGTTCAGCTGCTTCACCATG-
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Figure 3.3: Translational Activity of TOP and TOP-trctMut Vectors 
A. Diagrams howing the mutations introduced into the TOP 5' UTR. 
Mutated sequence in the TOP-trctMut vector is shown in orange. The 
initiation codons of each vector are shown in green. 
B. TOP and TOP-trctMut vectors were transfected in triplicate into HEK-
293 cells. The cells were harvested 48 hours after transfection and RNA 
was extracted from each replicate and combined. Northern blotting and 
phosphor-imaging wa carried out and firefly mRNA levels from one 
single experiment were normalised to actin mRNA levels. 
C. Luciferase acti ity was recorded in counts S·l from each replicate and 
normalised to TOP activity (100%). The standard deviation of the three 
replicates was used to calculate elTor values. 
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3.3 MicroRNA-lOa and the regulation of TOP and TOP-trctMut mRNAs 
MicroRNAs (miRNAs) are short single stranded RNA molecules of 21-23 
nucleotides in length, which bind to mRNAs and regulate gene expression at the post-
transcriptional level. This regulation generally takes the fonn of repression of protein 
production by destabilizing the target mRNA and translational silencing (Pillai et al. 
2005). MicroRNAs bind by means of imperfect base-pairing to target sites, which 
are commonly located within the 3' untranslated region of the target mRNA. These 
sites have sequence complementary to bases 2-8 of the miRNA, which is known as 
the seed region (Pillai et al. 2005). Individual miRNAs have been shown to have 
more than one mRNA target, and often target specific subsets of mRNAs (Pillai et al. 
2005). 
Ribosomal Protein mRNAs have been identified as a common target group for 
miRNA miR-IOa. Unusually, this miRNA has been shown to bind to the 5' UTR of 
these mRNAs immediately downstream of the 5'TOP motif. Interestingly, translation 
is enhanced upon binding, indicating that miR-IOa and the 5'TOP regulatory complex 
are functionally connected (Orom et al. 2008). As previously described, the TOP and 
TOP-trctMut constructs transcribe mRNAs, which contain the 5' UTR sequence of 
ribosomal protein S6. For this reason, the sequence of both 5'UTRs was analysed to 
identify potential miRNA-IOa binding sites. A region common to both TOP and 
TOP-trctMut was found to contain a potential miRNA-IOa binding site, with base 
pairing consistent to that previously predicted for this miRNA (Orom et al. 2008) 
(Figure 3.4A). Mutagenesis was carried out on three nuc1eotides within the potential 
binding site of both constructs but outside of the 5'TOP motif, to facilitate future 
investigation of the functionality of this site (for details of the method, refer to chapter 
2, section 2.4.5.3). Since the potential binding site did not contain a readily 
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A 
miRNA-IOa Alignment: 
~ ~ S 
GUGUUUAAGCC-UAGAUG-UCC-CAU miRNA-10a 
5' 
CCUCUtJUUCCGtJGGCGCCtJCGGAGGCGtJUCAGCUGCUUCACCAUG- Human RpS6 S'UTR 
CUCUtJUUUCGtJGACGCCtJCCCAGGCGCUCGGCUGUGUCAAGAUG- Mouse RpS6S'UTR 
B 
5'UTR of Constructs: 
CCTCTTTTCCGTGGCGCCTCGGAGGCGTTCAGCTGCTTCACCATG- TOPS'UTR 
~ ~ Mutasenesls 
CGACTTTTCCGTGGCGCCTCGGTCCCGTTCAGCTGCTTCACCATG- TOP-mirMut S'UTR 
t 
Mutation 
CGACTTTTCCGTGGCGCCTCGGAGGCGTTCAGCTGCTTCACCATG- TOP-trctMut S'UTR 
~ u t a t l o n n ~ ~ Mutasenesls 
CGACTTTTCCGTGGCGCCTCGGTCCCGTTCAGCTGCTTCACCATG- TOP-dblMut S'UTR 
t t 
Mutation Mutation 
Figure 3.4: Construction ofTOP-mirMut and TOP-dblMut Vectors 
A. Diagram showing the most probable alignment of miRNA-l Oa with the 
5'UTR of rpS6 mRNA. The aligned sequence is conserved in both 
Human and Mouse rpS6 mRNA and proposed base-pairing is indicated by 
purple and blue text. 
B. Schematic diagram showing the mutations introduced into the TOP 
5'UTR and TOP-trctMut constructs. Mutated sequences in the TOP· 
mirMut and TOP-dblMut vectors are shown in orange. The initiation 
codons of each vector are shown in green. 
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identifiable seed region, the point mutations were carried out at neighbouring 
positions to produce the longest possible region of non-complementarily. 
Mutagenesis of the TOP and TOP-trctMut constructs produced the new constructs 
TOP-mirMut and TOP-dblMut respectively (Figure 3.4B). 
To confirm that that new constructs were translationally active, TOP, TOP-
trctMut, TOP-mirMut and TOP-dbIMut vectors were transfected into HEK-293 cells 
in conjunction with Renilla luciferase expression construct (transfection control). The 
cells were harvested 48 hours after transfection and northern blotting was carried out 
to detect actin and firefly (reporter) mRNAs (Figure 3.5A). Quantification of the 
northern blots was carried out and the detected firefly (reporter) mRNA was 
normalised to the actin mRNA levels. A dualluciferase assay was also carried out 
and Firefly (reporter) activity was normalised using the Renilla luciferase transfection 
control (Figure 3.5e). 
These data confirmed that both TOP and TOP-trctMut constructs expressed 
the Firefly luciferase gene and were translationally active. Interesting, the data show 
that the mRNA levels and luciferase activity obtained from the TOP-mirMut and 
TOP-dblMut vectors, were approximately 10% of those obtained from the TOP 
vector. Whilst it is clear that both TOP-mirMut and TOP-dblMut constructs 
transcribe mRNA, they behave significantly different to the TOP-trctMut which does 
not possess the miRNA-IOa binding site. DNA sequencing of all four constructs 
confirmed that no mutations were present other than those expected. It is therefore 
possible that the relatively low mRNA levels and translational activity obtained from 
the TOP-mirMut and TOP-dblMut constructs, is related to the miRNA-lOa binding 
site mutation. It is possible that this mutation may have resulted in reduced mRNA 
stability, either as a result of abolition of the potential miRNA-l Oa binding or through 
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Figure 3.5: Translational Activity of TOP, TOP-trctMut, TOP-mirMut 
and TOP-dblMut Vectors 
A. TOP, TOP-trctMut, TOP-mirMut, and TOP-dblMut vectors were 
transfected in triplicate into HEK-293 cells. The cells were harvested 48 
hours after tran fection and RNA was extracted from each replicate and 
combined. Northern blotting was carried out on the combined extract. 
B. Quantification of firefly mRNA was carried out following detected by 
Northern blotting and phosphor-imaging. Values from one single 
experiment were normalised to actin mRNA levels. 
C. Luciferase activity was recorded in counts S-1 from each replicate and 
normalised to TOP activity (100%). The standard deviation of the three 
replicates wa u ed to calculate error values. 
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a loss of secondary structure within the rnRNA. As a result of the relatively low 
translational activity of these constructs, it was decided to use the TOP-trctMut as the 
main control construct for all subsequent experirnents, since its activity was rnore 
sirnilar to that of the TOP construct. 
3.4 Transcriptional Start Site Analysis using 5' RACE 
Determination of the transcription start site is irnportant, since the key 
structural elernents of TOP containing rnRNAs are directly related to their 5' end, as 
previously described. In collaboration with Dr Mark Coldwell (University of 
Southampton), a 5' Rapid amplification of cDNA ends (RACE) technique was used 
to determine the sequence at the 5' end of the rnRNA (refer to Figure 3.6.1 for a 
schernatic diagram). Following RNA extraction using TRI reagent (Sigrna), the 
samples were treated with calf intestinal alkaline phosphatase (CIP) to remove the 5'-
phosphate group frorn degraded rnRNA, tRNA, rRNA and DNA. Full length rnRNA 
was then de-capped using tobacco acid pyrophosphatase (TAP). A synthetic RNA 
adapter of known sequence was then ligated to the exposed 5'-phosphate group, which 
was only present on the full length-de-capped transcripts. Random-prirned reverse 
transcription reactions and nested PCRs were then carried out to amplify a PCR 
product containing the sequence at the 5'-end of the rnRNA transcript (Figure 3.6.2). 
The PCR products (4S0bp) were then cloned into pSC-B (Stratagene) and positive 
clones were sequenced with a T7 prirner (Figure 3.6.3A, Figure 3.6.3B). Using the 
sequencing results, the percentage of transcripts containing the expected TOP and 
TOP-trctMut 5' UTR sequence was calculated. 
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B 5' Full length mRNA 
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Figure 3.6.1: Schematic Diagram of 5'RACE (5' Rapid amplification of cDNA ends) 
A. Following RNA extraction, samples were treated with calf intestinal 
alkaline phosphata e (CIP) to remove the 5'-phosphate group from 
degraded mRNA, tRNA, rRNA and DNA. 
B, Full length mRNA was de-capped using tobacco acid pyrophosphatase 
(TAP). 
C. A synthetic RN A adapter of known sequence was ligated to the exposed 
5'-phosphate group (only present on fulllength-de-capped transcripts). 
D. A random-primed reverse transcription reaction was carried out to obtain 
cDNA. 
E. A peR was carried out to amplify a product containing the sequence at 
the 5'-end of the mRNA transcript. (RACE F primer supplied with kit.) 
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A 
Kb 2% Agarose gel, 
3.0 NEB 2-1og ladder (10.0 - 0.1 kb), 
2.0 Loaded 10ul of each 50 III peR 
1.5 
1.2 Gel Lanes 1.0 
0.9 l. TOP inner peR 
0.8 2. TOP-trctMut inner peR 
0.7 
0.6 
0.5 3. TOP-TAP control inner peR 
0.4 4. TOP-trctMut control inner peR 
0.3 S. TOP outer peR 
0.2 6. TOP-trctMut control outer peR 
0.1 7. TOP-TAP control outer peR 
8. TOP-trctMut-T AP control outer peR 
TOP outer clone TOP-lrctMut outer clones 
2% Agarose gels, NEB 2-log ladder (10.0 - 0.1 kb) 
Figure 3.6.2: RLM-RACE PCRs of TOP and TOP-trctMut Vectors 
A. 2% Agarose gel of PCR reactions using Ambion RLM-RACE kit. An 
Improm-II kit (Promega) was used for reverse transcription and Pfu Ultra 
HS (Stratagene) for amplification. Primers were designed to produce a 
450bp product for Outer PCRs and a 350bp PCR product for inner PCR 
reactions. TAP (tobacco acid pyrophosphatase) PCR reactions using 
template without ligated adapter produced a negative result, indicating 
specific priming from within RACE adapter. (NEB 2-10g ladder 10.0-
0.1 kb. 1 OJ-lI of 50J-lI PCR reactions were loaded.) 
B. Presence of clones in pSC-B (Stratagene) was confmned by EcoRI 
restriction digest. Positive clones from the lanes labelled in red, were 
sequenced with a T7 primer. (2% Agarose gels, NEB 2-1og ladder 10.0-
0.1 kb.) Work c8JTied out in collaboration with Dr. M. Coldwell, University of Southampton 
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CCGRCTTTTCCGTGGCGCCTCGGRGGCGTTCRGCTGCTTCRCCRTG 
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GRCTTTTCCGTGGCGCCTCGGRGGCGTTCRGCTGCTTCRCCRTG 
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Figure 3.6.3: Sequencing Analysis of TOP and TOP-trctMut Vectors 
Positive TOP clones CA) and TOP-trctMut clones (B) were sequenced with a 
T7 primer. The equence from the host vector and the RNA linker was 
removed prior to sequence alignment. Sequence in red is the 5'UTR and 
ATG start codon downstream of the mutated region. Sequence shown in blue 
is the expected first nucleotide succeeding the cap structure and/or the 
correctly mutated (TOP-trctMut) or un-mutated (TOP) second and third 
nuc1eotides. 
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Sequencing data from the PCR products obtained from TOP RACE clones, 
indicated that 75% contained a C-residue immediately downstream of the 5' terminal 
m70 cap and an uninterrupted polypyrimidine tract. All of these sequences however, 
did not contain the first expected 5' C-residue. Of the remaining TOP clones 
sequenced, 17% contained as' terminal C-residue but did not contain the first three 
expected nucleotides at their 5' Terminus. The data suggests that the majority of TOP 
transcript mRNA possess the expected 5'TOP characteristics. Analysis of PCR 
products obtained from TOP-trctMut RACE clones, indicated that 100% contained 
the polypyrimidine tract mutation expected. Of these, 62% contained this sequence at 
their immediate 5' terminus. This indicates that the majority of TOP-trctMut 
transcripts do not conform to the structural requirement of 5'TOP containing mRNAs. 
To independently validate this data, qPCR was carried out in collaboration 
with Dr Mark Coldwell (University of Southampton), to quantify the sequence of the 
mRNA 5' terminus. The data obtained from both sequencing and qPCR analysis is 
consistent and therefore provides a high level of confidence, that both TOP and TOP-
trctMut constructs produce TOP containing and non-TOP containing transcripts 
respectively (personal communication, Dr M. Coldwell). 
3.5 Determination of protein synthesis rate using in vivo 35S-methionine radio-
labelling 
In response to serum starvation and re-feeding, it is known that TOP 
containing mRNAs move from sub-polysomes onto polysomes (reviewed in Chapter 
1). It is therefore important to determine the time-frame in which serum-starved cells 
respond to serum re-feeding, so that experimental conditions can be optimised. A 
100 
common technique employed to obtain this information is to monitor the level of 
protein synthesis within cells after a period of nutrient stimulation. This data is 
obtained by recording the amount of radio-labelled 3sS-methionine that is 
incorporated into total cellular protein in vivo. 
Previous experiments investigating the response of 5'TOP containing mRNAs 
to cell starvation and re-feeding have utilised HEK-293T cells and the HEK-293 cell-
line from which HEK-293T cells are derived (Meyuhas et al. 1997; Stolovich et al. 
2002). Unlike HEK-293 cells, HEK-293T cells contain the SV40 Large T-antigen 
which facilitates episomal replication of plasmids containing the SV 40 origin of 
replication. This SV40 origin of replication is present in both TOP and Mut-TOP, 
facilitating their amplification and extended temporal expression (Dean, Bullock, 
1987). For this reason, the HEK-293T cell-line was chosen for use in this and all 
future experiments. 
HEK-293T cells were plated onto 6 well plates and serum starved for 18 hours 
in DMEM supplemented with 0.1 % Foetal calf serum (FCS). It has previously been 
shown that a serum re-feeding period of 3 hours is sufficient for HEK-293 cells to 
recover from serum starvation (Stolovich et al. 2002). For this reason HEK-293T 
cells in this experiment were re-fed over a 4 hour time course, with DMEM 
supplemented with 10% FCS. This time course incorporates the previously described 
conditions with an additional 1 hour extension to accommodate any differences, either 
in the incubation conditions, or between the HEK-293 and HEK-293T cell lines. For 
the final 30 minutes of each incubation 10 J,lCi 3sS-methionine was added in DMEM 
supplemented with 10% FCS. On completion of the time course, cells were 
harvested, precipitated in 25% Trichloroacetic Acid (TeA), washed and transferred to 
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Figure 3.7: 3 ~ S SMethionine Incorporation in HEK-293T Cells 
HEK-293T cells were plated onto 6 well plates and serum starved for 18 
hours in DMEM supplemented with 0.1% Foetal calf serum (FCS). 
Following starvation, cells were re-fed over a time course with DMEM 
supplemented with 10% FCS. For the final 30 minutes of each incubation, 
3sS-methionine was added to DMEM supplemented with 10% FCS. The cells 
were harvested and precipitated with 25% Trichloroacetic Acid (TCA). After 
washing with 10% TCA containing non-radio-Iabelled methionine, followed 
by IMS and Acetone, the samples were transferred to filter paper and dried. 
The samples were then placed in scintillation count bottles, scintillation fluid 
was added and a continuous count was carried out for 60 seconds per sample. 
The experiment was carried out in triplicate and standard deviation of the 
three replicates was used to calculate error values. 
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filter paper. After drying, scintillation fluid was added and a continuous count 
carried out using a scintillation counter for 60 seconds per sample (Figure 3.7). 
The data shows that when HEK-293T cells are re-fed with DMEM 
supplemented with 10% FCS, the recovery from serum-starvation is not complete 
after 3 hours. The difference observed in the 3sS-methionine incorporation between 
the starved and 3 hour time-point is within experimental error. It is likely that the 
differences between the HEK-293 and HEK-293T cell lines, or within the incubation 
conditions themselves, are responsible for the increased recovery time compared to 
the previously described conditions. After 4 hours, the rate of protein synthesis was 
approximately double that of starved cell conditions. For this reason the 4 hour time-
point was chosen as the re-feeding period for use in further experiments. 
3.6 Translational Profiling Using TOP and TOP-trctMut Constructs 
Growth dependent expression has already been introduced as a key 
characteristic of TOP containing mRNAs. For this reason, it was necessary to 
investigate whether the TOP construct produced mRNAs that were regulated in a 
growth dependent manner. Similarly it was also important to confirm that the 
mutations used to generate the TOP-trctMut construct were sufficient to relieve the 
growth dependent translation control. TOP and TOP-trctMut constructs were 
transfected into HEK-293T cells. After a period of 24 hours following transfection, 
the cells were starved for 18 hours, with or without re-feeding for 4 hours prior to 
harvesting. The cells were lysed and cytoplasmic extracts were loaded onto sucrose 
density gradients (50-10%) and after ultra-centrifugation (153000 x g for 2 hrs at 4°C 
in a Sorvall TH-641 rotor and stored at 4°C) the samples were fractionated, treated 
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Figure 3.8: Translational Profiling of StarvedIRe-fed HEK-293T Cel1s 
A. HEK 293T Cells were transfected with either TOP or TOP-trctMut constructs 
and incubated for either 18hr in conditions of serum starvation (0.1 % FCS), or 
18hr erum tarvation (0.1 % FCS) followed by 4hrs of serum replenishment 
(10% F ). Graphs show UV absorbance data as recorded during fractionation 
of ucro e den ity gradients. Northern blotting for firefly and actin mRNA was 
carried out. 
B. Quantification of firefly mRNA, as detected by Northern blotting and phosphor-
imaging. 
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with DNAseI to remove plasmid remaining from the transfection and subjected to 
northern blotting (Figure 3.8A). 
The UV absorbance data obtained from the sucrose density gradients, show 
that compared to the starved cells, the proportion of mRNAs associated with 
polysomes increases when the cells are re-fed prior to harvesting. The polysomal 
profiles obtained for both sets of re-fed cells are similar, although there appears to be 
less material recovered in the case of the cells transfected with the TOP-trctMut 
construct. This is unlikely to affect the trend in the data, as the quantification of the 
northern blot data is expressed as a percentage of total recovered material (Figure 
3.8B). In the case of cells which were serum starved but not re-fed, there is a more 
obvious difference between the two polysome profiles. The polysome profile 
obtained for cells transfected with the TOP construct contains a more clearly defined 
40S ribosomal peak than that obtained for cells transfected with the TOP-trctMut 
vector. Since these vectors are not expected to affect translation on a global level, this 
difference is unexpected and could indicate a potential problem with either set of 
transfected cells. It should be noted that this was a single experiment and that further 
repetition would increase the confidence in the data and help to determine whether the 
difference observed was significant. 
Analysis of the data obtained from northern blotting, indicates that TOP 
containing mRNA in the nutrient stimulated cells is predominantly associated with 
polysomes. In serum-starved cells TOP mRNA is almost entirely associated with 
sub-polysomal particles (Figure 3.8B). Previous experiments investigating the 
response of TOP containing mRNAs to serum-stimulation have considered the shift 
from combined sub-polysomal fraction to combined polysomal fractions (Meyuhas 
2000). If it is therefore assumed that the clearly defined 40S ribosomal peak of the 
105 
serum-starved cell has little influence on the trend outside of the sub-polysomal 
region, this result is consistent with the characteristic growth-dependent expression of 
TOP containing mRNAs. The TOP-trctMut mRNA shows a more gradual shift from 
lighter to heavier poJysomal fractions upon re-feeding and behaves more similarly to 
the non-TOP containing mRNA actin. It would therefore appear that both TOP and 
TOP-trctMut constructs produce TOP and non-TOP containing mRNAs respectively. 
Whilst repetition would increase the confidence in the result, the data from this single 
experiment indicates that both constructs are suitable for use in a model for 
investigating of the translation of TOP containing mRNAs. 
3.7 Signalling Pathway Response 
The mTOR (mammalian target of Rapamycin) signalling pathways have been 
implicated in the translational activation of TOP containing mRNAs by a number of 
studies (GroUeau et aI. 2002)(Figure 3.9.1). mTOR functions as a subunit of two 
catalytic complexes, mTOR Complex 1 (mTORC1) and (mTOR Complex 2) 
mTORC2. mTORCl is ideally placed in the signalling pathway to effect control of 
TOP containing mRNAs, as it has been shown to be activated by stimuli including 
insulin, growth factors, serum and amino acids (Kim et aI. 2002). Inhibition of 
mTORCl has been shown to occur in response to growth factor depletion, low 
nutrient levels and treatment with Rapamycin (Kim et al. 2002). mTORCl is 
comprised of mTOR, regulatory associated protein of mTOR (Raptor), mammalian 
LST8 and PRAS40 (Kim et al. 2002). mTORCl has been shown to target p70-S6 
Kinase 1 (S6Kl) and elF4E binding protein 1 (4E-BP1), resulting in their 
phosphorylation (Hay and Sonenberg 2004). 
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Figure 3.9.1: The PI3KJmTOR Signalling Pathway 
The PI3KJmTOR signalling pathway has been previously shown to 
selectively mediate translation initiation of 5'TOP mRNA translation. The 
role of the mTOR signalling pathway in the phosphorylation of ribosomal 
protein S6, 4E-BPl, eIF4B and eIF4G, makes it ideally positioned for a 
regulatory r le in the translation initiation of TOP mRNAs. 
Figure partially adapted from: Hamilton et al. 2006. 
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Phosphorylation of RPS6 has been shown to correlate with the translational 
activation of TOP containing mRNAs and there is evidence to suggest that kinases 
S6Kl and S6K2 phosphorylate RPS6 on a number of sites in response to mitogenic 
stimuli (Fumagalli and Thomas 2000). In resting cells eIF4E remains tightly bound to 
hypo-phosphorylated members of the 4E-BP family (Sonenberg 1993a; Lin et al. 
1994; Pause et al. 1994; Gingras et al. 200 1 b). Treatment of serum-starved quiescent 
cells with growth factor or serum results in the phosphorylation of 4E-BPs and 
subsequent disassociation of 4E-BPs from eIF4E (Hay and Sonenberg 2004). The 
availability of eIF4E facilitates formation of the cap-binding complex and allows 
translational activation to occur (Sonenberg 1993a). It is known that phosphorylation 
by mTOR can occur on at least two sites within 4E-BPs and can be prevented by the 
use of Rapamycin, an mTOR inhibitor (Pull en et al. 1998; Mothe-Satney et al. 2000). 
The implications of 4E-BPI phosphorylation are discussed in more detail in Chapter 
4. It is therefore of interest to investigate the role of this pathway in the translation of 
mRNA transcribed by the TOP and TOP-trctMut constructs. 
There is mounting evidence that the PI3K (phosphoinositide 3-kinase) 
signalling pathway is also involved in the activation of TOP containing mRNA 
translation and growth factor dependence of TOP containing mRNA translation has 
been shown to be completely relieved by the use of specific inhibitors of PI3K 
(Hamilton et al. 2006). Sucrose density gradient analysis has also been carried out in 
cells in which proteins that interfere with PI3K signalling were over-expressed. Upon 
serum stimulation in these cells, the recruitment of TOP containing mRNAs to 
polyribosomes was inhibited. In growth inhibited cells, the use of constitutively 
active forms of PI3K or PKB was shown to relieve this repression and allow the 
recruitment of TOP containing mRNAs to polysomes (Hamilton et al. 2006). 
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It was of interest to determine whether the mTOR and PI3K signalling 
pathways play a role in the translation of mRNAs transcribed from the TOP and TOP-
trctMut construct. Rapamycin was used to investigate the effect of inhibiting the 
mTOR signalling pathway, whereas the PI3K signalling pathway was investigated 
using the known PI3K inhibitors Wormannin and LY294002 (Vlahos et al. 1994). 
HEK-293T cells were co-transfected (in triplicate) with either TOP or TOP-trctMut 
construct, along with a transfection control vector, which expresses p-galactosidase. 
The cells were grown under control conditions and were not subjected to serum-
starvation or re-feeding. After 24 hours cells were treated with either: Rapamycin 
(50nM); Wortmannin (lOOnM); or LY294002 (lOJlM). Following 8 hours of 
incubation, both control and treated cells were harvested and luciferase activity was 
determined (Figure 3.9.2). 
The data show that treatment with either L Y294002 or Wortmannin, resulted 
in the translational inhibition of the mRNA transcribed by both TOP and TOP-trctMut 
constructs. The difference observed between the inhibition of TOP and TOP-trctMut 
does not appear to be statistically significant as it falls within the bounds of 
experimental error. The data obtained from the L Y294002 and Wortmannin treatment 
are not consistent with the PI3K signalling pathway having a significant effect on the 
translational activation of TOP containing mRNAs. In the case of Rapamycin 
treatment, the protein expression from the TOP mRNA does appear to have been 
inhibited more than that of TOP-trctMut mRNA. The translational activity of TOP· 
trctMut mRNA itself is not statistically significant from the control, suggesting that it 
is not affected by the mTOR signalling pathway. It is therefore possible that the 
mTOR signalling pathway is involved in the translational activation of TOP 
containing mRNAs. It should be noted however that the difference observed between 
109 
140 
120 
?ft. 
-Z-
:2: 100 
... 
u 
4: 
C1I 
c,I\ 
ro 80 .... 
C1I 
-.-
'u 
:J 
~ ~
>- 60 t+= 
C1I 
.... 
u:: 
C1I 
.2 40 ... 
.!!1 
C1I 
er:: 
20 
o 
.TOP 
OTOP-trctMut 
Control Ly294002 lOIlM 
8Hrs 
Wortmannin 
lOOn M 8Hrs 
Rapamycin SOnM 
8Hrs 
Figure 3.9.2: PI3K1mTOR Signalling Pathway Inhibition 
HEK-293T cells were transfected in triplicate with either TOP or TOP-
trctMut construct. After 24 hours non-control cells were treated with either: 
Rapamycin (50nM); Wortmannin (l00nM); or LY294002 (10J.1M). The cells 
were grown under control conditions and were not subjected to serum-
starvation or re-feeding. Following 8 hours of incubation, both control and 
treated cells were harvested and a luciferase assay was carried out. Data was 
normalised to control (untreated) cell values which was set at 100% for both 
constructs. Standard deviation of three replicates was used to calculate error 
values. 
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the translation activity of TOP and TOP-trctMut mRNA following Rapamycin 
treatment, lies only just outside the bounds of experimental error. Further repetition 
of this experiment may be required in order to increase the confidence in this result. 
3.8 Discussion 
3.8.1 S' UTR Sequencing and the TOP Motif 
The data presented here indicates that the TOP construct successfully 
transcribes mRNA that contains the 5'TOP structural motif. Analysis of the 5' RACE 
data confirmed the presence of C-residue immediately downstream of the 5' terminal 
m70 cap and an uninterrupted polypyrimidine tract (Figure 3.6.3). The mRNA 
transcribed by the TOP-trctMut construct was found to contain a O-residue 
immediately downstream of the 5' terminal m70 cap in 35% of transcripts and a 
disrupted polypyrimidine tract. The remaining transcripts were also non-TOP like in 
structure (Figure 3.6.3). 
It is noteworthy that the first C-residue, which was expected, based upon the 
NCBI database data for rpS6 mRNA, is not present in the TOP transcribed mRNA 
and consequently in the TOP-trctMut transcribed mRNA. It is possible that the 
sequence data contained within the database may have incorrectly predicted the 5' 
terminus of the transcript. A common method used to determine the transcription 
start site involves DNA sequencing of the gene in combination with the extension of 
the primer of the corresponding mRNA (Sambrook 1989). In this process, reverse 
transcriptase of the annealed DNA primer takes place on mRNA transcribed from the 
gene of interest. When the 5' terminus of the mRNA is reached, the reverse 
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transcription reaction stops. If identical primers are used for gene sequencing and 
primer extension, PAGE (polyacrylamide gel electophoresis) can be employed to 
determine the nucleotide at which the primer extension terminated. This nucleotide 
coincides with the mRNA transcription site. There are many reported instances of 
inconsistent transcription start sites being reported for many families of genes. 
Examples include the Euplotes genes (Kaufmann and Klein 1992; Ghosh et al. 1994; 
Bender and Klein 1997) and tubulin genes in S. Lemnae minichromosomes 
(Skovorodkin and Gilnzl A. 1999). It has been suggested that the differing processes 
of gene sequencing and primer extension produce DNA with slightly different 
electorphoretic mobility. This could result in an incorrect alignment between the 
primer extended DNA and the reference DNA produced from the gene sequencing 
reaction (pimenov 2008). This could potentially explain the differences in the 
observed transcription start site of the TOP and TOP-trctMut, when compared to the 
transcription start site ofrpS6 mRNA contained in the NCBI database. 
The difference between the results obtained for the TOP and TOP-trctMut 
constructs from the sucrose density gradient analysis, is consistent with the proven 
dependency on both the integrity of the eis-acting TOP motif and its immediate Cap-
proximal position. Detailed analysis of the polyribosome profiles obtained from 
sucrose density gradient analysis, indicates that fractions 12 and 13 were the highest 
occupied fractions containing significant levels of mRNA for both TOP and TOP-
trctMut constructs (Figure 3.8B). From analysis of fraction 12 in serum starved and 
re-fed cells (as an example), it is evident from the UV absorbance data that this 
fraction corresponds to approximately 6 to 8 translocating ribosomes per mRNA. 
Division of the number of bases in the Firefly Luciferase coding region (1652nt) by 
the number of ribosomes in the peak polysome fractions, results in an estimated 
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ribosome spacing of 207-275nt. Since Ribosomes are approximately 300A in 
diameter which is equivalent to approximately 90nt, the calculated spacing seems 
reasonable (Pe'ery and Mathews 2000). 
It is interesting to note that the predicted miRNA-l Oa binding site in ribosomal 
protein S6 does not contain a classical microRNA seed region, sequence 
complementary to bases 2-8 of the miRNA (Pillai et al. 2005). Instead, miRNA-IOa 
is predicted to bind along its entire length, by means of conventional base pairing 
along with relatively weaker V-G interactions.. This proposed binding is however 
consistent with that predicted for ribosomal protein L 13 mRNA, based upon mapping 
of the binding between miRNA-I0a and the 5' UTR of this mRNA. More detailed 
mapping of the miRNA-I0a binding site in the 5' VTR of rpS16, suggests that this 
type of microRNA-RNA interaction is common in a wide variety of 5'TOP containing 
mRNAs (Orom et al. 2008). 
3.8.2 The mTOR and PI3K Signalling Pathways 
Treatment of TOP and TOP-trctMut transfected cells with the PI3K inhibitors 
Wortmannin and LY294002 resulted in the translational down regulation of both TOP 
and TOP-trctMut transcribed mRNA. No significant difference was observed 
between TOP and TOP-trctMut mRNA under these conditions. This suggests that the 
PI3K signalling pathway does not have a significant involvement in the translational 
activation of TOP containing mRNAs. Interestingly, previous experiments using the 
HEK-293T cell-line have revealed selective and pronounced repression of TOP 
containing mRNAs encoding rpL32 and eEFIA when the cells were treated with 
L Y294002, compared to only mild repression upon Rapamycin treatment (Stolovich 
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et al. 2002). The data reported in the literature does not appear to be consistent with 
that obtained in this study. A possible explanation for this finding is that the response 
to the mTOR and/or PI3K signalling pathways differs between TOP containing 
mRNAs. It would therefore be of interest to repeat the experiments performed here 
using constructs containing the rpL32 5' UTR, and the 5'UTRs of a wide variety of 
different TOP containing mRNAs. 
Interestingly, the only difference observed between mRNAs transcribed from 
the TOP and TOP-trctMut constructs was with the use of Rapamycin, an mTOR 
pathway inhibitor. Whilst this difference was only just outside the bounds of 
experimental error, it suggests that the mTOR signalling pathway may affect the 
translation of TOP containing mRNAs. It is important to note that the HEK-293T cell 
line was used in this experiment and there is evidence that the signalling pathway 
response of TOP containing mRNAs is dependent upon cell type (Stolovich et al. 
2002). 
Early evidence suggested that the phosphorylation of RPS6 resulted in the 
selective translation of TOP containing mRNAs. When the mTOR inhibitor 
Rapamycin was used to block S6K activity in Swiss 3T3 cells, the translational 
activation of TOP containing mRNAs was almost completely repressed (Jefferies et 
al. 1994). However, when a similar experiment was carried out using the HEK-293 
cell-line, the translational activiation of 5'TOP containing mRNAs was only partially 
repressed (Tang et al. 2001). A study using S6K1-l-/S6KI1- mice has previously 
shown that the combined knockout of both S6Kl and S6K2 has no effect on the 
translational regulation of TOP containing mRNAs in response to mitogens (Pende et 
al. 2004). Drawing comparisons between the effect observed in this experiment and 
those observed in previous studies is not straightforward. The partial effect observed 
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following Rapamycin treatment in this study appears consistent with that previously 
observed in the HEK-293 cell-line. However, it is important to note that the earlier 
study specifically investigated the effect of Rapamycin on the translational activation 
of TOP containing mRNAs following serum starvation and re-feeding. In this 
experiment, HEK-293T cells were grown under control conditions. Interestingly, in 
the human BJAB B cell line, which was not subjected to serum-starvation or re-
feeding, TOP containing mRNAs encoding ribosomal proteins and elongation factors 
were selectively repressed (Zhu et al. 2003). In order to better compare the effect 
between this and previous studies, it may of interest to repeat this experiment under 
conditions of serum starvation and re-feeding. 
It has been suggested that functions of mTOR Complex 1 (mTORCl) are 
Rapamycin resistant and a model had been proposed whereby Rapamycin blocks 
access to only a specific subset of mTORCl substrates. In particular, it has been 
proposed that mTORCl, or a raptor containing mTOR complex, regulates 4E-BPl 
phosphorylation through a kinase-dependent mechanism, which is Rapamycin-
insensitive (Thoreen et al. 2009). Since a slight effect was observed following 
Rapamycin treatment, it remains possible that 4E-BPl is not involved in the 
regulation of TOP reporter mRNA. 
3.8.3 Canonical Initiation and Trans-acting Factor Requirements 
The potential involvement of the mTOR signalling pathway in the control of 
TOP containing mRNAs gives rise to the possibility that 4E-BPl and perhaps its 
binding partner eIF4E, may be involved in the regulation of TOP containing mRNAs. 
Indeed it would be interesting to determine the roles, if any, of the canonical initiation 
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factors that are required for cap-dependent translation. To date there have been no 
reported studies to determine the canonical initiation factor requirements S'TOP 
containing mRNAs. In addition to the canonical initiation factors, other trans-acting 
factors may be involved in S'TOP containing mRNA regulation. As is particularly 
evident from the 5' RACE analysis, the polypyrimidine tract is a key structural 
component of TOP containing mRNAs. Polypyrimidine-tract binding protein (PTB) 
is a multi-function protein, which preferentially binds polypyrimidine-rich regions of 
mRNA (Garcia-Blanco et al. 1989). It functions are dependent on its location within 
the cell and are known to include involvement in translation initiation (Jang and 
Wimmer 1990). It would therefore be of interest to investigate whether or not it is 
involved in the mechanism of S'TOP translational regulation. Another potential 
candidate for investigation is the La autoantigen. Previous research has suggested that 
La acts a specific trans-acting factor, involved in the translational regulation of TOP 
containing mRNA (Pellizzoni et al. 1996). 
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Chapter Four 
Canonical Initiation and Trans-acting Factor Requirements of 5' TOP 
Containing mRNAs 
4.1 Canonical Initiation factors in Cap-dependent Translation 
Initiation of protein synthesis in eukaryotes requires recruitment of the 
ribosome to the mRNA and its subsequent translocation to the AUO start codon. 
Cap-dependent translation is the major translation pathway, with estimates suggesting 
up to 97% of total cellular mRNAs are translated via this route (Merrick 2004). The 
mechanism requires the assembly of the 43S complex, which is comprised of the 40S 
ribosomal sub-unit bound to eIF2-0TPlMet-tRNAj and the canonical initiation factors 
eIFIA and eIF3 (previously reviewed in Chapter 1). This complex is recruited to the 
mRNA in a process which requires recognition of the 5' terminal m70 cap by the cap-
binding complex eIF4F though its sub-unit eIF4E. Once recruited, the 43S sub-unit 
traverses the mRNA in a 5' to 3' direction in a process known as scanning, stopping 
at the first AUO codon in favourable context for the initiation of translation to occur 
(Kozak 1987) 
The cap binding-complex eIF4F is comprised of eIF4E, eIF4A and the 
scaffold protein eIF40. eIF4A is an RNA helicase, whose function is enhanced by 
its association with eIF4B and/or eIF4H. In addition to binding eIF4E and eIF4A, 
eIF40 also binds to eIF3 and poly(A}-binding protein (p ABP), which also have 
important roles in translation initiation (refer to Chapter 1 for a more detailed 
discussion). The initiation factors therefore comprise a functional ensemble, which is 
integral to the cap dependent translation mechanism (Table 4.1). Despite the 
importance of the cap dependent mechanism for the majority of cellular messages, to 
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Name Function 
elF1 Start codon recognition 
elF1A Interaction between 40S subunit and Met-tRNAj 40S , 
dissociation 
elF2 a subunit binds elF2B 
~ ~ subunit binds elF2B and elFS 
V subunit binds GlP and Met-tRNA j, GlPase activity 
elF2B 5 subunits, guanosine nucleotide exchange factor 
(GNEF) for elF2 
elF3 11 subunits, interacts with 40S subunit as well as RNA, 
elFl, eIF4B, elF4G and elFS 
elF4AI AlP-dependent RNA helicase activity 
elF4AII AlP-dependent RNA helicase activity 
elF4B Stimulates elF4A and binds RNA 
elF4E Cap-binding protein 
elF4GI Binds via elF4E and interacts with eIF4A, e1F3, PABP and 
RNA 
elF4GII Binds via elF4E and interacts with eIF4A, e1F3, PABP and 
RNA 
elFS GlPase activating protein (GAP) of elF2 
elFSB 60S subunit joining at initiation AUG, GlPase activity 
elF6 60S subunit joining and dissociation 
Table 4.1: Names and Functions of the Eukaryotic Initiation Factors 
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date there have been no reported studies to determine the canonical initiation factor 
requirements S'TOP containing mRNAs. It is therefore of great interest to determine 
whether S'TOP containing mRNAs have specific canonical initiation factor 
requirements, and if their general requirements differ from those of non-TOP 
containing mRNAs. 
4.2 Over-expression of 4E-BPl 
In order for the cap-binding complex (eIF4F) to assemble and cap recognition 
to take place, eIF4E must be available to bind to the scaffold protein eIF4G. The 
eIF4E-binding protein family, the 4E-BPs (1-3), compete with elF4G for a common 
binding site on eIF4E. When this site is occupied by a member of the 4E-BP family, 
the cap-binding complex is unable to assemble and consequently translation is 
repressed. In resting cells elF4E remains tightly bound to hypo-phosphorylated 
members of the 4E-BP family (Sonenberg 1993a; Lin et a1. 1994; Pause et al. 1994; 
Gingras et a1. 2001 b). Treatment of serum-starved quiescent cells with growth factor 
or serum results in the phosphorylation of 4E-BPs and subsequent disassociation of 
4E-BPs from eIF4E. The availability of elF4E facilitates formation of the cap-
binding complex and translational activation to occur (Sonenberg 1993b). It is 
known that phosphorylation by mTOR can occur on at least two sites within 4E-BPs 
and can be prevented by the use of Rapamycin, an mTOR inhibitor (Pullen et al. 
1998; Mothe-Satney et a1. 2000). The mTOR signalling pathway has previously been 
implicated in the regulation of TOP containing mRNAs (as described in Chapter 1 
and Chapter 3), indicating a potential connection between the 4E-BPs and the 
translation regulation of TOP containing mRNAs. 
119 
In order to investigate the potential role of 4E-BPs in the regulation of TOP 
containing mRNA translation, 4E-BPl was over-expressed in HEK-293T cells that 
were transfected with the TOP or TOP-trctMut constructs and a transfection control 
vector expressing ReniIla. To reduce the number of variables in each transfection, it 
was necessary to ensure that a constant amount of DNA was transfected and each 
transfection contained the same ratio of DNA to transfection reagent. This was 
achieved by supplementing the pcDNA3.1 vector containing the 4E-BPl coding 
region (pcDNA3.1-4EBPl) with empty pcDNA3.1 vector, so that the total quantity of 
these two constructs was constant in each transfection. Thus, in addition to the 
reporter constructs, HEK-293T cells were also transfected with either a) 0.4 Jlg 
pcDNA3.1 vector; b) 0.1 Jlg pcDNA3.1-4EBPl & 0.3 Jlg pcDNA3.1; c) 0.2 Jlg 
pcDNA3.1-4EBPl & 0.2 Jlg pcDNA3.l; or d) 0.4 Jlg pcDNA3.1-4EBPl. After a 
period of 24 hours had elapsed, the cells were serum starved for 18 hours in DMEM 
supplemented with 0.1 % Foetal calf serum (FCS). These conditions were chosen 
after consideration of previous data, which determined the quantity of radio-labelled 
3sS-methionine incorporated into total cellular protein in vivo, following starvation 
and re-feeding (Chapter 3, Figure 3.8). To confirm over-expression of 4E-BP1, 
western blotting was carried out (Figure 4.2B). Luciferase activity was then 
determined to investigate the translational efficiency of both the TOP and TOP-
trctMut reporters (Figure 4.2A). 
The western blotting data shows that as the amount of transfected pcDNA3.1-
4E-BPl vector increased, an increase in 4E-BPl protein expression did not occur. 
Whilst the data obtained for the Actin loading control appears constant for across the 
pcDNA3.1-4EBPl titration, it is possible that the high relative abundance of Actin 
made it difficult to detect small changes between samples. An improved control for 
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Figure 4.2: Translational Activity of TOP and TOP-TrctMut upon 4E-
BPl Over-expression in HEK-293T Cells 
A. TOP or TOP-trctMut vectors were co-transfected into HEK-293T cells 
with Renilla luciferase expression vector (transfection control) and either 
a pcDNA3.1 empty vector (control) or increasing concentrations of 
pcDNA3. 1-4E-BPl expression vector. Cells were serum starved (0.1% 
FCS) for 18 hrs or serum starved (0.1 % FCS) for 18 hrs and serum 
stimulated (10% FCS) for 4 hours immediately prior to harvesting 48 
hours after transfection. A luciferase assay was carned out and the ratio of 
Firefly to Renilla luciferase activity was calculated. Error bars were 
calculated from the standard deviation of three replicates. 
B. Western blotting was then carried out to determine the levels oftota14E-
BP} and Actin (loading control). 
121 
this experiment would be to detennine the total cellular protein synthesis rate by 
measuring the incorporation of 3SS methionine. This data could then be used to 
nonnalise the data obtained by western blotting, in order to confirm that 4E-BPl 
expression increases as the amount of expression vector is increased. Total protein 
synthesis rates could also be used to normalise the luciferase assay data, which was 
used to quantify reporter activity. 
The antibody, which was used for western blotting, detected total4E·BPl and 
was therefore not specific to the un-phosphorylated form of 4E-BPl that is capable of 
sequestering eIF4E. In order to interpret the data with respect to the availability of 
unbound eIF4E, it is necessary to assume that in serum· starved cells, signalling 
through the PI3K1mTOR signalling pathway results in the majority of 4E-BPl being 
in the un-phosphorylated form. Since the PI3K1mTOR signalling pathway is 
responsive to mitogen and nutrient levels, this seems a reasonable assumption (Figure 
3.9.1). If this assumption is correct, then increasing the amount of 4E-BPl protein 
expression is likely to result in the sequestration eIF4E and the subsequent repression 
of cap-dependent translation. The translation of TOP-trctMut mRNA appears 
inhibited by 4E-BPl over-expression, dropping to approximately 50% of control 
levels with limited dose dependence (Figure 4.2A). This is consistent with TOP-
trctMut mRNA being under cap-dependent translational control. Interestingly, TOP 
containing mRNA translation initially drops by just 15%, but then increases to over 
100% of control levels with increasing 4E·BPl expression. It is therefore possible, 
that the translation activation of TOP containing mRNA does not require eIF4E. The 
increase in translation above control levels, may be due to TOP mRNAs being able to 
use the remaining translationally machinery with reduced competition from mRNA 
that require eIF4E. 
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Serum re-feeding is expected to result in signalling through the PI3KJmTOR 
pathway and the downstream effect of the phosphorylation of 4E-BPI (refer to section 
3.7). In its phosphorylated form, 4E-BPI is unable to bind eIF4E, therefore 
increasing the amount of eIF4E which is available for cap-dependent translation 
(Figure 3.9.1). With the absence of western blot data to confirm the levels of non-
phosphorylated 4E-BPl, it must be assumed that a quantity of 4E-BPl that is 
expressed from the transfected pCDNA3.1-4EBPI vector is also phosphorylated in 
this manner. However, it is important to realise the balance of how much of the 
additionally expressed 4E-BPI is phosphorylated could has an important bearing on 
the interpretation of the data. 
The translation of TOP-trctMut, mRNA following serum stimulation, appears 
to be less inhibited by 4E-BPI over-expression than in the case of un-stimulated cells. 
Translation of TOP-trctMut, drops by only 20-40% compared to control levels (Figure 
4.2A). This is consistent with eIF4E being required for the translational activation of 
TOP-trctMut mRNA. The fact that repression is still occurring following serum 
stimulation, suggests that the over-expression of 4E-BPl is still reSUlting in the 
sequestration of eIF4E. This implies that not all the additionally expressed 4E-BPI is 
phosphorylated following serum stimulation. 
The increase in translation of TOP mRNA, which was observed following 
serum-stimulation, is much greater than that observed in serum-starved cells. This is 
consistent with the known response of TOP containing mRNAs under conditions of 
serum-stimulation. Interestingly, TOP mRNA translation increased when more 4E-
BPI expression vector was transfected (Figure 4.2A) suggesting that sequestration of 
eIF4E was a still a factor despite the serum stimulation. If this was the case, the 
increase in translational activity with increasing 4E-BPI expression, is consistent with 
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that observed in serum-starved cells. Carrying out western blotting to detennine the 
levels ofunphosphorylated 4E-BP1 may provide a greater insight into the mechanism 
at work. 
The transfections were repeated using and 2x106 cells and 2.5 f.lg of 4E-BP1 
expression vector, which was detennined above to be a suitable ratio for examining 
the differences in translation activity of the mRNA transcribed by both constructs. 
After a period of 24 hours had elapsed, the cells were serum starved for 18 hours in 
DMEM supplemented with 0.1 % Foetal calf serum (FCS). Following starvation, cells 
were either re-fed for 4 hours with DMEM supplemented with 10% FCS and then 
harvested or harvested without re-feeding. Sucrose density gradients analysis was 
carried out and polyribosome profiles were obtained (Figures 4.3.1A & 4.3.1B). 
These data show that when 4E-BP1 was over-expressed, polysomally located mRNAs 
shifted to lower fractions. The most notable difference when 4E-BP1 is over-
expressed, is that the 60S ribosomal peak fonned a broad shoulder with the 80S peak, 
and there was an increased proportion of material in the sub-polysomal fractions. 
This is consistent with translational repression taking place when 4E-BP1 IS over-
expressed. 
Northern blotting was carried out for firefly (reporter) and actin (control) 
mRNAs, on the fractions obtained from the sucrose density gradients. Quantification 
was then carried out to detennine the percentage of reporter and control mRNA in 
each fraction (Figure 4.3.2). The actin control remains relatively consistent for both 
TOP and TOP-trctMut transfected cells regardless of 4E-BP1 over-expression (Figure 
4.3.2). In the case of TOP-trctMut, quantification of the firefly northern blots 
indicates that there is little change between control and 4E-BPl over-expression 
(Figure 4.3.2). The apparent shift ofmRNA from fraction 4 to fraction 6 upon 
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Figure 4.3.1: 4E-BP1 Over-expression in HEK-293T Cells 
TOP Of TOP-trctMut vectors were co-transfected into HEK-293T cells with 
either A) pcDNA3.1-4E-BPI expression vector or B) empty pcDNA3.1 
vectof. The cells were incubated for either IShr in conditions of serum 
starvation (0.1 % FCS) followed by 4hrs of serum replenishment (10% FCS). 
Graphs how UV absorbance data as recorded during fractionation of sucrose 
density gradients. Northern blotting fOf firefly mRNA was carried out on the 
10 fractions obtained from each gradient. 
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Figure 4.3.2: 4E-BPl Over-expression in HEK-293T CeUs 
A. Quantification of firefly (reporter) mRNA, as detected by Northern 
blotting and phosphor-imaging. 
B. Quantification of actin (control) mRNA, as detected by Northern blotting 
and pho phor-imaging. 
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4E-BPl over-expression was also observed for actin mRNA, indicating that it is 
likely to be related to the relative amount of mRNA loaded in those fractions. For the 
TOP construct, over-expression of 4E-BPl appears to result in a significantly 
different mRNA distribution. There is a clear shift of material from fraction 2 to the 
heavier fractions, particularly fractions 7 and 8 (Figure 4.3.1A). Although 
quantification of the actin mRNA under the same conditions shows a reduction in the 
amount of control mRNA in fraction 2, the difference is less than half that observed 
for the reporter mRNA. This suggests that the result is not due to difference in 
loading of the fractions immediately prior to northern blotting, but may instead be as a 
result of over-expression of 4E-BP 1. 
An interesting comparison can be drawn between the polysomal profiles 
obtained from the control cells in this experiment (Figure 4.3.1B) and the cells which 
were serum re-fed in the previous translational profiling experiment (Section 3.6, 
Figure 3.8A). These cells were transfected with the same vectors and subjected to the 
same incubation conditions. There is a clear difference between the two experimental 
data sets, in particular the 40S peak is more clearly defined in the second set of 
polysome profiles (Figure 4.3.1B) compared to the first set (Figure 3.8A). The 
reason for this difference is unclear, but it has previously been noted (Section 3.6) that 
a more distinguishable 40S peak was also obtained in polysomal profiles carried out 
on serum-starved cells, which had been transfected with the TOP construct. When 
the data obtained from northern blotting is compared, there also appears to be a 
difference between the two data sets. Comparison of the TOP construct (Figure 3.8B 
and Figure 4.3.2A - left panels, red lines). indicates that the mRNA distribution is not 
the same between data sets. In the first experiment, TOP mRNA is predominantly 
located in the sub-polysomal fractions, whereas in the second experiment TOP mRNA 
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is associated with polysomes. This is also found to be the case when an equivalent 
comparison is carried out for the TOP-trctMut construct (Figure 3.8B and Figure 
4.3.2A - right panels, red lines). The difference could possibly be due to the unique 
conditions each experiment was performed under or be related to cell cycle effects. 
Within each experimental data set, comparison of the TOP and TOP-trctMut mRNA 
indicates that a clear difference remains in behaviour the behaviour of these mRNAs 
under identical conditions. 
The data obtained from the sucrose density gradient analysis performed in this 
experiment and the luciferase assay to determine translational activity (Figure 4.2A), 
appears to be consistent. The TOP-trctMut construct transcribed mRNA that does not 
appear to be significantly affected by 4E-BPl over-expression, whereas the mRNA 
transcribed from the TOP construct appears to be up-regulated under the same 
conditions. These data suggest that TOP containing mRNAs may not require eIF4E. 
The apparent up-regulation of TOP containing mRNAs when the availability of eIF4E 
is expected to be diminished, suggests that an alternative mechanism of translation 
initiation could be favoured. 
4.3 elF4E Knockdown 
To independently validate the requirements of TOP containing mRNAs for 
eIF4E, a MISSION plasmid (Sigma-Aldrich) based short hairpin RNA (shRNA) 
expression vector was used to induce gene silencing of eIF4E. This vector produces 
shRNA transcripts upon transfection, which specifically targets eIF4E transcripts for 
degradation utilising the endogenous RNAi machinery (Figure 4.4.1). Four different 
MISSION shRNA plasmid clones were available, all of which specifically target 
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Figure 4.4.1: Vector Diagram of pLKO.l-puro (sigma) elF4E Knockdown 
plasmid 
A plasmid based short hairpin RNA (shRNA) expression vector was used to 
induce gene silencing. The MISSION shRNA clones obtained from Sigma 
(NM_001968.2-898s1cl is shown) produce shRNA transcripts upon 
transfection, which specifically target eIF4E transcripts for degradation 
utilising the endogenous RNAi machinery. MISSION Non-target shRNA 
vector (sequence not shown) was used in control transfections. 
Figure adapted from Sigma-Aldrich online catalogue 
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Available shRNA Plasmids 
NM_001968 Organism: Human Symbol: EIF4E 
NM_001968.2-1310s1cl 
Sequence: CCGGCTGTTGTTAATGTTAGAGCTACTCGAGTAGCTCTAACATTAACAACAGTTTTTG 
N M _001968.2-10365 1c1 
Sequence: CCGGCGGCTGATCTCCAAGTTTGATCTCGAGATCAAACTTGGAGATCAGCCGTTTTTG 
NM_001968.2-898s1c1 
Sequence: CCGGCCGACTACAGAAGAGGAGAAACTCGAGTTTCTCCTCTTCTGTAGTCGGTTTTTG 
NM_001968.2-1426s1c1 
Sequence: CCGGCCAAAGATAGTGATTGGTTATCTCGAGATAACCAATCACTATCTTTGGTTTTTG 
Figure adapted from Sigma-A1drich online catalogue 
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Figure 4.4.2: Selection of shRNA Plasmid 
elF4E 
I Actin 
A. The catalogue number (Sigma-Aldrich) and sequence of the shRNA 
region of four available plasmids that target human eIF4E are shown. 
B. Western blots confinning the knockdown of eIF4E compared to Actin 
(loading control) are shown for transfections carried out with either 0.5J.lg 
or 1 Ilg of the candidate shRNA plasmid. The greatest reduction of eIF4E 
levels was observed for the plasmid with catalogue number 898 (column 
3). Work earried out in collaboration with Dr. L. Cobbold. 
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eIF4E (Figure 4.4.2A). In collaboration with Dr Laura Cobbold, transfections were 
carried out in HEK-293T cells, using 0.5 or 1 ~ g g quantities of each MISSION eIF4E 
shRNA vector. MISSION Control non-target shRNA vector was used as a control. 
Transfected cells were incubated in DMEM supplemented with 10% FCS and cells 
were harvested 48 hours after transfection. Western analysis was then carried out to 
determine which MISSION shRNA plasmid produced the greatest reduction in eIF4E 
levels (Figure 4.4.2B). The data indicated that the NM_001968.2-898s1cl clone 
produced the greatest reduction in eIF4E levels. This clone was therefore chosen for 
use in this experiment. 
The reduction of eIF4E levels usmg the MISSION shRNA plasmid 
(NM_001968.2-898s1cl ) was carried out with co-transfection of either TOP or TOP-
trctMut reporter constructs in collaboration with Dr Laura Cobbold (Figure 4.4.3). 
Transfections were performed in HEK-293T cells which were grown in DMEM 
supplemented with 10% FCS and not subjected to serum starvation or re-feeding. 
Luciferase assays were carried out 48 hours after transfection, to determine the 
translational efficiency of TOP and TOP-trctMut mRNA (Figure 4.4.3). 
TOP containing mRNA translational efficiency was found to increase by 
100%, when eIF4E levels were reduced. During 4E-BPl over-expression, 
translationally efficiency also increased to a level above that of the control (Figure 
4.2A). In both cases the availability ofunbound eIF4E is expected to be reduced and 
the two data sets obtained for the TOP construct are consistent. Interesting the data 
obtained from transfection of the TOP-trctMut construct also appears to show an 
increase in translational efficiency when the levels of eIF4E were reduced. This result 
was unexpected based upon the data obtained when 4E-BPl was over-expressed. A 
reduction in the availability of eIF4E by the over-expression of 4E-BPI, previously 
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Figure 4.4.3: Translational Activity of TOP and TOP-trctMut Vectors 
upon eIF4E Knock-down in HEK293T Cells 
A. TOP or TOP-trctMut vectors were co-transfected into HEK-293T cells 
with ~ - g a l a c t o s i d a s e e expression vector (transfection control) and either a 
Non-Target Mission shRNA Control vector (Sigma) or an eIF4E-Target 
Mission shRNA vector (Sigma). The cells were harvested 48 hours after 
transfection and a luciferase assay was carried out. The ratio of Firefly 
luciferase to ~ - g a l a c t o s i d a s e e (transfection control) activity was calculated 
and expressed as a percentage relative to control cells. Error bars were 
calculated from the standard deviation of three replicates and data was 
normalised to control cells. 
B. Western blots confirming the knockdown of eIF4E compared to Actin 
(loading control) which appears evenly loaded under control and eIF4E 
knockdown conditions. Successful knockdown is shown for both TOP and 
TOP-Mut transfections. Work carried out in collaboration with Dr. L. Cobbold. 
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resulted in a decrease in the translational efficiency of TOP-trctMut mRNA (Figure 
4.2A). The data obtained for the TOP-trctMut is therefore inconsistent. Analysis of 
the western blots indicates a lower knockdown efficiency of eIF4E in the case of the 
TOP-trctMut vector transfection, compared to the TOP vector transfection. Whilst 
this in itself does not explain the increase in the translational efficiency of TOP-
trctMut mRNA compared to the control conditions, it does suggest that less 
significance should be placed on this result, when compared to the 4E-BPl over-
expression data. Further repetition of this experiment may be required to increase the 
confidence in the data. 
4.4 Computational Modelling of tbe eIF4E Binding Site of eIF4G 
In collaboration with Dr Paul McEwan (University of Nottingham), 
computation modelling was carried to investigate the structure and conformation of 
the eIF4E binding site and its interaction with the 5' terminal m'O cap and 5' UTR of 
mRNA. It was determined that the m'O cap binding region of eIF4E contains a cleft, 
which allows eIF4E to interact with the first and second nucleotide adjacent to the 
mRNA cap structure (personal communication, data not shown). Whilst it has not 
been determined whether or not molecular recognition of these sites influences the 
binding of eIF4E to the cap structure, it is nevertheless interesting when considering 
the difference between TOP and TOP-trctMut mRNA. The 5'RACE procedure 
(detailed in Chapter 3) determined that the first and second nucleotides differ between 
mRNA transcribed by these constructs, and in a broader context, the first nucleotide 
adjacent to the cap structure differs between 5'TOP containing mRNAs and other 
cellular mRNAs. 
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4.5 eIF4G Knockdown and expression of elF4G Mutants 
To further investigate the canonical initiation factor requirements of TOP 
containing mRNAs, the level of eIF4GI was reduced in He La cells using a plasmid 
based RNAi system (Coldwell and Morley 2006). The RNAi plasmid (pSilencer31) 
was co-transfected with TOP or TOP-trctMut reporter constructs and one of two 
plasmids, which contained the coding region of eIF4Glf. This isoform was chosen as 
it is the longest form (1600 amino acids) and contains the poly(A)-binding protein 
(PABP) binding site (Coldwell and Morley 2006). The eI4G 1 f-WT plasmid was used 
to re-introduce eIF4G and the eIF4Glf-eIF4E plasmid was used to introduce a mutant 
form of eIF4G, which contained a deletion of the eIF4E binding site (Hinton et al. 
2007) (Figure 4.5.1 B). The mRNAs transcribed from these plasmids were resistant 
to targeting by the pSilencer31 siRNA, due to silent point mutations located within 
their coding sequence. These mutations were designed to reduce the base-
complementarity between the target region of the eIF4GlfmRNA and the seed region 
of the targeting pSilencer31 siRNA. Successful reduction of eIF4GI expression and 
relative re-expression from eIF4Glf and its associated mutants, were confirmed by 
western blotting (Figure 4.5.2B). The translational efficiency of reporter mRNAs was 
then determined for each experiment by carrying out an assay to determine luciferase 
activity (Figure 4.5.2A). This enabled the requirement of eIF4GI and those factors 
prevented from binding to eIF4GI, to be identified for both TOP and non-TOP 
containing mRNA. 
When eIF4GI levels were reduced without concurrent re-expression using the 
4G If vector, the translational efficiency of TOP containing mRNA appears to have 
increased by 20%. This increase falls within experimental error and therefore may 
not be significant. Under the same experimental conditions, the translational 
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Figure 4.5.1: Schematic Diagrams Showing siRNA Target Site in the N 
terminu of eIF4G and eIF4G Mutant Construct. 
Constructs were the kind gift of Dr. M. J. Coldwell (University of 
Southampton) and Dr. S. J, Morley (University of Sussex). 
A. Oligonucleotide 31 corresponding to the si RNA target site was cloned 
into pSilenccr 3.0 HI plasmid (Ambion) to create a new plasmid. A 
mutated control ver ion (si31M) was also created with three mismatches 
to the target site (Coldwell and Morley 2006). 
B. Site directed mutagenesis was used to introduce mutations in the eIF4G 
nucleotide sequence as shown to disable the binding of eIF4E. Constructs 
were in erted into the pCDNA3.1-myc plasmid (Hinton et aL 2007). 
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Figure 4.5.2: The Requirements of TOP Containing mRNAs for eIF4G 
and elF4E 
A. TOP, TOP-trctMut or TOP-mirMut vectors were co-transfected into HEK-
293 cells with Renilla luciferase expression vector (transfection control) 
and either: 1) pcDNA3.l and pSilencer31M (control); 2) pcDNA3.1 and 
pSilencer31 ; 3) pcDNA3.l-eIF4Glf-M and pSilencer31; 4) pcDNA3.l-
eIF4Glf-eIF4e and pSilencer31. The eIF4G knockdown and replacement 
system has been described previously (Hinton, 2007). 4G-M corresponds 
to pcDNA3.1-eIF4Glf-M, which is resistant to the pSilencer31 
knockdown plasmid. 4G-4E corresponds to the pcDNA3.1-eIF4Glf-
eIF4E plasmid. Cells were serum starved (0.1% FCS) for 18 hrs and 
serum stimulated (l0% FCS) for 4 hours immediately prior to harvesting 
(48 hours after transfection). A luciferase assay was carried out and the 
ratio of Firefly to Renilla luciferase activity was calculated. Error bars 
were calculated from the standard deviation of three replicates. 
B. Western blotting was then carried out to determine the levels of eIF4G 
and Actin (loading control). 
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efficiency of TOP-trctMut mRNA remained relatively unchanged. This suggests that 
neither TOP nor TOP-trctMut mRNA, require elF4GI for translation initiation to take 
place. When eIF4GI without the eIF4E binding-site was expressed following eIF4GI 
knock-down, the translational efficiency of the TOP-trctMut reporter decreased by 
approximately 15%. Although this suggests that eIF4E is required for TOP-trctMut 
mRNA translation, which is consistent with the data obtained during 4E-BPl over-
expression, the decrease observed falls within the bounds of experimental error and 
may not be statistically significant. The translational efficiency of TOP containing 
mRNA increased by 20% compared to conditions where fully functional eIF4GI was 
expressed. This result is outside the error bounds of the experiment and is therefore 
statistically significant. Since eIF4GI does not appear to be required by TOP 
containing mRNAs, it is difficult to directly attribute this increase to the absence of 
the eIF4E binding site This data does however, support the trend observed when 4E-
BPl was over-expressed and eIF4E expression was decreased. 
Significant repression of translation for TOP-trctMut was not observed when 
eIF4GI levels were reduced or when the eIF4E binding-site deletion mutant was 
expressed. This data appears to suggest that cap-dependent initiation is not involved 
in the translational activation of TOP-trctMut mRNA and is therefore inconsistent 
with the result obtained when 4E-BPl was over-expressed (Figure 4.2). Several 
limitations within the experimental method may be the cause of this inconsistency. 
Firstly, the reduction in the level of eIF4GI by the transfection of the pSilencer31 
vector, should have no effect on the levels of the eIF4GII isoform of eIF4G. Western 
blotting was expected to detect both isoforms of eIF4G, which may explain why the 
reduction in eIF4G levels appears incomplete (Figure 4.5.2B). It is therefore possible 
that initiation of translation of TOP-trctMut mRNA may have occurred via a cap-
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dependent pathway that utilised eIF4GII. Secondly, the TOP-trctMut mRNA contains 
only two adjacent nucleotide mutations compared to TOP containing mRNA. As a 
result of this, the TOP-trctMut mRNA may still possess some characteristics of TOP 
translation. To determine whether the data was specific to the non-TOP containing 
mRNA reporter, transfections were also carried out in parallel using the TOP-mirMut 
vector (Figure 4.5.2A). The data obtained for the TOP-mirMut was within 8% of that 
obtained for the TOP-trctMut construct and followed the same trend. The data 
obtained for TOP-mirMut translation following eIF4GI knockdown or eIF4GI mutant 
expression, was not therefore significantly different to control levels. 
4.6 Candidate Trans-acting Factors 
4.6.1 La Autoantigen 
Previous research has suggested that the La auto antigen acts a specific trans-
acting factor, involved in the translational regulation of TOP containing mRNA. La 
has been shown to interact with S'TOP containing mRNAs from both humans and 
Xenopis laevis, including specific association with TOP containing mRNAs in the 
polysomal fraction (Pellizzoni et al. 1996; Cardinali et a1. 2003). Although it is clear 
that La can modulate the translational behaviour of TOP containing mRNAs, its 
precise role and mode of action remains unresolved. 
An experiment was therefore performed, to test the role of La in this system. 
HEK-293T cells were co-transfected with either an empty pcDNA3.1 vector or a 
titration of pcDNA3.1 containing the La coding region, alongside the TOP or TOP-
trctMut constructs and a transfection control vector, which expressed Renilla 
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luciferase. After 24 hours the cells were serum starved for 18 hours in DMEM 
supplemented with 0.1 % Foetal calf serum (FCS). Following starvation, cells were 
either re-fed for 4 hours with DMEM supplemented with 10% FCS and then 
harvested or harvested without re-feeding. Luciferase activity was then determined to 
investigate the effect of La on translational efficiency (Figure 4.6A), in conjunction 
with western analysis to confirm over-expression of La (Figure 4.6B). 
The western blot data clearly show that the quantity of La has increased upon 
transfection of the expression vector, compared to the loading control (Figure 4.6B). 
Translational efficiency of the TOP reporter, as determined by luciferase activity 
(Figure 4.6A) appears unaffected under both serum starved and re-fed conditions. 
The TOP-trctMut reporter appears to be slightly down-regulated by the over-
expression of La in starved cells, but with the exception of the lowest level of La 
over-expression in the titration, all data is within the error limits. It therefore appears 
that La does not affect the translation of either reporter under the chosen experimental 
conditions. 
4.6.2 PTB (Polypyrimidine-Tract-Binding Protein) and hnRNP-K 
Polypyrimidine-tract binding protein (PTB) is a multi-function protein, which 
preferentially binds polypyrimidine-rich regions of mRNA (Garcia-Blanco et al. 
1989). The functions of PTB are dependent on its location within the cell and are 
known to include involvement in translation initiation (Jang and Wimmer 1990). The 
four distinct RNA recognition motifs (RRMs) of PTB, have the ability to bind a 
different polypyrimidine-rich consensus sequence simultaneously within the same 
RNA molecule (Auweter et a1. 2007). PTB is therefore a potential candidate for 
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ribosome recruitment in 5'TOP containing mRNAs, which by definition also possess 
a polypyrimidine tract. 
To investigate the role of PTB in this system, HEK-293T cells were co-
transfected with either an empty pcDNA3.l vector or a titration of pcDNA3.l 
containing the PTB coding region, in conjunction with the TOP or TOP-trctMut 
constructs and a transfection control vector, which expressed Renilla luciferase. After 
24 hours the cells were serum starved for 18 hours in DMEM supplemented with 
0.1 % FCS. Following starvation, cells were either re-fed for 4 hours with DMEM 
supplemented with 10% FCS and then harvested, or harvested without re-feeding. 
Luciferase activity was then determined to investigate the effect of PTB on 
translational efficiency (Figure 4.7.1A), in conjunction with western analysis to 
confirm over-expression ofPTB (Figure 4.7.1 B). 
When PTB is over-expressed luciferase activity derived from either TOP or 
TOP-trctMut vector, shows a similar trend regardless of whether the cells are serum 
starved or re-fed (Figure 4.7.1A). Both TOP and TOP-trctMut reporter transcribed 
mRNAs appear to be translationaUy activated by PTB over-expression, with the effect 
increasing with the amount of PTB expression vector transfected. Under both serum 
starved and re-fed conditions, transfection of the largest quantity of PTB expression 
vector resulted in an approximate increase in translational activity of 80% for the TOP 
reporter and 40% for the TOP-trctMut reporter. Since both reporter mRNAs posses a 
polypyrimidine-tract in their 5' UTR, it is perhaps unsurprising that both behave in a 
similar manner (5' UTR confirmed by RACE analysis in Chapter 3). The greatest 
effect is observed for the TOP construct which possesses an uninterrupted 
polypyrimidine tract that is two nucleotides longer. The data therefore suggests that 
141 
A 
220 1 
* 
200 
-
180 
>-
.... 160 ';; 
'<:; 
- TOP 
o TOP-trctMut 
u 140 « 
Q) 
\I) 
120 I "' l-Q) 100 
-'u 
::s 80 .-J 
Q) 
> 60 .<:; 
"' Qj 40 0:: 
20 • 
0 
Amount of PTS Expression Vector Transfected 
B HEK293TSerum Starved for 18 hrs, Re-fed (10%FCS) 4 hrs 
[ PTe 
ACTIN 
PTS Expression 
Vector Transfected I ~ ~ = 0 0.1 0.2 0.4 
(Control) 
Figure 4.7.1: Tran lational Activity of TOP and TOP-TrctMut upon 
PTB Over-e pre 'ion HEK-293T Cells 
A. TOP or TOP-trctMut vectors were co-transfected into HEK-293T cells 
with Renilla luciferase expression vector (transfection control) and either 
a pcD A .1 empt vector (control) or increasing concentrations of 
p 0 A3.1-4 -BP 1 expression vector. Cells were serum starved (0.1 % 
Fe ) for J 8 hrs or serum starved (0.1 % FCS) for 18 hrs and serum 
timulatcd (10% ) for 4 hours immediately prior to harvesting (48 
hour after tran fcction). A luciferase assay was carried out and the ratio 
of Firefly to Renilla luciferase activity was calculated. Error bars were 
calculated from the standard deviation oftbree replicates. 
B. We ·tern bl tting was then carried out to determine the levels of PTB and 
Actin (loading control). 
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under the experimental conditions, PTB does up-regulate the translation of both these 
mRNAs. 
It is known that PTB often functions in co-operation with other proteins 
including PCBPI (Sawicka et al. 2008). Heterogeneous nuclear ribonuclear protein K 
(bnRNP K), which selectively binds poly(C) homopolymer, has been shown to 
operate as a translational silencer in conjunction with PCBPl (Ostareck et al. 1997). 
In order to investigate the role of hnRNP K in this system, HEK-293T cells were co-
transfected with either an empty pSG5 vector or a titration of pSG5 containing the 
hnRNP K coding region, alongside the TOP or TOP-trctMut constructs and a 
transfection control vector, which expressed Renilla luciferase. After 24 hours the 
cells were serum starved for 18 hours in DMEM, supplemented with 0.1 % Foetal calf 
serum (FCS). Following starvation, cells were either re-fed for 4 hours with DMEM 
supplemented with 10% FCS and then harvested, or harvested without re-feeding. 
Luciferase activity was then detennined to investigate the effect of hnRNP K on 
translational efficiency (Figure 4.7.2A), in conjunction with western analysis to 
conftrm over-expression of hnRNP K (Figure 4.7 .2B). 
The over-expression of hnRNP K also shows a similar trend for both serum 
starved and serum starved and re-fed cells. The data appears to show an approximate 
10% average decrease in the luciferase activity of the TOP-trctMut reporter. 
Translational activity of the TOP reporter mRNA appears to increase with the amount 
of hnRNP K expression vector transfected, reaching a maximum increase of 30%. 
However, this increase is within the error limits of the experiment and is therefore, not 
statistically significant. 
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A. TOP or TOP-trctMut vectors were co-transfected into HEK-293T cells 
with Renilla lucifera e expression vector (transfection control) and either 
a p 05 empty vector (control) or increasing concentrations of pSG5-
hnRPP-K expre ion vector. Cells were serum starved (0.1% FCS) for 18 
hrs or 'crum larved (0.1 % FCS) for 18 hrs and serum stimulated (10% 
F ) for 4 h urs immediately prior to harvesting (48 hours after 
tran fe ti n). A lucifcrasc assay was carried out and the ratio of Firefly to 
Renilla lucifer, e activity was calculated. Error bars were calculated 
from the tandard deviation of three replicates. 
B. We -tern bl tting was then carried out to determine the levels of hnRNP-
K and Actin (loading control). 
144 
4.7 Discussion 
4.7.1 Canonical Initiation Factor Requirements of S'TOP containing mRNAs 
The potential involvement of the mTOR signalling pathway in the 
translational regulation of TOP containing mRNAs (as discussed in Chapter 3), gives 
rise to the possibility that 4E-BPl, a downstream target of mTOR, is involved in the 
translational control of TOP containing mRNAs. In the mTOR signalling pathway, 
serum starvation is expected to lead to eIF4E remaining tightly bound to hypo-
phosphorylated members of the 4E-BP family (Davuluri et al. 2000; Suzuki et aI. 
2000). In this instance, when it is unable to bind to eIF4G to form eIF4F, eIF4E 
would act as a rate-limiting component of translation initiation. The over-expression 
of 4E-BPl is expected to lead to an increase in the amount of eIF4E associated with 
4E-BPl, therefore reducing further the amount of eIF4E available and leading to 
translational repression. The luciferase expression data for the TOP-trctMut are 
therefore consistent with the expected trend, as over-expression of 4E-BPl leads to an 
approximate 40% decrease in translational efficiency (Figure 4.2). For the TOP 
construct however, an increase in over-expression of 4E-BPl leads to an overall 
increase in translational efficiency. This is contrary to the expected trend and raises 
the possibility that the availability of eIF4E is not a rate-limiting factor in the 
translation initiation of 5'TOP containing mRNAs. 
Analysis of the data obtained from sucrose density gradient analysis (Figures 
4.3.1 and 4.3.2), appears to corroborate the trend that reduced eIF4E availability does 
not result in a down-regulation of TOP reporter mRNA as expected, but instead 
results in the apparent up-regulation of translation. This data also appears to be 
supported by the observation that the translational efficiency of the mRNA 
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transcribed by the TOP construct, was found to increase by 100% when eIF4E levels 
were reduced (Figure 4.4.2). A possible explanation for the observed trend is that 
TOP containing mRNA translation may utilise an alternative mechanism of 
translation initiation, which does not require eIF4E. When the availability ofunbound 
eIF4E is reduced, either by knock-down or 4E-BPl over-expression, the translation 
efficiency of non-TOP containing mRNAs also reduces. As this occurs, it is possible 
that other factors bound to non-TOP containing mRNAs may be released. This newly 
available pool of factors could then be utilised by TOP containing mRNAs, resulting 
in an increase in their translational efficiency. Surprisingly, the data obtained from 
transfection of the TOP-trctMut construct also appears to show an increase in 
translational efficiency when the levels of eIF4E were reduced. This result was 
inconsistent with the data obtained when 4E-BPl was over-expressed and was not 
expected based upon the known involvement of eIF4E in cap-dependent initiation. 
Analysis of the western blots indicated a low knockdown efficiency of eIF4E in the 
case of the TOP-trctMut vector transfection compared, which may explain this result. 
It is also possible that the mutations introduced into the TOP-trctMut mRNA were 
insufficient to distinguish it from TOP mRNA and render it under cap-dependent 
translational control. Repetition of this experiment, with improved reduction of 
eIF4E levels in the case of the TOP-trctMut transfection, would help to increase the 
confidence in this data. 
This potential lack of involvement of eIF4E in the translation initiation of TOP 
containing mRNAs, appears to be consistent with the result of an earlier study, in 
which eIF4E was over-expressed. It was found that in quiescent cells, over-
expression of eIF4E did not relieve the translational expression of ribosomal protein 
mRNAs, which are a subset of TOP containing mRNAs (Mamane et aI. 2007). 
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It remains uncertain as to whether the phosphorylation state of elF4E plays a 
role in the regulation of translation initiation and this has been the subject of 
considerable debate (Scheper and Proud 2002). It is known that elF4E is 
phosphorylated by MAP-kinase signal-integrating kinases Mnkl and Mnk2 (Flynn 
and Proud 1995). However, it has been shown than mice which have both Mnkl and 
Mnk2 genes deleted, are apparently normal (Ueda et al. 2004). This suggests that 
both Mnk genes function in adaptive pathways during conditions of cellular stress. 
More interestingly in the context of TOP containing mRNAs, the phosphorylation of 
elF4E is increased by serum treatment of cells and addition of growth factors, in a 
process which appears to be mediated via the MEKlErk pathway (Flynn and Proud 
1996). Two distinct models have been proposed for the role of eIF4E 
phosphorylation in translation initiation (Scheper and Proud 2002). In both models 
phosphorylation of eIF4E decreases its affinity for capped RNA, which is consistent 
with observations in which high levels of elF4E phosphorylation impair cap 
dependent translation (Scheper et al. 2002). The point in the initiation process at 
which eIF4E phosphorylation occurs differs between the two models. Another 
important difference is whether elF4E phosphorylation is required to enhance 
initiation on the same mRNA or on another message (Scheper and Proud 2002). 
Neither model appears to explain the apparent lack of elF4E involvement in the 
translation initiation of TOP containing mRNAs in this system. 
It is interesting that TOP containing mRNAs, which generally have relatively 
short 5'UTRs, may potentially have little or no requirement for eIF4E. It has been 
shown that the m70 cap structure does not significantly contribute to the binding of 
elF4F to mRNAs, which have 5'UTRs greater than 60 nucleotides in length and 
intrinsic RNA binding by eIF4F occurs for these mRNAs (Kaye et al. 2009). With a 
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5' VTR length of 41 nucleotides, the mRNA transcribed by the TOP construct does 
not fulfil the criteria for intrinsic RNA binding by eIF4F. The model would instead 
predict a requirement for cap recognition by eIF4E in this system, which does not 
appear to be supported by the data obtained. While this difference lends supports the 
suggestion that TOP containing mRNAs do not require eIF4E, it also raises the 
question as to whether or not eIF4F is required. 
The data obtained for the experiments in which eIF4GI levels were reduced, 
raises the possibility that TOP containing mRNAs do not require eIF4GI for the 
initiation of translation. The translational efficiency of TOP mRNA increased by 
20% under conditions in which eIF4GI levels were reduced without the concurrent re-
expression using the 4G 1 f vector. It is possible that this increase in translational 
efficiency is due to TOP containing mRNAs utilising other factors for translation 
initiation, which prior to the reduction in eIF4GI levels, were bound to non-TOP 
containing mRNAs. However, the data also shows that the translation activity of 
TOP-trctMut and TOP-mirMut transcribed mRNAs remained unaffected by the 
reduction in eIF4GI levels, challenging this proposal. The translational activity of 
TOP-trctMut and TOP-mirMut mRNAs also remained unchanged when eIF4GI 
without the eIF4E binding-site was expressed following eIF4GI knock-down. As 
previously discussed in section 4.5, the reduction in the level of eIF4GI by the 
transfection of the pSilencer31 vector, should have no effect on the levels of the 
eIF4GII isoform of eIF4G. It is therefore possible that initiation of translation of 
TOP-trctMut mRNA may have occurred via a cap-dependent pathway that utilised 
eIF4GII. An increase in translational activity of TOP mRNA was observed when 
eIF4GI without the eIF4E binding-site was expressed following eIF4GI knock-down. 
This result appears to be consistent with the broader suggestion that neither eFI4GI 
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nor eIF4E are required for the initiation of translation of TOP containing mRNAs. 
However, before drawing a finn conclusion it may be necessary to repeat this 
experiment with the simultaneous reduction in the level of both eIF4GI and eIF4GII. 
This would provide a clearer point of comparison with TOP-trctMut mRNA and 
would also reduce a critical variable in the reduction of eIF4G levels. 
Consideration of the similarity in behaviour of the TOP-trctMut and TOP-
mirMut transcribed mRNAs in this experiment raises interesting questions about how 
the 5'TOP motif is recognised. Despite the mutations being located in different 
regions of the 5' UTR, both constructs behaved in a similar manner, which was not 
the same as that observed for TOP construct transcribed mRNA. From the data 
available, it is not possible to detennine whether the mutations affect the same or 
different processes within the TOP translation pathway. The data raises the 
possibility however, that both the mutated region within the potential miR-IOa 
binding site and the two nucleotides immediately adjacent to the m7G cap structure, 
play a pivotal role in the regulation of TOP containing mRNAs. 
4.7.2 Trans-acting Factor Requirements of5' TOP containing mRNAs 
The data obtained upon over-expression of La, suggests that La has no effect 
on the translation of mRNA transcribed by both TOP and TOP-trctMut constructs, 
under the experimental conditions used in this system. It has previously been shown 
using sucrose density gradient analysis, that over-expression of wild-type La causes 
RPIA mRNA to shift from sub-polysomes to polysomes in growth-arrested cells 
(Crosio et al. 2000). These experiments and others (more thoroughly reviewed in 
Chapter 1) have led to a model being proposed, in which the specific interaction of La 
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with TOP containing mRNAs results in translational up-regulation of these mRNAs. 
However, this model has been challenged and conflicting evidence exists. TOP 
containing mRNAs have been found to associate preferentially with phosphorylated 
La (reviewed in Chapter 1), and over-expression of a non-phosphorylatable La has 
been shown to increase the abundance of subpolysomal TOP containing mRNAs 
(Schwartz et al. 2004). Studies carried out in vitro, have also shown that La can 
inhibit TOP containing mRNA translation (Zhu et al. 2001). The data obtained in this 
study, does not appear to resolve this dichotomy. It is possible that the behaviour 
observed is related to the sequence of the 5' VTR of the TOP under study, rather that 
all TOP containing mRNAs as a group. 
It has been suggested that La may act in competition with cellular nucleic acid 
binding protein (CNBP). Both La and CNBP have been shown in Xenopus to bind 
5'TOP containing mRNA in a mutually exclusive manner with the co-operation of the 
autoantigen R060 (Pellizzoni et al. 1998; Crosio et al. 2000). This has led to the 
proposal that La exerts a positive effect on translation through competitive binding 
with CNBP, which potentially acts a translational repressor (Crosio et al. 2000). It 
may therefore be of interest to determine whether or not CNBP plays a role in 5'TOP 
containing mRNA translation in this system, especially since it appears that the cap-
recognition complex may not be required for TOP containing mRNA translation. 
The data obtained for PTB over-expression shows that both TOP and TOP-
trctMut constructs, were translationally up-regulated under the conditions used in this 
system. This suggests that PTB acts by binding to the polypyrimidine tract as 
expected. This data appears inconsistent with other studies, which have shown that 
when vectors expressing TOP containing mRNAs were co-transfected alongside a 
vector expressing PTB, over-expression of PTB did not affect the translational 
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efficiency of TOP containing mRNAs (Meyuhas 2000). Translational up-regulation 
was greatest for mRNA transcribed by the TOP constructs. This may be due to PTB 
binding to the relatively longer polypyrimidine tract of the TOP transcribed mRNA, 
compared to the TOP-trctMut mRNA. It is possible that this increased 
polypyrimidine track length of 2 nucleotides is sufficient to increase the likelihood of 
PTB binding the same mRNA multiple times. It is known that when mUltiple binding 
of PTB occurs, this may give rise to the formation of RNA loop structures, especially 
when these sites are separated within the RNA molecule (Petoukhov et al. 2006). 
Ribosomal recruitment in internal ribosome entry site (IRES)-mediated translation 
initiation, is believed to require such conformational changes (Mitchell et al. 2003). 
Indeed, it has been shown under conditions that inhibit cap-dependent translation, 
most cellular lRESs require PTB to function, leading to the proposal that PTB is a 
general lRES trans-acting factor (IT AF)(Mitchell et al. 2005). Ribosome recruitment 
mediated by PTB, has been found to require the consensus sequence (CCU)n as part 
of a polypyrimidine tract (Mitchell et al. 2005). This may provide a potential 
explanation for the increoase in translational efficiency of the mRNA transcribed by 
both the TOP and TOP-trctMut constructs. 
An interesting follow-up experiment would be to investigate the effect upon 
the translation of TOP and TOP-trctMut mRNAs, following a directed reduction in 
PTB expression levels using siRNA. If PTB is required for the translation of TOP 
containing mRNAs, the data would be expected to indicate a reduction of TOP 
mRNA translation following PTB knockdown. A similar experiment has been carried 
out in which the translational of endogenous TOP containing mRNAs was examined 
following a reduction in PTB expression, which was mediated by siRNA transfection 
(personal communication from K. Sawicka, University of Nottingham, data not 
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shown). The data obtained from sucrose density gradients and northern blotting, 
indicated that ribosomal proteins RPS6 and RPS28 were translationally down-
regulated when PTB expression was reduced. Both endogenous RPS6 mRNA and the 
mRNA transcribed by the TOP construct share a common 5'UTR sequence. It would 
therefore be interesting to repeat this experiment with co-transfections of both the 
TOP and TOP-trctMut constructs. 
Investigation of the effect of hnRNP K over-expression on TOP and TOP-
trctMut construct transcribed mRNAs, suggests that the TOP containing rnRNA is 
relatively unaffected in both serum starved and serum starved and re-fed cells. These 
data are consistent with review literature, which citing unpublished data, indicates that 
hnRNP K does not act to repress the translation of TOP containing mRNAs (Meyuhas 
2000). It would perhaps be interesting to repeat this experiment with simultaneous 
expression of hnRNP El, which has been shown to operate in conjunction with 
hnRNP K as a translational silencer (Ostareck et a1. 1997). 
4.7.3 Translational Differences between Sub-sets of 5' TOP containing mRNAs 
It is apparent from previous studies carried out involving La and CNPB, that 
conflicting models exist regarding the role of these trans-acting factors in the 
translational regulation of 5'TOP containing mRNAs. In these studies (discussed in 
more detail in Chapter 1), the differing results were obtained from experiments, which 
investigated the regulation of different TOP containing mRNAs. This raises the 
possibility that different TOP containing mRNAs respond differently to different 
factors and that sub-sets of 5'TOP containing mRNAs may exist. Further evidence 
for the potential existence of TOP containing mRNAs sub-sets, was revealed in the 
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microarray analysis of polysomal mRNA obtained from an eIF4E-inducible cel1line 
(Mamane et aI. 2007). Novel eIF4E targets were identified that were involved in 
ribosome biogenesis, cell proliferation and survival. Despite earlier studies 
suggesting that eIF4E could stimulate ribosomal protein mRNA translation both in 
vivo and in vitro (Kaspar et al. 1990; Hammond et al. 1991), eIF4E over-expression 
affected the translation of only a subset of TOP containing mRNAs. It would 
therefore be of interest to repeat many of the experiments carried out thus far, with a 
selection of constructs which contain the 5'UTRs of other known 5'TOP containing 
mRNAs. 
4.7.4 Direct Determination of the Trans-acting Factor Requirements of 5'TOP 
containing mRNAs 
In the experiments described thus far, the activity of TOP and non-TOP 
containing mRNA was compared under a variety of conditions. No direct attempt has 
been made to directly identify the specific factors which bind to 5'TOP containing 
mRNAs. The recent identification of micro RNA-lOa as a potential enhancer of TOP 
containing mRNA translation was achieved using an affinity purification approach. 
This method utilised biotin-tagged miRNA, which after binding to its mRNA target, 
was purified using Streptavidin beads (Orom et al. 2008). The application of a similar 
technique to 5'TOP containing mRNAs may facilitate the purification of such 
mRNAs and any associated protein complexes that may be required for their 
translation. 
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Chapter Five 
Identification of Factors Which Bind and Control TOP Containing mRNAs 
5.1 Introdudion 
Recently, through the use of affinity purification using biotin-tagged miRNA, 
it has been shown that miRNAs associate with 5'TOP containing mRNAs (Orom et 
a1. 2008). The experiment itself was not designed to specifically identify 5'TOP 
containing mRNAs, but instead utilised affinity purification of a microRNA-IOa to 
specifically identify all mRNAs, which were directly associated with it. There are 
however no reported instances of the application of this technique being reversed to 
specifically identify factors, which bind to 5'TOP containing mRNAs. It would 
therefore be of great interest to develop a technique in which 5'TOP containing 
mRNAs are specifically purified whilst bound to factors, which are potentially 
involved in their regulation. These factors could then be identified using mass 
spectrometry, thus providing a list of candidates that are potential regulators of 5'TOP 
containing mRNA translation. 
5.2 Development of an MS2 Fusion Protein Pull-down System 
S.2.1 Purification of 6xHis-MS2 Fusion Protein 
Affinity purification of mRNAs can be achieved by the use of tagged-fusion 
proteins, which specifically bind to sites that have been deliberately incorporated into 
the mRNA. Fusion proteins of MS2 bacteriophage may be used to pull-down mRNAs 
that contain MS2 binding sites. Indeed, it has been shown that when two MS2 
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binding sites are incorporated at the 3' end of mRNA splicing substrates, purified 
MS2-GST (glutathione S-transferase) fusion protein can be used to specifically pull-
down in vitro-assembled spliceosomes (Zhang and Krainer 2007). In order to utilise a 
similar technique in this system, the TOP and TOP-trctMut constructs were designed 
to transcribe mRNAs that contain binding sites for the bacteriophage MS2 coat 
protein within their 3' UTR (Witherell et al. 1991). 
Three MS2 binding sites were inserted into the XbaI site of the TOP and TOP. 
trctMut reporter constructs (Figure 5.1.1). Each binding site contains a 19 nucleotide 
stem-loop which is specifically bound by the coat protein of the RNA bacteriophage 
MS2 (Witherell et a1. 1991). The MS2 binding sites were obtained by peR from the 
construct pcDNA3.1-MS2x3 (previously created in the lab). The sites were spaced 
13 nucleotides apart to reduce steric hindrance that may prevent multiple protein 
binding. The sites were also located 70 nucleotides downstream of the firefly 
luciferase stop codon, in order to reduce interference with termination of translation 
(Figure 5.1.2A). The endogenous MS2 binding site contains adjacent uracil residues 
within the hairpin loop, whereas the TOP and TOP-trctMut transcribed mRNAs have 
been designed to contain hairpin structures in which one uracil is replaced with 
cytosine (Figure 5.1.2B). This modification has been shown to result in at least a 50-
fold increase in the binding affinity of the MS2 protein (Lowary and Uhlenbeck 
1987). 
A 6xHis-MS2 fusion protein was selected for use in the mRNA pull-down 
experiment. The presence of polyhistidine-tags enables the MS2 fusion protein to be 
affinity purified following expression in E.coli. through the use of metal chelate 
chromatography. It has been shown that the relatively high affinity of the 
polyhistidine-tags for both C02+ and Ni2+ metal ions, enables the fusion protein to be 
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Figure 5.1.1: Final Construction of TOP and TOP-trctMut Vectors 
The M 2 binding ' ite fragment (obtained by peR from pcLuc-mS2x3) was digested 
with Xbal. Thi wa then ligated into the pGL3-rpS6 vector, which had been 
retran fonned in INV 11 0 competent cells, digested with XbaI and dephosphorylated. 
DNA sequencing wa ' carried out to select clones with the correct fragment 
orientation. 
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Figure 5.1.2: chematic Diagram of TOP and TOP-trctMut Vectors 
A. The TOP and TOP-trctMut vector constructs. 
B. The tran eription products of both the TOP and TOP-trctMut vector 
con truet , contain three MS2 binding sites within their 3' UTR. The MS2 
binding ite contain hairpin structures in which one uracil is replaced 
with cyto ine. This modi fication has been shown to result in at least a 50-
fold increase in the binding affinity of the MS2 protein (Lowary and 
hlenbeck 1987). 
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separated from bacterial proteins with up to 95% purity (Hengen 1995) A 6xHis-
MS2 expression vector was transformed into BL21 competent cells, which were 
grown to an optical density of 0.6 (at 600 nm) before expression was induced by the 
addition of IPTO (Isopropyl J3-D-l-thiogalactopyranoside). Prior to the carrying out 
the pull-down assay, optimisation of the purification of 6xHis-MS2 fusion protein was 
carried out. Initially, purification was performed using a Ni-NTA (nickel-
nitrilotriacetic acid) Agarose bead HPLC column and an Imidazole gradient elution of 
50mM to 250mM (with SOmM incremental increases) (Figure 5.2A). A Co-Agarose 
bead HPLC column was also used to purify 6xHis-MS2 fusion protein, using a fixed 
Imidazole concentration of 250mM (Figure 5.2B). Comparison of the fractions 
following Coomassie staining revealed that the fractions eluted from the Co-Agarose 
HPLC column appeared to contain only the 14.7 kDa 6xHis-MS2 fusion protein. The 
fractions eluted from the Ni-NTA column, also contained a protein of 14.7 kDa 
corresponding to 6xHis-MS2 fusion protein, however additional proteins were also 
observed, which were of higher than expected molecular weight. Consequently, 
fractions from the Ni-NT A column were discarded and those collected from the Co-
Agarose column were retained and dialysed against TBS (Tris Buffered Saline) for 18 
hours. 
5.2.2 Optimisation of 6xHis-MS2 Protein-mRNA Binding Conditions 
The mRNA pull-down procedure requires the 6xHis-MS2 fusion proteins to 
bind to the MS2 binding sites of mRNA transcribed from the TOP (or TOP-trctMut) 
construct, following addition of the protein to the lysate of transfected cells. In 
addition, the 6xHis-MS2 protein must remain bound to the mRNA until the final 
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Imidazole: SO mM 100 mM 150 mM 200 mM 250 mM 
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Figure 5.2: Optimi ation of 6xHis-MS2 Protein Purification Conditions 
A. Purification of 6xHis-MS2 fusion protein (14.7 kDA) perfonned using a 
Ni-NTA (nickel-nitrilotriacetic acid) Agarose bead HPLC column and an 
Imidazole gradient elution of 50mM to 250mM (with 50mM incremental 
increases). Additional proteins were also observed which were of higher 
than expected molecular weight (indicated by light grey dotted line). 
B. Purification of 6 IIis-MS2 fusion protein (14.7 kDA) perfonned using a 
Co-Agaro e bead HPLC column with a fixed Imidazole concentration of 
250mM. 
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elution in order for proteins of interest to be detected and separated using PAGE 
(polyacrylamide gel electophoresis) (Figure 5.3.1A). For this reason, it was 
necessary to optimise the binding conditions prior to carrying out the pull-down 
assay. Using the TOP construct as a PCR template, a forward peR primer was 
designed to contain a 5' overhanging T7 promoter sequence (Figure 5.3.1B). One 
reverse PCR primer was designed to produce a PCR product containing the MS2 
binding site region and a second primer was designed to ensure that this region was 
excluded from the PCR product (Figure 5.3.1B). PCR reactions were then carried out 
using the common forward T7 primer and each of the reverse PCR primers. The 
subsequent PCR products were then used as a template for two separate transcription 
reactions, in which T7 RNA polymerase was employed to produce radio-labelled 
RNA transcripts (refer to Chapter 2: Materials and Methods). Two RNA transcripts 
were produced; one containing three MS2 binding sites and one in which no MS2 
binding sites were present. The latter RNA transcript was not expected to bind to 
6xHis-MS2 protein and therefore acted as a negative-control for protein binding, in 
the optimisation experiments. 
In order to determine the optimal protein-RNA binding conditions, a common 
binding buffer was used for each optimisation experiment. The protein-RNA binding 
conditions are therefore directly related to the choice of lysis buffer used in the 
experiment. Two candidate lysis buffers were selected to determine the optimal 
binding conditions. It has previously been shown that MS2 protein binds to mRNA, 
which contains MS2 binding sites, under conditions in which TMK (Tris-MgCh-KCI) 
buffer is used (Talbot et aI. 1991). A TMK based lysis buffer was therefore selected 
as a potential candidate for use in MS2 pull-down experiments. A second TMN 
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Figure 5.3.1: Optimisation of 6xHis-MS2 Protein-mRNA Binding Conditions 
A. The mR A pull-down procedure requires the 6xHis-MS2 fusion protein 
to bind to the M 2 binding sites of mRNA transcribed from the TOP (or 
T P-trctMut) con truct, following addition of the protein to the lysate of 
transfected cells. 
B. Location of P R priming sites within the 5' and 3' UTRs of the TOP 
Vect r. The two peR products were then used as a template for two 
eparate tran cription reactions, in which T7 RNA polymerase was 
emp! cd to produce radio-labelled RNA transcripts. 
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(Tris-MgCh-NaCI) lysis buffer was also chosen for investigation (refer to Chapter 2 
for buffer components). 
The pre-binding of 6xHis-MS2 protein to Ni-NTA beads was carried out by 
the addition of 1 pmol of 6xHis-MS2 fusion protein to 1 00 ~ l l Ni-NTA beads and 100 
~ l l Ni-NTA binding buffer. Following incubation for I hr at room temperature, the 
beads and bound protein were isolated using a magnetic stand and the Ni-NTA 
binding buffer was removed. The Ni-NTA beads (and associated 6xHis-MS2 
protein) were then washed twice with I ml of either the TMK, or the TMN lysis 
Buffer. For each optimisation experiment, 500 ~ l l of lysis buffer was added to the Ni-
NTA beads (and associated 6xHis-MS2 protein), followed by the addition of 1 pmol 
of either control or non-control RNA transcript. Following incubation for 1 hr at 4°C, 
the Ni-NTA beads were isolated using a magnet and washed, four times using Iml of 
wash buffer containing 50mM, 75mM, 100mM and 200mM NaCI(aq) respectively, A 
final elution was carried out with 300mM NaCl(aq). Each fraction was collected and 
the level of radioactivity was quantified using a 60 second continuous scintillation 
count. The total scintillation count was determined for each experiment by 
combining the scintillation count from the eluted fractions, with the scintillation count 
of the material remaining bound to the Ni-NTA beads on completion of the 
experiment. This total count was then used to determine the percentage of radio-
labelled RNA eluted following each wash. In addition, a scintillation count was also 
obtained for the un-bound flow through material. This was used to determine the 
percentage of RNA, which initially bound to the 6xHis-MS2 protein. 
The data obtained for the experiment in which TMN lysis buffer was used 
(Figure 5.3.2A) show that 8% of both the control RNA and the RNA containing three 
MS2 binding sites remained bound to the 6xHis-MS2 protein following incubation. 
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Figure 5.3.2: Optimi ation of 6xHis-MS2 Protein-mRNA Binding Conditions 
A. Optimi ation of binding conditions using the TMN (Tris-MgCI2-NaCl) 
buffer. Two radio-labelled RNA transcripts were used one containing 
three M 2 binding sites and a control transcript in which no MS2 binding 
site were present. The total scintillation count was determined for each 
experiment and was used to determine the percentage of radio-labelled 
RNA eluted following each NaCl(aq) wash. 
B. This proce ' wa then repeated using the TMK (Tris-MgC12-KCl) buffer. 
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Following the initial 50 mM NaCI wash, 88% of the RNA that had associated with the 
6xHis-MS2 protein, was eluted for both the control RNA and the RNA containing 
three MS2 binding sites. A near constant amount of transcript, both with and without 
the MS2 binding sites, was released from the tethered 6xHis-MS2 protein, in each of 
the subsequent washes and in the final elution. At all stages in the experiment the 
difference between transcripts did not exceed 0.6%, indicating that there was no 
significant difference in the binding affinity of either RNA transcript for the 6xHis-
MS2 protein. The data therefore suggests that the RNA-protein binding observed was 
a result of non-specific binding and not as a result of the association of the 6xHis-
MS2 protein with the MS2 binding sites within the RNA transcript. 
Analysis of the data obtained using the TMK lysis buffer Figure 5.3.2B, 
indicates that contrary to the expected trends, only 6% of the RNA containing the 
three MS2 binding sites associated with the 6xHis-MS2 protein compared to 11 % of 
the control transcript. It should be noted however, that the total amount of 
radioactivity incorporated for the control RNA transcript was approximately double 
that incorporated for the RNA transcript containing the three MS2 binding sites. 
Comparison of the binding profiles for both transcripts does not appear to show a 
promising trend. 
Following the initial 50mM NaCI wash, 6% more RNA remained associated 
with the 6xHis-MS2 protein when three MS2 binding sites were present. This 
suggests that the binding specificity is greater for the RNA containing the MS2 
binding sites, compared to the control RNA. With the increase ofNaCI concentration 
to 75mM, a greater percentage of RNA containing the MS2 binding sites was eluted. 
The next significant difference occurs at the 300mM NaCI elution, when 4.7% of 
RNA containing the MS2 binding sites was eluted, compared to 2.5% of control 
164 
RNA. While it was the case that less RNA containing the MS2 binding sites initially 
associated with the tethered 6xHis-MS2 protein, it appears that the specificity of 
binding was slightly higher compared to the control RNA, although the difference 
may not be statistically significant. 
The data show that when either TMK or TMN lysis buffers were used as a 
protein-RNA binding medium, there was not a significant difference in the association 
of 6xHis-MS2 protein with either the control RNA transcript or the RNA containing 
the MS2 binding sites. For this reason, it was decided that a new approach should be 
investigated, in which an MS2 fusion protein is co-expressed in vivo with the TOP or 
TOP-trctMut construct. It is also possible that the interaction between the MS2 
protein and the MS2 binding sites located within the RNA is too weak to result in any 
significant specific association of the protein and RNA. For this reason, it was 
decided that both TOP and TOP-trctMut constructs should be re-designed to 
incorporate an increased number of MS2 binding sites. 
5.3 Modification of TOP and TOP-trctMut Constructs 
In order to increase the number of MS2 binding sites within both TOP and 
TOP-trctMut constructs, additional cloning was required within the region of each 
construct which encodes the mRNA 3' UTR. The key consideration in the cloning 
strategy was to maintain the spacing between the binding sites in order to reduce 
steric hindrance, which would prevent multiple binding of the MS2 protein. 
Previously, tethering assays have been carried out using MS2-EGFP fusion protein 
and mRNAs containing twelve MS2 binding sites within their 3' UTR (Chen et al. 
2008). It was therefore decided that at least twelve MS2 binding sites should be 
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Figure SA.l: Construction o f T O P ~ 1 4 x x I T O P ~ t r c t M u t ~ 1 4 X X Vectors 
A. Location fPeR pliming sites within the 5' and 3' UTRs of the pSL1180-
M 2-) 2x Vector (A kind gift from Prof. Robert H. Singer, Albert Einstein 
College of Medicine, Yeshiva University). 
B. A P R product was obtained which contained 12x MS2 binding sites. 
C. Diagram howing the sequence, orientation and location of the 12x MS2 
binding ite in the transcribed mRNA, relative to the restriction sites 
within the vector. 
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tTctMut- 14.· ye tor con truct contain 2x MS2 binding sites from the original 
ectoT. and 12x additional M 2 binding sites. 
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present in the 3' UTR of the modified TOP and TOP-trctMut constructs. The MS2 
binding sites were obtained by PCR from the plasmid pSL-MS2-12X (a gift from 
Prof. Robert H. Singer, Albert Einstein College of Medicine, Yeshiva University). 
This plasmid contains twelve MS2 binding sites cloned into the pSL1180 vector 
between the BamHI and BglII restriction sites (Figure 5.4.1). The PCR product 
obtained was cloned into both the TOP and TOP-trctMut vectors, between the EcoRI 
and the NheI restriction. The twelve new MS2 binding sites replaced the first of the 
original three MS2 binding sites that were present in the TOP and TOP-trctMut 
constructs (Figure 5.4.2). Upon sequencing, it was confirmed that the two new 
vectors, TOP-14x and TOP-trctMut-14x, each contained a total of fourteen MS2 
binding sites in the correct orientation. 
5.4 Flag-MS2 Fusion Protein 
An alternative method to the pull-down strategy previously implemented is to 
utilise in vivo expression of MS2 protein. The use of mammalian expression vector 
for MS2 protein eliminates the need for purification of the protein prior to association 
with the mRNA. The main benefit of this technique, is that it facilitates in vivo 
association of the MS2 protein with the MS2 binding sites of both TOP-14x and TOP-
trctMut-14x mRNA. This reduces the need for optimisation of the binding conditions, 
although it is still necessary to ensure that the wash and elution conditions are 
optimised to recover the protein-mRNA complex. In its dimeric form, MS2 protein 
contains two head-to-tail molecules, which may be synthesised from a single mRNA 
following genetic fusion of the two open reading frames (Peabody and Lim 1996). It 
has been reported that the in-frame insertion of octa-peptide sequence called Flag 
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within the reading frame of this dimer MS2 coat protein, can be achieved without 
significant functional impairment and with an increase in structural stability compared 
to the wild-type protein (Peabody 1997). Flag-MS2 fusion protein has previously 
been used in RNA tethering experiments (Keryer-Bibens et al. 2008) and has been 
successfully purified from whole-cell lysates HEK-293T cells using anti-Flag-M2 
affinity resin (SIGMA) (Pellizzoni et al. 2002). The successful combination of these 
proven techniques should enable the isolation of mRNAs, which contain MS2 binding 
sites. This process would remove the need for bacterial expression of 6xHis-MS2 and 
the subsequent optimisation of the binding conditions, which is required for affinity 
purification using Ni-NTA beads. 
5.5 Isolation of TOP-14x & TOP-trctMut-14x mRNAs using Flag-MS2 Affinity 
Purification 
An investigation was carried out to determine the efficacy of the Flag-MS2 
affinity purification technique described above. A co-transfection of 5xl06 HEK-
293T cells was carried out in duplicate, using 9 J..lg of mammalian Flag-MS2 
expression vector (a kind gift from Dr A. Marcello, Laboratory of Molecular Biology, 
leGEB, Trieste, Italy) and 3 J..lg of either TOP-14x or Top-trctMut-14x construct. 
After a period of 48 hours had elapsed following the transfection, the cells were 
serum starved for 4 hours in DMEM supplemented with 0.1 % FeS. Following 
serum starvation, the cells were re-fed for 45 minutes with DMEM supplemented 
10% FeS. Using one set of the duplicate plates, TRI reagent (Sigma) was used to 
isolate total RNA from the samples. HEK-293T cells from the second set of 
transfected plates were SUbjected to lysis and affinity purification using anti-Flag-M2 
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resin (Sigma), using the procedure described in the material and methods chapter 
(Section 2.6.1). TRI reagent (Sigma) was then added to the anti-Flag-M2 affinity 
resin to extract the bound RNA. Northern blotting was carried out for firefly 
(reporter) mRNA, on the fractions obtained from the total lysate and the fractions 
obtained following anti-Flag-M2 affinity purification (Figure S.SA). The data clearly 
show that correctly sized reporter mRNA was present in the total cell lysate of TOP-
14x and TOP-trctMut-14x transfected cells (Figure S.SA). The northern blot data that 
obtained for the affinity purified samples shows that these too contain correctly sized 
reporter mRNA. Thus, the affinity purification process appears to have successfully 
isolated reporter mRNA. The ratio of the transfected reporter and protein expression 
vectors appears to have been within a suitable range to facilitate in vivo binding of 
mRNA and protein. Additionally, it appears that the wash-buffers used are suitable to 
allow the Flag-MS2 protein to remain bound to the reporter mRNA during the 
purification process. 
5.6 Western Analysis oCProteins Associated with Affinity Purified mRNAs 
The successful isolation of reporter mRNAs using the anti-Flag-M2 affinity 
purification technique. opens the possibility for experiments to be carried out, which 
attempt to identify the proteins associated with TOP and TOP-trctMut mRNAs. 
Once isolated, these proteins could then be separated using PAGE, and specific 
proteins of interest could then be detected by western blot. Potential differences 
between the specific proteins which are associated with TOP containing mRNAs and 
not-TOP containing mRNAs could then be determined. 
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Figure 5.5: ffinity Purification of TOP-14x and TOP-trctMut-14x mRNA 
A. nhem blotting was carried out for firefly (reporter) mRNA, on the 
fracti ns obtained from the total lysate and the fractions obtained 
~ ~ 1I0wing anti Flag-M2 affinity purification. "T" corresponds to TOP-
14x and" fM" corrc p nd to TOP-trctMut-14x. 
B. llr K - ~ ~9 T cells was carried out in duplicate, using 9 ~ g g of mammalian 
Flag-M 2 cxprc ion vector and 3 ~ g g of either TOP-14x or Top-trctMut-
14x con trucL After a period of 48 hours had elapsed following the 
tran fecti n, ell were serum starved (0.1 % FCS) for 4 hrs or serum 
starved (0.1 % F for 4 hr and serum stimulated (10% FCS) for 45 min 
immediately prior to har e ling Affinity purification followed by western 
blotting wa then carried out on the fractions obtained. 
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In order to investigate which proteins are bound to TOP and non-TOP 
containing mRNAs, a co-transfection of 5xl06 HEK-293T cells was carried out in 
duplicate, using 9 ~ g g of mammalian Flag-MS2 expression vector and 3 ~ g g of either 
TOP-14x or Top-trctMut-14x construct. After a period of 48 hours had elapsed 
following the transfection, the cells were serum starved for 4 hours in DMEM 
supplemented with 0.1 % FCS. These conditions were chosen in order to reduce the 
need for overnight affinity-purification, which could potentially result in the 
destabilisation and degradation of the proteins and protein-mRNA complex. 
Following serum starvation, one set of cells were re-fed for 45 minutes with DMEM 
supplemented 10% FCS, while the other set of cells were immediately harvested. 
Lysis of the lIEK-293T cells and subsequent Flag-M2 affinity purification was 
carried out using the procedure described in the material and methods chapter 
(Section 2.6.1). Samples (comprising 10%) of both crude and cleared lysate fractions 
were retained for comparison with the finale eluted fraction. A wash fraction was 
also obtained, the recovery of which is also described in the material and methods 
chapter (Section 2.6.1). The crude lysate, cleared lysate, combined wash and final 
eluted fractions were loaded onto a polyacrylamide gel. Following electrophoresis, 
the proteins were transferred to a PVDF (Polyvinylidene Fluoride) membrane. 
It was first necessary to confirm that the Flag-MS2 protein had remained 
associated with the anti-Flag-M2 beads throughout the purification process. Western 
blotting was carried out using anti-bodies specific to the Flag-tag of the MS2 protein 
(Figure 5.58). A 15 kDa band corresponding to Flag-MS2 was clearly visible in the 
Pull-down lanes of both serum-starved and serum-starved and re-fed cells. Thus the 
Flag-MS2 protein remained associated with the anti-Flag-M2 beads until the final 
elution. This supports the earlier data obtained by northern blotting, which confirmed 
172 
the presence of TOP and TOP-trctMut mRNAs in the eluted fractions. The western 
data from the starved then re-fed cells does not appear to confirm the presence of the 
Flag-MS2 proteins in the cleared lysate fraction, and only moderate amount in the 
crude lysate. It is possible that the protein had migrated off the bottom of the gel or 
did not transfer onto the PVDF membrane efficiently. The combined wash fractions 
from both starved and re-fed cells do not appear to contain sufficient Flag-MS2 
protein to be visible on the western blot. This suggests that the majority of the protein 
remained associated with the beads, and suggests that the affinity purification process 
has a high degree of efficiency. 
With confirmation that the technique is capable of purifying Flag-MS2 
protein and associated mRNAs, it is now possible to determine whether specific 
proteins are associated with either TOP or non-TOP reporter mRNAs. The 
requirement of eIF4E in the translation of TOP containing mRNAs has previously 
been challenged by several observations, including the result that mRNA transcribed 
by the TOP construct was found to increase by 100% when eIF4E levels were reduced 
(Figure 4.4.2). It has previously been suggested that a possible explanation for the 
observed trend is that TOP containing mRNA translation may utilise an alternative 
mechanism of translation initiation, which does not require eIF4E. A western blot 
was carried out to determine whether or not eIF4E was associated with TOP-14x and 
TOP-trctMut-14x mRNAs (Figure 5.58). In serum-starved cells, eIF4E was found to 
be associated with TOP-trctMut-14x mRNA, but not TOP-14x mRNA. Analysis of 
the data for serum starved and re-fed cells indicates that more un-associated eIF4E 
was removed from the anti-Flag-M2 beads prior to the final elution. This suggests 
that levels of elF4E were higher in serum re-fed cells, as would be expected. It 
appears that eIF4E is associated approximately equally with both TOP-trctMut-14x 
173 
and TOP-14x mRNAs. It should, however, be noted that comparison of the un-bound 
wash and cleared lysate fractions suggests that eIF4E are slightly higher in cells 
transfected with the TOP-14x construct compared to TOP-trctMut-14x transfected 
cells. However, this does not affect the trend that eIF4E is associated with TOP-14x 
mRNA in serum re-fed cells but not in serum starved cells. 
The eukaryotic initiation factor 4B (eIF4B) plays a crucial role in the 
recruitment of the 40S ribosomal subunit to the mRNA. It has been shown to be 
phosphorylated in response to insulin in a process controlled by the PI3K1mTOR 
signalling pathway (Shahbazian et al. 2006). This makes eIF4B ideally positioned to 
play a role in the regulation of TOP containing mRNAs. A western blot was 
therefore carried out, in order to determine whether or not eIF4B is associated with 
TOP containing mRNAs in conditions of serum starvation, or stimulation with 
nutrients following serum re-feeding (Figure 5.5B). The data clearly shows that 
eIF4B was not associated with either TOP-14x or TOP-trctMut-14x mRNA under the 
conditions investigated. It would therefore appear that eIF4B is not an essential 
requirement of translation of both TOP-14x or TOP-trctMut-14x mRNA, perhaps due 
to the relatively short unstructured 5' VTR. It is also possible that eIF4E was 
removed during the washing stage and did not remain bound until the final elution. 
As previously discussed (Chapter 4), Polypyrimidine-tract binding protein 
(PTB) is a multi-function protein, which preferentially binds polypyrimidine-rich 
regions of mRNA (Garcia-Blanco et al. 1989). It was previously observed that both 
TOP and TOP-trctMut reporter transcribed mRNAs appear to be translationally 
activated by PTB over-expression, with the observed activation increasing with the 
amount of PTB expression vector transfected (Figure 4.7.1). It was, therefore, of 
interest to investigate whether PTB was associated with TOP-14x and TOP-trctMut-
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14x mRNAs under similar experimental conditions. The data show that the majority 
of PTB is removed in the cleared lysate fractions, and that the subsequent washing of 
the anti-Flag-M2 beads does not result in the elution of more PTB protein (Figure 
5.5B). This suggests that PTB, which is present in the eluted pull-down fractions, has 
remained specifically bound to the mRNA associated with the Flag-MS2 protein. The 
data for both the serum-starved and serum starved and re-fed cells, show that PTB is 
associated with both TOP-14x and TOP-trctMut-14x mRNA under both conditions. 
In the serum starved cells, PTB appears more associated with TOP-14x mRNA than 
TOP-trctMut-14x mRNA, a trend which appears to be reversed in cells which were 
serum starved then re-fed. 
The potential association ofmicroRNAs within the 5' VTR of TOP containing 
mRNAs raises the possibility that components normally involved in miRNA 
repression are also associated with TOP containing mRNAs. Argonaute 2 (AG02) is 
a critical component of the RNA-induced silencing complex (RISC) and is, therefore, 
essential for miRNA repression (Cannell et al. 2008)]. Interestingly, AG02 possesses 
a cap binding motif, which is similar to that found in elF 4 E and has been detected by 
affinity chromatography with m'GTP-Sepharose (Kiriakidou et al. 2007). Western 
blotting shows that in serum starved cells and in cells which have been serum starved 
then re-fed, AG02 is associated with both TOP-14x and TOP-trctMut-14x mRNAs 
(Figure 5.5B). In the serum re-fed cells however, it appears that more AG02 is 
associated with TOP-14x mRNA than TOP-trctMut-14x mRNA. This data suggests 
that AG02 potentially plays a role in the translation of TOP containing mRNAs 
following nutrient stimulation. 
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5.7 Mass Spectrometry Analysis of Proteins Associated with Affinity Purified 
mRNAs 
The western blot data obtained in the previous experiment confirm that it is 
possible to detennine whether or not specific proteins are with TOP and TOP-trctMut 
mRNAs. It was decided to expand upon this technique and attempt to identify 
unknown proteins which may be associated with TOP and TOP-trctMut mRNAs. In 
order to identify unknown proteins, mass spectrometry was employed to compare the 
proteins obtained from the affinity purification process. As before, co-transfection of 
5x 106 HEK-293T cells was camed out in duplicate, using 9 Jlg of mammalian Flag-
MS2 expression and 3 Jlg of either TOP-14x or Top-trctMut-14x construct. After a 
period of 48 hours had elapsed following the transfection, the cells were serum 
starved for 4 hours in DMEM supplemented with 0.1 % FCS. Following serum 
starvation, one set of cells were re-fed for 45 minutes with DMEM supplemented 10% 
FCS, while the other set of cells were immediately harvested. The anti-Flag-M2 
affinity purification technique (described Section in 2.6.1) was then carried on both 
TOP and TOP-trctMut transfected cells. SDS loading buffer (40 JlI) was used in the 
final elution to recover the proteins which had associated with the Flag-MS2 bound 
mRNA. Four samples were obtained: TOP-14x transfected serum-starved cells, 
TOP-trctMut-14x transfected serum-starved cells, TOP-14x transfected serum-starved 
and re-fed cells, and TOP-trctMut-14x transfected serum-starved and re-fed cells. 
The four protein samples were loaded onto a polyacrylamide gel. Following 
electrophoresis, the gel was then sliced into its constituent lanes, which were in turn 
sub-divided into eight equal sections. These gel segments were then subjected to 
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Mass Spectrometry analysis (carried out at the Cambridge Centre for Proteomics, 
School of the Biological Sciences, University of Cambridge). 
The data obtained was compared to a known protein database using Mascot 
database search engine software (Perkins et al. 1999) and the complete dataset can be 
found in the Appendix section. Comparison of the proteins associated with TOP and 
TOP-trctMut mRNAs was then carried out (Figure 5.6). An important consideration 
to be made when analysing the data, is the lack of experimental validation of the data 
obtained following mass spectrometry. There are a large number of different proteins, 
which are purportedly co-purified with TOP and TOP-trctMut mRNAs. However, the 
difference between these two mRNAs is limited to a mutation of just two nuc1eotides 
within the 5'UTR. This suggests that there are potentially a large number of false-
positives within the dataset. It is apparent from examining the data, that a wide 
variety of ribosomal proteins of both the 40S and 60S ribosomal subunits are 
associated with both TOP-14x and TOP-trctMut-14x mRNA. This is consistent with 
ribosomes being associated with both types ofmRNA during translation. 
La autoantigen has previously been implicated in the translational control of 
5'TOP containing mRNAs (discussed in Chapter 4). The data obtained by mass 
spectrometry indicates that La and La related proteins (including LARPl, LARP2 and 
LARP7) were found to be associated with both TOP-14x and TOP-trctMut-14x 
mRNAs under both sets of experimental conditions. This is consistent with the trend 
observed when La was over-expressed, which indicated that there was no significant 
difference between the translational activity of TOP and TOP-trctMut mRNAs under 
serum starved and serum re-fed conditions (Figure 4.6). 
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When a direct comparison was carried out on the proteins found to be 
associated with each reporter mRNA, P A2G4 was found to be associated with TOP-
14x mRNA, but not TOP-trctMut-14x mRNAs. This protein was found to be 
associated with TOP-14x mRNAs under both serum starved and serum re-fed 
conditions. PA2G4, also known as EBPl (ErbB3-binding protein 1) has been shown 
to bind an array of RNA targets including the FMDV IRES (Pilipenko et al. 2000a), 
and ribosomal RNA (Squatrito et al. 2004). The association of EBPl with 
Nucleophosmin!B23 has been demonstrated as being essential for regulating cell 
proliferation (Okada et at. 2007). Interestingly, NPMl (isoform 2 ofNucleophosmin) 
was also found to be associated with TOP-14x mRNAs under both serum starved and 
serum re-fed conditions. 
Another prominent difference between the TOP-14x and TOP-trctMut-14x 
data, is the observation that ILF2 (also known as NF45) was found to be associated 
with TOP-14x mRNAs and not TOP-trctMut-14x samples. Interestingly, NF45 was 
found to be associated with TOP-14x mRNAs under both serum starved and serum re-
fed conditions. NF45 has been shown to associate with NF90 (also called ILF3: 
Interleukin enhancer binding factor 3) in a variety of different cell types (Guan et a1. 
2008). Other binding partners have also been identified, including RNA helicase A, 
nucleolin and Heterogeneous nuclear ribonuclear proteins M and U (hnRNP-M & 
hnRNP-U) (Guan et at. 2008). These proteins along with NF90, were all identified as 
being associated with TOP-14x mRNAs under serum starved conditions. 
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S.8 Microarray Analysis of Micro-RNAs Associated with Affinity Purified Reporter 
mRNA 
The transfections and anti Flag M2 affinity purification described above were 
repeated exactly. Following RNA extraction using TRI reagent (Sigma), northern 
blotting was carried out to confirm the presence of affinity purified reporter mRNA. 
The concentration of both total and affinity purified mRNA was then obtained by UV-
Vis spectroscopy. Total RNA (2.5 ~ g ) ) was labelled using CyS fluorescent dye (-650 
nm excitationl670 nm emission) and affinity purified RNA was labelled using Cy3 
dye (-550/570 nm). Labelled samples were denatured, loaded microRNA microarray 
chips (obtained from Dr T.W. Gant, MRC Toxicology Unit, University of Leicester) 
prior to hybridisation at 45°C for 16 hours. Following hybridisation, the chips were 
scanned using an Axon Genepix 4000b scanner (Figure 5.7.1). In order to extract 
data from the images obtained, a grid containing probe definitions was assigned by 
using the gridding algorithm within the Genepix Pro software (Molecular Devices). 
The algorithm assigned grid was visually verified and assignments corrected as 
necessary. The fluorescence intensities of the Cy5 and Cy3 dyes and the respective 
background were then recorded in preparation for data analysis. 
Normalisation of the microarray sample data was performed using the 
LIMMA package (Smyth and Speed 2003) running in R statistical environment 
(http://www.r-project.org). The data sets obtained, contained Log2 of the expression 
ratio and media spot intensity at the measured wavelengths. Global locally weighted 
scatter-point smoothing (LOWESS) was carried to normalise the data. It is 
documented that this method provides a balance between the dependence of log-ratio 
on measured spot intensity and the centre of the log-ratio distribution relative to zero 
(Leung and Cavalieri 2003). Following normalisation, the RankProd package within 
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MicroRNA! Differentially Associated with TOP-14x mRNA (P ~ ~ 0.05) 
Rank Name Gene Index P.value 
1 miRPlus_17960 237 0.001 
2 hsa-miR-197 741 0.003 
3 miRPlus_17820 665 0.005 
4 hsa-miR-200a 65 0.007 
5 hsa-miR-9 84 0.007 
6 hsa-miR-154 * 654 0.008 
7 hsa-miR-335 274 0.009 
8 miRPlus_17863 507 0.010 
9 hsa-miR-583 655 0.014 
10 miRPlus_17880 71 0.015 
11 hsa-miR-642 72 0.019 
12 miRPlus_17953 239 0.019 
13 hsa-miR-62S 342 0.020 
14 hsa-miR-585 223 0.021 
15 miRPlus_17928 671 0.021 
16 hsa-miR-365 220 0.023 
17 hsa-miR-51ge* 656 0.028 
18 hsa-miR-454 238 0.029 
19 hsa-miR-148a 781 0.029 
20 miRPlus_17932 70 0.031 
21 hsa-miR-409-5p 117 0.033 
22 hsa-miR-453 57 0.034 
23 hsa-miR-616* 564 0.036 
24 miRPlus_17848 285 0.037 
25 hsa-miR-30c 544 0.038 
26 hsa-miR-657 234 0.039 
27 miRPlus_17875 22 0.040 
28 hsa-miR-205 692 0.041 
29 miRPlus_17952 1689 0.041 
30 hsa-miR-130a 114 0.045 
31 miRPlus_17910 292 0.045 
32 hsa-let-7a 1686 0.047 
33 hsa-miR-195 308 0.049 
34 hsa-miR-181b 173 0.050 
Figure 5.7.2: Analysis of M i ~ r o R N A A M i ~ r o a r r a y y Data 
Nonnalisation of the microarray data was perfonned and identification of 
the differentially associated microRNAs between the TOP-14x and TOP-
trctMut-14x mRNA, was carried out. Those microRNAs which are more 
associated with TOP-14x mRNA than TOP-trctMut-14x mRNA following 
serum re-feeding, are located towards the top of the summary list. The 
complete dataset obtained following nonnalisation and ranking can be 
found in the appendix section. (* refers to the strand of the microRNA 
duplex that is not normally used and undergoes degradation.) 
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the R environment was used to identify differentially associated microRNAs between 
the TOP-14x and TOP-trctMut-14x mRNA, based on the estimated percentage of 
false predictions. Those microRNAs, which are more associated with TOP-14x 
mRNA than TOP-trctMut-14x mRNA following serum re-feeding are located towards 
the top of the list which was produced. A summary of the most differentially 
associated miRNAs can be found in Figure 5.7.2. The complete dataset can be found 
in the Appendix section. 
An alignment was then carried out between the TOP-14x mRNA sequence and 
the sequences of the fifteen microRNAs, which were found to be more associated 
with TOP-14x mRNA than TOP-trctMut-14x mRNA (Figure 5.7.3). Of these, five 
example sequence alignments are shown, all of which were found to align to the TOP-
14x mRNA sequence with mis-matched loop regions of less than three nucleotides in 
length (Figure 3.10). This alignment criterion is therefore consistent with that used in 
the identification of the microRNA-lOa (Orom et at. 2008). The data indicates that all 
five miRNAs potentially have a high degree of base-pairing with the 5' UTR of TOP-
14x mRNA (sequence derived from Human rpS6 mRNA). Of the five chosen 
miRNAs, microRNA-200a was found to be have the largest difference in association 
between TOP-14x and TOP-trctMut-14x mRNA. Analysis of the TOP-14x mRNA 
sequence confirms that it does not contain a complementary sequence to the 
microRNA-200a seed-region, which it usually a requirement of microRNA binding 
(Pillai et at. 2005). This suggests that the isolation of this microRNA is therefore a 
result of binding to the target mRNA at the position indicated within the 5' UTR. The 
presence of these miRNAs should also be confirmed by northern blotting in order to 
validate the microarray data. 
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Figure 5.7.3: Alignment of MicroRNAs with TOP Containing mRNA 
An alignment was then carried out between the TOP-14x mRNA 5' VTR 
sequence and the sequences of the fifteen microRNAs which were found to 
be more associated with TOP-14x mRNA than TOP-trctMut-14x mRNA. 
Five example sequence alignments are shown, all of which were found to 
align to the TOP-14x mRNA sequence with mis-matched loop regions of 
less than three nuclcotides in length. 
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5.9 Discussion 
5.9.1 Analysis of the Proteins Associated with TOP and non-TOP Reporter 
m RN As 
PTB was found to be associated with both TOP-14x and TOP-trctMut-14x 
mRNA under both the serum-starved and serum starved and re-fed cells. This result 
supports the earlier observation that PTB is involved in the translational up-regulated 
of TOP and TOP-trctMut mRNAs, which both possess a polypyrimidine tract (refer to 
Chapter 4). In the serum starved cell, PTB is more associated with TOP-14x mRNA 
than TOP-trctMut-14x mRNA, which is consistent with the previous data in which 
TOP containing mRNA was up-regulated to a greater extent than Top-trctMut mRNA, 
when PTB was over-expressed (Figure 4.7.1). Surprising, in cells that were serum 
starved then re-fed, PTB appears to be more associated with TOP-trctMut-14x mRNA 
than TOP-14x mRNA. It is therefore possible that in cells that are serum starved 
then re-fed, PTB may bind to TOP containing mRNAs in competition with an as yet 
undetermined protein. Repetition of this experiment may be necessary in order to 
confirm the observed trend. 
It has previously been observed that eIF4E does not appear to be involved the 
translation initiation of TOP containing mRNAs. For the TOP construct, over-
expression of 4E-BPl resulted in an overall increase in translational efficiency 
(Figure 4.2). It was also found that translational efficiency of the mRNA transcribed 
by the TOP construct was found to increase by 100% when eIF4E levels were reduced 
(Figure 4.4.2). In serum starved and re-fed cells, eIF4E was found to be associated 
approximately equally with both TOP-trctMut-14x and TOP-14x mRNAs. This data 
does not appear to fit the previously observed trend, which suggested that eIF4E was 
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not required by 5'TOP containing mRNAs. This data could be skewed however, as 
comparison of the un-bound wash and cleared lysate fractions suggests that eIF4E 
levels are slightly higher in cells transfected with the TOP-14x construct compared to 
TOP-trctMut-14x transfected cells. When this difference is taken into account, it is 
possible that TOP-14x mRNAs were associated with less of the available eIF4E than 
TOP-trctMut-14x mRNAs. Repetition of this experiment is required to confirm this 
trend. In serum-starved cells, eIF4E was found to be associated with TOP-trctMut-
14x mRNA, but not TOP-14x mRNA (Figure 5.5B). This data appears to be 
consistent with an earlier study in which eIF4E was over-expressed. It was found that 
in quiescent cells, over-expression of eIF4E did not relieve the translational 
expression of ribosomal protein mRNAs, which are a subset of TOP containing 
mRNAs (Mamane et al. 2007). 
Argonaute 2 (AG02) was found to be associated with both TOP-14x and 
TOP-trctMut-14x mRNAs. Following serum re-feeding it was found that more 
AG02 was associated with TOP-14x mRNA than TOP-trctMut-14x mRNA. This 
data suggests that AG02 potentially plays a role in the translation of TOP containing 
mRNAs following nutrient stimulation. AG02 is a critical component of the RNA-
induced silencing complex (RISe) and it is therefore possible that its detection in 
serum-refed cells is related to the binding of miRNAs within the 5' VTR, as 
previously confirmed by microarray analysis. The potential involvement of Ago2 at 
the 5' terminus ofmRNA is supported by the fact that AG02 possesses a cap binding 
motif, which is similar to that found in eIF4E (Kiriakidou et al. 2007). Interestingly, 
it has also been shown that AG02, which is normally thought of as being involved in 
translational repression by its involvement with miRNAs, can also be involved in 
translational up-regulation. It has been shown that fragile-X-mental-retardation-
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related protein 1 (FXRl) and AG02 associated with AU-rich elements (AREs), 
present in mRNA 3'-UTRs, exclusively during translation activation (Vasudevan and 
Steitz 2007). It would therefore be interesting to carry out a western blot to 
determine if FXRl is also associated with TOP containing mRNAs under serum re-
fed conditions. 
The conditions of serum-starvation and re-feeding in this experiment were 
considerably shorter than in the previous experiments, in which the translation of TOP 
and TOP-trctMut mRNAs was investigated. This decision was made in an attempt to 
reduce the need for overnight affinity-purification, which may have resulted in the 
destabilisation and degradation of the proteins and protein-mRNA complex. 
Although the 4 hour serum-starvation period has previously been used for 
investigations involving TOP reporter constructs, stimulation for 45 minutes has only 
previously been reported utilising amino acid addition rather than the re-addition of 
serum (Stolovich et al. 2002). It is possible that the serum re-feeding conditions may 
not have been sufficient to affect translation activation of TOP containing mRNA. In 
order to confirm the effectiveness of the serum re-feeding, the experiment to 
determine 35S methionine incorporation (described in section 3.5) could be repeated 
with the new conditions. This would help to improve the confidence in the data 
obtained by western blotting. Additional negative controls could also be incorporated 
into this experiment and the subsequent experiment which detected differentially 
associated proteins using mass spectrometry. Constructs which did not encode MS2 
binding sites could also be used to confirm the specificity of the binding of the 
mRNA-protein complex with the anti-Flag M2 beads. An mRNA transcript could 
also be transfected which did not contain a 5 'UTR, but did contain the MS2 binding 
sites. This could be used to potentially eliminate from consideration, proteins that did 
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not bind within the vicinity of the 5'TOP motif. Whilst this may eliminate the 
detection of proteins that bound within the 5'UTR and also elsewhere on the mRNA, 
it may substantially reduce the number of false-positive results. 
5.9.2 Analysis of the Proteins Detected by Mass Spectrometry 
The data obtained following mass spectroscopy suggests that there are large 
differences between the number and type of proteins which bound to both TOP and 
TOP-trctMut mRNAs under serum-stimulated and serum-deprived conditions. In the 
case of the longest list (TOP, serum starved conditions), 310 proteins were detected, 
compared to just 74 proteins in the shortest list (TOP, serum re-fed conditions). A 
large number of differences also exist between the proteins purportedly co-purified 
with TOP and TOP-trctMut mRNAs. This result is particularly surprising considering 
that the difference between these two mRNAs is limited to a mutation of just two 
nucleotides within the 5'UTR. As previously s u g g e s t e ~ ~ it is therefore likely that 
these lists contain a large number of false-positive results. In order to draw firm 
conclusions, it would first be necessary to independently validate the data obtained 
using at least one different experimental technique. This could be achieved by 
repeating the affinity purification process and carrying out directed western blotting to 
attempt to detect specific proteins of interest. Experiments could also be carried out 
to determine the effect of over-expression or a reduction in levels of the candidate 
proteins. With these limitations in mind, considered analysis of the data can used to 
suggest candidate proteins which may be involved in the translation of TOP 
containing mRNAs. 
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La autoantigen and La related proteins (including LARPI, LARP2 and 
LARP7) were found to be associated with both TOP-14x and TOP-trctMut-14x 
mRNAs under both sets of experimental conditions. Previously, it was shown that the 
over-expression of La had no effect on the translation of mRNA transcribed by both 
TOP and TOP-trctMut constructs under similar experimental conditions (Figure 4.6). 
It is therefore likely that La is a polypyrimidine tract binding protein and does not 
contribute significantly to the translational regulation of 5'TOP containing mRNAs. 
NF45 (ILF2) was found to be associated with TOP-14x mRNAs and not TOP-
trctMut-14x samples. Interestingly, other known binding partners ofNF45 including 
NF90 (ILF3), RNA helicase A, nucleolin and Heterogeneous nuclear ribonuclear 
proteins M and U (hnRNP-M & hnRNP-U) were also found to be associated with 
TOP-14x mRNA under serum stimulated conditions. NF90 is known to contain two 
double-stranded RNA (dsRNA) binding domains, allowing it to bind to double-
stranded and structured single-stranded RNAs (Guan et al. 2008). When either NF45 
or NF90 are knocked-down, the rate of cell division has been shown to decrease. 
NF45, with a half life of 1.5 hrs in Hela cells, is relatively unstable and is protected by 
NF90 (Guan et al. 2008). This rapid turnover raises the possibility that NF45 could 
have a potential role as a regulatory subunit. 
Like AG02, NF90 has also been shown to bind to AD-rich elements (AREs), 
present in mRNA 3'-UTRs (Guan et al. 2008). AG02 and miRNAs have been shown 
to migrate together with messenger ribonuc1eoproteins (mRNPs) (Kim et al. 2004a; 
Nelson et al. 2004). AG02 was found to sediment with three distinct AGO 
complexes (I-Ill). Interestingly, RNA helicase A, hnRNP-U, NF90 and NF45 were 
all found to be associated with AG02 complex 11, and with the exception of NF90, 
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AG02 complex III (Hock et al. 2007). It is therefore possible that AG02 functions 
with NF90 and its binding partners in the control of S'TOP regulation. 
The discovery that EBP} was only found to be associated with TOP-14x 
mRNA, gives rise to the possibility that it is involved in the translational regulation of 
TOP containing rnRNAs. It has been previously shown that EBP} appears to act 
synergistically with PTB in stimulating formation of 48S initiation complexes 
(pestova et al. 2001). It has been demonstrated using mass spectrometry that EBPl 
is part of ribonucleoprotein complexes and associates with different rRNA species. 
This has led to speculation that EBP} may provide a link between ribosome 
biosynthesis and cell proliferation (Squatrito et a1. 2004). 
It has been shown that EBP} is localized to both the cytoplasm and to the 
nucleolus (Squatrito et al. 2004). Nucleophosmin (NPM), is one of the most abundant 
proteins in the nucleolus (Schmidt-Zachmann et al. 1987), and was also found to be 
associated with TOP-14x mRNA. EBP} has been shown to form a complex with 
NPM, which plays a critical role in cell proliferation and survival (Okada et al. 2007). 
When levels of NPM or EBP 1 are reduced it has been shown that both ribosome 
biogenesis and cell survival substantially decrease (Okada et al. 2007). Interestingly, 
EBP 1 has been shown to be associated with mature ribosomes in the cytoplasm. It 
has also been shown that EBP} is capable of inhibiting the phosphorylation of 
eukaryotic initiation factor 2a (eIF2a) (Squatrito et a1. 2006). It has been previously 
suggested that the phosphorylation eIF2a may be connected to the mTOR signalling 
pathway (Caldarola et al. 2004). EBPl is highly conserved and it had been suggested 
that EBP 1 could be involved downstream of multiple signal transduction pathways 
(Xia et al. 2001). EBPl therefore appears to be perfectly positioned to regulate the 
translation S'TOP containing mRNAs. It would therefore be of great interest to 
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further investigate the role of this protein in this system. Carrying out both over-
expression and reduction of EBP 1 levels and investigating the effect on endogenous 
and reporter S'TOP containing mRNAs may yield useful information on the depth of 
involvement of this protein. 
Although it is difficult to draw firm conclusions from the mass spectrometry 
data due to the lack of experimental validation, it should be possible to use these data 
to validate the results which were obtained following western blotting. Surprisingly, 
none of the proteins (specifically PTB, AG02 and eIF4B), which were identified by 
western blotting as being associated with TOP and TOP-trctMut mRNA, are present 
in the mass spectrometry results. Since there is no obvious explanation for this, it 
would therefore be of interest to repeat the mass spectrometry and western blotting, 
using samples obtained from the same experiment. 
5.9.3 Micro-RNA! Associated with Affinity Purified Reporter mRNA 
It is interesting that of the sequence alignments carried out using the list of 
TOP-14x associated microRNAs, all five proposed binding sites of the microRNAs 
were outside of the region that differs between the TOP-trctMut-14x mRNA and 
TOP-14x mRNA (Figure S.7.3A, indicated in red). This result calls into question the 
significance of the data, since the differential association of miRNAs cannot directly 
be associated with the differences in the mRNA sequences. It has been previously 
proposed that microRNA-lOa specifically associates with the 5'UTR of TOP 
containing mRNAs (Orom et a1. 2008). The mRNA transcribed by the TOP-mirMut-
14x construct contains a mutation within the proposed binding site ofmicroRNA-10a. 
Therefore, a more direct experimental approach would have been to compare the 
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differential association of microRNAs between the mRNA transcribed by the TOP· 
14x construct and a new TOP-mirMUT-14x construct. 
If it is assumed that the difference between TOP-14x mRNA and TOP· 
trctMut-14x mRNA is unlikely to affect miRNA binding, then it may be possible to 
treat the data obtained from the TOP-trctMut mRNA as a replicate. The comparative 
list (refer to Appendix) was ranked with those microRNAs most differentially 
associated with the TOP-14x mRNA at the top of the list, and those most 
differentially associated with the TOP-trctMut-14x mRNA at the bottom of the list. 
Therefore, the microRNAs which are located towards the centre of the list are those 
which were found to associate with similar affinity to both TOP mRNA and its 
replicate. The comparative list contains 720 microRNAs, meaning that the 
microRNAs with the greatest affinity to TOP mRNA are clustered around rank 370. 
Interestingly, Micro-RNA-lOa is located at rank 372 on the comparative list. If the 
earlier assumption is correct and the TOP-trctMut data may be treated as a replicate, 
then this data is consistent with the earlier study in which microRNA-lOa was shown 
to be associated with the 5' UTR of TOP containing mRNAs (Orom et al. 2008). 
Confirmation of this data could be carried out by repeating the affinity purification 
experiment and comparing the differential association of microRNAs between the 
mRNA transcribed by the TOP-14x construct and a new TOP-mirMut-14x construct. 
Despite the evidence which suggests that microRNA-lOa associates with TOP 
containing mRNA, it remains unclear what functional role is performed by this 
association. 
192 
Chapter Six 
Discussion 
6.1 5' TOP Containing mRNAs 
As previously discussed the critical structural features of mRNAs containing 
the 5'tenninal oligopyrimidine tract motif, are the presence of a C residue 
immediately preceding the 5' tenninal m'O cap structure of the mRNA and an 
uninterrupted 4-14 nucleotide polypyrimidine tract (reviewed in Chapter 1). Two 
distinct translational modes, which operate in a growth dependent manner, are 
common to all TOP containing mRNAs thereby facilitating a mechanism for their co-
ordinated expression. In growing cells, TOP containing mRNAs are loaded with a 
full complement of ribosomes and are also translated with full efficiency. In growth 
arrested cells however, TOP containing mRNAs are entirely shifted into the sub-
polysomal, non-translating population (Loreni and Amaldi 1992). 
One of the primary aims of this project was to develop a 5' TOP containing 
mRNA reporter vector construct. Analysis of the 5' RACE data (Figure 3.6.3) 
confinns that the TOP construct transcribes mRNA that contains the 5'TOP motif 
with a C-residue immediately downstream of the 5' tenninal m'O cap and an 
uninterrupted polypyrimidine tract. Sucrose density gradient analysis also confinned 
that mRNAs transcribed by the TOP construct were predominantly associated with 
polysomes in nutrient stimulated cells, while in starved cells the mRNA was almost 
entirely associated with sub-polysomal particles (Figure 3.88). This is consistent 
with the characteristic growth-dependent expression of TOP containing mRNAs and 
therefore suggests that the first objective of the project was successfully achieved. 
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6.2 Signalling Pathways and 5' TOP containing mRNAs 
An initial focus of research involving signalling pathways and their role in 5' 
TOP containing mRNA translational regulation was the observation that the 
translational activation of 5' TOP messages in response to mitogenic stimuli 
correlated with the phosphorylation of RPS6 (Thomas et al. 1980). RPS6 is a 
downstream target ofS6Kl and S6K2, and as previously discussed, both of which are 
known to be involved in the mTOR signalling pathway and are themselves 
downstream targets of mTORCl (Kim et al. 2002). mTORl has been shown to be 
sensitive to inhibition by Rapamycin and the repression of translation of 5' TOP 
containing mRNAs has been observed following Rapamycin treatment (Jefferies et al. 
1997). In this study, the treatment of TOP and TOP-trctMut transfected HEK-293T 
cells with Rapamycin resulted in the translational down-regulation of mRNA 
transcribed from the TOP construct. Interestingly, translation of the TOP-trctMut 
remained relatively unaffected when compared to the control (Figure 3.1 OB). Whilst 
this data is only just outside the bounds of experimental error, it suggests that the 
regulation of 5' TOP containing mRNAs may be mediated by the mTOR signalling 
pathway. However, as previously discussed, evidence exists which suggest that this 
inhibition may be cell type specific (Tang et al. 2001; Stolovich et al. 2002). 
Repetition of this experiment in a wider variety of cells lines would help to determine 
if the observed trend is specific to the HEK-293T cell-line. 
The PI3K (phosphoinositide 3-kinase) signalling pathway has also been 
implicated in translational regulation of 5' TOP containing mRNAs. It has been 
shown that activation of PI3K signalling occurs upon insulin or mitogenic stimuli 
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(Burgering and Coffer 1995; Kohn et a1. 1995). The translational activation of 5' 
TOP containing mRNAs is completely blocked when cells are treated with L Y294002 
and Wortmannin, which are both inhibitors of the PI3K signalling pathway (Vlahos et 
al. 1994; Tang et al. 2001; Caldarola et a1. 2004). This result was also obtained when 
cells were treated with the PI3K inhibitor Wortmannin (Caldarola et a1. 2004). As 
discussed in section 3.8.2, studies in which HEK-293 cells were treated with 
L Y294002, have revealed selective and pronounced repression of protein synthesis 
directed by TOP containing mRNAs encoding rpL32 and eEFIA. (Stolovich et al. 
2002). Following the treatment of HEK-293T cells with both Wortmannin and 
L Y294002 in this study (Figure 3.10B), no significant difference was observed 
between TOP and TOP-trctMut transcribed mRNAs. Luciferase activity from both 
constructs was reduced, suggesting that the effect observed was not specific to 5' TOP 
containing mRNAs. This data is therefore inconsistent with that obtained in previous 
studies. It is possible that the effects previously observed were specific to the 
particularly TOP containing mRNA that was investigated. As previously discussed, it 
would be of interest to repeat the experiments performed here using constructs 
containing the 5 'UTRs of a wide variety of different TOP containing mRNAs. 
6.3 Canonical Initiation Factors and 5' TOP Containing mRNAs 
4E-BP was identified as a downstream target of mTOR and provides a 
potential link between this signalling pathway and the translational regulation of 5' 
TOP containing mRNAs. Under conditions of serum starvation, eIF4E is expected to 
remain tightly bound to hypo-phosphorylated members of the 4E-BP family and 
therefore act a rate limiting component in the cap-dependent initiation of translation 
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(Davuluri et al. 2000; Suzuki et a1. 2000). The luciferase expression data (Figure 4.2) 
obtained following transfection of the TOP-trctMut construct is consistent with this 
hypothesis, with an observed decrease in translational efficiency of between 20-40% 
following over-expression of 4E-BPl. The fact that repression is still occurring 
following serum stimulation, suggests that the over-expression of 4E-BPl is still 
resulting in the sequestration of eIF4E. This implies that not all the additionally 
expressed 4E-BPl is phosphorylated following serum stimulation. 
Contrary to the expected trend for cap-dependent initiation of translation, an 
increase in translational efficiency was observed following 4E-BPl over-expression 
in the case of the TOP construct. This data raised the possibility that eIF4E 
availability may not be a rate-limiting factor in the translation initiation of 5' TOP 
containing mRNAs. The increase in translation of TOP mRNA, which was observed 
following serum-stimulation, was much greater than that observed in serum-starved 
cells. This is consistent with the known response of TOP containing mRNAs under 
conditions of scrum-stimulation. 
As previously discussed, the western blotting data shows that as the amount of 
transfected pcDNA3.1-4E-BPl vector increased, an increase in 4E-BPl protein 
expression was not observed. The loading control (Actin) appears relatively constant, 
although the relatively high abundance of Actin may have made it difficult to detect 
small changes between samples. It is also relevant the antibody, which was used for 
western blotting, detected total 4E-BPl and was therefore not specific to the un-
phosphorylated form of 4E-BPl that is capable of sequestering eIF4E. An improved 
control for this experiment would be to determine the total cellular protein synthesis 
rate by measuring the incorporation of 3SS methionine. Carrying out western blotting 
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to determine the levels of unphosphorylated 4E-BPl may also provide a greater 
insight into the mechanism at work. 
The data obtained from sucrose density gradient analysis (Figures 4.3.1 and 
4.3.2) also indicated that the translational efficiency of mRNA transcribed from the 
TOP construct increased following the over-expression of 4E-BP1. A similar trend 
was also observed following the reduction in eIF4E levels, which carried out using a 
plasmid expressing shRNA (Figure 4.4.2). However, when this experiment was 
repeated using the TOP-trctMut construct, the data obtained casts doubt on the 
significance of this experiment. Surprisingly, an increase in the translational 
efficiency of TOP-trctMut mRNA was observed when the levels of eIF4E were 
reduced. This result was inconsistent with that obtained when 4E-BPl was over-
expressed (Figure 4.2A). This anomalous result may potentially be explained by the 
subsequent analysis of the western blot data, which indicated a lower knockdown 
efficiency of eIF4E in the case of the TOP-trctMut vector transfection. Further 
repetition of this experiment may therefore be required to increase the confidence in 
the data. 
It is difficult to draw firm conclusions from these experiments due to the 
limitations, which have been described. However, when these data are considered 
collectively, the possibility is raised that eIF4E may not be required for the initiation 
of translation of 5' TOP containing mRNAs. This proposal is challenged however, by 
the data obtained following the affinity purification of TOP-trctMut-14x and TOP-14x 
roRNAs, which indicated that eIF4E was associated approximately equally with both 
mRNAs. It should however be noted, that eIF4E levels were slightly higher in cells 
transfected with the TOP-14x construct compared to TOP-trctMut-14x transfected 
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cells. In serum-starved cells, eIF4E was found to be associated with TOP-trctMut-
14x mRNA, but not TOP-14x mRNA (Figure 5.5B). 
With the requirement of eIF4E by 5' TOP containing mRNAs called into 
question, investigations were carried out to determine whether its binding partner 
eIF4G (whose function is reviewed in Chapter I) was also required. The translational 
efficiency of TOP mRNA increased by 20% under conditions in which eIF4GI levels 
were reduced without the concurrent re-expression using the 4G If vector. An in 
increase observed in the translational activity of TOP mRNA was also observed when 
eIF4GI without the eIF4E binding-site was expressed following eIF4GI knock-down. 
These data appears consistent with the broader suggestion that neither eFI4GI nor 
eIF4E are required for the initiation of translation of TOP containing mRNAs. It is 
possible that as the translation of other mRNAs that require eiF4GI is reduced, TOP 
containing mRNAs can utilise the newly available pool of other initiation factors. In 
both of the above cases, the translation activity of TOP-trctMut and TOP-mirMut 
transcribed mRNAs remained unaffected. It is possible that initiation oftranslation of 
TOP-trctMut and TOP-mirMut mRNA may have occurred via a cap-dependent 
pathway that utilised eIF4GII, which was not expected to be affected by eIF4GI 
knockdown. The continued presence of elF4GII as a variable in the data makes is 
impossible to draw a firm conclusion. Simultaneous reduction in the levels of both 
elF4GI and eIF4GII would provide a clearer point of comparison. Real-time PCR 
could also be performed to confirm that the observed trends are related to translation 
effects and are not merely a function of cellular mRNA levels. 
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6.4 MicroRNAs 
Recently, it has been reported that miR-lOa binds to the 5' UTR of TOP 
containing mRNAs that encode ribosomal proteins and enhances their translation 
(Orom et al. 2008). It appears that Mir-lOa is capable of alleviating the translational 
repression imposed upon 5' TOP containing mRNAs following amino acid starvation 
and that the 5' TOP motif is specifically required for this to occur (Orom et a1. 2008). 
The mTOR signalling pathway has also been implicated in the regulation by miR-lOa, 
since it has been determined that the translational enhancement imposed by miR-I0a 
is Rapamycin sensitive (Orom et a1. 2008). As a result of these observations, the 
affinity purification of TOP-l4x and TOP-trctMut-l4x was coupled microRNA 
microarray analysis to determine whether any microRNAs were specifically 
associated with either reporter mRNA. 
Interestingly, the data revealed that all five proposed micro RNA binding sites 
were outside of the region that differs between the TOP-trctMut-14x mRNA and 
TOP-l4x mRNA (Figure 5.7.3). As a result, it was decided that it may have been 
more appropriate to treat the data obtained using the TOP-trctMut construct as an 
experimental replicate. Those microRNAs which were found to be associated with 
both TOP-14x and TOP-trctMut-l4x would therefore be located towards the centre of 
a ranked list of differential association. Micro-RNA-lOa was found to be located at a 
mid-way position on the list. This is consistent with the earlier study in which 
microRNA-10a was shown to be associated with the 5' UTR of TOP containing 
mRNAs (Orom et al. 2008). This data does not however provide any indication as to 
whether microRNA-lOa binds within the earlier predicted location within the 5'UTR 
of TOP-14x mRNA. Repetition of the experiment using mRNA transcribed by the 
TOP-14x construct and a new TOP-mirMUT-14x construct, would more directly 
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address this question. Despite the evidence which suggests that microRNA-lOa 
associates with TOP containing mRNAs, it remains unclear what functional role is 
performed by this association. 
6.5 Trans-acting Factors 
It has been suggested that the translation of 5' TOP containing mRNAs may 
be regulated by a variety of Irans-acting factors (reviewed extensively in Chapter 1). 
To date, there have been no direct attempts to specifically purify factors that are 
bound to 5' TOP containing mRNAs. For this reason, a method was devised in which 
reporter mRNAs containing the 5' TOP motif, could be specifically purified whilst 
still bound to factors which are involved in their regulation. Following affinity 
purification, western blotting was carried out to investigate the association of 
previously identified candidate proteins with TOP containing mRNA. In addition, 
mass spectrometry was also carried out in an attempt to identify proteins which 
specifically associated with TOP mRNAs. As previously discussed in section 5.7, the 
lack of independent validation of the data obtained following mass spectrometry is a 
limitation to consider when evaluating the data. Without western blotting to confirm 
association of the proteins with the TOP-14x and TOP-trctMut-14x mRNAs, it is not 
possible to conclude that the proteins identified are not false-positive results. Indeed, 
the large number of different between TOP-14x and TOP-trctMut-14x associated 
proteins, for just a two nucleotide mutation, suggests that there are potentially a large 
number of false-positives within the dataset. Using the mass-spectrometer data to 
independently validate the western blots obtained in the first affinity purification also 
raises an interesting point to consider. PTB, AG02 and eIF4B, which were identified 
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by western blotting as being associated with TOP and TOP-trctMut mRNA, are not 
present in the mass spectrometry results. Further repetition of the experiment is 
therefore required to increase confidence in the data. The limitations discussed here 
should be applied to the analysis of the candidate Irans-acting factors discussed 
below. 
The protein La has been linked to the regulation of 5' TOP containing mRNAs 
in numerous publications (reviewed in Chapter 1). It have been observed that La co-
sediments with polysomes in an RNA-dependent manner and is specifically 
associated with 5' TOP containing mRNAs in the polysome fraction (Cardinali et al. 
2003). Other research has proposed that La exerts a positive effect on translation 
through competitive binding with another protein called CNBP, which potentially acts 
a translational repressor (Crosio et a1. 2000). 
The data obtained upon over-expression of La, suggests that La has no effect 
on the translation of mRNA transcribed by both TOP and TOP-trctMut constructs 
under the experimental conditions used in this system (Figure 4.6). Interestingly, 
despite this observation, mass spectrometry carried out following the affinity 
purification of TOP-14x and TOP-trctMut-14x mRNAs indicated that La auto antigen 
and La related proteins (including LARPl, LARP2 and LARP7) were associated with 
both under both serum starVed and serum re-fed conditions. Together these data 
suggest that La may be a general polypyrimidine tract binding protein and although it 
associates with 5' TOP containing mRNAs, it does not contribute significantly to the 
regulation of their translational. CNBP, which has been proposed as a translational 
repressor of 5' TOP containing mRNAs, was not found to be associated with either 
the TOP-14x or TOP-trctMut-14x mRNA. It may be of interest in the future to carry 
out an experiment in which CNBP is over-expressed under the same experimental 
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conditions carried out in this study. If CNBP is indeed a translational repressor of 
mRNAs containing the 5' TOP motif, then under conditions in which CNBP was 
over-expressed a reduction in the translational efficiency of 5' TOP containing 
mRNAs would be expected. 
PTB (polypyrimidine tract binding protein) is a multi-function protein, which 
preferentially binds polypyrimidine-rich regions of mRNA (Garcia-Blanco et a1. 
1989). It is known that PTB often functions in collaboration with other proteins, 
including hnRNP K, to initiate translation (Sawicka et al. 2008). To date, no direct 
evidence has been published, which has definitively proven or disproven the 
involvement of PTB in the regulation of 5' TOP containing mRNAs. Following PTB 
over-expression in this study, both TOP and TOP-trctMUT constructs were 
translationally up-regulated. It is likely that PTB was binding to the polypyrimidine 
tract, which is a common feature of both mRNAs. Affinity purification and 
subsequent western blotting confinned that PTB associated with both TOP-14x and 
TOP-trctMut-14x mRNA under both the serum-starved and serum starved and re-fed 
cells. As previously discussed, PTB was not detected by mass spectrometry. 
Investigation of the effect of hnRNP K over-expression on TOP and TOP-trctMut 
construct transcribed mRNAs, suggests that the 5' TOP containing mRNAs are 
relatively unaffected in both serum starved and serum starved and re-fed cells. It 
would perhaps be interesting to repeat this experiment with simultaneous expression 
of hnRNP El, which has been shown to operate in conjunction with hnRNP K as a 
translational silencer (Ostareck et al. 1997). 
Perhaps the most interesting candidate trans-acting factor to be identified 
following affinity purification and mass spectrometry is NF45 (ILF2). Interestingly, 
NF45 was found to be associated with TOP-14x mRNAs, but not TOP-trctMut-14x 
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mRNAs. As described in more detail in Chapter S, additional binding partners of 
NF90 including RNA helicase A, nucleolin and Heterogeneous nuclear ribonuclear 
proteins M and U (hnRNP-M & hnRNP-U) were also found to be associated with 
TOP-14x mRNA under serum stimulated conditions. Repetition of this experiment 
could be carried out to confirm the association of NF45 and its known binding 
patterns with TOP-14x mRNAs. It may also be interesting to investigate the effect of 
over-expression or siRNA mediated reduction of NF45 and its associated proteins 
upon S' TOP containing mRNAs. Preliminary data from experiments in which the 
TOP and TOP-trctMut vectors were transfected into NF45 deficient cell lines, showed 
relative translational up-regulation of TOP containing mRNA (personal 
corn..munication from Dr. L. Cobbold). 
Interestingly, NF90, NF45, RNA helicase A, and hnRNP-U have all been 
found to associate with known AG02 complexes (Hock et al. 2007). AG02 and 
microRNAs have been shown to migrate together with messenger ribonucleoproteins 
mRNPs (Kim et at. 2004a; Nelson et al. 2004). Thus, it is possible that AG02 
functions with NF90 and its binding partners in the control of S' TOP regulation and 
that microRNAs are potentially involved in this process. AG02 was found to be 
associated with both TOP-14x and TOP-trctMut-14x mRNAs. Following serum re-
feeding it was found that more AG02 was associated with TOP-14x mRNA than 
TOP-trctMut-14x mRNA. This data suggests that AG02 potentially plays a role in 
the translation of S' TOP containing mRNAs following nutrient stimulation. 
EBPl was also found to be associated specifically with TOP-14x mRNAs and 
not TOP-trctMut-14x. This is also an interesting result since EBPl has been shown to 
act synergistically with PTB in stimulating formation of 48S initiation complexes 
(PiJipenko et al. 2000b). It has been demonstrated using mass spectrometry, that 
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EBPl is part of ribonucleoprotein complexes and associates with different rRNA 
species. This has led to speculation that EBPl may provide a link between ribosome 
biosynthesis and cell proliferation (Squatrito et al. 2004). Thus, EBPl appears 
perfectly positioned for a role in the regulation of 5' TOP containing mRNAs. 
6.6 Future Work 
After addressing the limitations and implementing the experimental 
improvements discussed above, there are several research areas identified in this 
project which are likely to be worthy of future experimental work. If the additional 
data obtained does indeed suggest that TOP containing mRNAs do not require eIF4E 
for the initiation of translation, this study could be extended to include the over-
expression of eIF4E. If the proposal is correct, the translation of TOP containing 
mRNAs should remain largely unaffected by eIF4E over-expression. Sucrose density 
gradient analysis could also be carried out following the over-expression of 4E-BPl, 
with the addition of Northern blotting to determine the polysomal distribution of 
known endogenous 5' TOP containing mRNAs. This may provide an insight as to 
whether all TOP containing mRNAs behave in the same way when 4E-BPl is over-
expressed. 
If the results of the affinity purification and mass spectrometry are repeatable 
and can be validated by western blotting, the potential role of EBPl could also be 
investigated further. A series of experiments involving over-expression of EBPl and 
si RNA mediated reduction in EBPl proteins levels could be carried out. It would be 
interesting to observe the effect on the translation of endogenous TOP containing 
mRNAs and also TOP and TOP-trctMut mRNA. 
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The data discussed above, suggests that AG02 may play a role in the 
translation of 5' TOP containing mRNAs following nutrient stimulation. It has been 
shown that fragile-X-mental-retardation-related protein 1 (FXRl) and AG02 
associated with AU-rich elements (AREs), present in mRNA 3'-UTRs, exclusively 
during translation activation (Vasudevan and Steitz 2007). It would therefore be 
interesting to determine if FXRl is also associated with TOP containing mRNAs 
under serum re-fed conditions. The over-expression of AG02 or carrying out an 
siRNA mediated reduction in AG02 proteins levels, may also provide further insight 
into the role (if any) of AG02 in the regulation of 5' TOP containing mRNAs. 
As previously discussed, the anti-Flag M2 affinity purification procedure 
could be repeated using a TOP-mirMut-14x construct and a new list of differentially 
associated microRNAs could be generated. Validation of any individual microRNA 
that is ranked highly on the list could then be carried out through the transfection of a 
2'-O-methyl RNA oligonucleotide that has a complementary sequence to the miRNA 
of interest. The complementary 2'-O-methyl RNA oligonucleotide should sequester 
the candidate miRNA and prevent it from interacting with TOP containing mRNAs. 
Observing the translational effect on TOP mRNA may then provide an indication as 
to the likely significance of that miRNA in the translation of TOP containing mRNAs. 
The constructs that contain 14x MS2 binding sites may also be useful for 
future studies involving the localisation of 5' TOP containing mRNAs. Co-
transfection of these vectors with a vector expressing MS2-GFP fusion protein could 
be carried out. Following the association of the MS2·GFP fusion protein with the 
MS2 binding sites located in the 3' UTR of mRNAs, confocal microscopy could be 
used to visualise the location of these mRNAs. This is a proven technique for the 
visualisation of mRNAs and also has the advantage of being able to detect mRNA 
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mobility under a selection of cellular conditions (Fusco et al. 2003). Carrying out this 
technique following serum starvation and serum re-feeding may reveal new 
infonnation about the location and movement of 5' TOP containing mRNAs under 
these conditions. 
206 
References 
Abramson, R.D., Dever, T.E., and Merrick, W.C. 1988. Biochemical evidence supporting 
a mechanism for cap-independent and internal initiation of eukaryotic mRNA. J Bioi Chem 
263(13): 6016-6019. 
Acker, M.G., Shin, B.S., Dever, T.E., and Lorsch, J.R. 2006. Interaction between 
eukaryotic initiation factors lA and 5B is required for efficient ribosomal subunit joining. J Bioi 
Chem 281(13): 8469-8475. 
Algire, M.A., Maag, D., Savio, P., Acker, M.G., Tarun, S.Z., Jr., Sachs, A.B., Asano, K., 
Nielsen, K.H., Olsen, D.S., Phan, L., Hinnebusch, A.G., and Lorsch, J.R. 2002. Development and 
characterization of a reconstituted yeast translation initiation system. RNA 8(3): 382-397. 
Antoine, M. and Kiefer, P. 1998. Functional characterization of transcriptional regulatory 
elements in the upstream region and intron I of the human S6 ribosomal protein gene. Biochem J 
336 ( Pt 2): 327-335. 
Asano, K., Clayton, J., Shalev, A., and Hinnebusch, A.G. 2000. A multifactor complex of 
eukaryotic initiation factors, eIFI, eIF2, e1F3, eIF5, and initiator tRNA(Met) is an important 
translation initiation intennediate in vivo. Genes Dev 14(19): 2534-2546. 
Auweter, S.D., Oberstrass, F.C., and AlIain, F.H. 2007. Solving the structure of PTB in 
complex with pyrimidine tracts: an NMR study of protein-RNA complexes of weak affinities. J 
Mol Bioi 367( 1): 174-186. 
Avni, D., Shama, S., Loreni, F., and Meyuhas, O. 1994. Vertebrate mRNAs with a 5'-
tenninal pyrimidine tract are candidates for translational repression in quiescent cells: 
characterization of the translational eis-regulatory element. Mol Cell Bioi 14(6): 3822-3833. 
Barth-Baus, D., Stratton, C.A., Parrott, L., Myerson, H., Meyuhas, 0., Templeton, D.J., 
Landreth, G.E., and Hensold, J.O. 2002. S6 phosphorylation-independent pathways regulate 
207 
translation of 5 '-tenninal oligopyrimidine tract-containing mRNAs in differentiating 
hematopoietic cells. Nucleic Acids Research 30(9): 1919-1928. 
Belsham, G.J. and Sonenberg, N. 1996. RNA-protein interactions in regulation of 
picornavirus RNA translation. Microbiol Rev 60(3): 499-511. 
Bender, J. and Klein, A. 1997. The telomere binding protein of Euplotes crassus prevents 
non-specific transcription initiation but has no role in positioning transcription initiation 
complexes. Nucleic Acids Res 25(14): 2877-2882. 
Benne, R. and Hershey, 1.W. 1978. The mechanism of action of protein synthesis 
initiation factors from rabbit reticulocytes. J B;ol Chem 253(9): 3078-3087. 
Beretta, L., Gingras, A" Svitkin, Y.V., Hall, M.N., and Sonenberg, N. 1996. Rapamycin 
blocks the phosphorylation of 4E-BPl and inhibits cap-dependent initiation of translation. 
European Molecular Biology Organization Journal 15: 658-664. 
Bernstein, E., Caudy, A.A., Hammond, S.M., and Hannon, G.l. 2001. Role for a bidentate 
ribonuclease in the initiation step of RNA interference. Nature 409(6818): 363-366. 
Bhattacharyya, S.N., Habermacher, R., Martine, U., Closs, E.I., and Filipowicz, W. 2006. 
Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 
125(6): t t t 1-1124. 
Biberman, Y. and Meyuhas, O. 1999. TOP mRNAs are translationally inhibited by a 
titratable repressor in both wheat genn extract and reticulocyte lysate. Febs Letters 456(3): 357-
360. 
Bonnan, A.M., Michel, Y.M., and Kean, K.M. 2000. Biochemical characterisation of 
cap-poly(A) synergy in rabbit reticulocyte Iysates: the eIF4G-PABP interaction increases the 
functional affinity of eIF4E for the capped mRNA 5'-end. Nucleic Acids Res 28(21): 4068-4075. 
Bucher, P. 1990. Weight matrix descriptions of four eukaryotic RNA polymerase 11 
promoter elements derived from 502 unrelated promoter sequences. J Mol B;01212(4): 563-578. 
208 
Burgering, B.M. and Coffer, PJ. 1995. Protein kinase B (c-Akt) in phosphatidylinositol-
3-0H kinase signal transduction. Nature 376(6541): 599-602. 
BusheIl, M., Stoneley, M., Kong, Y.W., Hamilton, T.L., Spriggs, K.A., Dobbyn, H.C .• 
Qin, X.L., Sarnow, P., and Willis, A.E. 2006. Polypyrimidine tract binding protein regulates 
IRES-mediated gene expression during apoptosis. Molecular CeI/23(3): 401-412. 
Byrd. M.P., Zamora, M., and Lloyd, R.E. 2002. Generation of multiple isoforms of 
eukaryotic translation initiation factor 4GI by use of alternative translation initiation codons. 
Molecular and Cellular Biology 22( 13): 4499-4511. 
Cai, X., Hagedorn, C.H .• and Cullen, B.R. 2004. Human microRNAs are processed from 
capped, polyadenylated transcripts that can also function as mRNAs. RNA 10(12): 1957-1966. 
Caldarola, S .• Amaldi, F., Proud, C.G., and Loreni. F. 2004. Translational regulation of 
terminal oligopyrimidine mRNAs induced by serum and amino acids involves distinct signaling 
events. Journal of Biological Chemistry 279(14): 13522-13531. 
CanneIl, I.G., Kong. Y.W .• and Bushell, M. 2008. How do microRNAs regulate gene 
expression? Biochem Soc Trans 36(Pt 6): 1224-1231. 
Cantley, L.C. and Neel, B.G. 1999. New insights into tumor suppression: PTEN 
suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl 
A cad Sei USA 96(8): 4240-4245. 
Cardinali, B.. Carissimi, C .• Gravina, P., and Pierandrei-Amaldi, P. 2003. La protein is 
associated with terminal oligopyrimidine mRNAs in actively translating polysomes. Journal of 
Biological Chemistry 278(37): 35145-35151. 
Caruthers, J.M., Johnson, E.R., and McKay, D.S. 2000. Crystal structure of yeast 
initiation factor 4A. a DEAD-box RNA helicase. Proceedings of the National Academy of 
Sciences of the United States of America 97(24): 13080-13085. 
209 
Ceci, M., Gaviraghi, C., Gorrini, C., Sala, L.A., Offenhauser, N., Marchisio, P.C., and 
Biffo, S. 2003. Release of eIF6 (p27BBP) from the 60S subunit allows 80S ribosome assembly. 
Nature 426(6966): 579-584. 
Chakravarty, I., Bagchi, M.K., Roy, R., Banerjee, A.C., and Gupta, N.K. 1985. Protein 
synthesis in rabbit reticulocytes. Purification and properties of an Mr 80,000 polypeptide (Co-eIF-
2A80) with Co-eIF-2A activity. J Bioi Chem 260(1 1): 6945-6949. 
Chappell, S.A., Edelman, G.M., and Mauro, V.P. 2000. A 9-nt segment of a cellular 
mRNA can function as internal ribosome entry site (IRES) and when present in linked multiple 
copies greatly enhances IRES activity. Proc Natl A cad Sei USA 97(4): 1536-1541. 
Charlesworth, A., Welk, J., and MacNicol, A.M. 2000. The temporal control of Weel 
mRNA translation during Xenopus oocyte maturation is regulated by cytoplasmic polyadenylation 
elements within the 3'-untranslated region. Dev Bioi 227(2): 706-719. 
Chaudhuri, J., Chowdhury, D., and Maitra, U. 1999. Distinct functions of Eukaryotic 
translation initiation factors elFIA and eIF3 in the formation of the 40S ribosomal preinitiation 
complex. The Journal of Biological Chemistry 25(18): 17975-17980. 
Chen, N., Onisko, B., and Napoli, J.L. 2008. The nuclear transcription factor RARalpha 
associates with neuronal RNA granules and suppresses translation. J Bioi Chem 283(30): 20841-
20847. 
Chendrimada, T.P., Gregory, R.I., Kumaraswamy, E., Norman, J., Cooch, N., Nishikura, 
K .• and Shiekhattar, R. 2005. TRBP recruits the Dicer complex to Ag02 for microRNA processing 
and gene silencing. Nature 436(7051): 740-744. 
Child, S.1., Miller, M.K., and Geballe, A.P. 1999. Translational control by an upstream 
open reading frame in the HER-2/neu transcript. J Bioi Chem 274(34): 24335-24341. 
Cho, S. and Hoffman, D.W. 2002. Structure of the beta subunit of translation initiation 
factor 2 from the archaeon Methanococcusjannaschii: a representative of the eIF2betaleIF5 family 
of proteins. Biochemistry 41(18): 5730-5742. 
210 
Clemens, Mol., Bushell, M., and Morley, S.l 1998. Degradation of eukaryotic 
polypeptide chain initiation factor (elF) 40 in response to induction of apoptosis in human 
lymphoma cell lines. Oncogene 17: 2921-2931. 
Coldwell, Mol. and Morley, Sol. 2006. Specific isoforms of translation initiation factor 
4GI show differences in translational activity. Molecular and Cellular Biology 26(22): 8448-8460. 
Coller, lM., Gray, N.K., and Wickens, M.P. 1998. mRNA stabilization by poly(A) 
binding protein is independent of poly(A) and requires translation. Genes Dev 12(20): 3226-3235. 
Cordin, 0., Banroques, J., Tanner, N.K., and Linder, P. 2006. The DEAD-box protein 
family of RNA helicases. Gene 367: 17-37. 
Cosson, B., Berkova, N., Couturier, A., Chabelskaya, S., Philippe, M., and Zhouravleva, 
G. 2002. Poly(A)-binding protein and eRF3 are associated in vivo in human and Xenopus cells. 
Bioi Cell 94(4-5): 205-216. 
Craig, A.W., Haghighat, A., Vu, A.T.K., and Sonenberg, N. 1998. Interaction of 
polyadenylate-binding protein with the elF4G homoloue PAIP enhances translation. Nature 392: 
520-523. 
Crosio, C., Boyl, P.P., Loreni, F., Pierandrei-Amaldi, P., and Amaldi, F. 2000. La protein 
has a positive effect on the translation of TOP mRNAs in vivo. Nucleic Acids Research 28(15): 
2927-2934. 
Cuesta, R., Laroia, G., and Schneider, Rol. 2000. Chaperone Hsp27 inhibits translation 
during heat shock by binding eIF4G and facilitating dissociation of cap-initation complexes. 
Genes Dev 14: 1460-1470. 
Oas, S. and Maitra, U. 2000. Mutational analysis of mammalian translation initiation 
factor 5 (eIFS): role of interaction between the beta subunit of eIF2 and eIF5 in elF5 function in 
vitro and in vivo. Mol Cell Bioi 20(1 1): 3942-3950. 
211 
Davuluri, R.V., Suzuki, Y., Sugano, S., and Zhang, M.Q. 2000. CART classification of 
human 5' UTR sequences. Genome Res 10(11): 1807-1816. 
de Melo Neto, O.P., Standart, N., and Martins de Sa, C. 1995. Autoregulation ofpoly(A)-
binding protein synthesis in vitro. Nucleic Acids Res 23(12): 2198-2205. 
Dever, T.E. 2002. Gene-specific regulation by general translation factors. Cell 108(4): 
545-556. 
Dmitriev, S.E., Terenin, I.M., Dunaevsky, Y.E., Merrick, W.C., and Shatsky, I.N. 2003. 
Assembly of 48S translation initiation complexes from purified components with mRNAs that 
have some base pairing within their 5' untranslated regions. Mol Cell Bioi 23(24): 8925-8933. 
Donahue, T.F., Cigan, A.M., Pabich, E.K., and Valavicius, B.C. 1988. Mutations at a 
Zn(U) finger motif in the yeast eIF-2 beta gene alter ribosomal start-site selection during the 
scanning process. Cell 54(5): 621-632. 
Dorrello, N.V., Peschiaroli, A., Guardavaccaro, D., Colburn, N.H., Sherman, N.E., and 
Pagano, M. 2006. S6Kl- and betaTRCP-mediated degradation of PDCD4 promotes protein 
translation and cell growth. Science 314(5798): 467-471. 
Duncan, R.F., Milbum, S.C., and Hershey, J.W.B. 1987. Regulated phosphorylation and 
low abundance of HeLa-cell-initiation-factor eIF-4F suggest a role in translational control-heat 
shock effects on eIF-4F. J Bioi Chem 262: 380-388. 
Elbashir, S.M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., and Tuschl, T. 2001. 
Duplexes of 2 I-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 
411(6836): 494-498. 
Erickson, F.L., Nika, J., Rippel, S., and Hannig, E.M. 2001. Minimum requirements for 
the function of eukaryotic translation initiation factor 2. Genetics 158(1): 123-132. 
212 
Etchison, D. and Foul, S. 1985. Human rhinovirus 14 infection of HeLa cells results in 
the proteolytic cleavage of the p220 cap-binding complex subunit and inactivates globin mRNA 
translation in vitro. J Viral 54(2): 634-638. 
Eulalio, A., Huntzinger, E., and lzaurralde, E. 2008. Getting to the root of miRNA-
mediated gene silencing. Cell 132(1): 9-14. 
Farruggio, D., Chaudhuri, J., Maitra, U., and RajBhandary, U.L. 1996. The A 1 x un 
base pair conserved in eukaryotic initiator tRNAs is important specifically for binding to the 
eukaryotic translation initiation factor e1F2. Mol Cell Bioi 16(8): 4248-4256. 
Flynn, A. and Proud, C.G. 1995. Serine 209, not serine 53, is the major site of 
phosphorylation in initiation factor eIF-4E in serum-treated Chinese hamster ovary cells. J Bioi 
Chem 270(37): 21684-21688. 
-. 1996. Insulin-stimulated phosphorylation of initiation factor 4E is mediated by the 
MAP kinase pathway. FEBS Lell 389: 162-166. 
Fumagalli, S. and Thomas. G. 2000. S6 Phosphorylation and Signal Transduction. in 
Translational Control of Gene Expression (ed. N. Sonenberg, J.W.B. Hershey, and M.B. 
Mathews), pp. 695-718. Cold Spring Harbor Laboratory Press. 
Fusco, D., Accomero, N., Lavoie, B., Shenoy, S.M., Blanchard, J.M., Singer, R.H., and 
Bertrand, E. 2003. Single mRNA molecules demonstrate probabilistic movement in living 
mammalian cells. Curr Bioi 13(2): 161-167. 
Futterer, J., Kiss-Laszlo, Z., and Hohn, T. 1993. Nonlinear ribosome migration on 
cauliflower mosaic virus 35S RNA. Cell 73: 789-802. 
Galili, G., Kawata, E.E., Smith, L.D., and Larkins, B.A. 1988. Role of the 3'-poly(A) 
sequence in translational regulation ofmRNAs in Xenopus laevis oocytes. J Bioi Chem 263(12): 
5764-5770. 
213 
Garcia-B1anco, M.A .. Jamison, S.F., and Sharp, P.A. 1989. Identification and purification 
of a 62,000-dalton protein that binds specifically to the polypyrimidine tract of introns. Genes & 
Dev3: 1874-1886. 
Gerbasi, V.R. and L i n ~ ~ AJ. 2007. The myotonic dystrophy type 2 protein ZNF9 is part 
of an ITAF complex that promotes cap-independent translation. Mol Cell Proteomics 6(6): 1049-
1058. 
Geyer, P.K., Mcyuhas. 0 .• Perry. R.P., and Johnson, L.F. 1982. Regulation of ribosomal 
protein mRNA content and translation in growth-stimulated mouse fibroblasts. Mol Cell Bioi 2(6): 
685-693. 
Ghosh, S., Jaraczewski. J.W .• Klobutcher, L.A., and Jahn, C.L. 1994. Characterization of 
transcription initiation. translation initiation, and poly(A) addition sites in the gene-sized 
macronuclear DNA molecules of Euplotes. Nucleic Acids Res 22(2): 214-221. 
Gingras, A.C .• Raught, D., Gygi, S.P .• Niedzwiecka, A., Miron, M., Burley, S.K .• 
Polakiewicz, R.D .• Wyslouch-Cieszynska, A., A ebersold, R., and Sonenberg, N. 2001a. 
Hierarchical phosphorylation of the translation inhibitor 4e-BPl. Genes and Development IS: 
2852-2864. 
Gingras, A.C .. Raught, B .• and Sonenberg. N. 1999. elF4 initiation factors: effectors of 
mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem 68: 913-963. 
-. 200 I b. Regulation of translation initiation by FRAP/mTOR. Genes and Development 
IS: 807-826. 
Goossen. B. and IIcntze. M.W. 1992. Position is the critical determinant for function of 
iron-responsive elements as translational regulators. Mol Cell Bioi 12(5): 1959-1966. 
Goss, DJ., Parkhurst, L.J., Mehta, IlB., Woodley, C.L., and Wahba, AJ. 1984. Studies 
on the role of eukaryotic nucleotide exchange factor in polypeptide chain initiation. J Bioi Chem 
2S9(12): 7374-7377. 
214 
Goumans, 11., Thomas, A., Verhoeven, A., Voorma, H.O., and Benne, R. 1980. Biochim 
Biophys Acra 608: 39-46. 
Gradi, A., Imataka, 11., Svitkin, V.V., Rom, E., Raught, B., Morino, S., and Sonenberg, 
N. 1998. A novel functional human eukaryotic translation initiation factor 4G. Molecular and 
Cellular Biology IS( I): 334-342. 
Gray, N.K. and Hentze, M.W. 1994. Regulation of protein synthesis by mRNA structure. 
Mol Bioi Reports 19: 195-200. 
Gregory, R.I., Van, K.P., Amuthan, G., Chendrimada, T .• Doratotaj, B., Cooch, N., and 
Shiekhattar, R. 2004. The Microprocessor complex. mediates the genesis of microRNAs. Nature 
432(7014): 235-240. 
Grolleau, A., Bowman, J., Pradet-Balade. B., Puravs, E., Hanash. S., Garcia-Sanz, J.A., 
and Beretta, L. 2002. Global and specific translational control by rapamycin in T cells uncovered 
by microarrays and protcomics. J Bioi Cllt!m 277(25): 22175-22184. 
Gross, J.D., Moerke, N.J., von der Haar, T., Lugovskoy, A.A., Sachs, A.B., McCarthy, 
J.E., and Wagner, G. 2003. Ribosome loading onto the mRNA cap is driven by conformational 
coupling between elF4G and eIF4E. Cell 115(6): 739-750. 
GuM, D., Altan-Bonnet, N., Parrott, A.M., Arrigo, C.J., Li, Q., Khaleduzzaman, M., Li, 
H., Lee, C.G., Pe'ery, T., and Mathews, M.B. 2008. Nuclear factor 45 (NF45) is a regulatory 
subunit of complexes with NF90IIIO involved in mitotic control. Mol Cell Bioi 28(14): 4629-
4641. 
Haghighat. A. and Sonenberg, N. 1997. elF4G dramatically enhances the binding of 
elF4E to the mRNA S'-cap structure. J Bioi Chem 272(35): 21677-21680. 
Hamilton. T.L.. Stoneley, M., and Bushell, M. 2006. TOPs and their regulation. 
Biochemical Society Tran.'taclion.'f 34: 12- t 6. 
215 
lIammond. M.L., Menick. W., and Bowman, L.H. 1991. Sequences mediating the 
translation of mouse S 16 ribosomal protein mRNA during myoblast differentiation and in vitro 
and possible control points for the in vitro translation. Genes Dev 5(9): 1723-t 736. 
Harding. fI.P., Zhang. Y.H., Bertolotti, A., Zeng, H.Q., and Ron, D. 2000. Perk is 
essential for translational regulation and cell survival during the unfolded protein response. 
Molecular Cell 5(5): 897-904. 
flay. N. and Sonenbcrg, N. 2004. Upstream and downstream of mTOR. Genes Dev 
18(16): 1926-1945. 
Ilemmings-Meiszczak, M. and Hohn, T. 1999. A stable hairpin preceded by a short open 
reading frame promotes non linear ribosome migration on a synthetic mRNA leader. RNA 5: 
t 149-1157. 
Hengen, P. 1995. Purification of His-Tag fusion proteins from Escherichia coli. Trends 
Biochem Sci 20(7): 285-286. 
lIentze, M.W., Caughman, S.W., Rouault, T.A., Baniocanal, J.O., Dancis, A., Harford, 
J .B., and Klausner, R.D. 1987. Identification of the Iron-Responsive element for the translational 
regulation of Human Ferritin mRNA. Science 238: 1570-1573. 
lIerman, R.C. 1989. Alternatives for the initiation of translation. Trends Biochem Sci 
14(6): 219-222. 
Hershey, J.W.B. and Merrick. W.C. 2000. Pathway and mechanism of initiation of 
protein synthesis. in Translational Control of Gene Expression (ed. N. Sonenberg, J.W.B. 
Hershey, and M.B. Mathews), pp. 33-88. Cold Spring Harbor Laboratory Press. 
Hinnebusch, A.G. 1997. Translation regulation of yeast OCN4: A window on factors that 
control initiator-tRNA binding to the ribosome. J Bioi Chem 272: 21661-21664. 
216 
-. 2000. Mechanism and regulation of initiator methionyl-tRNA binding to ribosome. in 
Translational Control of Gt?ne E:rpression (ed. N. Sonenberg. J.W.B. Hershey. and M.B. 
Mathews). pp. 185·243. Cold Spring lIarbor Laboratory Press. 
Hinton. T.M .• Coldwcll. M.J .• Carpenter. G.A., Morley. SJ., and Pain, V.M. 2007. 
Functional analysis of individual binding activities of the scaffold protein eIF4G. Journal of 
Biological Chemistry 282(3): 1695-1708. 
Hiremath. L.S., Wcbb. N.R.. and Rhoads, R.E. 1985. Immunological detection of the 
messenger RNA cap-binding protein. J BioI Chem 260(13): 7843·7849. 
Hock. J., Weinmann, L. Ender, C., Rudel, S., Kremmer. E., Raabe, M., Urlaub, H., and 
Meister, G. 2007. Proteomic and functional analysis of Argonaute-containing mRNA-protein 
complexes in human cells. EMBO Rep 8(11): 1052·1060. 
Holl., M.K., Ballif, B.A., Gygi. S.P .• and Blenis, J. 2005. mTOR and S6Kl mediate 
assembly of the translation preinitiation complex through dynamic protein interchange and 
ordered phosphorylation events. Ce/l123( 4): 569-580. 
Homstein. E., Git. A., Braunstcin. I., Avni, D., and Meyuhas, O. 1999a. The expression 
ofpoly(A)-binding protein gene is translationally regulated in a growth-dependent fashion through 
a 5'-terminal oligopyrimidine tract motif. J Bioi Chem 274(3): 1708-1714. 
-. 1999b. The expression of poly(A)-binding protein gene is translationally regulated in a 
growth-dependcnt fashion through a 5 '-terminal oligopyrimidine tract motif. Journal of 
Biological Chemistry 274(3): 1708·1714. 
Huans, II.K., Yoon,II., Hannig. E.M., and Donahue, T.F. 1997. GTP hydrolysis controls 
stringent selection of the AUG start codon during translation initiation in Saccharomyces 
cerevisiae. Gene.' Dev 11 (18): 2396-2413. 
Huel., I., Creancicr. L., Audiger. S .• Gensac. M.-C., Prats. A.-C., and Prats, H. 1998. Two 
independent internal ribosome entry sites are involved in translation initiation of vascular 
endothelial growth factor mRNA. Mol Cell BioI 18(11): 6178-6190. 
217 
Hutvagner, G. and Zamore, P.D. 2002. A microRNA in a multiple-turnover RNAi 
enzyme complex. Science 297(5589): 2056-2060. 
Iadevaia, V., Caldarola, S., Tino, E., Amaldi, F., and Loreni, F. 2008. All translation 
elongation factors and the e, f, and h subunits of translation initiation factor 3 are encoded by 5'-
terminal oligopyrimidine (TOP) mRNAs. RNA 14(9): 1730-1736. 
Intine, R.V., Dundr, M., Vassilev, A., Schwartz, E., Zhao, Y., Deparnphilis, M.L., and 
Maraia, R.J. 2004. Nonphosphorylated human La antigen interacts with nucleolin at nuc1eolar 
sites involved in rRNA biogenesis. Mol Cell Bioi 24(24): 10894-10904. 
Jang, S.K., Krausslich, H., Nicklin, M.J.H., Duke, G.M., Palmenberg, A.C., and Wimmer, 
E. 1988. A segement of the 5' Nontranslated region of encephalomyocarditis virus RNA directs 
internal entry ofribosomes during in vitro translation. Journal o/Virology 62(8): 2636-2643. 
Jang, S.K. and Wimmer, E. 1990. Cap-independent translation of encephalomyocarditis 
virus RNA: structural elements of the internal ribosome entry site and involvement of a cellular 
57-kD RNA-binding protein. Genes Dev 4: 1560-1572. 
JefTeries, H.B., Reinhard, J.C., Kozma, S.C., and Thomas, G. 1994. Rapamycin 
selectively represses translation of the "polypyrimidine tract" mRNA family. Proceedings of the 
National Academy of Sciences USA 91: 4441-4445. 
Jefferies, H.B. and Thomas, G. 1994. Elongation factor-! alpha mRNA is selectively 
translated following mitogenic stimulation. J Bioi Chem 269(6): 4367-4372. 
JefTeries, H.B.J., Fumagalli, S., Dennis, P.B., Reinhard, C., Pearson, R.B., and Thomas, 
G. 1997. Rapamycin suppresses 5'TOP mRNA translation through inhibition of p70(S6k). Embo 
Journal 16(12): 3693-3704. 
Johannes, G., Carter, M.s., Eisen, M.B., Brown, P.O., and Samow, P. 1999. Identification 
of eukaryotic mRNAs that are translated at reduced cap-binding complex eIF4F concentrations 
using a cDNA microarray. Proc Nail Acad Se; USA 96: 13118-13123. 
218 
Jopling, C.L., Vi, M., Lancaster, A.M., Lemon, S.M., and Sarnow, P. 2005. Modulation 
of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309(5740): 1577-
1581. 
Kahvejian, A., Svitkin, Y.V., Sukarieh, R., M'Boutchou, M.N., and Sonenberg, N. 2005. 
Mammalian poly(A)-binding protein is a eukaryotic translation initiation factor, which acts via 
multiple mechanisms. Genes Dev 19(1): 104-113. 
Kapp, L.D. and Lorsch, J.R. 2004. GTP-dependent recognition of the methionine moiety 
on initiator tRNA by translation factor eIF2. J Mol Bio1335( 4): 923-936. 
Kaspar, R.L., Rychlik, W., White, M.W., Rhoads, R.E., and Morris, D.R. 1990. 
Simultaneous cytoplasmic redistribution of ribosomal protein L32 mRNA and phosphorylation of 
eukaryotic initiation factor 4E after mitogenic stimulation of Swiss 3T3 cells. J Bioi Chem 265(7): 
3619-3622. 
Kaufmann, J. and Klein, A. 1992. Gene dosage as a possible major determinant for equal 
expression levels of genes encoding RNA polymerase subunits in the hypotrichous ciliate 
Euplotes octocarinatus. Nucleic Acids Res 20(17): 4445-4450. 
Kaye, N.M., Emmett, K.J., Merrick, W.C., and Jankowsky, E. 2009. Intrinsic RNA 
binding by the eukaryotic initiation factor 4F depends on a minimal RNA length but not on the 
m7G cap. J Bioi Chem 284(26): 17742-17750. 
Keryer-Bibens, C., Barreau, C., and Osborne, H.B. 2008. Tethering of proteins to RNAs 
by bacteriophage proteins. Bioi Cel/lOO(2): 125-138. 
Khaleghpour, K., Kahvejian, A., De Crescenzo, G., Roy, G., Svitkin, Y.V., Imataka, H., 
O'Connor-McCourt, M., and Sonenberg, N. 2001a. Dual interactions of the translational repressor 
Paip2 with Poly(A) binding protein. Molecular and Cellular Biology 21(15): 5200-5213. 
KhaJeghpour, K., Svitkin, Y.V., Craig, A.W., DeMaria, C.T., Deo, R.C., BurJey, S.K., 
and Sonenberg, N. 2001b. Translational repression by a novel partner of human poly(A) binding 
protein, Paip2. Molecular Cell 7: 205-216. 
219 
Khvorova, A., Reynolds, A., and Jayasena, S.D. 2003. Functional siRNAs and miRNAs 
exhibit strand bias. CeI/IIS(2): 209-2 I 6. 
Kim, D.-H., Sarbassov, 0.0., Ali, S.M., King, J.E., Latek, R.R., Erdjument-Bromage, H., 
Tempest, P., and Sabatini, D.M. 2002. mTOR interacts with raptor to form a nutrient-sensitive 
complex that signals to the cell growth machinery. Cel/HO: 163-175. 
Kim, J., Krichevsky, A., Grad, Y., Hayes, G.D., Kosik, KS., Church, G.M., and Ruvkun, 
G. 2004a. Identification of many microRNAs that co purify with polyribosomes in mammalian 
cells. PNAS 101: 360-365. 
-. 2004b. Identification of many microRNAs that copurify with polyribosomes in 
mammalian neurons. Proc Natl Acad Set USA 101(1): 360-365. 
Kim, J.H. and Richter, J.D. 2006. Opposing polymerase-deadenylase activities regulate 
cytoplasmiC polyadenylation. Mol CeI/24(2): 173-183. 
Kim, V.N. 2005. MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol 
Cell Bioi 6(5): 376-385. 
Kinch, L.N. and Grishin, N.V. 2009. The human Ago2 MC region does not contain an 
elF4E-like mRNA cap binding motif. Bioi Direct 4: 2. 
Kiriakidou, M., Tan, G.S., Lamprinaki, S., De PlanelI-Saguer, M., Nelson, P.T., and 
Mourelatos, Z. 2007. An mRNA m7G cap binding-like motif within human Ago2 represses 
translation. Cel/129(6): 1141-1151. 
Kohn, A.D., Kovacina, K.S., and Roth, R.A. 1995. Insulin stimulates the kinase activity 
of RAC-PK, a pleckstrin homology domain containing ser/thr kinase. EMBO J 14(17): 4288-4295. 
Kong, V.W., CannelI, I.G., de Moor, C.H., Hill, K, Garside, P.G., Hamilton, T.L., 
Meijer, H.A., Dobbyn, H.C., Stoneley, M., Spriggs, KA., Willis, A.E., and Bushell, M. 2008. The 
mechanism of micro-RNA-mediated translation repression is determined by the promoter of the 
220 
target gene. Proceedings of the National Academy of Sciences of the United States of America 
105(26): 8866-8871. 
Korneeva, N.L., First, E.A., Benoit, C.A., and Rhoads, R.E. 2005. Interaction between the 
NH2-terminal domain of elF4A and the central domain of eIF40 modulates RNA-stimulated 
ATPase activity. J Bioi Chem 280(3): 1872-1881. 
K o ~ ~ M. 1987. At least six nucleotides preceding the AUO initiator codon enhance 
translation in mammalian cells. J Mol Bioi 196: 947-950. 
-. 1989a. Circumstances and mechanisms of inhibition of translation by secondary 
structures in eukaryotic mRNAs. Mol Cell Bioi 9: 5134-5142. 
-. 1989b. The scanning model for translation: an update. JCell Bioi 108: 229-241. 
-. 1990. Downstream secondary structure facilitates recognition of initiator codons by 
eukaryotic ribosomes. Proc Nail Acad Sci USA 87: 8301-8305. 
-. 1991a. An analysis of vertebrate mRNA sequences: intimations of translation control. J 
Cell Bioi 1 15: 887-903. 
-. 1991 b. An analysis of vertebrate mRNA sequences: Intimations of translational control. 
The Journal of Cell Biology 11S( 4): 887-903. 
-. 1992. A consideration of alternative models for the initiation of translation in 
eukaryotes. Crir Rev Biochem Mol Bioi 27(4-5): 385-402. 
-. 1995. Adherence to the first-AUO rule when a second AUO codon follows closely 
upon the first. Proc Natl Acad ScI USA 92: 2662-2666. 
-. 1997. Recognition of AUO and alternative initiator codons is augmented by 0 in 
postion +4 but is not generally affected by the nuc1eotides in position +5 and +6. EMBO J 16: 
2483-2492. 
221 
-. 2001. Constraints on reinitiation in mammals. Nucleic Acids Research 29(24): 5226-
5232. 
Kyrpides, N.C. and Woese, C.R. 1998. Archaeal translation initiation revisited: the 
initiation factor 2 and eukruyotic initiation factor 28 alpha-beta-delta subunit families. Proc NaIl 
A cad Sci USA 95(7): 3726-3730. 
Lachance, P.E.D., Miron, M., Raught, B., Sonenberg, N., and Lasko, P. 2002. 
Phosphorylation of eukruyotic translation initiation factor 4E is critical for growth. Molecular and 
Cellular Biology 22(6): 1656-1663. 
Lagos-Quintana, M., Rauhut, R., Lendeckel, W., and Tuschl, T. 2001. Identification of 
novel genes coding for small expressed RNAs. Science 294(5543): 853-858. 
Lamphear, BJ., Kirchweger, R., Skern, T., and Rhoads, R.E. 1995. Mapping of 
Functional Domains in Eukaryotic Protein Synthesis Initiation Factor 4G (eIF4G) with 
Picomaviral Proteases. J Bioi Chem 270: 21975-21983. 
Lau, N.C., Lim, L.P., Weinstein, E.G., and Bartel, D.P. 2001. An abundant class of tiny 
RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294(5543): 858-862. 
Le Quesne, J.P.C., Stoneley, M., Fraser, G.A., and Willis, A.E. 2001. Derivation of a 
structural Model for the c-myc lRES. Journal of Molecular Biology 310: 111-126. 
Lee, Y., Jeon, K., Lee, J.T., Kim, S., and Kim, V.N. 2002. MicroRNA maturation: 
stepwise processing and subcellular localization. EMBOJ21(17): 4663--4670. 
Lee, Y., Kim, M., Han, J., Yeom, K.H., Lee, S., Baek, S.H., and Kim, V.N. 2004. 
MicroRNA genes are transcribed by RNA polymerase 11. EMBO J23(20): 4051-4060. 
Leung, Y.F. and Cavalieri, D. 2003. Fundamentals of cDNA microarray data analysis. 
Trends Genet 19(11): 649-659. 
Lewis, B.P., Burge, C.B., and Bartel, D.P. 2005. Conserved seed pairing, often flanked by 
adenosines, indicates that thousands of human genes are microRNA targets. Cell 120(1): 15-20. 
222 
Lin, T.-A., Kong, X., Haystead, T.AJ., Pause, A., Belsham, G., Sonenberg, N., and 
Lawrence, J.C. 1994. PHAS-I as a link between mitogen-activated protein kinase and translation 
initiation. Science (Wash DC) 266: 653-656. 
Liu, J., Carmell, M.A., Rivas, F.V., Marsden, C.G., Thomson, J.M., Song, J.J., 
Hammond, S.M., Joshua-Tor, L., and Hannon, GJ. 2004. Argonaute2 is the catalytic engine of 
mammalian RNAi. Science 305(5689): 1437-1441. 
L1oyd, R.E., Jense, H.G., and Ehrenfeld, E. 1987. Restriction of translation of capped 
mRNA in vitro as a model for poliovirus-induced inhibition of host cell protein synthesis: 
relationship to p220 cleavage. J ViroI61(8): 2480-2488. 
Loreni, F. and Amaldi, F. 1992. Translational regulation of ribosomal protein synthesis in 
Xenopus cultured cells: mRNA relocation between polysomes and RNP during nutritional shifts. 
EurJ Biochem 205(3): 1027-1032. 
Lorsch, J.R. and Herschlag, D. 1998. The DEAD Box proein eIF4A. A minimal kinetic 
and thermodynamic framework reveals coupled binding of RNA and nucleotide. Biochemistry 37: 
2180-2193. 
Lowary, P.T. and Uhlenbeck, O.C. 1987. An RNA mutation that increases the affinity of 
an RNA-protein interaction. Nucleic Acids Res 15(24): 10483-10493. 
Maag, D., Fekete, C.A., Gryczynski, Z., and Lorsch, J.R. 2005. A conformational change 
in the eukaryotic translation preinitiation complex and release of eIFl signal recognition of the 
start cod on. Mol Cell 17(2): 265-275. 
Macejak, D.G. and Sarnow, P. 1991. Internal initiation of translation mediated by the 5' 
leader of a cellular mRNA. Nature 353: 90-94. 
Mamane, Y., Petroulakis, E., Martineau, Y., Sato, T.A., Larsson, 0., Rajasekhar, V.K., 
and Sonenberg, N. 2007. Epigenetic activation ofa subset ofmRNAs by eIF4E explains its effects 
on cell proliferation. PLoS One 2(2): e242. 
223 
Marissen, W. and Lloyd, R.E. 1998. Eukaryotic translation initiation factor 4G is 
targetted for proteolytic cleavage by caspase 3 during inhibition of translation in apoptotic cells. 
Mol Cell BioI 18: 7565-7574. 
Maroney, P.A., Yu, Y., Fisher, J., and Nilsen, T.W. 2006. Evidence that microRNAs are 
associated with translating messenger RNAs in human cells. Nat Struct Mol BioI 13(12): 1102-
1107. 
Martineau, Y., Derry, M.C., Wang, X., Yanagiya, A., Berlanga, J.J., Shyu, A.B., Imataka, 
H., Gehring, K., and Sonenberg, N. 2008. Poly(A)-binding protein-interacting protein 1 binds to 
eukaryotic translation initiation factor 3 to stimulate translation. Mol Cell BioI 28(21): 6658-6667. 
Mathonnet. G., Fabian, M.R., SVitkin, Y.V., Parsyan, A., Huck, L., Murata, T., BifTo, S., 
Merrick, W.C., Darzynkiewicz, E., PilIai, R.S., Filipowicz, W., Duchaine, T.F., and Sonenberg, N. 
2007. MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex 
eIF4F. Science 317(5845): 1764-1767. 
Matthews, M.B., Sonenberg, N., Hershey, J.W.B .. 2000. Origins and Principles of 
Translation Control. in Translational Control of Gene Expression (ed. N. Sonenberg, Hershey, 
J.W.B., and Matthews, M.B.), pp. 1-32. Cold Spring Harbor Laboratory Press, New York. 
Matunis, MJ., Michael, W.M., and Dreyfuss, G. 1992. Characterization and primary 
structure of the poly(C)-binding heterogeneous nuclear ribonucleoprotein complex K protein. Mol 
Cell BioI t2( 1): 164-171. 
Meijer, H.A. and Thomas, A.A.M. 2002. Control of eukaryotic protein synthesis by 
upstream open reading frames in the S' untranslated region of an mRNA. Biochem J 367: 1-11. 
Meister. G., Landthaler, M., Patkaniowska, A., Dorsett, Y., Teng, G., and Tuschl, T. 
2004. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol Cell 
15(2): 185-197. 
Mendez, R. and Richter, J.O. 200 1. Translational control by CPEB: a means to the end. 
Nal Rev Mol Cell Oio/2(7): 521-529. 
224 
Merrick. W.C. 2004. Cap-dependent and cap-independent translation in eukaryotic 
systems. Gene 332: 1-11. 
Meyuhas, O. 2000. Synthesis of the translational apparatus is regulated at the translational 
Icvel. European Journal of Biochemistry 267(21): 6321-6330. 
Meyuhas, 0., Avni, D., Bibennan, Y., Shama, S., Ostareck. D.H., Ostareck-Lederer, A., 
and Hentze, M.W. 1997. Growth-dependent translational control of TOP mRNAs. Faseb Journal 
11 (9): 2500. 
Milligan, J.F. and Uhlenbeck, O.C. 1989. Synthesis of small RNAs using T7 RNA 
polymerase. Methods Enzymol180: 51-62. 
Mitchell, S.A., Spriggs, K.A., Bushell, M., Evans, J.R., Stoneley, M., Le Quesne, lP.C., 
Spriggs, R.V., and Willis, A.E. 2005. Identification of a motif that mediates polypyrimidine tract-
binding protein-dependent internal ribosome entry. Genes & Development 19(13): 1556-1571. 
Mitchell, S.A., Spriggs, K.A., Coldwell, MJ., Jackson, R.J., and Willis, A.E. 2003. The 
Apaf-l intcrnal ribosome entry segment attains the correct structural confonnation for funcion via 
interactions with PTB and unr. Mol Cell 11: 757-711. 
Morley, S.J., McKendrick, L., and M., B. 1998. Cleavage of translation initiation factor 
40 during anti-fas IgM induced apoptosis does not require signalling through the p38 mitogen-
activated protein kinase. FEBS letters 438: 41-48. 
Morley, SJ. and Nacgele, S. 2002. Phosphorylation of eukaryotic initiation factor (elF) 
4E is not required for de novo protein synthesis following recovery from hypertonic stress in 
human kidney cells. J Bioi Chem 277(36): 32855-32859. 
Morley, S.J. and Traugh, J.A. 1990. Differential stimulation of phosphorylation of 
initiation factors eIF-4F, eIF-4B, eIF-3, and ribosomal protein S6 by insulin and phorbol esters. J 
Bioi Chem 265(18): 10611-10616. 
225 
Morris, D.R. and Geballe, A.P. 2000. Upstream open reading frames as regulators of 
mRNA translation. Molecular and Cellular Biology 20(23): 8635-8642. 
Mothe-Satney, I., Brunn, G.1., McMahon, L.P., Capaldo, C.T., Abraham, R.T., and 
Lawrence, J.C., Jr. 2000. Mammalian target of rapamycin-dependent phosphorylation of PHAS-I 
in four (Srr)p sites detected by phospho-specific antibodies. J Bioi Chem 275(43): 33836-33843. 
Muckenthaler, M., Gray, N.K., and Hentze, M.W. 1998. IRP-l binding to ferritin mRNA 
prevents the recruitment of the small ribosomal subunit by the cap-binding complex eIF4F. Mol 
Cell 2(3): 383-388. 
Nelson, P.T., Hatzigeorgiou, A.G., and Mourelatos, Z. 2004. miRNP:mRNA association 
in polyribosomes in a human neuronal cell line. RNA 10(3): 387-394. 
Niessing, D., Blanke, S., and Jackle, H. 2002. Bicoid associates with the 5'-cap-bound 
complex of caudal mRNA and represses translation. Genes Dev 16(19): 2576-2582. 
Nika, J., Rippel. S., and Hannig, E.M. 2001. Biochemical analysis of the eIF2beta gamma 
complex reveals a structural function for eIF2alpha in catalyzed nucleotide exchange. J Bioi Chem 
276(2): 1051-1056. 
Nomoto, A., Kitamura, N., Golini, F., and Wimmer, E. 1977. The 5'-terminal structures of 
poliovirion RNA and poliovirus mRNA differ only in the genome-linked protein VPg. Proc NaIl 
Acad Sc; USA 74(12): 5345-5349. 
Nottrott, S., Simard, M.J., and Richter, lO. 2006. Human let-7a miRNA blocks protein 
production on actively translating polyribosomes. Nal Slruct Mol Bioi 13(12): 1108-1114. 
Oberer, M., Marintchev, A., and Wagner, G. 2005. Structural basis for the enhancement 
ofelF4A helicase activity by eIF4G. Genes Dev 19(18): 2212-2223. 
Okada, M., Jang. S.W., and Ye, K. 2007. Ebpl association with nucleophosminIB23 is 
essential for regulating cell proliferation and suppressing apoptosis. J Bioi Chem 282(50): 36744-
36754. 
226 
Orom, V.A., Nielsen, F.C., and Lund, A.H. 2008. MicroRNA-IOa binds the 5 ' VTR of 
ribosomal protein mRNAs and enhances their translation. Molecular Cell 30(4): 460-471. 
Ostareck, D.H., Ostareck-Lederer, A., Wilm, M., Thiele, BJ., Mann, M., and Hentze, 
M.W. 1997. mRNA silencing in erythroid differentiation: hnRNP K and hnRNP El regulate 15-
Jipoxygenase translation from the 3'end. Cell 89: 597-606. 
Pain, V.M.EJ.B. 1996. Initiation of protein synthesis in eukaryotic cells. Eur J Biochem 
236: 747-771. 
Paulin, F.E., Campbell, L.E., O'Brien, K., Loughlin, J., and Proud, C.G. 2001. Eukaryotic 
translation initiation factor 5 (eIF5) acts as a classical GTPase-activator protein. Curr Bioi 11(1): 
SS-59. 
Pause, A., Belsham, G.J., Gingras, A.-C., Donze, 0., Lin, T.-A., Lawrence Jr, J.C., and 
Sonenberg, N. 1994. Insulin-dependent stimulation of protein synthesis by phosphorylation of a 
regulator of 5'-cap function. Nature (London) 371: 762-767. 
Pe'ery, P. and Mathews, M.B. 2000. Viral Translational Strategies and Host Defence 
Mechanisms. in Translational Control of Gene Expression (ed. N. Sonenberg, J.W.B. Hershey, 
and M.B. Mathews), pp. 371-424. Cold Spring Harbor Laboratory Press. 
Peabody, D.S. 1997. Role of the coat protein-RNA interaction in the life cycle of 
bacteriophage MS2. Mol Gen Genet 254(4): 358-364. 
Peabody, D.S. and Lim, F. 1996. Complementation of RNA binding site mutations in 
MS2 coat protein heterodimers. Nucleic Acids Res 24(12): 2352-2359. 
Pelletier, J. and Sonenberg, N. 1988. Internal initiation of translation of eukaryotic 
mRNA directed by a sequence derived from poliovirus RNA. Nature 334: 320-325. 
Pellizzoni, L., Baccon, J., Rappsilber, J., Mann, M., and Dreyfuss, G. 2002. Purification 
of native survival of motor neurons complexes and identification of Gemin6 as a novel 
component. J Bioi Chem 277(9): 7540-7545. 
227 
Pelliuoni, L., Cardinali, B., Lin-Marq, N., Mercanti, D., and Pierandrei-Amaldi, P. 1996. 
A Xenopus laevis homologue of the La autoantigen binds the pyrimidine tract of the 5' UTR of 
ribosomal protein mRNAs in vitro: implication of a protein factor in complex formation. J Mol 
Bioi 259(5): 904-915. 
Pelliuoni, L., Lotti, F., Rutjes, S.A., and Pierandrei-Amaldi, P. 1998. Involvement of the 
Xenopus laevis ROO0 autoantigen in the alternative interaction of La and CNBP proteins with the 
5'UTR ofL4 ribosomal protein mRNA.J Mol Bioi 281(4): 593-608. 
Pende, M., Urn, S.H., Mieulet, V., Sticker, M., Goss, V.L., Mestan, J., Mueller, M., 
Fumagalli, S., Kozma, S.C., and Thomas, G. 2004. S6Kl(-I-)/S6K2(-I-) mice exhibit perinatal 
lcthality and rapamycin-sensitive 5'-terminal oligopyrimidine mRNA translation and reveal a 
mitogen-activated protein kinase-dependent S6 kinase pathway. Mol Cell Bioi 24(8): 3112-3124. 
Perkins, D.N., Pappin, DJ., Creasy, D.M., and Cottrell, J.S. 1999. Probability-based 
protein idcntification by searching sequence databases using mass spectrometry data. 
Electrophoresis 20(18): 3551-3567. 
Pest ova, T., Shatsky, I.N., and Hellen, U.T. 1996. Functional dissection of eukaryotic 
initiation factor 4F: the 4A subunit and the central domain of the 4G subunit are sufficient to 
mediate internal entry of 43s preinitiation complex. Mol Cell Bioi 16: 6870-6878. 
Pestova, T.V., Borukhov, S.I., and Hellen, C.U. 1998a. Eukaryotic ribosomes require 
initiation factors 1 and lA to locate initiation codons. Nature 394(6696): 854-859. 
Pestova, T.V., Borukhov, S.I., and Hellen, C.U.T. 1998b. Eukaryotic ribosomes require 
initiation factors I and lA to locate inititation codons. Nature 394: 854-859. 
Pestova, T.V. and Hellen, C.U. 2001. Functions of Eukaryotic Factors in Initiation of 
Translation. in The Ribosome, pp. 389-396. Cold Spring Harbor Laboratory Press, New York. 
Pestova, T.V. and Kolupaeva, V.G. 2002. The roles of individual eukaryotic translation 
initiation factors in ribosomal scanning and initiation codon selection. Genes Dev 16(22): 2906-
2922. 
228 
Pestova, T.V., Kolupaeva, V.G., Lomakin.I.B., Pilipenko, E.V., Shatsky, I.N., Agol, V.I., 
and Hellen, C.V. 2001. Molecular mechanisms of translation initiation in eukaryotes. Proceedings 
of the National Academy of&ience USA 98(13): 7029-7036. 
Pestova, T.V., Lomakin, LB., Lee, J.H., Choi, S.K., Oever, T.E., and Hellen, C.V. 2000. 
The joining of ribosomal subunits in eukaryotes requires eIF5B. Nature 403(6767): 332-335. 
Pestova, T.V., Lorsch, J.R., and Hellen, C.V. 2007. The mechanism of translation 
initiation in eukaryotes. In Translational control in Biology and Medicine M Ma/hews. N 
Sonenberg and JWB Hershey, Cold Spring Harbor NY, CSHL Press: 57-128. 
Petcrsen, C.P., Bordeleau, M.E., Pettetier, J., and Sharp, P.A. 2006. Short RNAs repress 
translation after initiation in mammalian celts. Mol Ce1l21( 4): 533-542. 
Petoukhov, M.V., Monie, T.P., Attain, F.H., Matthews, S., Curry, S., and Svergun. 0.1. 
2006. Conformation of polypyrimidine tract binding protein in solution. Structure 14(6): 1021-
1027. 
Pickering, B.M., Mitchetl, S.A., Spriggs, K.A., Stoneley, M., and Willis, A.E. 2004. 
BAG-l internal ribosome entry segment activity is promoted by structural changes mediated by 
poly ( ~ ) ) binding protein 1 and recruitment of polypyrimdine tract binding protein 1. Mol Cell 
Bioi 24: 5595-5604. 
Pilipenko, E.V., Pestova, T.V., Kolupaeva, V.G., Khitrina, E.V., Poperechnaya, A.N., 
Agol, V.I., and Hetlen, C.V. 2000a. A cen cycle-dependent protein serves as a template-specific 
translation initiation factor. Genes and Development 14(16): 2028-2045. 
Pilipenko, E.V., Pestova, T.V., Kolupaeva, V.G., Khitrina, E.V., Poperechnaya, A.N., 
Agol, V.I., and Hetlen, C.V.T. 2000b. A cell cycle-dependent protein serves as a template-specific 
translation initiation factor. Genes Dell 14: 2028-2045. 
Pill ai, R.S., Bhattacharyya, S.N., Artus, C.G., Zolter, T., Cougot, N., Basyuk, E., 
Bertrand, E., and Fitipowicz, W. 2005. Inhibition oftranslational initiation by Let-7 MicroRNA in 
human cells. Science 309(5740): 1573-1576. 
229 
PilIai, R.S., Bhattacharyya, S.N., and Filipowicz, W. 2007. Repression of protein 
synthesis by miRNAs: how many mechanisms? Trends Cell Bioi 17(3): 118-126. 
Pimenov, A. 2008. Transcription start site determination in Stylonychia lemnae tubulin 
genes. Tsilologiia 50(7): 623-628. 
Poyry, T.A., Kaminski, A., and Jackson, R.J. 2004. What determines whether mammalian 
ribosomes resume scanning after translation of a short upstream open reading frame? Genes Dev 
18(1): 62-75. 
Ptushkina, M., von der Haar, T., Vasilescu, S., Frank, R., Birkenhager, R., and McCarthy, 
lE. 1998. Cooperative modulation by eIF40 of eIF4E-binding to the mRNA 5' cap in yeast 
involves a site partially shared by p20. EMBO J 17(16): 4798-4808. 
Pull en, N., Dennis, P.B., Andjelkovic, M., Dufner, A., Kozma, S.C., Hemmings, B.A., 
and Thomas, O. 1998. Phosphorylation and activation of p70s6k by PDKl. Science 279(5351): 
707-710. 
Pyronnet, S., Imataka, H., Oingras, A.C., Fukunaga, R., Hunter, T., and Sonenberg, N. 
1999. Human eukaryotic translation initiation factor 40 (eIF4G) recruits mnkl to phosphorylate 
eIF4E. EMBO J 18(1): 270-279. 
Radford, H.E., Meijer, H.A., and de Moor, C.H. 2008. Translational control by 
cytoplasmic polyadenylation in Xenopus oocytes. Biochim Biophys Acta 1779(4): 217-229. 
Rao, T.R. and Slobin, L.I. 1987. Regulation of the utilization of mRNA for eucaryotic 
elongation factor Tu in Friend erythroleukemia cells. Mol Cell Bioi 7(2): 687-697. 
Rau, M., Ohlmann, T., Morley, S.l., and Pain, V.M. 1996. A reevaluation of the cap-
binding protein as a rate limiting factor in initiaiton of translaiton in reticulocyte lysate. The 
Journal of Biological Chemistry 271( 15): 8983-8990. 
230 
Raught. B., Gingras, A.C., Gygi, S.P., Imataka, H., Morino, S., Gradi, A., Aebersold, R., 
and Sonenberg, N. 2000. Serum-stimulated, rapamycin-sensitive phosphorylation sites in the 
eukaryotic translation initiation factor 4GI. EMBO J 19(3): 434-444. 
Raychaudhuri, P., Chaudhri, A., and Maitra, U. 1985. Formation and release of 
eukaryotic initiation factor-2.GDP complex during eukaryotic ribosomal peptide chain initiation 
complex formation. J Bioi Chem 260: 2140-2145. 
Redpath, N.T., Foulstone, E.J., and Proud, C.O. 1996. Regulation of translation 
elongation factor-2 by insulin via a rapamycin-sensitive signalling pathway. EMBO J 15(9): 2291-
2297. 
Redpath, N.T. and Proud, C.O. 1993. Purification and phosphorylation of elongation 
factor-2 kinase from rabbit reticulocytes. Eur J Biochem 212(2): 511-520. 
Richter, J.O. 2000. Influence of Polyadenylation-induced Translation on Metazoan 
Development and Neuronal Synaptic Fucntion. in Translational Control of Gene Expression (ed. 
N. Sonenberg, J.W.B. Hershey, and M.B. Mathews), pp. 785-806. Cold Spring Harbor Laboratory 
Press. 
Rogers, O.W., Richter, NJ., Lima, W.F., and Merrick, W.C. 2001. Modulation of the 
helicase activity of elF4A by eIF4B, elF4H, and eIF4F. Journal of Biological Chemistry 276(33): 
309] 4-30922. 
Roll-Mccak, A., Alone, P., Cao, C., Dever, T.E., and Burley, S.K. 2004. X-ray structure 
of translation initiation factor eIF2gamma: implications for tRNA and eIF2alpha binding. J Bioi 
Chem 279(1 1): 10634-10642. 
Romanelli, A., Martin, K.A., Toker, A., and Blenis, J. 1999. p70 S6 kinase is regulated by 
protein kinase Czeta and participates in a phosphoinositide 3-kinase-regulated signalling complex. 
Mol Cell Bioi 19(4): 2921-2928. 
Roy, A.L., Chakrabarti, D., Datta, B., HiJeman, R.E., and Gupta, N.K. 1988. Natural 
mRNA is required for directing Met-tRNA(f) binding to 40S ribosomal subunits in animal cells: 
231 
involvement of Co-eIF-2A in natural mRNA-directed initiation complex formation. Biochemistry 
27(21): 8203-8209. 
Roy, R., Ghosh-Dastidar, P., Das, A., Yaghmai, B., and Gupta, N.K. 1981. Protein 
synthesis in rabbit reticulocytes. Co-eIF-2A reverses mRNA inhibition of ternary complex (Met-
tRNAf.eIF-2.GTP) formation by eIF-2. J Bioi Chem 256(10): 4719-4722. 
Rozen, F., Edery, I., Meerovitch, K., Dever, T.E., Merrick, W.C., and Sonenberg, N. 
1990. Biderectional RNA helicase activity of eukaryotic translation initiation factor-4A and 
factor-4F. Mol Cell BiollO: 1134-1144. 
Sambrook, J., Fritsch, E.F., Maniatis, T.,. 1989. Molecular Cloning: A Laboratory 
manual. Cold Spring Harbor Laboratory Press. 
Samow, P. 1989. Translation of glucose-regulated protein 78/immunoglobulin heavy-
chain binding protein mRNA is increased in poliovirus-infected cells at a time when cap-
dependent translation of cellular mRNA is inhibited. Proc Natl Acad Sei USA 86: 5795-5799. 
Sasaki, T., Shiohama, A., Minoshima, S., and Shimizu, N. 2003. Identification of eight 
members of the Argonaute family in the human genome small star, filled. Genomics 82(3): 323-
330. 
Sawicka, K., Bushell, M., Spriggs, K.A., and Willis, A.E. 2008. Polypyrimidine-tract-
binding protein: a multifunctional RNA-binding protein. Biochem Soc Trans 36(Pt 4): 641-647. 
Scheper, G.C. and Proud, C.G. 2002. Does phosphorylation of the cap-binding protein 
elF4E play a role in translation initiation? Eur J Biochem 269(22): 5350-5359. 
Scheper, G.C., van Kollenburg, B., HUt J., Luo, Y., Goss, DJ., and Proud, C.G. 2002. 
Phosphorylation of eukaryotic initiation factor 4E markedly reduces its affinity for capped mRNA. 
The Journal of Biological Chemistry 277(5): 3303-3309. 
232 
Schibler, V., Kelley, D.E., and Perry, R.P. 1977. Comparison of methylated sequences in 
messenger RNA and heterogeneous nuclear RNA from mouse L cells. J Mol Bio/llS(4): 695-
714. 
Schmidt-Zachmann, M.S., Hugle-Dorr, B., and Franke, W.W. 1987. A constitutive 
nucleolar protein identified as a member of the nucleoplasmin family. EMBO J 6(7): 1881-1890. 
Schmitt, E., Blanquct, S., and Mechulam, Y. 2002. The large subunit of initiation factor 
alF2 is a close structural homologue of elongation factors. EMBO J1l(7): 1821-1832. 
Schutz, P., Bumann, M., Oberholzer, A.E., Bieniossek, C., Trachsel, H., Altmann, M., 
and Baumann, V. 2008. Crystal structure of the yeast eIF4A-eIF4G complex: an RNA-helicase 
controlled by protein-protein interactions. Proc Nail A cad Se; USA 105(28): 9564-9569. 
Schwartz, E.I., Intine, R.V., and Maraia, RJ. 2004. CK2 is responsible for 
phosphorylation of human La protein serine-366 and can modulate rpL37 5
'
-terminal 
oligopyrimidine mRNA metabolism. Mol Cell Bioi 14(21): 9580-9591. 
Searfoss, A., Dever, T.E., and Wickner, R. 2001. Linking the 3' poly(A) tail to the subunit 
joining step of translation initiation: relations of Pab 1 p, eukaryotic translation initiation factor 5b 
(Fun12p), and Ski2p-Slhtp. Mol Cell Bio/1l(l5): 4900-4908. 
Sengoku, T., Nureki, 0., Nakamura, A., Kobayashi, S., and Yokoyama, S. 2006. 
Structural basis for RNA unwinding by the DEAD-box protein Drosophila Vasa. Cell 125(2): 287-
300. 
Shahbazian, D., Roux, P.P., Mieulet, V., Cohen, M.S., Raught, B., Taunton, 1., Hershey, 
J.W., Blenis, J., Pende, M., and Sonenberg, N. 2006. The mTORIPI3K and MAPK pathways 
converge on eIF4B to control its phosphorylation and activity. EMBOJ25(t2): 2781-2791. 
Shama, S. and Meyuhas, O. 1996. The translational eis-regulatory element of mammalian 
ribosomal protein mRNAs is recognized by the plant translational apparatus. Eur J Biochem 
236(2): 383-388. 
233 
Shin, B.S., Maag, D., RolI-Mecak, A., Arefin, M.S., Burley, S.K., Lorsch, J.R., and 
Dever, T.E. 2002. Uncoupling of initiation factor eIF5BIIF2 GTPase and translational activities by 
mutations that lower ribosome affinity. Cell 111(7): 1015-1025. 
Skovorodkin, I.N., Bollgonn, S., Ammermann, D., and and GUnzl A. 1999. Stable 
Transfection of the Hypotrichous Ciliate 
Stylonychia lcmnae with Tagged alpha 1 Tubulin Minichromosomes. Eur J Protistol3S: 
70-80. 
Slepenkov, S.V., Darzynkiewicz, E., and Rhoads, R.E. 2006. Stopped-flow kinetic 
analysis of eIF4E and phosphorylated eIF4E binding to cap analogs and capped 
oligoribonucleotides: evidence for a one-step binding mechanism. J Bioi Chem 281(21): 14927-
14938. 
Smyth, G.K. and Speed, T. 2003. Normalization of cDNA microarray data. Methods 
31(4): 265-273. 
Sonenberg, N. 1993a. Remarks on the mechanism of ribosome binding to eukaryotic 
mRNAs. Gene Expr 3(3): 317-323. 
-. 1993b. Translation factors as effectors of cell growth and tumorigenesis. CU" Opin 
Cell Bioi 5: 955-960. 
Squatrito, M., Mancino, M., Donzelli, M., Areces, L.B., and Draetta, G.F. 2004. EBPI is 
a nucleolar growth-regulating protein that is part of pre-ribosomal ribonucleoprotein complexes. 
Oncogene 23(25): 4454-4465. 
Squatrito, M., Mancino, M., Sala, L., and Draetta, G.F. 2006. Ebpl is a dsRNA-binding 
protein associated with ribosomes that modulates eIF2alpha phosphorylation. Biochem Biophys 
Res Commun 344(3): 859-868. 
Stebbins-Boaz, B., Cao, Q., de Moor, C.H., Mendez, R., and Richter, J.D. 1999. Maskin 
is a CPEB-associated factor that transiently interacts with eIF-4E. Mol Cell 4(6): 1017-1027. 
234 
Stolovich, M., Tang, H., Hornstein, E., Levy, G., Cohen, R., Bae, S.S., Birnbaum, M.J., 
and Meyuhas, O. 2002. Transduction of growth or mitogenic signals into translational activation 
of TOP mRNAs is fully reliant on the phosphatidylinositol 3-kinase-mediated pathway but 
requires neither S6Kl nor rpS6 phosphorylation. Mol Cell BioI 22(23): 8101-8113. 
Stoneley, M., Chappell, S.A., Jopling, C.L., Dickens, M., MacFarlane, M., and Willis, 
A.E. 2000. c-Myc protein synthesis is initiated from the internal ribosome entry segment during 
apoptosis. Mol Cell Bioi 20(4): 1162-1169. 
Stoneley, M., Paulin, F.E.M., Le Quesne, J.P.C., Chappell, S.A., and Willis, A.E. 1998. 
C-Myc 5' untranslated region contains an internal ribosome entry segment. Oncogene 16: 423-
428. 
Subkhankulova, T., Mitchell S.A., and Willis, A.E. 2001. Internal ribosome entry 
segment mediated initiation of c-Myc protein synthesis following genotoxic stress. Biochem J 
359: 183-192. 
Suzuki, Y., Ishihara, D., Sasaki, M., Nakagawa, H., Hata, H., Tsunoda, T., Watanabe, M., 
Komatsu, T., Ota, T., Isogai, T., Suyama, A., and Sugano, S. 2000. Statistical analysis of the 5' 
untranslated region of human mRNA using "oligo-capped" cDNA libraries. Genomics 64: 286-
297. 
Talbot, SJ., Medina, G., Fishwick, C.W., Haneef, I., and Stockley, P.G. 1991. 
Hyperreactivity of adenines and conformational flexibility of a translational repression site. FEBS 
Lell 283( 1): 159-164. 
Tang, H .• Hornstein, E., Stolovich, M., Levy, G., Livingstone, M .• Templeton, D., 
A vruch, J., and Meyuhas, O. 200 I. Amino acid-induced translation of TOP mRNAs is fully 
dependent on phosphatidylinositol 3-kinase-mediated signaling, is partially inhibited by 
rapamycin. and is independent of S6KI and rpS6 phosphorylation. Mol Cell Bioi 21(24): 8671-
8683. 
235 
Thomas, G. 1986. Translational control of mRNA expression during the early mitogenic 
response in Swiss mouse 3T3 cells: identification of specific proteins. J Cell Bioi 103(6 Pt 1): 
2137-2144. 
Thomas, G. and Luther, H. 1981. Transcriptional and translational control of cytoplasmic 
proteins after serum stimulation of quiescent Swiss 3T3 cells. Proc Natl Acad Sci USA 78(9): 
5712-5716. 
Thomas, G., Siegmann, M., Kubler, A.M., Gordon, 1., and Jimenez de Asua, L. 1980. 
Regulation of 40S ribosomal protein S6 phosphorylation in Swiss mouse 3T3 cells. Ce/l19(4): 
1015-1023. 
Thoreen, C.C., Kang, S.A., Chang, J.W., Liu, Q., Zhang, J., Gao, Y., Reichling, L.J., Sim, 
T., Sabatini, D.M., and Gray, N.S. 2009. An ATP-competitive mammalian target of rapamycin 
inhibitor reveals rapamycin-resistant functions of mTORC 1. J Bioi Chem 284(12): 8023-8032. 
Tomoo, K., Shen, X., Okabe, K., Nozoe, Y., Fukuhara, S., Morino, S., Ishida, T., 
Taniguchi, T., Hasegawa, H., Terashima, A., Sasaki, M., Katsuya, Y., Kitamura, K., Miyoshi, H., 
Ishikawa, M., and Miura, K. 2002. Crystal structures of 7-methylguanosine 51-triphosphate 
(m(7)GTP)- and P( I )-7-methylguanosine-P(3)-adenosine-Sl,51-triphosphate (m(7)GpppA)-bound 
human full-length eukaryotic initiation factor 4E: biological importance of the C-tenninal flexible 
region. Biochem J 362(Pt 3): 539-544. 
Trachsel, H., Emi, B., Schreier, M.H., Braun, L., and Staehelin, T. 1979. Purification of 
seven protein synthesis initiation factors from Krebs 11 ascites cells. Biochim Biophys Acta 561(2): 
484-490. 
Trachsel, H., Emi, B., Schreier, M.H., and Staehelin, T. 1977. Initiation of mammalian 
protein synthesis. 11. The assembly of the initiation complex with purified initiation factors. J Mol 
Bioi 116(4): 755-767. 
236 
Ueda, T., Watanabe-Fukunaga, R., Fukuyama, H., Nagata, S., and Fukunaga, R. 2004. 
Mnk2 and Mnk 1 are essential for constitutive and inducible phosphorylation of eukaryotic 
initiation factor 4E but not for cell growth or development. Mol Cell Bioi 24(15): 6539-6549. 
Vasudevan, S. and Steitz, J.A. 2007. AU-rich-element-mediated upregulation of 
translation by FXR 1 and Argonaute 2. Cell 128(6): 1105-1118. 
Vasudevan, S., Tong, Y., and Steitz, J.A. 2007. Switching from repression to activation: 
microRNAs can up-regulate translation. Science 318(5858): 1931-1934. 
Vezina, C., Kudelski, A., and Sehgal, S.N. 1975. Rapamycin (AY-22,989), a new 
antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active 
principle. J Anlibiol (I'okyo) 28(10): 721-726. 
Vlahos, C.J., Matter, W.F., Hui, K.Y., and Brown, R.F. 1994. A specific inhibitor of 
phosphatidylinositol 3-kinase, 2-( 4-morpholinyl)-8-phenyl-4H-l-benzopyran-4-one (L Y294002). 
J Bioi Chem 269(7): 5241-5248. 
von Der Haar, T., Ball, P.D., and McCarthy, J.E. 2000. Stabilization of eukaryotic 
initiation factor 4E binding to the mRNA 5'-Cap by domains of eIF4G. J BioI Chem 275(39): 
30551-30555. 
von der Haar, T., Gross, J.O., Wagner, G., and McCarthy, J.E. 2004. The mRNA cap-
binding protein elF4E in post-transcriptional gene expression. Nal Strucl Mol Bio1U(6): 503-511. 
Wakiyama, M., Takimoto, K., Ohara, 0., and Yokoyama, S. 2007. Let-7 microRNA-
mediated mRNA deadenylation and translational repression in a mammalian cell-free system. 
Genes Dev 21(15): 1857-1862. 
Wang, B., Love, T.M., Call, M.E., Doench, J.G., and Novina, C.D. 2006. Recapitulation 
of short RNA-directed translational gene silencing in vitro. Mol Cell 22(4): 553-560. 
Warner, J.R., Vilardell, J., and Sohn, J.H. 2001. Economics of ribosome biosynthesis. 
Cold Spring Harb Symp Quant Bioi 66: 567-574. 
237 
Williams, 0.0., Price, N.T., Loughlin, AJ., and Proud, C.G. 2001. Characterization of 
the mammalian initiation factor eIF2B complex as a GDP dissociation stimulator protein. J Bioi 
Chem 276(27): 24697-24703. 
WiIson, J.E., Pestova, T.V., Hellen, C.U., and Sarnow, P. 2000. Initiation of protein 
synthesis from the A site of the ribosome. Cell 102(4): 511-520. 
Witherell, G.W., Gott, J.M., and Uhlenbeck, O.C. 1991. Specific interaction between 
RNA phage coat proteins and RNA. Prog Nucleic Acid Res Mol BioI 40: 185-220. 
Wu, J. and Bag, J. 1998. Negative control of the poly(A)-binding protein mRNA 
translation is mediated by the adenine-rich region of its 5'-untranslated region. J Bioi Chem 
273(51): 34535-34542. 
Wu, L., Fan, J., and Belasco, J.G. 2006. MicroRNAs direct rapid deadenylation of 
mRNA. Proc Nail Acad Se; USA 103(11): 4034-4039. 
Xia, X., Cheng, A., Lessor, T., Zhang, Y., and Hamburger, A.W. 2001. Ebpl. an ErbB-3 
binding protein, interacts with Rb and affects Rb transcriptional regulation. J Cell PhysioI187(2): 
209-217. 
Yamamoto, Y., Singh, C.R., Marintchev, A., Hall, N.S., Hannig, E.M., Wagner, G., and 
Asano, K. 2005. The eukaryotic initiation factor (elF) 5 HEAT domain mediates multifactor 
assembly and scanning with distinct interfaces to eIFl, elF2, elF3, and eIF4G. Proc Natl Acad Sei 
USA 102(45): 16164-16169. 
Yang, G. and Samow, P. 1997. Location of the internal ribosome entry site in the 5' non-
coding region of the immunoglobulin heavy chain binding protein (BiP) mRNA:evidence for 
specific RNA-protein interactions. Nucleic Acids Res 25: 2800-2807. 
Yatime, L., Mechulam, Y., Blanquet, S., and Schmitt, E. 2006. Structural switch of the 
gamma subunit in an archaeal aIF2 alpha gamma heterodimer. Structure 14( 1): 119-128. 
238 
Yatime, L., Schmitt, E., Blanquet, S., and Mechulam, Y. 2004. Functional molecular 
mapping of archaeal translation initiation factor 2. J Bioi Chem 279( 16): 15984-15993. 
-.2005. Structure-function relationships of the intact aIF2alpha subunit from the archaeon 
Pyrococcus abyssi. Biochemistry 44(24): 8749-8756. 
Yueh, A. and Schneider, R.J. 2000. Translation by ribosome shunting on adenovirus and 
hsp70 mRNAs facilitated by complementarity to 18S rRNA. Genes Dev 14: 414-421. 
Zhang, Z. and Krainer, A.R. 2007. Splicing remodels messenger ribonucleoprotein 
architecture via eIF4A3-dependent and -independent recruitment of exon junction complex 
components. Proc NaIl Acad Se; USA 104(28): 11574-11579. 
Zhu. J., Hayakawa, A., Kakegawa, T., and Kaspar, R.L. 2001. Binding of the La 
autoantigen to the 5' untranslated region of a chimeric human translation elongation factor 1 A 
reporter mRNA inhibits translation in vitro. Biochim Biophys Acta 1521(1-3): 19-29. 
Zhu, J., Spencer, E.D., and Kaspar, R.L. 2003. Differential translation of TOP mRNAs in 
rapamycin-treated human B Iymphocytes. Biochim Biophys Acta 1628(1): 50-55. 
239 
Appendix 
7.1 Mass Spettrometry Data following Affinity Purification 
7.1.1 TOP-trctMut-14x Affinity Purification (Serum Starved) 241 
7.1.2 TOP-14x Affinity Purification (Serum Starved) 244 
7.1.3 TOP-trttMut-14x Affinity Purification (Serum Starved & Re-fed) 250 
7.1.4 TOP-14x Affinity Purification (Serum Starved & Re-fed) 253 
7.2 MicroRNA Microarray Data following Affinity Purification 255 
240 
7.1.1 Top-trctMut-14x Affinity Purification: Mass Spectrometry Results 
(Serum Starved) 
Anti-colorectal carcinoma heavy chain 
CDNA FU46155 fis, clone TESTI4001517, moderately similar to Keratin, type I cytoskeletal18 
Kappa light chain variable region (Fragment) 
Myosin-reactive immunoglobulin light chain variable region (Fragment) 
Similar to 40S ribosomal protein S18 
Similar to ribosomal protein S27 
WUGSC:H_RG054D04.1 protein 
ANK2 Isoform 1 of Ankyrin-2 
APOB Apolipoprotein B-l00 precursor 
ARID4B Isoform 4 of AT-rich interactive domaln-containlng protein 48 
ARS2 Arsenite-resistance protein ARS2 
ATG2A lsoform 1 of Autophagy-related protein 2 homolog A 
C1QBP Complement component 1 Q subcomponent-binding protein, mitochondrial precursor 
C200rf74Isoform 3 of 250 kDa substrate of Akt 
CAPRINl Caprln-l 
CEPll0 Centrosomal protein 110kDa 
DCD Dermcldin precursor 
DHX30 Isoform 1 of Putative ATP-dependent RNA heJicase DHX30 
DHX9 ATP-dependent RNA hellcase A 
EFCAB5 Isoform 3 of EF-hand calcium-binding domain-containing protein 5 
EIF3B Isoform 1 of Eukaryotic translation initiation factor 3 subunit B 
EIF3C Eukaryotic translation initiation factor 3 subunit C 
GADD45GIPl Growth arrest and DNA-damage-induclble proteins-interacting protein 1 
GNB2Lllung cancer oncogene 7 
hCG_2033311 Uncharacterized protein ENSP00000375173 
hCG_2040224 Uncharacterized protein ENSP00000375262 
hCG_2040224 Uncharacterized protein ENSPOOO00375262 
hCG_21078 hypothetical protein LOC389435 
HNRNPU lsoform Short of Heterogeneous nuc:lear ribonucleoprotein U 
HNRPULllsoform 1 of Heterogeneous nuclear ribonucleoprotein U-lIke protein 1 
ICTllmmature colon carcinoma transcript 1 protein precursor 
ING3 lsoform 1 of Inhibitor of growth protein 3 
KIFll Kinesin-Jike protein KIFll 
KRTl Keratin, type 11 cytoskeletall 
KRTlO Keratin, type I cytoskeletall0 
KRTl2 Keratin, type I cytoskeletall2 
KRT2 Keratin, type 11 cytoskeletal 2 epidermal 
KRT6B Keratin, type 11 cytoskeletal 6B 
KRT77 Keratin 17 
KRT9 Keratin, type I cytoskeletal 9 
LARP11soform 1 of la-related protein 1 
LOC284393 similar to ribosomal protein Ll0 Isoform 1 
lOC389342 similar to ribosomal protein LlO isoform 6 
L0C390998 similar to 60S ribosomal protein LlO 
l0C391370 similar to ribosomal protein 512 
LOC402057 Uncharacterlzed protein ENSPOOOO0375215 
LOC644511 Uncharacterized protein ENSP00000375499 
lOC644937 similar to 60S ribosomal protein L10 
lOC729293 similar to ribosomal protein 518 
lOC729611 similar to 60S ribosomal protein U9 
LOC730070 similar to 60S ribosomal protein L26 
LOC731S67;RPL21;LOC729402 60S ribosomal protein l21 
LVZ lysozyme C precursor 
MRPL12 395 ribosomal protein L12, mitochondrial precursor 
'41 
MRPL2 395 ribosomal protein L2, mitochondrial precursor 
MRPL23 Mltochondrial39S ribosomal protein L23 
MRPL28 39S ribosomal protein L28, mitochondrial precursor 
MRPL43 mitochondrial ribosomal protein L43 isoform d 
MRPS23 Mitochondrial ribosomal protein S23 
MRPS26 28S ribosomal protein 526, mitochondrial precursor 
MRP534 Mitochondrial 285 ribosomal protein 534 
MRP57 285 ribosomal protein 57, mitochondrial precursor 
NBEAL2 SQFE253 
NCL lsoform 1 of Nucleolin 
N05T3lsoform 1 of Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 3 
NOLI NOL1 protein 
POAP128 kOa heatand acid-stable phosphoprotein 
POPl Ribonucleases P/MRP protein subunit POP1 
PRSS3 Isoform A of Trypsin-3 precursor 
PSMOllsoform 2 of 26S proteasome non-ATPase regulatory subunit I 
RPL10A 25 kOa protein 
RPLlOL 60S ribosomal protein LlO-like 
RPLlllsoform 1 of 60S ribosomal protein Lll 
RPL12 60S ribosomal protein Ll2 
RPL13 605 ribosomal protein L13 
RPL13A 60S ribosomal protein Ll3a 
RPL14 RPL14 protein 
RPL1S 60S ribosomal protein L1S 
RPL1S;LOC6S3232 Ribosomal protein LlS pseudogene 3 
RPL17 60S ribosomal protein Lt7 
RPL18 605 ribosomal protein Ll8 
RPLl8A 60S ribosomal protein Ll8a 
RPLl9 605 ribosomal protein L19 
RPL22 605 ribosomal protein L22 
RPL23 60S ribosomal protein l23 
RPl23A;hCG_16001 60S ribosomal protein L23a 
RPL24 60S ribosomal protein L24 
RPL26 60S ribosomal protein L26 
RPL27 60S ribosomal protein L27 
RPL28 60S ribosomal protein L28 
RPL3 31 kOa protein 
RPL30 60S ribosomal protein L30 
RPL3160S ribosomal protein L31 
RPL34 60S ribosomal protein L34 
RPL35 60S ribosomal protein L35 
RPL35A 60S ribosomal protein L35a 
RPL36 60S ribosomal protein L36 
RPl7 60S ribosomal protein L7 
RPl7A 60S ribosomal protein L7a 
RPl8 60S ribosomal protein L8 
RPl9 60S ribosomal protein L9 
RPlPl60S acidic ribosomal protein PI 
RPlP2 60S acidic ribosomal protein P2 
RPSI0 40S ribosomal protein S10 
RPS1140S ribosomal protein Sl1 
RP512 ribosomal protein S12 
RP513 40S ribosomal protein S13 
RPSl4 40S ribosomal protein S14 
RPSl5A 40S ribosomal protein SISa 
RPS16 40S ribosomal protein S16 
RPS17 405 ribosomal protein S17 
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RPS18 405 ribosomal protein 518 
RP519 405 ribosomal protein 519 
RPS2 405 ribosomal protein S2 
RPS20 40S ribosomal protein 520 
RPS23 405 ribosomal protein 523 
RPS24 Isoform 1 of 405 ribosomal protein 524 
RP525 405 ribosomal protein 525 
RP5260TIHUMPOOOOOO18641 
RPS3 405 ribosomal protein S3 
RPS3 40S ribosomal protein 53 
RPS3A 405 ribosomal protein 53a 
RPS4X 405 ribosomal protein S4, X isoform 
RPS5 405 ribosomal protein 55 
RPS6 405 ribosomal protein 56 
RPS7 405 ribosomal protein S7 
RPS8 40S ribosomal protein S8 
RPS9 405 ribosomal protein 59 
RPSA Ribosomal protein 5A 
5AMD9 Isoform 1 of Sterile alpha motif domain-containing protein 9 
5LC2SAS ADP/ATP translocase 2 
SMC4 SMC4 protein (Fragment) 
SNDl Staphylococcal nuclease domain-containing protein 1 
SSB lupus la protein 
THOC4 THO complex subunit 4 
TMEM63C Transmembrane protein 63C 
TPX2 Targeting protein for Xklp2 
TSRl Pre-rRNA-processing protein TSRl homolog 
UPFllsoform 1 of Regulator of nonsense transcripts 1 
ZC3HAV1lsoform 2 of Zinc finger eCCH type antiviral protein 1 
ZFR 115 kDa protein 
ZNFS71 HERV-T_19q13.11 provirus ancestral Env polyproteln precursor 
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7.1.2 Top-14x Affinity Purification: Mass Spectrometry Results 
(Serum Starved) 
Anti-colorectal carcinoma heavy chain 
Kappa light chain variable region (Fragment) 
Keratin-8-like protein 1 
Myosin-reactive immunoglobulin light chain variable region (Fragment) 
Putative plS0 
RcNSEP1 (Fragment) 
Similar to 40S ribosomal protein S18 
Similar to N-acetylgalactosaminyltransferase 7 
Similar to ribosomal protein S27 
WUGSC:H_RGOS4D04.1 protein 
ACBD3 Golgi resident protein GCP60 
AHSAl Activator of 90 kDa heat shock protein ATPase homolog 1 
AKAP12 A-kinase anchor protein 12 isoform 2 
AMPH Amphiphysin I variant CT4 (Fragment) 
ARHGEF18 Rho guanine nucleotide exchange factor 18 
ATP1Bl1soform 2 of Sodium/potassium-transporting ATPase subunit beta-l 
ATPSB ATP synthase subunit beta, mitochondrial precursor 
BVSl Bystin 
C20orf23 Isoform 1 of Kinesin-like motor protein C200rf23 
C40rf14 Uncharacterized protein C40rf14 
C7orfSO Uncharacterlzed protein C70rfSO 
CCDC113 Coiled-coil domain-containlng protein 113 
CCDCSO Isoform 2 of Coiled-coil domain-containlng protein 50 
CCNU Cyclin-Tl 
CHMP2A Charged multivesicular body protein 2a 
CIT Isoform 1 of Citron Rho-interacting kinase 
ClASP2 CLIP-associating protein 2 
CSDA Isoform 1 of DNA-binding protein A 
CTAGE1 Protein cTAGE-2 
DAP3 Mitochondrial 28S ribosomal protein 529 
DAP3 Mitochondrial 28S ribosomal protein 529 
DCD Dermcidln precursor 
DCD Dermcldin precursor 
DDX1 ATP-dependent RNA helicase DDX1 
DDX18 ATP-dependent RNA helicase DDX18 
DDX211soform 1 of Nucleolar RNA helicase 2 
DDX28 Probable ATP-dependent RNA heilcase DDX28 
DDX3X ATP-dependent RNA helicase DDX3X 
DDXS Probable ATP-dependent RNA helicase DDXS 
DHX1S Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX1S 
DHX30 Isoform 1 of Putative ATP-dependent RNA helicase DHX30 
DHX9 ATP-dependent RNA helicase A 
DHX9 ATP-dependent RNA helicase A 
DIAPH3 Isoform 2 of Protein diaphanous homolog 3 
DMAP1 DNA methyltransferase 1 associated protein 1 
DNAJA1 DnaJ homolog subfamily A member 1 
DNAJA2 DnaJ homolog subfamily A member 2 
DUSP27 Inactive dual speclficity phosphatase 27 
EEF1A1 Elongation factor 1-alpha 
EEF2 Elongation factor 2 
EFCABS Isoform 3 of EF-hand calcium-binding domain-containing protein 5 
EFTUD2 116 kDa US small nuclear ribonucleoprotein component 
EIF3EIP Eukaryotic translation Initiation factor 3 subunit 6 interacting protein 
EIF3F Eukaryotic translation initiation factor 3 subunit 5 
EIF3H Eukaryotic translation initiation factor 3 subunit 3 
EMD Emerln 
ERAl11soform HERA-A of GTP-blnding protein era homolog 
244 
GFPTllsoform 1 of Glucosamine-fructose-6-phosphate aminotransferase [isomerizing) 1 
GNB2Ll Lung cancer oncogene 7 
GTPBP4 Nucleolar GTP-binding protein 1 
GTPBP4 Nucleolar GTP-binding protein 1 
hCG_1644323 similar to 60S ribosomal protein L32 
hCG_2023776 similar to Heterogeneous nuclear ribonucleoprotein A1 
hCG_2033311 Uncharacterized protein ENSPOOOOO375173 
hCG_2040224 Uncharacterlzed protein ENSP00000375262 
hCG_2040224 Uncharacterlzed protein ENSPOOOOO375262 
hCG_21078 hypothetical protein LOC389435 
HEJIHEJl 
HISTlH1C Histone Hl.2 
HLA class I histocompatibility antigen, B-7 alpha chain precursor 
HNRNPAO Heterogeneous nuclear ribonucleoprotein AO 
HNRNPA11soform A1-B of Heterogeneous nuclear ribonucleoprotein A1 
HNRNPA2Bl1soform B1 of Heterogeneous nuclear ribonucleoproteins A2/B1 
HNRNPC Isoform Cl of Heterogeneous nuclear ribonucleoproteins C1/C2 
HNRNPR Heterogeneous nuclear ribonucleoprotein R 
HNRNPU lsoform Short of Heterogeneous nuclear ribonucleoprotein U 
HNRPA3 Isoform 1 of Heterogeneous nuclear ribonucleoprotein A3 
HNRPAB Isoform 2 of Heterogeneous nuclear ribonucleoprotein AlB 
HNRPAB Isoform 2 of Heterogeneous nuclear ribonucleoprotein AlB 
HNRPCLl Heterogeneous nuclear ribonucleoprotein C-like 1 
HNRPO Isoform 1 of Heterogeneous nuclear ribonucleoprotein 00 
HNRPOL Isoform 3 of Heterogeneous nuclear ribonucleoprotein O-like 
HNRPH1 Heterogeneous nuclear ribonucleoprotein H 
HNRPK Isoform 1 of Heterogeneous nuclear ribonucleoprotein K 
HNRPM lsoform 1 of Heterogeneous nuclear ribonucleoprotein M 
HNRPUL1lsoform 4 of Heterogeneous nuclear ribonucleoprotein U-lIke protein 1 
HSP90ABl Heat shock protein HSP 90-beta 
HSP90AB2P Heat shock protein 90Sb 
HSPA1B;HSPAIA Heat shock 70 kDa protein 1 
HSPA2 Heat shock-related 70 kOa protein 2 
HSPA5 HSPA5 protein 
HSPA7 Putative heat shock 70 kDa protein 7 
HSPA8 Isoform 1 of Heat shock cognate 71 kOa protein 
HSPA9 Stress-70 protein, mitochondrial precursor 
HSPDI 60 kDa heat shock protein, mitochondrial precursor 
IGF2BP1lnsulin-like growth factor 2 mRNA-binding protein 1 
IGF2BP3 Isoform 1 of Insulin-like growth factor 2 mRNA-binding protein 3 
IGHV30R16-13;IGHAIIGHAl protein 
ILl6 ILl6 protein 
ILF2 Interleukln enhancer-binding factor 2 
ILF3 Interleukln enhancer binding factor 31soform c variant (Fragment) 
ILF3 lsoform 5 of Interleukin enhancer-binding factor 3 
ITPR2 Isoform Long of Inositoll,4,5-trisphosphate receptor type 2 
KCNK1 Potassium channel, subfamily K, member 1 
KIFll Kinesin-like protein KIFll 
KIF13A Isoform 3 of Kinesin-like protein KIF13A 
KIF27 Isoform 1 of Kinesin-like protein KIF27 
KRTl Keratin, type 11 cytoskeletal 1 
KRTlO Keratin, type I cytoskeletallO 
KRTl2 Keratin, type I cytoskeletal12 
KRT14 Keratin, type I cytoskeletal14 
KRT18 Keratin, type I cytoskeletal18 
KRT2 Keratin, type 11 cytoskeletal 2 epidermal 
KRT4 keratin 4 
KRT5 Keratin, type 11 cytoskeletal 5 
KRT6B Keratin, type 11 cytoskeletal 6B 
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KRT73 Isoform 1 of Keratin, type 11 cytoskeletal 73 
KRT77 Keratin 77 
KRT9 Keratin, type I cytoskeletal 9 
LARP11soform 1 of la-related protein 1 
LARP7 lupus la protein family protein 
lDHC l-Iactate dehydrogenase C chain 
lIlRS3 leukocyte immunoglobulin-like receptor, subfamily S, member 3 isoform 2 
l0C388720 similar to ubiquitin and ribosomal protein 527a precursor 
l0C389342 similar to ribosomal protein l10 isoform 6 
l0C390998 similar to 605 ribosomal protein l10 
lOC4020S7 Uncharacterized protein EN5P00000375215 
lOC4400S5 similar to ribosomal protein 512 
lOC440577 similar to nucleophosmin llsoform 1 
lOC644511 Uncharacterized protein EN5POOO00375499 
lOC644937 similar to 605 ribosomal protein l10 
lOC646195;RP528;lOC645899 405 ribosomal protein 528 
lOC649946 lOC649946 protein 
lOC729293 similar to ribosomal protein 518 
lOC729611 similar to 605 ribosomal protein l29 
l0C729611 similar to 605 ribosomal protein l29 
lOC730037 similar to Collagen alpha-2(XI) chain precursor 
lOC730070 similar to 605 ribosomal protein l26 
lYAR Cell growth-regulating nucleolar protein 
MASTl Microtubule-associated serine/threonine-protein kinase 1 
MEPCE 75K snRNA methylphosphate capping enzyme 
ML13 Isoform 1 of Myeloid/lymphoid or mixed-lineage leukemia protein 3 homolog 
MRP110 mitochondrial ribosomal protein l10 isoform b 
MRPlll 395 ribosomal protein l11, mitochondrial precursor 
MRPl2 395 ribosomal protein l2, mitochondrial precursor 
MRPl21 395 ribosomal protein l21, mitochondrial precursor 
MRPl28 395 ribosomal protein l28, mitochondrial precursor 
MRP13 Mitochondrial 395 ribosomal protein l3 
MRP137 395 ribosomal protein L37, mitochondrial precursor 
MRPL38 395 ribosomal protein L38, mitochondrial precursor 
MRPL39 Isoform 2 of Mitochondrial 395 ribosomal protein L39 
MRPL43 mitochondrial ribosomal protein l43 isoform d 
MRPl44 395 ribosomal protein l44, mitochondrial precursor 
MRPL45 395 ribosomal protein l4S, mitochondrial precursor 
MRPl48 Isoform 1 of 395 ribosomal protein l48, mitochondrial precursor 
MRPl49 Mitochondrial 395 ribosomal protein l49 
MRPLSO Mitochondrial 395 ribosomal protein LSD 
MRPl9 Mitochondrial ribosomal protein 19 
MRP516 285 ribosomal protein 516, mitochondrial precursor 
MRP518A 285 ribosomal protein 518a, mitochondrial precursor 
MRP518S 285 ribosomal protein 518b, mitochondrial precursor 
MRP522 Mitochondrial 285 ribosomal protein S22 
MRP523 Mitochondrial ribosomal protein 523 
MRP526 285 ribosomal protein 526, mitochondrial precursor 
MRP527 Mitochondrial 285 ribosomal protein 527 
MRP530 Mitochondrial 285 ribosomal protein 530 
MRPS31285 ribosomal protein 531, mitochondrial precursor 
MRPS34 Mitochondrial 285 ribosomal protein 534 
MRP57 285 ribosomal protein 57, mitochondrial precursor 
MRP59 mitochondrial ribosomal protein 59 
MTDH Protein lYRIC 
NCl (DNA FU45706 fis, clone FEBRA2028457, highly similar to Nucleolin 
NCllsoform 1 of Nucleolin 
ND5n Isoform 1 of Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 3 
NFE2l11soform 1 of Nuclear factor erythroid 2-related factor 1 
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NOBI RNA-binding protein NOBI 
NPMllsoform I of Nucleophosmln 
PA2G4 Proliferation-associated protein 2G4 
PABPC11soform 1 of Polyadenylate-binding protein 1 
PABPCll Polyadenylate-binding protein I-like 
PABPCll2A;PABPC1l2B Polyadenylate-binding protein I-like 2 
PABPC3 Polyadenylate-binding protein 3 
PABPC4 Poly 
PCBP2 poly(rC)-blndlng protein 2 Isoform b 
PCCA Proplonyl Coenzyme A carboxylase, alpha polypeptide 
PCDH15 lsoform 1 of Protocadherin-l5 precursor 
PLA2Gl2A Group XIIA secretory phospholipase A2 precursor 
PN01 RNA-binding protein PN01 
POPl Ribonucleases P/MRP protein subunit POPl 
POP1 Ribonucleases P/MRP protein subunit POPl 
PPFIAl 7 kDa protein 
PPMIG Protein phosphatase IG 
PRKDC lsoform 1 of DNA-dependent protein kinase catalytic subunit 
PRPF19 Pre-mRNA-processing factor 19 
PRPF3 Isoform 1 of U4/U6 small nuclear ribonucleoprotein Prp3 
PRSSl Trypsln-l precursor 
PRSS2 Protease serine 2 Isoform B 
PRSS3 Isoform A of Trypsin-3 precursor 
PSMCS 26S protease regulatory subunit 8 
PTCDl Pentatricopeptide repeat-containing protein 1 
PTCD3 Isoform 1 of Pentatricopeptide repeat-containing protein 3, mitochondrial precursor 
RBM26 Isoform 1 of RNA-binding protein 26 
RBMX Heterogeneous nuclear ribonucleoprotein G 
RCN2 Retlculocalbln-2 precursor 
RNMn1 RNA methyltransferase-Iike protein 1 
RPAP31soform 1 of RNA polymerase II-assoclated protein 3 
RPllOA 2S kDa protein 
RPlI0l 60S ribosomal protein UO-Iike 
RPllllsoform 1 of 60S ribosomal protein ll1 
RPllllsoform 1 of 60S ribosomal protein ll1 
RPl12 60S ribosomal protein L12 
RPL13 60S ribosomal protein L13 
RPl13A 60S ribosomal protein L13a 
RPl14 RPl14 protein 
RPl15 60S ribosomal protein US 
RP117 60S ribosomal protein l17 
RPl18 60S ribosomal protein Ll8 
RPl18A 60S ribosomal protein U8a 
RPll9 60S ribosomal protein 119 
RPl22 60S ribosomal protein l22 
RPl23 60S ribosomal protein l23 
RPL23A;hCG_1600160S ribosomal protein L23a 
RPl24 60S ribosomal protein l24 
RPL26 60S ribosomal protein l26 
RPl27 60S ribosomal protein l27 
RPl28 60S ribosomal protein l28 
RPl3 31 kDa protein 
RPL3 60S ribosomal protein L3 
RPL30 60s ribosomal protein L30 
RPL3160S ribosomal protein l3l 
RPL34 60s ribosomal protein L34 
RPl35 60S ribosomal protein L35 
RPL3SA 60S ribosomal protein L3Sa 
RPL36 60S ribosomal protein L36 
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RPL3L 605 ribosomal protein L3-like 
RPL4 605 ribosomal protein l4 
RPlS 60S ribosomal protein lS 
RPl6 60S ribosomal protein l6 
RPl7 60S ribosomal protein l7 
RPl7A 60S ribosomal protein l7a 
RPL8 60S ribosomal protein L8 
RPl9 60S ribosomal protein 19 
RPLPO 60S acidic ribosomal protein PO 
RPlPl 60S acidic ribosomal protein Pl 
RPlP2 60S acidic ribosomal protein P2 
RP510 405 ribosomal protein S10 
RP511405 ribosomal protein 511 
RP513 405 ribosomal protein S13 
RPS14 40S ribosomal protein S14 
RPS1SA 40S ribosomal protein S15a 
RPS16 40S ribosomal protein S16 
RPS17 405 ribosomal protein 517 
RPS18 405 ribosomal protein S18 
RPS19 405 ribosomal protein S19 
RPS19BP1405 ribosomal protein S19-binding protein 1 
RPS2 40S ribosomal protein S2 
RP52 405 ribosomal protein S2 
RPS20 405 ribosomal protein S20 
RP524 lsoform 1 of 405 ribosomal protein S24 
RPS2S 405 ribosomal protein S2S 
RPS260TIHUMPOOOOOO18641 
RP53 405 ribosomal protein S3 
RP53A 405 ribosomal protein S3a 
RP53A 405 ribosomal protein S3a 
RPS4X 40S ribosomal protein S4, X Isoform 
RP5S 40S ribosomal protein SS 
RPS6 40S ribosomal protein S6 
RPS7 40S ribosomal protein S7 
RPS7 405 ribosomal protein S7 
RP58 405 ribosomal protein S8 
RP59 405 ribosomal protein S9 
RP5A Ribosomal protein SA 
RPSA Ribosomal protein SA 
RPSAP15 laminin receptor-like protein LAMRLS 
SAMD9 Isoform 1 of Sterile alpha motif domain-containing protein 9 
SCN1A Isoform 1 of Sodium channel protein type 1 subunit alpha 
SERBP11soform 1 of Plasminogen activator inhibitor 1 RNA-binding protein 
SF382 splicing factor 38 subunit 2 
SFRS4 Splicing factor, arginine/serine-rich 4 
SlC2SA3 Isoform A of Phosphate carrier protein, mitochondrial precursor 
SlC2SAS ADP/AlP translocase 2 
SMC4 SMC4 protein (Fragment) 
SMC6 Isoform 1 of Structural maintenance of chromosomes protein 6 
SRP68 Isoform 1 of Signal recognition particle 68 kDa protein 
SRP72 Signal recognition particle 72 kDa protein 
SSB lupus la protein 
STAU11soform long of Double-stranded RNA-binding protein Staufen homolog 1 
THOC4 THO complex subunlt 4 
TIEl Tyrosine-protein kinase receptor Tie-1 precursor 
TIMMSO Import Inner membrane translocase subunit TIMSO, mitochondrial precursor 
TlN2Talin-2 
TROVE2 Isoform long of 60 kDa S5-A/Ro ribonucleoprotein 
TSEN34 tRNA-spllting endonuclease subunit Sen34 
?4R 
TSR1 Pre-rRNA-processing protein TSR1 homolog 
TTN Isoform 4 of Titin 
TTN titin isoform novex-1 
TUBAlA Tubulin alpha-lA chain 
TUBA1B Tubulin alpha-lB chain 
TUBA4B Tubulin alpha-4 chain 
TUSS Tubulin beta chain 
TUBB Tubulin beta chain 
TUBB2e Tubulin beta-2e chain 
TUBB2e Tubulin beta-2e chain 
TUFM Tu translation elongation factor, mitochondrial 
UBC;UBB;RPS27A ubiquitin and ribosomal protein S27a precursor 
WBP11 WW domain-binding protein 11 
VBX1 Nuclease sensitive element-binding protein 1 
YSK4 79 kDa protein 
ZC3HAV1lsoform 2 of Zinc finger CCCH type antiviral protein 1 
ZNFS71 HERV-T_19q13.11 provirus ancestral Env polyprotein precursor 
ZNF622 Zinc finger protein 622 
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7.1.3 Top-trctMut-14x Affinity Purification: Mass Spectrometry Results 
(Scrum Stan'cd & Rc-fed) 
Anti-colorectal carcinoma heavy chain 
CDNA FU46155 fis, clone TEST14oo1517, moderately similar to Keratin, type I cytoskeletal18 
Kappa light chain variable region (Fragment) 
Keratin-8-like protein 1 
Myosin-reactive immunoglobulin light chain variable region (Fragment) 
OTTHUM POO000028841 
RcNSEPl (Fragment) 
Short heat shock protein 60 Hsp60s2 
Similar to Ribosomal protein S2 
WUGSC:H_RGOS4D04.1 protein 
ABCF11soform 2 of ATP-binding cassette sub-family F member 1 
ADCY6 Isoform 1 of Adenylate cyclase type 6 
AFFl Putative FelC 
ARHGAP28 Isoform 2 of Rho GTPase-activating protein 28 
BYSL Bystin 
CIQBP Complement component 1 Q subcomponent-binding protein, mitochondrial precursor 
CCDC12 Coiled-coil domain-containing protein 12 
CCDC15 Coiled-coil domain-containing protein 15 
CCDC40 Isoform 3 of Coiled-coil domain-containing protein 40 
CCDC66 CCDC66 protein 
CENPJ Centromere protein J 
CENTDl Centaurin-delta-l 
CEP110 Centrosomal protein 110kDa 
CIT Isoform 1 of Citron Rho-interacting kinase 
CSDA Isoform 1 of DNA-binding protein A . 
DAP3 Mitochondrial 28S ribosomal protein S29 
DCD Dermcidin precursor 
DDX3X AlP-dependent RNA helicase DDX3X 
DDX5 Probable ATP-dependent RNA helicase DDX5 
DIAPH3 Isoform 2 of Protein diaphanous homolog 3 
DNA2 Isoform 3 of DNA2-like helicase 
DNAHll Ciliary dynein heavy chain 11 
DUSP9 Similar to dual specificity phosphatase 9 
ECT2 epithelial cell transforming sequence 2 oncogene protein 
FCHSD2 Isoform 2 of FCH and double SH3 domains protein 2 
FU46111 FU46111 protein 
FRY WUGSC:H_2G3A.l protein 
GALKl Galactokinase 
GNB2Ll Lung cancer oncogene 7 
GNL3 Isoform 2 of Guanine nucleotide-binding protein-like 3 
GTPBP4 Nucleolar GlP-binding protein 1 
HISTlHIC Histone H1.2 
HNRNPAllsoform A1-B of Heterogeneous nuclear ribonucleoprotein A1 
HNRNPA2Bl1soform B1 of Heterogeneous nuclear ribonucleoproteins A2/B1 
HNRNPl heterogeneous nuclear ribonucleoprotein l isoform a 
HNRNPR Heterogeneous nuclear ribonucleoprotein R 
HNRNPU lsoform Short of Heterogeneous nuclear ribonucleoprotein U 
HNRPCll Heterogeneous nuclear ribonucleoprotein C-like 1 
HNRPHl Heterogeneous nuclear ribonucleoprotein H 
HNRPK Isoform 1 of Heterogeneous nuclear ribonucleoprotein K 
HNRPM lsoform 1 of Heterogeneous nuclear ribonucleoprotein M 
HSPA1B;HSPA1A Heat shock 70 kDa protein 1 
HSPA1L Heat shock 70 kDa protein 1l 
HSPA6 Heat shock 70 kDa protein 6 
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HSPA8 Isoform 1 of Heat shock cognate 71 kDa protein 
HYDIN;HYDIN2 Uncharacterized protein HYDIN2 
IGF2BPllnsulin-lIke growth factor 2 mRNA-bindlng protein 1 
IGF2BP3 lsoform Z of Insulin-like growth factor Z mRNA-blndlng protein 3 
ITPR2 Isoform Long of Inositoll,4,5-trisphosphate receptor type 2 
KIF13A Isoform 3 of Kinesin-like protein KIF13A 
KRTl Keratin, type 11 cytoskeletall 
KRTlO Keratin, type I cytoskeletallO 
KRT12 Keratin, type I cytoskeletal12 
KRTl3 keratin 13 isoform b 
KRTl4 Keratin, type I cytoskeletal14 
KRT16 Keratin, type I cytoskeletal16 
KRTl8 Keratin, type I cytoskeletal18 
KRTl9 Keratin, type I cytoskeletal19 
KRT2 Keratin, type 11 cytoskeletal 2 epidermal 
KRT3 Keratin, type 11 cytoskeletal 3 
KRT4 keratin 4 
KRT4 keratin 4 
KRT4 keratin 4 
KRT5 Keratin, type 11 cytoskeletal 5 
KRT6A Keratin, type 11 cytoskeletal 6A 
KRT6B Keratin, type 11 cytoskeletal 6B 
KRT73 Isoform 1 of Keratin, type 11 cytoskeletal 73 
KRT75 Keratin, type 11 cytoskeletal 75 
KRT76 Keratin, type 11 cytoskeletal2 oral 
KRT77 Keratin 77 
KRT8 Keratin, type 11 cytoskeletal 8 
KRT80 Isoform 3 of Keratin, type 11 cytoskeletal 80 
KRT85 Keratin type 11 cuticular Hb5 
KRT9 Keratin, type I cytoskeletal 9 
LARP2 Isoform 1 of La-related protein 2 
LARP7 Lupus La protein family protein 
LOC343851 similar to 405 ribosomal protein 510 
L0C387867 similar to 405 ribosomal protein 5A 
LOC729611 similar to 605 ribosomal protein L29 
L1Vl Protein L1Vl homolog 
LYAR Cell growth-regulating nucleolar protein 
METTL3 Isoform 1 of N6-adenosine-methyltransferase 70 kDa subunlt 
MRPLl mitochondrial ribosomal protein Ll precursor 
MRPL19 395 ribosomal protein L19, mitochondrial precursor 
MRPL2 395 ribosomal protein L2, mitochondrial precursor 
MRPL28 395 ribosomal protein L28, mitochondrial precursor 
MRPL39 Isoform 2 of Mitochondrial 395 ribosomal protein L39 
MRPL4 Isoform 1 of Mitochondrial 39S ribosomal protein l4 
MRPL44 395 ribosomal protein L44, mitochondrial precursor 
MRPl9 Mitochondrial ribosomal protein L9 
MRP522 Mitochondrial 285 ribosomal protein 522 
MRP534 Mitochondrial 285 ribosomal protein 534 
NCL CDNA FU45706 fis, clone FEBRA2028457, highly similar to Nucleolin 
NPM11soform Z of Nucleophosmln 
NRAP Isoform 2 of Nebulin-related-anchoring protein 
PABPC11soform 1 of Polyadenylate-binding protein 1 
PABPCll Polyadenylate-blnding protein l-Iike 
PABPC4 Isoform 2 of Polyadenylate-binding protein 4 
PACSIN3 Protein kinase C and casein kinase substrate in neurons protein 3 
PRSS3 Isoform A of Trypsin-3 precursor 
PSMC5 265 protease regulatory subunit 8 
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PSMC5 26S protease regulatory subunit 8 
RBJ Rab-related GTP-binding protein RabJ 
RBM34 RNA-binding protein 34 
RPL10A 25 kDa protein 
RPL13 60S ribosomal protein L13 
RPL13A 60S ribosomal protein L13a 
RPL14 RPL14 protein 
RPL15 60S ribosomal protein L15 
RPL17 605 ribosomal protein L17 
RPL18 60S ribosomal protein L18 
RPL18A 60S ribosomal protein U8a 
RPL19 60S ribosomal protein L19 
RPL3 60S ribosomal protein L3 
RPL35 60S ribosomal protein L35 
RPL4 60S ribosomal protein L4 
RPLS 60S ribosomal protein LS 
RPL6 60S ribosomal protein L6 
RPL7 60S ribosomal protein L7 
RPL7A 60S ribosomal protein L7a 
RPL8 60S ribosomal protein L8 
RPL9 60S ribosomal protein L9 
RPLPO 60S acidic ribosomal protein PO 
RPS2 40S ribosomal protein S2 
RPS3 40S ribosomal protein S3 
RP53A 405 ribosomal protein 53a 
RPS4X 40S ribosomal protein 54, X Isoform 
RPSS 405 ribosomal protein 55 
RPS6 405 ribosomal protein S6 
RPS7 40S ribosomal protein 57 
RPS8 40S ribosomal protein S8 
RSL1Dl Ribosomal Ll domain-containing protein 1 
SERBPl Isoform 4 of Plasminogen activator inhibitor 1 RNA-binding protein 
SLC2SA13 Mitochondrial aspartate-glutamate carrier protein 
SLC2SA5 ADP/ATP translocase 2 
SMC6 Isoform 1 of Structural maintenance of chromosomes protein 6 
SRP68 Isoform 2 of Signal recognition particle 68 kDa protein 
SSB Lupus La protein 
SYNCRIP Isoform 1 of Heterogeneous nuclear ribonucleoprotein Q 
THAPl THAP domain-containing protein 1 
TMEM63C Transmembrane protein 63C 
TROVE2 Isoform Long of 60 kDa SS-A/Ro ribonucleoprotein 
TIBK2 Tau-tubulin kinase 
TIN 2268 kDa protein 
TUBAlA Tubulin alpha-lA chain 
TUBA1B Tubulin alpha-1S chain 
TUBS Tubulin beta chain 
TUSS2C Tubulin beta-2C chain 
TUBBl Tubulin beta-3 chain 
TUBGCP6 TUBGCP6 protein 
VBXl Nuclease sensitive element-binding protein 1 
ZBTS33 Transcriptional regulator Kaiso 
ZNF571 HERV-T_19q13.11 provirus ancestral Env polyprotein precursor 
7.1.4 Top-14x Affinity Purification: Mass Spectrometry Results 
(Serum Starved & Re-fed) 
Anti-colorectal carcinoma heavy chain 
Kappa light chain variable region (Fragment) 
Myosin-reactive immunoglobulin light chain variable region (Fragment) 
RcNSEP1 (Fragment) 
DAP3 Mitochondrial 28S ribosomal protein S29 
DNAJA1 DnaJ homolog subfamily A member 1 
EEF1A2 Elongation factor 1-alpha 2 
ERAl11soform HERA-A of GTP-binding protein era homolog 
GRIA3 Isoform Flip of Glutamate receptor 3 precursor 
hCG_2033311 Uncharacterized protein ENSPOOOO0375173 
hCG_21078 hypothetical protein lOC389435 
HNRNPA2B11soform B1 of Heterogeneous nuclear ribonucleoproteins A2/B1 
HNRNPC Isoform Cl of Heterogeneous nuclear ribonucleoproteins Cl/C2 
HNRPAB Isoform 2 of Heterogeneous nuclear ribonucleoprotein AlB 
HNRPCL1 Heterogeneous nuclear ribonucleoprotein C-like 1 
HNRPD Isoform 1 of Heterogeneous nuclear ribonucleoprotein DO 
ILF2 Interleukln enhancer-binding factor 2 
KRTl Keratin, type 11 cytoskeletall 
KRTlO Keratin, type I cytoskeletal10 
KRT12 Keratin, type I cytoskeletal 12 
KRT13 Isoform 1 of Keratin, type I cytoskeletal13 
KRT16 Keratin, type I cytoskeletal16 
KRT2 Keratin, type 11 cytoskeletal 2 epidermal 
KRT4 keratin 4 
KRT77 Keratin 77 
KRT9 Keratin, type I cytoskeletal 9 
lOC440577 similar to nucleophosmin 1 isoform 1 
MRPl37 39S ribosomal protein l37, mitochondrial precursor 
MRPl38 39S ribosomal protein L38, mitochondrial precursor 
MRP139 Isoform 2 of Mitochondrial 39S ribosomal protein l39 
MRPS22 Mitochondrial 28S ribosomal protein S22 
MRPS27 Mitochondrial 28S ribosomal protein S27 
MRP527 Mitochondrial 285 ribosomal protein 527 
MRPS3128S ribosomal protein S31, mitochondrial precursor 
MRPS9 mitochondrial ribosomal protein S9 
NPM11soform 2 of Nucleophosmln 
PA2G4 Proliferation-associated protein ZG4 
PCBP2 poly(rC)-blnding protein 21soform b 
PRS53 Isoform A ofTrypsin-3 precursor 
RBMX Heterogeneous nuclear ribonucleoprotein G 
RPl22 60S ribosomal protein l22 
RPl23 60S ribosomal protein l23 
RPl27 60S ribosomal protein l27 
RPL3 60S ribosomal protein l3 
RPL30 60S ribosomal protein l30 
RPl3160S ribosomal protein l31 
RPl35 60S ribosomal protein L35 
RPL3SA 60S ribosomal protein l35a 
RPl3L 60S ribosomal protein l3-like 
RPl49 kDa protein 
RPl6 60S ribosomal protein l6 
RPlPO 60S acidic ribosomal protein PO 
RPlP1 60S acidic ribosomal protein P1 
RPlP2 60S acidic ribosomal protein P2 
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RPS10 40S ribosomal protein S10 
RPS13 40S ribosomal protein 513 
RP514405 ribosomal protein 514 
RP51SA 405 ribosomal protein 515a 
RP516405 ribosomal protein 516 
RP517 405 ribosomal protein 517 
RP518 40S ribosomal protein 518 
RP519 405 ribosomal protein 519 
RPS2 405 ribosomal protein 52 
RPS20 40S ribosomal protein 520 
RP523 40S ribosomal protein 523 
RPS25 40S ribosomal protein S2S 
RP5260TTHUMPOOOOO018641 
RPS8 405 ribosomal protein 58 
RP5A Ribosomal protein 5A 
RPSAP1S Laminin receptor-like protein LAMRLS 
5FR5S Isoform 5RP40-1 of 5plicing factor, arginine/serine-rich 5 
SSB Lupus La protein 
UBC;UBB;RP527A ubiquitin and ribosomal protein 527a precursor 
U5P20 Ubiquitin carboxyl-terminal hydrolase 20 
VBX1 Nuclease sensitive element-binding protein 1 
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Rank Ordered List of MicroRNAs Most Differentially Associated with TOP-I·h mRNA 
Rank Name Gene Index P.value 
1 miRPlus_17960 
2 hsa-miR-197 
3 miRPlus_17820 
4 hsa-miR-200a 
5 hsa-miR-9 
6 hsa-miR-154· 
7 hsa-miR-335 
8 miRPlus_17863 
9 hsa-miR-583 
10 miRPlus_17880 
11 hsa-miR-642 
12 miRPlus_17953 
13 hsa-miR-625 
14 hsa-miR-585 
15 miRPlus_17928 
16 hsa-miR-365 
17 hsa-miR-51ge· 
18 hsa-miR-454 
19 hsa-miR-148a 
20 miRPlus_17932 
21 hsa-miR-409-5p 
22 hsa-miR-453 
23 hsa-miR-616· 
24 miRPlus_17848 
25 hsa-miR-30c 
26 hsa-miR-657 
237 
741 
665 
65 
84 
654 
274 
507 
655 
71 
72 
239 
342 
223 
671 
220 
656 
238 
781 
70 
117 
57 
564 
285 
544 
234 
27 miRPlus_17875 22 
28 hsa-miR-205 692 
29 miRPlus_17952 1689 
30 hsa-miR-130a 114 
31 miRPlus_17910 292 
32 hsa-let-7a 1686 
33 hsa-miR-195 308 
34 hsa-miR-181b 173 
35 hsa-miR-137 66 
36 hsa-miR-154 870 
37 hsa_negative_control_l 1258 
38 hsa-miR-486-5p 441 
39 hsa-miR-617 348 
40 miRPlus_17950 934 
41 hsa-miR-325 64 
42 hsa-miR-326 1570 
43 hsa-miR-148a 660 
44 hsa-miR-92b 1475 
45 hsa-miR-641 288 
46 miRPlus_17946 1097 
47 hsa-miR-517c 494 
48 miRPlus_17927 886 
49 U6-snRNA-2 1416 
50 hsa-miR-51ge 872 
51 hsa-miR-18a 1375 
52 hsa-miR-S77 271 
S3 hsa-miR-151-Sp 630 
54 5pike_control..J 421 
SS hsa-miR-371-3p 1634 
56 hsa-miR-I0b 768 
57 hsa-miR-503 1676 
58 hsa-miR-219-5p 653 
59 hsa-miR-518d-5p/518f· IS 272 
60 hsa-miR-578 SS 
9.00E-04 
0.0032 
0.0049 
0.0067 
0.0072 
0.0084 
0.009 
0.0095 
0.0142 
0.0148 
0.0188 
0.0194 
0.02 
0.0205 
0.0211 
0.0234 
0.0275 
0.0286 
0.0292 
0.031 
0.0333 
0.0339 
0.0356 
0.0373 
0.0379 
0.0391 
0.0396 
0.0408 
0.0414 
0.0448 
0.0454 
0.0466 
0.0489 
0.0501 
0.0506 
0.0518 
0.053 
0.0547 
0.0553 
0.0611 
0.0628 
0.0663 
0.068 
0.0686 
0.0697 
0.0709 
0.0715 
0.0732 
0.0738 
0.0749 
0.0755 
0.0761 
0.0767 
0.0773 
0.0778 
0.0784 
0.0796 
0.0807 
0.0819 
0.0836 
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Rank Name 
61 hsa_SNORD14B 
62 hsa-miR-424 
63 hsa-miR-34b· 
64 hsa-miR-492 
65 hsa-miR-552 
66 hsa-miR-331-3p 
67 hsa-miR-451 
68 hsa-miR-634 
69 miRPlus_17870 
70 hsa-miR-454 
71 hsa-miR-342-3p 
72 hsa-miR-484 
73 hsa-miR-29a 
74 hsa-miR-151-3p 
75 hsa-miR-92a 
76 miRPlus_17840 
77 hsa-miR-206 
78 hsa-miR-20a 
79 miRPlus_17942 
80 miRPlus_17864 
81 hsa-miR-524-3p/525-3p 
82 hsa-miR-665 
83 miRPlus_17893 
84 hsa-miR-19b-l· 
85 hsa-miR-429 
86 hsa-miR-181a 
87 hsa-miR-574-3p 
88 hsa-miR-147 
89 hsa-miR-651 
90 hsa-miR-221. 
91 hsa-miR-129-5p 
92 hsa-miR-493 
93 hsa-miR-519d 
94 hsa-miR-302c 
95 hsa-miR-192 
96 hsa-miR-626 
97 hsa-miR-487b 
98 hsa-miR-21 
99 hsa-let-7b 
100 hsa-miR-560 
101 hsa-miR-448 
102 miRPlus_17892 
103 hsa-miR-489 
104 hsa-miR-409-3p 
105 hsa-miR-612 
106 miRPlus_17925 
107 hsa-miR-606 
108 miRPlus_17845 
109 miRPlus_17923 
110 hsa-miR-520e 
111 hsa-let-7i 
112 hsa-miR-132 
113 miRPlus_17872 
114 hsa-miR-99a 
115 hsa-miR-33D-3p 
116 hsa-miR-29c· 
117 hsa-miR-142-5p 
118 miRPlus_17904 
119 hsa-miR-32 
120 hsa-miR-15a 
Gene Index 
110 
722 
1516 
651 
547 
490 
705 
78 
561 
204 
658 
1089 
166 
1518 
1691 
291 
1523 
281 
1157 
1479 
1681 
235 
1150 
295 
1143 
1037 
1045 
876 
1530 
156 
330 
219 
1088 
118 
335 
126 
9 
875 
1470 
541 
63 
718 
1299 
333 
1428 
455 
1044 
1421 
880 
866 
174 
1362 
503 
395 
74 
994 
492 
23 
1144 
146 
Rank Name Gene Index P.value Rank Name Gene Index P.value 
121 miRPlus_17924 615 0.1571 181 hsa-miR-769-3p 1581 0.2497 
122 hsa-miR-574-3p 1477 0.1577 182 miRPlus_17849 393 0.2503 
123 hsa-miR-199b-5p 1145 0.1618 183 miRPlus_17916 21 0.2509 
124 hsa-mi R-548b-3p 379 0.1623 184 hsa_SNORD6 596 0.252 
125 hsa-miR-143 276 0.1629 185 hsa-miR-17* 824 0.2543 
126 hsa-miR-596 1482 0.1635 186 hsa-miR-18a 1253 0.2555 
127 hsa_negative_control_: 1042 0.1641 187 hsa-miR-628-3p 1374 0.2567 
128 hsa-miR-g* 890 0.1681 188 hsa-miR-202 1327 0.2584 
129 hsa-miR-518a-5p/527 62 0.171 189 miRPlus_17947 664 0.2601 
130 hsa-miR-25 388 0.1733 190 hsa-miR-20a 497 0.2613 
131 hsa-miR-95 1043 0.1745 191 hsa-mi R-148b 444 0.2619 
132 hsa-miR-19b 713 0.1756 192 hsa-miR-490-3p 1083 0.2648 
133 hsa-miR-569 277 0.1768 193 miRPlus_17935 773 0.2659 
134 hsa-miR-591 649 0.1797 194 hsa-miR-297 775 0.2671 
135. hsa-miR-605 1260 0.1837 195 hsa-miR-649 240 0.2705 
136 hsa-miR-153 349 0.1866 196 miRPlus_17957 1480 0.2746 
137 hsa-miR-299-5p 598 0.1889 197 hsa-miR-520b/520c-3p 8 0.2763 
138 hsa-miR-24-1* 1505 0.1913 198 miRPlus_17926 669 0.2769 
139 hsa-miR-581 1087 0.193 199 miRPlus_17819 454 0.2775 
140 hsa-miR-328 1354 0.1936 200 hsa-miR-542-5p 1459 0.2798 141 hsa-miR-126 245 0.1942 201 hsa-miR-671-5p 1419 0.281 142 hsa-miR-517a/517b 710 0.1947 202 miRPlus_17874 1365 0.2815 143 hsa-miR-135b 355 0.1953 203 hsa-miR-139-5p 139 0.2833 144 hsa-miR-129* /129-3p 725 0.1959 204 hsa-miR-19a 929 0.2844 145 hsa-miR-488 1255 0.1965 205 hsa-miR-518c 1352 0.2856 146 miRPlus_17903 933 0.197 206 hsa-miR-7-1* 1473 0.2891 147 hsa-miR-149 228 0.1976 207 miRPlus_17869 1211 0.2914 148 hsa-miR-15a 1721 0.1982 208 hsa-mi R-485-5p 657 0.292 149 miRPlus_17917 177 0.1994 209 hsa-miR-92b 26 0.2925 150 miRPlus_17871 1534 0.2005 210 hsa-miR-505 391 0.2931 151 hsa-miR-574-3p 919 0.2023 211 hsa-miR-598 1050 0.2972 152 hsa-miR-215 44 0.204 212 hsa-miR-20b 1091 0.2983 153 hsa-miR-621 1206 0.2046 213 hsa-miR-506 1628 0.3006 154 hsa-miR-93 1259 0.2069 214 hsa_SNORD15A 164 0.3012 155 hsa-miR-564 1357 0.2086 215 miRPlus_17852 1311 0.3018 
156 hsa-miR-7 1278 0.2092 216 hsa-miR-449a 1569 0.3041 157 hsa-miR-27a 1506 0.2098 217 hsa-miR-9* 1501 0.307 
158 hsa-miR-205 59 0.2109 218 miRPlus_17876 941 0.3087 
159 hsa-miR-432* 495 0.2115 219 hsa-miR-521 434 0.3093 
160 hsa-miR-632 510 0.2133 220 hsa-miR-18b 1199 0.3099 
161 hsa-miR-373 387 0.2185 221 hsa-let-7c 1254 0.3105 
162 hsa-miR-643 1536 0.219 222 miRPlus_17843 1474 0.3122 
163 hsa-miR-137 530 0.2208 223 hsa-miR-519c-5p 1082 0.3134 
164 miRPlus_17885 69 0.2219 224 hsa-miR-210 659 0.3151 
165 hsa-miR-140-5p 1140 0.2266 225 miRPlus_17941 1529 0.3157 
166 hsa-miR-220 221 0.2289 226 hsa-miR-561 325 0.3168 
167 hsa-miR-556-5p 1405 0.2295 227 hsa-miR-17* 1469 0.3186 
168 hsa-miR-296-5p 814 0.23 228 hsa-miR-192 1208 0.3192 
169 hsa-miR-200a* 1571 0.2306 229 miRPlus_17813 347 0.3215 
170 hsa-miR-222 1684 0.237 230 hsa-miR-633 294 0.3238 
171 hsa-miR-30a 976 0.2405 231 hsa-miR-512-5p 116 0.3244 
172 miRPlus_17821 1257 0.2428 232 hsa-miR-380 1629 0.3261 
173 hsa-let-7f 606 0.2433 233 hsa-miR-575 703 0.3273 
174 hsa-miR-599 834 0.2439 234 miRPlus_17907 448 0.329 
175 hsa-miR-192 119 0.2445 235 hsa-miR-624* 558 0.3302 
176 hsa-miR-301b 642 0.2451 236 hsa-miR-647 672 0.3307 
177 hsa-miR-191* 551 0.2457 237 miRPlus_17823 609 0.3325 
178 hsa-miR-27b 458 0.2462 238 hsa-miR-545 811 0.333 
179 miRPlus_17920 1312 0.2486 239 hsa-miR-496 1466 0.3348 
180 miRPlus_17859 17 0.2491 240 hsa-miR-196b 727 0.3354 
256 
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241 hsa-miR-500· /502-3p 602 0.3377 301 hsa-miR-208 1307 0.4054 
242 hsa-miR-55B 973 0.3382 302 hsa-miR-l0S 816 0.4077 
243 hsa-miR-562 109 0.3388 303 hsa-miR-145 1524 0.41 
244 hsa-miR-198 113 0.34 304 hsa-mi R-12Sb 187 0.4106 
245 hsa-miR-302d 1408 0.3406 305 hsa-miR-410 1623 0.4112 
246 hsa-miR-150 565 0.3423 306 hsa-miR-638 936 0.4141 
247 hsa-miR-512-3p 332 0.3435 307 miRPlus_17853 130 0.4146 
248 hsa-miR-30a* 1192 0.344 308 hsa-miR-96* 791 0.4193 
249 hsa-miR-S14 1406 0.3458 309 hsa-miR-146a 1213 0.4204 
250 hsa-miR-137 1472 0.3463 310 hsa-miR-S20g/520h 650 0.4222 
251 hsa-miR-520a-3p 440 0.3469 311 hsa-miR-187 383 0.4233 
252 hsa-miR-127-3p 978 0.3475 312 miRPlus_17958 232 0.4285 
253 miRPlus_17879 1426 0.3516 313 hsa-mi R-425· 1575 0.4291 
254 hsa-miR-S67 709 0.3533 314 hsa-miR-33a 470 0.4308 
255 hsa-miR-511 548 0.3539 315 miRPlus_17841 1096 0.4314 
256 miRPlus_17883 233 0.3573 316 hsa-miR-553 331 0.4332 257 hsa-miR-185 815 0.3585 317 hsa-miR-620 1422 0.4349 258 hsa-miR-27b 1246 0.3591 318 hsa-miR-630 942 0.4355 259 miRPlus_17898 1095 0.3597 319 hsa-miR-199a-5p 1571 0.4378 260 miRPlus_17911 1535 0.3602 320 hsa-miR-183 1247 0.4389 261 hsa-miR-155 438 0.3614 321 spike_control_b 847 0.4395 262 hsa-miR-346 226 0.362 322 hsa-miR-549 1411 0.4401 263 hsa-miR-30d 328 0.3626 323 hsa-miR-338-3p 1522 0.4407 264 hsa_SNORD118 974 0.3631 324 hsa-miR-645 1104 0.4416 265 hsa-miR-I06b 384 0.3637 325 hsa-miR-37S 1461 0.4442 266 hsa-miR-501-5p 386 0.3666 326 hsa-miR-302c* 1154 0.4447 267 hsa-miR-507 1412 0.3672 327 hsa-miR-148a 258 0.4482 268 hsa-miR-656 450 0.3689 328 hsa-miR-146a 1715 0.4499 269 hsa-miR-636 1368 0.3695 329 hsa-miR-374b 286 0.4517 270 hsa-miR-568 493 0.3704 330 hsa-miR-650 24 0.4523 271 miRPlus_17347 1587 0.3712 331 hsa-miR-379 165 0.4528 272 hsa-miR-548c-3p 163 0.3718 332 hsa-miR-297 554 0.4546 273 hsa-miR-182* 1463 0.373 333 hsa-miR-30e* 112 0.4551 
274 hsa-miR-215 1517 0.3736 334 miRPlus_17842 1367 0.4557 
275 miRPlus_17866 1372 0.3747 335 hsa-miR-141 924 0.4563 
276 miRPlus_17936 1103 0.3759 336 miRPlus_17918 1690 0.458 
217 miRPlus_17944 940 0.3764 337 hsa_SNORDI0 326 0.4586 
278 hsa-miR-133a/133b 1146 0.3782 338 hsa-miR-30e 1576 0.4621 
279 hsa-miR-33a 423 0.3793 339 hsa-miR-369-3p 1467 0.4661 
280 hsa-miR-125b 1626 0.3805 340 miRPlus_17854 1589 0.4667 
281 hsa-miR-198 527 0.3811 341 hsa-miR-107 168 0.4679 
282 hsa-miR-639 720 0.3834 342 hsa-miR-888* 1596 0.4696 
283 hsa-miR-613 1212 0.384 343 miRPlus_17851 1696 0.4725 
284 hsa-miR-15a 222 0.3869 344 hsa-miR-519b-3p 1520 0.4742 
285 hsa-miR-644 1320 0.388 345 hsa-miR-214 11 0.4748 
286 hsa-miR-362-5p 868 0.3886 346 hsa-miR-631 726 0.476 
287 hsa-miR-515-5p 1574 0.3892 347 hsa-mi R-548d-3p 1627 0.4171 
288 miRPlus_17838 718 0.3903 348 miRPlus_17894 1528 0.4783 
289 miRPlus_17913 1205 0.3909 349 hsa-miR-58O 1303 0.4789 
290 hsa-miR-9* 371 0.3915 350 hsa-miR-211 443 0.48 
291 hsa-miR-32S 506 0.3932 351 hsa-miR-629* 1158 0.4824 
292 hsa-miR-138 1572 0.3938 352 miRPlus_17830 1209 0.4858 
293 hsa-miR-302c* 1624 0.395 353 hsa-miR-485-3p 873 0.4887 
294 hsa-miR-193a-3p 1625 0.3979 354 hsa-miR-654-5p 882 0.4899 
295 hsa-miR-497 1250 0.3984 355 hsa-miR-106a/17 600 0.4905 
296 miRPlus_17811 125 0.399 356 hsa-miR-218 869 0.4939 
297 hsa-miR-520d-3p 1298 0.4013 357 hsa-miR-450a 921 0.4945 
298 hsa-miR-325 1178 0.4031 358 hsa-miR-587 1513 0.4968 
299 hsa-miR-590-5p 865 0.4036 359 hsa-miR-302c 1451 0.4986 
300 hsa-miR-4SOb-5p 878 0.4042 360 hsa-miR-544 1243 0.4991 
257 
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361 hsa-miR-518b 1568 0.4997 421 hsa-miR-223 1468 0.5923 
362 hsa-miR-34c-5p 1300 0.5009 422 hsa-miR-519c-3p 1304 0.594 
363 hsa-miR-421 975 0.502 423 hsa-miR-495 1682 0.5958 
364 hsa-miR-607 828 0.5032 424 hsa-miR-518c· 1136 0.5987 
365 hsa-miR-380 884 0.5061 425 hsa-miR-516a-3p/516b' 1358 0.6004 
366 miRPlus_17889 719 0.5072 426 hsa-miR-380· 1413 0.6016 
367 hsa-miR-378 543 0.5095 427 miRPlus_17834 779 0.605 
368 hsa-let-7g 390 0.5107 428 hsa-miR-200b 1355 0.6073 
369 hsa-miR-526b* 817 0.513 429 hsa-miR-660 1481 0.6079 
370 hsa-miR-370 1035 0.5136 430 hsa-miR-339-5p 1306 0.6091 
371 hsa-miR-302a 982 0.5148 431 miRPlus_17833 1425 0.6097 
372 hsa-miR-10a 984 0.5171 432 hsa-miR-196b 545 0.6108 
373 hsa-miR-615-3p 780 0.5182 433 hsa-miR-101 1267 0.6114 
374 hsa-mi R-24-2· 1340 0.5188 434 hsa-miR-212 227 0.612 
375 hsa-miR-424* 938 0.52 435 miRPlus_17822 1102 0.6131 
376 hsa-miR-1 1062 0.5205 436 mi RPlus_17411 777 0.6155 
377 miRPlus_17921 1641 0.5211 437 miRPlus_17855 616 0.6172 
378 hsa-miR-640 504 0.5234 438 hsa-miR-637 1152 0.6178 
379 hsa-miR-412 1191 0.5281 439 hsa-miR-7 617 0.6189 
380 hsa-miR-487a 225 0.5292 440 miRPlus_17836 346 0.6195 
381 hsa-miR-595 1698 0.5304 441 hsa-miR-196b 1124 0.6207 
382 hsa-miR-652 1314 0.531 442 hsa-miR-433 279 0.6212 
383 hsa-miR-376c 1683 0.5344 443 hsa-miR-619 1638 0.6224 384 hsa-miR-345 442 0.535 444 hsa-miR-19a 79 0.623 385 hsa-miR-603 1692 0.5367 445 miRPlus_17895 1588 0.6236 386 hsa-miR-202* 908 0.5379 446 hsa-miR-329 1138 0.6241 387 hsa-miR-193b 1409 0.5385 447 hsa-miR-22* 400 0.6253 388 hsa-miR-151-3p 1256 0.5391 448 hsa-miR-204 275 0.6288 389 miRPlus_17884 508 0.5396 449 hsa-miR-182 1679 0.6293 390 miRPlus_17914 1635 0.5408 450 hsa-miR-611 1644 0.6305 391 hsa_SNORD2 542 0.5425 451 miRPlus_17934 1366 0.6311 392 hsa-miR-573 1135 0.5431 452 miRPlus_17808 293 0.6322 393 hsa-miR-432 711 0.5443 453 hsa-miR-422a 759 0.6334 394 hsa-miR-23b 820 0.5448 454 hsa-miR-99b 179 0.6351 395 hsa-miR-204 1424 0.5454 455 hsa-miR-142-Sp 1645 0.6357 396 miRPlus_17949 1313 0.546 456 hsa_SNORD4A 812 0.6369 397 hsa-miR-423-3p 327 0.5466 457 hsa-miR-374a 1677 0.638 398 hsa-miR-589* 1081 0.5486 458 hsa-miR-20a 31 0.6386 
399 hsa-miR-135a 714 0.5495 459 hsa-miR-216b 889 0.6415 
400 hsa-miR-194 1193 0.5501 460 hsa-miR-31 1538 0.6421 
401 hsa-miR-489 576 0.5512 461 hsa-miR-26a 172 0.6438 
402 hsa-miR-29b 1630 0.5518 462 hsa-miR-199a-5p 608 0.6467 
403 hsa-miR-510 764 0.5547 463 hsa-miR-659 1697 0.6473 
404 hsa-miR-565 1141 0.5558 464 hsa-miR-135b 571 0.649 
405 miRPlus_17837 449 0.557 465 miRPlus_17888 995 0.6502 
406 hsa-miR-708 1610 0.5628 466 hsa-miR-183 1214 0.6508 
407 miRPlus_17922 1582 0.5634 467 hsa-miR-635 1584 0.6513 
408 hsa-miR-431 927 0.5639 468 miRPlus_17905 1427 0.6531 
409 hsa-miR-493* 435 0.568 469 miRPlus_17930 1041 0.6542 
410 hsa-miR-16 1685 0.5697 470 hsa-miR-516b 1142 0.6548 
411 hsa-mi R-126 * 1194 0.5709 471 miRPlus_17931 16 0.6565 
412 hsa-miR-26a 1678 0.572 472 hsa-miR-135b 498 0.6589 
413 miRPlus_17873 75 0.5726 473 miRPlus_17814 123 0.66 
414 hsa-miR-655 666 0.5807 474 hsa-miR-520a-5p 224 0.6606 
415 hsa-miR-614 996 0.5813 475 miRPlus_17902 1319 0.6612 
416 hsa-miR-124 336 0.5825 476 hsa-miR-134 930 0.6617 
417 hsa-miR.31 1108 0.5848 477 miRPlus_17827 1264 0.6635 
418 hsa-miR-377 597 0.5871 478 hsa-miR-518e 704 0.6641 
419 hsa-miR-195 1165 0.5883 479 hsa-miR-33a 922 0.6646 
420 hsa-miR-16 1236 0.5894 480 hsa-miR-139-5p 1356 0.6664 
258 
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481 miRPlus_17847 1047 0.6675 541 hsa-miR-563 1573 0.7555 
482 miRP'us_17899 129 0.6704 542 hsa-miR-523 2 0.7561 
483 hsa-miR-122 552 0.671 543 miRPlus_17878 881 0.7567 
484 hsa-miR-27a 1462 0.6745 544 hsa-miR-195 977 0.7578 
485 hsa-miR-572 1351 0.6751 545 hsa-miR-30e* 686 0.7613 
486 miRPlus_17919 1527 0.6768 546 hsa-miR-559 757 0.7619 
487 hsa-miR-302b 550 0.6803 547 hsa-let-7d 1038 0.763 
488 miRPlus_17862 1151 0.6808 548 hsa-miR-27b 1074 0.7636 
489 hsa-miR-SS7 1189 0.6814 549 hsa-miR-627 1590 0.7648 
490 hsa-miR-361-Sp 1084 0.682 550 hsa-miR-I0b 1281 0.7682 
491 hsa-miR-543 825 0.6826 551 hsa-miR-504 1460 0.7688 
492 hsa-mi R-132 * 1219 0.6837 552 hsa-miR-623 774 0.7694 
493 hsa-miR-449a 1235 0.6843 553 hsa-miR-301a 635 0.7105 
494 hsa-miR-455-5p 1521 0.6872 554 hsa-miR-532-5p 385 0.7111 
495 hsa-miR-181a* 821 0.6901 555 hsa-mi R-542-3p 1675 0.7729 
496 hsa-miR-181b 605 0.6947 556 hsa-miR-lOO 1464 0.774 
497 miRPlus_17860 670 0.6953 557 hsa-miR-l 1680 0.7163 
498 hsa-miR-153 1086 0.6965 558 hsa-miR-571 1567 0.7186 
499 hsa-miR-190 983 0.697 559 miRPlus_17826 935 0.7792 
500 hsa-miR-302b· 1370 0.6976 560 miRPlus_17857 989 0.7798 
501 hsa-miR-30b 760 0.6982 561 hsa-miR-515-3p 1190 0.7804 
502 hsa-miR-586 7 0.6988 562 hsa-miR-297 1704 0.7821 
503 hsa-miR-449b 1353 0.6999 563 hsa-miR-24-1* /24-2· 1631 0.7833 
504 miRPlus_17891 131 0.7017 564 miRPlus_17653 71 0.7879 
505 hsa-miR-508-3p 1196 0.7023 565 hsa-miR-20a* 414 0.7885 
506 miRPlus_17858 723 0.708 566 hsa-miR-662 1049 0.7891 507 miRPlus_17831 1533 0.7086 567 hsa-miR-31 1716 0.7902 508 hsa-miR-367 4 0.7092 568 hsa-miR-554 115 0.7937 509 hsa-miR-324-5p 280 0.7115 569 hsa-miR-499-Sp 803 0.7943 510 hsa-miR-18a* 1415 0.7121 570 miRPlus_17954 987 0.7948 511 hsa-miR-425 1359 0.7127 571 hsa-miR-369-5p 1251 0.796 512 miRPlus_17961 399 0.7144 572 hsa-miR-483-3p 1305 0.7983 513 hsa-miR-202* 1111 0.7161 573 hsa-miR-301a 1198 0.7995 514 hsa-miR-196a 761 0.7167 574 hsa-miR-34b· 1648 0.8001 515 hsa-miR-592 433 0.7179 575 hsa-miR-33b 1090 0.8041 
516 hsa-miR-31 1360 0.7185 576 U6-snRNA-1 1632 0.8064 
517 hsa-miR-202 176 0.7208 577 hsa-miR-610 180 0.807 
518 hsa-miR-363 652 0.7266 578 hsa-miR-345 1148 0.8076 
519 hsa-miR-411 1407 0.7271 579 miRPlus_17868 555 0.8082 
520 miRPlus_17890 345 0.73 580 hsa-let-7d· 563 0.8087 
521 hsa-miR-551b 763 0.7306 581 miRPlus_17906 124 0.8093 
522 hsa-m i R-199a-3p/199b· 1361 0.7318 582 hsa-miR-488* 1515 0.8105 
523 hsa-miR-376a 1245 0.7323 583 hsa-miR-29a 1118 0.8111 
524 hsa-miR-505 1244 0.7329 584 miRPlus_17908 509 0.8116 
525 miRP'us_17929 1156 0.7335 585 hsa-miR-I0b* 403 0.8128 
526 hsa-miR-155 1040 0.7341 586 hsa-miR-299-3p 382 0.8163 
527 hsa-miR-593· 217 0.7376 587 hsa-miR-566 925 0.8168 
528 hsa-miR-489 1014 0.7381 588 hsa-miR-555 1621 0.818 
529 hsa-miR-133a 787 0.741 589 hsa_SNORD13 1028 0.8197 
530 hsa-miR-142-3p 708 0.7433 590 miRPlus_17940 1642 0.8209 
531 hsa-miR-499-5p 818 0.7445 591 miRPlus_17829 1637 0.8215 
532 hsa-miR-22 437 0.7457 592 hsa-miR-2ooc 1139 0.822 
533 hsa-miR-381 1586 0.7462 593 hsa-miR-381 1197 0.8267 
534 hsa-miR-193a-3p 1499 0.7468 594 hsa_SNORD3 758 0.829 
535 miRPlus_17938 76 0.748 595 hsa-miR-584 439 0.8313 
536 hsa-miR-146a 1308 0.7497 596 hsa-miR-517· 926 0.833 
537 miRPlus_1781S 1420 0.7509 597 hsa-miR-23a 1036 0.8342 
538 hsa-miR-373· 171 0.7514 598 hsa-miR-130a 1494 0.8354 
539 hsa-miR-34a 10 0.752 599 hsa-let-7e 822 0.8377 
S40 hsa-miR-98 611 0.7526 600 hsa-miR-522· 601 0.8388 
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601 hsa-miR-582-5p 871 0.8411 661 hsa-miR-203 491 0.9158 
602 hsa-miR-9 401 0.8417 662 miRPlus_17882 1048 0.917 
603 miRPlus_17897 339 0.8423 663 hsa-miR-618 132 0.9175 
604 miRPlus_17818 394 0.844 664 hsa-miR-103 1032 0.9181 
605 hsa-miR-216a 1301 0.8446 665 hsa-miR-622 990 0.9193 
606 miRPlus_17887 183 0.8452 666 miRPlus_17812 887 0.9222 
607 hsa-miR-601 402 0.8458 667 hsa-miR-646 888 0.9239 
608 hsa-miR-9 1542 0.8492 668 hsa-miR-126 1410 0.9256 
609 hsa-miR-29c 1414 0.8504 669 miRPlus_17824 1263 0.928 
610 hsa-miR-9· 185 0.8545 670 hsa-miR-31 836 0.9291 
611 miRPlus_17861 1149 0.855 671 hsa-miR-96· 1447 0.9303 
612 miRPlus_17943 1155 0.8556 672 hsa-miR-382 981 0.9326 
613 spike_control_d 637 0.8562 673 hsa-miR-367 254 0.9337 
614 hsa-miR-320 928 0.8568 674 hsa-miR-539 169 0.9349 
615 hsa-miR-525-5p 1249 0.8573 675 miRPlus_17896 832 0.9355 
616 hsa-miR-518a-3p 278 0.8602 676 hsa_SNORD12 380 0.9395 
617 miRPlus_179oo 771 0.8614 677 hsa-miR-494 3 0.9407 
618 hsa-miR-609 396 0.8631 678 hsa-miR-384 549 0.9418 
619 miRPlus_17850 1101 0.8637 679 hsa-miR-383 668 0.9436 
620 hsa-miR-637 1418 0.8643 680 hsa-miR-15b 6 0.9453 
621 hsa-miR-217 1085 0.8649 681 hsa-miR-191 767 0.947 
622 hsa-miR-450b-3p 662 0.8678 682 miRPlus_17865 717 0.9488 
623 hsa-miR-509-3p 980 0.8695 683 miRPlus_17856 453 0.9494 
624 hsa-miR-146b-5p 1092 0.8701 684 miRPlus_17937 885 0.9534 625 hsa-miR-136 282 0.8712 685 miRPlus_17951 1371 0.954 626 hsa-miR-302a 98 0.8718 686 hsa-miR-181c 389 0.9552 627 hsa-miR-602 186 0.8724 687 miRPlus_17828 184 0.9563 628 hsa-miR-491-5p 867 0.8736 688 hsa-miR-424 111 0.958 629 hsa-miR-524-5p 1465 0.8747 689 miRPlus_17955 1643 0.9604 630 hsa-miR-383 765 0.8759 690 hsa-miR-5S1a 979 0.9638 631 miRPlus_17915 1203 0.8764 691 hsa-miR-574-5p 102 0.9644 632 m iRPlus_17909 1636 0.877 692 hsa-miR-297 338 0.9656 633 hsa-miR-550· 1195 0.8782 693 miRPlus_17877 1318 0.9679 634 miRPlus_17886 562 0.8793 694 hsa-miR-498 1034 0.9685 635 hsa-miR-502-5p 170 0.8822 695 hsa-miR-608 612 0.969 636 hsa-miR-518d-3p 920 0.8828 696 hsa-miR-146b-5p 997 0.9696 637 hsa-miR-588 1297 0.8845 697 hsa-miR-604 1476 0.9702 638 hsa-miR-152 1302 0.8851 698 miRPlus_17912 557 0.9714 
639 hsa-miR-124 425 0.8863 699 hsa-miR-33D-3p 706 0.9725 
640 hsa-miR-376b 813 0.8874 700 miRPlus_17956 178 0.9742 
641 hsa-miR-548a-3p 595 0.8903 701 hsa-miR-101 1248 0.9748 
642 miRPlus_17825 724 0.8909 702 hsa-miR-221 5 0.9777 
643 hsa-miR-663 833 0.8915 703 hsa-miR-130b 1578 0.9783 
644 hsa-miR-I0b 835 0.8927 704 miRPlus_17933 340 0.9789 
645 miRPlus_17817 1317 0.8932 705 hsa-miR-526b 1033 0.98 
646 hsa-miR-372 603 0.8938 706 miRPlus_17945 501 0.9806 
647 hsa-miR-802 588 0.8944 707 hsa-miR-648 456 0.9812 
648 let-7a-e 788 0.895 708 hsa-miR-28-5p 1030 0.9829 
649 hsa-m i R-125a-5p 120 0.8961 709 hsa-miR-378· 381 0.9835 
650 hsa-miR-597 1266 0.899 710 miRPlus_17867 939 0.9841 
651 hsa-miR-550 87 0.8996 711 hsa-miR-197 329 0.9847 
652 hsa-miR-I0a 619 0.9002 712 miRPlus_17881 831 0.9852 
653 hsa-miR-661 1265 0.9013 713 miRPlus_17816 502 0.9881 
654 hsa-miR-96 827 0.9048 714 hsa-miR-188-5p 167 0.9887 
655 m i RPlus_17832 993 0.9071 715 hsa-miR-150 12 0.9933 
656 miRPlus_17844 341 0.9089 716 hsa-miR-600 618 0.9939 
657 hsa-miR-520c-3p/520f 1514 0.9117 717 hsa-miR-l84 1031 0.9968 
658 miRPlus_17959 1373 0.9129 718 miRPlus_17810 1210 0.9974 
659 hsa-miR-24 604 0.9141 719 miRPlus_17948 287 0.998 
660 hsa-miR-371-3p 819 0.9152 720 hsa-miR-658 18 0.9991 
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